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Abstract 
In recent years, extensive research has been carried out on the health benefits of 
milk proteins and peptides. Biologically active peptides are defined as specific 
protein fragments which have a positive impact on the physiological functions of 
the body; such peptides are produced naturally in vivo, but can also be generated 
by physical and/or chemical processes, enzymatic hydrolysis and/or microbial 
fermentation. The aims of this thesis were to investigate not only the traditional 
methods used for the generation of bioactive peptides, but also novel processes 
such as heat treatment, and  the role of indigenous milk proteases, e.g., in mastitic 
milk, in the production of such peptides. In addition, colostrum was characterised 
as a source of bioactive proteins and peptides. Firstly, a comprehensive study was 
carried out on the composition and physical properties of colostrum throughout the 
early-lactation period. Marked differences in the physico-chemical properties of 
colostrum compared with milk were observed. Various fractions of colostrum were 
also tested for their effect on the secretion of pro- and anti-inflammatory cytokines 
from a macrophage cell line and bone marrow dendritic cells, as well as insulin 
secretion from a pancreatic beta cell line. A significant reduction in the secretion of 
the pro-inflammatory cytokines, TNF-α, IL-6, IL-1β and IL-12, a significant increase in 
the secretion of the anti-inflammatory cytokine, IL-10, as well as a significant 
increase in insulin secretion were observed for various colostrum fractions. Another 
study examined the early proteomic changes in the milk of 8 cows in response to 
infusion with the endotoxin lipopolysaccharide (LPS) at quarter level in a model 
mastitic system; marked differences in the protein and peptide profile of milk from 
LPS challenged cows were observed, and a pH 4.6-soluble fraction of this milk was 
found to cause a substantial induction in the secretion of IL-10 from a murine 
macrophage cell line. Heat-induced hydrolysis of sodium caseinate was investigated 
from the dual viewpoints of protein breakdown and peptide formation, and, a 
peptide fraction produced in this manner was found to cause a significant increase 
in the secretion of the anti-inflammatory cytokine, IL-10, from a murine 
macrophage cell line. The effects of sodium caseinate hydrolysed by chymosin on 
the gut-derived satiety hormone glucagon-like peptide-1 (GLP-1) were investigated; 
the resulting casein-derived peptides displayed good in vitro and in vivo secretion of 
GLP-1. Overall, the studies described in this thesis expand on current knowledge 
and provide good evidence for the use of novel methods for the isolation, 
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Milk is a fluid secreted by the female of all (approximately 4500) mammalian 
species (Darewicz et al., 2011). It is a complete source of carbohydrate, protein, fat 
and minerals, the primary function of which is to meet the complete nutritional 
requirements of the neonate, while also serving several physiological functions 
(Fox, 2009a). In addition to its principal components, milk contains several hundred 
minor constituents, e.g., vitamins, hormones, enzymes, metal ions and flavour 
compounds (Fox and McSweeney, 1998). The majority of the non-nutritional 
functions of milk are carried out by proteins and peptides, including 
immunoglobulins, enzymes and enzyme inhibitors, binding or carrier proteins, 
growth factors and antibacterial agents (Fox and McSweeney, 1998).  
Milk is an aqueous solution consisting of lactose, organic and inorganic salts and 
several compounds at trace levels (milk serum). In the milk serum, colloidal 
particles of three size ranges are dispersed: whey proteins dissolved at the 
molecular level, the caseins dispersed as large (50-500 nm) colloidal aggregates 
(micelles), and lipids emulsified as large (1-20 µm) globules (Fox, 2009a).  
The composition of milk is highly variable between species, reflecting the different 
nutritional and physiological requirements of the young, which is the result of a 
long and slow adaptive evolutionary process that started 150 million years ago 
(Zeder, 2008). In addition to interspecies differences, the composition of milk of any 
particular species varies due to a number of factors, including individuality of the 
animal, breed, health (mastitis and other diseases), nutritional status, stage of 
lactation, age and interval between milkings (Walstra et al., 2006). The milk of the 
principal dairying species, i.e., cow, goat, sheep and buffalo, and the human are 
among those that are well characterised (Jensen, 1995).  
Colostrum is the milk secreted following parturition. The duration for which milk is 
classified as colostrum varies considerably amongst authors, i.e., immediately after 
parturition (Levieux and Ollier, 1999; Nakamura et al., 2003; Godhia and Patel, 
2013), two days (Playford et al., 2000; Playford, 2001), three to four days (Foley and 
Otterby, 1978; Gopal and Gill, 2000; Davis et al., 2007; Zhang et al., 2011) or five to 
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seven days post partum (Marnila and Korhonen, 2002; Georgiev, 2008; Zarcula et 
al., 2010; Abd El-Fattah et al., 2012). As with mature milk, the composition of 
colostrum is highly variable between different species, as shown in Table 1.1. For 
the purposes of this review, colostrum, unless otherwise defined, will refer to the 
early post partum milkings from dairy cows. 
 
Table 1.1 Composition of colostrum from various species (per 100 mL) (data taken 
from Emmett and Rogers, 1997; El-Agamy, 2006; Park, 2006; Silk et al., 2006; Kehoe 
et al. 2007; Csapo et al., 2009; Pecka et al., 2012) 
 
 
The composition and physical properties of colostrum are highly variable, due to a 
number of factors, including individuality, breed, parity, prepartum ration, length of 
dry period of cows, and time post partum (Parrish et al., 1947, 1948, 1949; Moody 
et al., 1951). In general, colostrum contains less lactose and more fat, protein, 
peptides, non-protein nitrogen, ash, vitamins and minerals, hormones, growth 
factors, cytokines and nucleotides than mature milk and, except for lactose, the 
levels of these compounds rapidly decrease during the first 3 days of lactation 
(Campana and Baumrucker, 1995; Blum and Hammon, 2000a,b; Uruakpa et al., 
2002). Colostrum is best characterised by its very high concentration of 
immunoglobulin G (IgG), in particular from the IgG1 subclass (Butler, 1981). This is of 
Nutrient Bovine Human Camel Yak Mare Sow
Total solids (g) 27.6 11.8 25.1 33 19.3 20.5
Protein (g) 14.9 2 17.8 16.1 15.2 10.6
Fat (g) 6.7 2.6 0.45 14 1.7 5.8
Lactose (g) 2.5 6.6 4.3 1.9 2.5 3.4
Ash (g) 0.05 na 2.6 1 0.59 0.7
Calcium (mg) 472 28 156 na 74.8 na
Phosphorus (mg) 445 14 255 na 74.2 na
Sodium (mg) 106 47 na na 32 na
Potassium (mg) 285 70 na na 92.8 na
Iron (Fe) 0.53 0.07 na na 0.1 na
Magnesium (mg) 73.3 3 45 na 14 na
Zinc (mg) 3.8 0.6 na na 0.3 na
na = information not available
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particular importance to the neonate, whose gut, immediately following 
parturition, allows the passage of large immunoglobulins, thereby conferring 
passive immunity (Marnila and Korhonen, 2002; Tsioulpas et al., 2007; Stelwagen et 
al., 2009). It is essential that the newborn calf receives an adequate supply of 
colostrum as both the concentration of immunoglobulins and permeability of the 
gut decrease rapidly over the first 48 h following parturition (Bush and Staley, 1980; 
Moore et al., 2005). Additionally, colostrum intake influences metabolism, 
endocrine systems and the nutritional state of neonatal calves (Guilloteau et al., 
1997; Blum and Hammon, 2000a,b) and stimulates the development and function 
of the gastrointestinal tract (Hadorn et al., 1997; Guilloteau et al., 1997; Buhler et 
al., 1998; Blum and Hammon, 2000a,b). 
Colostrum accounts for approximately 0.5% of a cow’s annual milk output 
(Scammell, 2001). Most healthy dairy cows produce colostrum far in excess of the 
calf’s nutritional requirements (Muller et al., 1975; Rindsig, 1976; Oyeniyi and 
Hunter, 1978). In the past, milk collected during the colostrum period was 
considered unmarketable (Foley and Otterby, 1978) and was excluded from bulk 
milk collection (Marnila and Korhonen, 2002). The high protein content of 
colostrum leads to multiple problems in industrial processes, e.g., poor heat 
stability and subsequent low clotting temperature interferes with pasteurisation 
(Marnila and Korhonen, 2002; McMartin et al., 2006). Also, the high content of 
antimicrobial components in colostrum may affect the fermentation process 
(Marnila and Korhonen, 2002).  Despite this, colostrum has attracted considerable 
interest as a functional food ingredient (Korhonen, 1998). Colostrum preparations 
are currently available in the US and Europe as health food supplements. These 
products contain large amounts of potent growth factors and have been shown to 
influence cell growth and migration in vitro and prevent gastric and small intestinal 
injury induced by the non-steroidal anti-inflammatory drug (NSAID) indomethacin 
in vivo (Playford et al., 1993, 1999; Chinery and Playford, 1995). Colostrum has also 
been used for treatment of other ulcerative conditions of the bowel (Simmen et al., 
1990; Playford et al., 1999). The high concentrations of growth factors in colostrum, 
namely transforming growth factors alpha and beta (TGF-α and β), have been linked 
5 
 
with muscle and cartilage repair and promotion of wound healing (Tollefsen et al., 
1989; Wilson, 1997). Several authors have shown that TGF-β has a suppressive 
effect on the cytotoxic activity of monocytes (Ho and Lawton, 1978; Kohl et al., 
1980). Several studies have correlated the effectiveness of a colostrum supplement 
(IntactTM) (Whyte, 1994) with improved athletic performance (Buckley et al., 1998, 
1999, 2000, 2002; Smeets, et al., 2001; Kreider et al., 2001a,b). In general, these 
trials have shown improved rates of recovery from exhaustive exercise, improved 
muscle power and performance, and increased body mass. Hofman et al. (2002) 
and Brinkworth et al. (2002) reported an improvement in athletic performance in 
elite hockey players and elite female rowers, respectively, with colostrum 
supplementation. Several authors have reported the benefit of colostrum for the 
treatment of chronic diarrhoea among persons with immune deficiency syndromes. 
In general, supplementation resulted in improved stool volume and decreased 
frequency of diarrhoea (Stephan et al., 1990; Rump et al., 1992; Kelly, 2003).  
Boosting the natural concentrations of immune components in colostrum through 
vaccination of cows with appropriate antigens offers great potential for their use as 
prophylactic or therapeutic products in humans (Stelwagen et al., 2009). Several 
commercial immune milk products are available on the market which target a 
variety of conditions (Pakkanen and Aalto, 1997), e.g., Gastrogard (Northfield 
Laboratories, Oakden, Australia) helps prevent diarrhoea caused by rotavirus in 
young children (Davidson et al., 1989, 1994), Pro-Immune 99 (GalaGen Inc., 
Minnesota, USA) helps prevent scours caused by E. coli in young calves, 
Lactimmunoglobulin Biotest (Biotest Pharm GmbH, Frankfurt, Germany) is used in 
the treatment of severe diarrhea in AIDS patients (Stephan et al., 1990), Bioenervi 
(Viable Bioproducts Ltd., Turku, Finland) provides growth and antimicrobial factors 
during strenuous physical activity (Mero, 1995). Hyperimmune colostrum has 
shown some degree of efficacy in either prophylaxis or treatment against 
Cryptosporidia (Tzipori et al., 1987; Ungar et al., 1990), Helicobacter pylori (Tarpila 
et al., 1995; Oona et al., 1997), rotavirus (Mach and Pahud, 1971; Mitra et al., 
1995), Clostridium difficile (Van Dissel et al., 2005; Numan et al., 2007; Young et al., 
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2007), Escherichia coli (Tawfeek et al., 2003) and Shigella (Tacket et al., 1992; 
Ashraf et al., 2001).  
Foley and Otterby (1978) reviewed the literature on the composition of colostrum, 
but, to the best of the authors’ knowledge, no comprehensive review on the 
composition of colostrum has been published since. Changes in the composition 
and physical properties of milk throughout lactation have been studied extensively 
(White and Davies, 1958a,b,c; Cerbulis and Farrell, 1976; Donnelly and Horne, 1986; 
Horne et al., 1986; Rodriguez et al., 2001), however, little is known about the 
composition and stability of colostrum. The objectives of this review are to discuss 
comprehensively the composition and physico-chemical properties of colostrum.  
 
1.2 Chemical constituents 
1.2.1 Carbohydrate 
1.2.1.1 Lactose 
Lactose, β-D-galactopyranosyl-(1-4)-D-glucose, is the principal carbohydrate in milk. 
It is a reducing disaccharide, composed of galactose and glucose linked through a β 
1-4 glycosidic linkage (Walstra et al., 2006). Lactose synthesis, which occurs in 
mammary epithelial cells, is catalysed by the enzyme lactose synthase, which 
consists of the membrane-bound enzyme β1,4-galactotransferase and the 
regulatory protein α-lactalbumin (Meser and Tadasu, 2002). The lactose content of 
bovine milk ranges from 4.4 to 5.2%, averaging at 4.8% anhydrous lactose (Ganzle 
et al., 2008). Several factors influence the lactose content of milk, i.e., breed of 
cow, individuality factors, udder infection and, in particular, the stage of lactation 
(Fox and McSweeney, 1998). The concentration of lactose in milk is higher at the 
beginning of lactation but then decreases to about 70% of its maximum towards 
the end of lactation (Fox, 2009b). The concentration of lactose is reduced in 
colostrum and behaves inversely to other constituents such as solids, protein and 
ash (Parrish et al., 1950; Kehoe et al., 2007). A low level of lactose in early post 
partum milkings, followed by a steady increase thereafter, until normal levels are 
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reached, has been reported by several authors (Parrish et al., 1948, 1950; Kilmes et 
al., 1986; Madsen et al., 2004; Georgiev, 2005; Kehoe et al., 2007; Tsioulpas et al., 
2007; Georgiev, 2008; Abd El-Fatah et al., 2012; Morill et al., 2012). Lactose 
concentrations as low as 1.2% have been reported in colostrum (Kehoe et al., 2007; 
Morrill et al., 2012). In general, lactose concentration reaches normal 
concentrations within 7 days post partum; however, Tsioulpas et al. (2007) 
reported that the lactose content of milk did not reach normal levels until 60 days 
post partum; however, no samples were taken between 30 and 60 days post 
partum. 
Lactose is responsible for about 50% of the osmotic pressure of milk (Fox, 2009b); 
its production causes the movement of water from the cytoplasm of mammary 
epithelial cells into the secretory vesicles and subsequently into milk (Kuhn et al., 
1980). This influx of water into milk through osmotic effects regulates the volume 
of milk produced and the concentration of casein in milk (Jenness and Holt, 1987). A 
low level of lactose results in the production of milk that is extremely viscous and 
contains little water due to the absence of the osmoregulator lactose (Bleck et al., 
2009). In the study of Madsen et al. (2004), the density of the first post partum 
milking was found to be 1.048 g/mL, which is significantly higher than the average 
density of milk (1.029 g/mL), as reported by Walstra et al. (2006). This value 
decreased over the first six milkings until a normal level was reached, while in 
parallel the lactose concentration increased from 2.6% to 4.4% (Madsen et al., 
2004). Similarly, Strekozov et al. (2008) reported the density of first post partum 
milkings from 62 cows ranged from 1.054 g/mL to 1.072 g/mL. Czister (2003) 
reported that low level of lactose in colostrum helps to ensure a high viscosity, 
which may play a role in prevention of diarrhoea in the calf. In order to maintain 
osmotic pressure, milk with a low level of lactose has an elevated level of inorganic 






1.2.1.2 Oligosaccharides  
In addition to lactose, milk contains trace amounts of other sugars, including 
glucose, fructose, glucosamine, galactosamine, neuraminic acid and 
oligosaccharides (Fox and McSweeney, 1998). Oligosaccharides are defined as 
carbohydrates that contain 3 to 10 monosaccharides covalently linked through 
glycosidic bonds (Mehra and Kelly, 2006). Oligosaccharides are divided into two 
broad classes, i.e., neutral and acidic. Neutral oligosaccharides, or galacto-
oligosaccharides (GOS), contain no charged carbohydrate residues, whereas, acidic 
oligosaccharides contain one or more negatively charged residues of N-
acetylneuraminic acid (sialic acid) (Gopal and Gill, 2000). The concentration of 
oligosaccharides in colostrum is approximately 0.7 to 1.2 g/L (Veh et al., 1981; 
Nakamura et al., 2003), the majority of which are acidic, whereas mature milk 
contains only trace amounts (Gopal and Gill, 2000). To date, 40 oligosaccharides 
have been identified in bovine colostrum (Tao et al., 2008, 2009; Barile et al., 2010). 
The total number of oligosaccharides in colostrum varies between individual cows 
due to unique genetic variability (Ninonuevo et al., 2006). In one study, the total 
number of oligosaccharides in colostrum from individual cows ranged between 14 
and 32 (Barile et al., 2010). 3’Sialylactose (3’SL), 6’sialylactose (6’SL), 
6’sialylactosamine (6’SLN), and disialyllactose (DSL) are the predominant 
oligosaccharides in colostrum, with 3’SL accounting for 70% of the total 
oligosaccharide content (Martin-Sosa et al., 2003; Nakamura et al., 2003; McJarrow 
and van Amelsfort-Schoonbeek, 2004; Tao et al., 2009; Urashima et al., 2009). 
Nakamura et al. (2003) reported that levels of 3’SL, 6’SL and 6’SLN in colostrum 
were highest immediately following parturition and decreased rapidly by 48 h post 
partum, whereas neutral oligosaccharides increased. McJarrow and van Amelsfort-
Schoonbeek (2004) found the concentrations of 3’SL, 6’SL, 6’SLN and DSL to be 681, 
243, 239 and 201 mg/L, respectively, in Holstein colostrum and 867, 136, 220 and 






Bovine milk contains about 3.5% protein but the level varies considerably during 
lactation (Fox and McSweeney, 1998). Proteins in bovine milk can be divided into 
two groups based on their solubility at pH 4.6. Caseins are insoluble at pH 4.6 and 
represent approximately 80% of milk protein, whereas whey proteins are soluble at 
pH 4.6 and account for the remaining 20% of milk protein. Caseins are synthesised 
exclusively in the mammary gland; some whey proteins (e.g., β-lactoglobulin, α-
lactalbumin and lactoferrin) are also synthesised in the mammary gland while 
others (e.g., serum albumin and immunoglobulins) are derived from the blood. 
Both the caseins and whey proteins are heterogeneous groups of proteins. There 
are four caseins, i.e., αS1-, αS2-, β- and к-casein, which are present in the relative 
proportions 37:10:35:12, respectively. The whey proteins are a much more 
heterogeneous group, consisting primarily of β-lactoglobulin, α-lactalbumin, serum 
albumin, immunoglobulins, lactoferrin and the proteose-peptone fractions (Farrell 
et al., 2004); however, bovine whey contains more than 200 different proteins, the 
majority of which are present at trace amounts (Golinelli et al., 2011). 
Few reports exist in the literature on changes in the properties of the caseins in 
milk from the colostrum period to early lactation. The concentration of casein is 
higher in colostrum than in milk (Crowther and Raistrick, 1916; Cerbulis and Farrell, 
1975). Parrish et al. (1948) reported that the concentration of casein decreased 
from 6.4% to 2.8% over the course of the first 16 post partum milkings. Madsen et 
al. (2004) reported a similar trend, but, the concentration of casein in the first post 
partum milking was 9.24%, i.e., significantly higher than the value reported by 
Parrish et al. (1948). Sobscuz-Szul et al. (2013), who investigated changes in the 
relative proportions of the individual caseins in colostrum, found that early post 
partum milkings contained reduced proportions of αs-casein, which increased with 
time post partum, and elevated proportions of к-casein, which decreased with time 
post partum, while the proportion of β-casein remained constant throughout. A 
negative correlation between к-casein and αs-casein was also observed by 
Wielgosz-Groth, (2004). Glycomacropeptide (GMP) is a hydrophilic glycopeptide 
(f106-169) which is released from the C-terminal region of κ-casein by the action of 
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chymosin (Korhonen, 2012) and comprises 15-20% of cheese whey proteins (Saito 
et al., 2001).  Furlanetti and Prata (2003) reported that the level of free-GMP in milk 
is highest during the colostral period and decreases rapidly following parturition.  
 
Table 1.2 Concentration of major whey proteins in mature milk and colostrum (data 
taken from Marnila and Korhonen, 2002; Pihlanto and Korhonen, 2003) 
 
 
The immunoglobulins, of which there are three major classes in milk, i.e., IgG, IgM 
and IgA, account for about 1% of the total milk protein or about 6% of the total 
whey protein (Farrell et al., 2004). Factors which affect the Ig concentrations in milk 
include breed, age of the cow, lactation number and volume of the first post 
partum milking (Oyeniyi and Hunter, 1978; Muller and Ellinger, 1981; Pritchett et 
al., 1991; Mechor et al., 1992; Vacher and Blum, 1993; McFadden et al., 1997). 
Colostrum has a distinct protein composition that differs substantially from that of 
milk and contains elevated levels of IgG, IgA and IgM (Smolenski et al., 2007). 
Immunoglobulins make up 70-80% of the total protein in colostrum (Larson, 1992), 
which is of particular importance to the neonate, as transfer of passive immunity to 
the calf occurs through colostrum and not via the placenta (Zhang et al., 2011). 
Changes in the level and relative proportions of the Igs in colostrum compared with 















1999; Korhonen et al., 2000; Elfstrand et al., 2002; Zhao et al., 2010). The 
concentration of Igs in the first post partum milking can vary considerably, from 30 
to 200 mg/mL (Hancock, 1985; Larson, 1992; Korhonen et al., 1995; Gapper et al., 
2007). IgG1 comprises over 75% (46.4 mg/mL) of the Igs in colostral whey, followed 
by IgM (6.8 mg/mL), IgA (5.4 mg/mL) and IgG2 (2.9 mg/mL) (Butler, 1974). The 
concentration of Igs in milk declines rapidly following parturition to around 0.7-1.0 
mg/mL (Korhonen et al., 2000). In blood serum, both IgG subclasses are present at 
roughly equal concentrations (Korhonen et al., 2000). The preferential occurrence 
of IgG1 in milk and colostrum suggests a subclass-specific transport mechanism 
(Butler et al., 1972; Morgan et al., 1981), however, the precise mechanism remains 
unclear. One possible explanation is that a significant proportion of IgG2 taken up 
by mammary epithelial cells from blood serum during colostrum formation does 
not pass on to the alveolar lumen (Hurley and Thiel, 2011). 
The concentrations of β-lg and α-la are higher in colostrum than in mature milk (see 
Marnila and Korhonen, 2002; Georgiev, 2008). Marnila and Korhonen (2002) 
reported that the initial concentration of β-lg in colostrum ranges from 7.9 to 30 
g/L, the average being 14 g/L in the first milking and falling sharply thereafter to 8 
g/L in the second to fourth milkings. The decrease is more gradual until the 
sixteenth milking, when the average is 5 g/L. These results are in agreement with 
those reported by Levieux and Ollier (1999) and Sobczuk-Szul et al. (2013). Marnila 
and Korhonen (2002) reported that the level of α-la in colostrum decreases more 
gradually from 2 g/L in the first milking to 1.4 g/L in the sixteenth milking, which 
was as reported by Levieux and Ollier (1999). However, the results mentioned 
above differ substantially from those reported by Sobczuk-Szul et al. (2013), who 
observed that the initial concentration of α-la in colostrum from Jersey and Polish 
Holstein-Friesian cows was 13.82 and 7.91 g/L, respectively. The concentration ratio 
of β-lg:α-la is four times greater in colostrum than in mature milk, suggesting that 
β-lg may play a specific role during the early post partum period (Perez et al., 1990). 
Serum albumin represents about 1.5% of the total protein in mature milk and about 
8% of total whey protein (Farrell et al., 2004). The concentration of serum albumin 
in colostrum is higher than in milk (Zhang et al., 2011). Perez et al. (1989) reported 
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that the first milking post partum contains 2.63 mg/mL albumin. This value 
decreases substantially within 24 h and reaches normal levels by the second week 
post partum (0.2 mg/mL). A similar trend was observed by Levieux and Ollier 
(1999), but the initial concentration of serum albumin was slightly lower (1.2 
mg/mL) than that reported by Perez et al. (1989). The increased concentration of 
serum albumin in colostrum is a result of increased leakage from the circulating 
blood (Zhang et al., 2011), which may play a role in the transport of small 
molecules, i.e., free fatty acids released from adipocytes (Evans, 2002). 
Lactoferrin is a cationic iron-binding glycoprotein that is of mammary origin (Farrell 
et al., 2004) which, in milk, plays a key role in the defense of the mammary gland 
(Cheng et al., 2008). The concentration of lactoferrin in milk is significantly 
associated with somatic cell count (SCC), levels of serum albumin, stage of lactation, 
and milk production (Harmon et al., 1975), and ranges from 0.02 to 0.75 mg/mL 
(Hahn et al., 1998; Fox and Kelly, 2003; Turner et al., 2003; Chen and Mao, 2004). 
Several authors have reported an increased concentration of lactoferrin in 
colostrum (Pakkanen and Aalto, 1997; Hahn et al., 1998; Zhang et al., 2002, 2011; 
Sobczuk-Szul et al., 2013). Reiter (1978) reported that the concentration of 
lactoferrin in colostrum is 30-fold higher than that in milk, while Indyk and Filonzi 
(2005) observed a 100-fold higher concentration of lactoferrin in colostrum (5 
mg/mL) than in milk (0.05 mg/mL). Typically, the concentration of lactoferrin in 
colostrum ranges from 1.5 to 5 mg/mL (Korhonen, 1977; Tsuji et al., 1990; Hahn et 
al., 1998). 
There are few reports in the literature on the occurrence of minor proteins in 
colostrum. This is because detection and identification of minor proteins is difficult 
due to the high concentration of the principal proteins, which reduce detection 
sensitivity of mass spectrometry. Yamada et al. (2002) used immunoabsorption to 
remove major proteins (β-casein and IgG) from colostrum and milk prior to 2D-
PAGE, which enabled the detection of several otherwise undetectable minor milk 
proteins. In the same study, a total of 29 minor proteins were identified in 
colostrum and milk, of which several were only observed in colostrum, i.e., 
fibrinogen β-chain, chitinase 3-like 1, α-antitrypsin, complement C3 α-chain, 
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gelsolin and apolipoprotein H. Smolenski et al. (2007), using a combination of liquid 
chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) and two-
dimensional gel electrophoresis (2-DE) followed by matrix-assisted laser 
desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF/MS), and 
D’Amato et al. (2009), using combinatorial peptide ligand libraries, identified 53 and 
149 minor proteins in whey from colostrum or milk, respectively, some of which 
were identified only in colostrum. Using ion-exchange chromatography, Le et al. 
(2011) identified a total of 293 whey proteins in colostrum and milk, of which 36 
were identified exclusively in colostrum. Nissen et al. (2012) identified 403 minor 
proteins in colostrum using 2D-LC-MS/MS, which, to the best of the authors’ 
knowledge, is the most comprehensive characterisation of whey proteins in 
colostrum to date. It is interesting to note that, in a follow-on study, Nissen et al. 
(2013), also using 2D-LC-MS/MS, identified a total of 742 minor proteins in milk, 
however; 366 of these proteins were identified only in one replicate and are 
therefore regarded as tentative results. 
To date, over 120 proteins have been identified in the milk fat globule membrane 
(MFGM) (Reinhardt and Lippolis, 2006; Affolter et al., 2010). The major MFGM 
proteins are butyrophilin (BTN), adipophilin (ADPH), periodic acid Schiff 6/7 (PAS 
6/7, also known as lactadherin) and xanthine dehydrogenase/oxidase (XDH/XO) 
(Fong et al., 2007). Minor proteins include polymeric immunoglobulin receptor 
protein, apolipoprotein E (APOE), apolipoprotein A1 (APOA1), 71 kDa heat-shock 
cognate protein, clusterin, lactoperoxidase, immunoglobulin heavy chain, 
peptidylprolyl isomerase A, actin, fatty acid-binding protein (FABP), cluster of 
differentiation 36 (CD36) and mucin (MUC) (Dewettinck et al., 2008). Reinhardt and 
Lipollis (2008) studied changes in the MFGM proteome during the transition from 
colostrum to milk. MUC, BTN, FABP, XDH were upregulated 2.6- to 7.7-fold in 
MFGM from milk compared with colostrum MFGM. APOA1, APOE and clusterin 
were downregulated 2.6- to 3.6-fold in MFGM milk compared with colostrum 
MFGM while no changes in the concentrations of polymeric immunoglobulin 
receptor, peptidylprolyl isomerase A, 71 kDa heat-shock cognate protein, CD 36, 
actin and lactadherin were noted. 
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1.2.3 Growth Factors 
Growth factors may be defined as proteins or polypeptides which bind to receptors 
on cell surfaces, resulting in cellular proliferation and/or differentiation (Gauthier et 
al., 2006). The main growth factors present in milk and colostrum are epidermal 
growth factor (EGF) (Yagi et al., 1986; Iacopetta et al., 1992), betacellulin (BTC) 
(Dunbarr et al., 1999; Bastian et al., 2001), insulin-like growth factor I (IGF-I) 
(Malven et al., 1987; Collier et al., 1991), IGF-II (Vega et al., 1991; Schams, 1994), 
transforming growth factor-β1 (TGF-β1) (Jin et al., 1991; Ginjala and Pakkanen, 
1998), TGF-β2 (Cox and Burk, 1991; Jin et al., 1991), fibroblast growth factor 1 and 2 
(FGF1 and FGF2) (Kirihara and Ohishi, 1995; Rogers et al., 1995; Hironaka et al., 
1997), and platelet-derived growth factor (PGDF) (Belford et al., 1997). The 
concentration of growth factors in colostrum and milk are highly variable according 
to the stage of lactation and also the method used for quantification; however, in 
general, the concentration of growth factors in colostrum is highest during the 
initial hours post partum and declines significantly in a time-dependant manner 
(Collier et al., 1991; Kishikawa et al., 1996; Ginjala et al., 1998; Bastian et al., 2001). 
The most abundant growth factors in colostrum are IGF-1 and IGF-II (Marnila and 
Korhonen, 2002). Pakkanen and Aalto (1997) reported that the concentration of 
IGF-I and IGF-II in colostrum ranges from 50-2000 µg/L and 200-600 µg/L, 
respectively, whereas milk contains < 10 µg/L of each. Yagi et al. (1986) found the 
concentration of EGF in colostrum and milk to be 324 µg/L and 155 µg/L, 
respectively; however, the study of Iacopetta et al. (1992) reported concentrations 
of EGF in colostrum and milk to be 4-8 µg/L and < 2 µg/L, respectively. The 
concentration of TGF-β1 in colostrum ranges from 12 to 43 µg/L, compared with 0.8 
to 3.5 µg/L in milk (Ginjala and Pakkanen, 1998). Similarly, the concentration of 
TGF-β2 is higher in colostrum than in milk, i.e., 150-1150 µg/L and 13-71 µg/L, 







Approximately 70 indigenous enzymes have been reported in milk (Fox et al., 2003), 
most of which have no obvious physiological role in the biosynthesis or secretion of 
milk. There are four principal sources of enzymes in milk, i.e., blood plasma, 
secretory cell cytoplasm, milk fat globule membrane (MFGM) and somatic cells (Fox 
and Kelly, 2006 a,b). In general, the enzyme content of colostrum is higher than in 
milk (Shahani et al., 1973). 
 
1.2.4.1 Antioxidants 
Lactoperoxidase (LPO) is a member of the peroxidase family whose primary 
function, in the presence of hydrogen peroxide, is to catalyse the oxidation of 
thiocyanates, leading to the generation of intermediate compounds with a wide 
range of antimicrobial activities (Fox and Kelly, 2006a). Following xanthine 
oxidoreductase (XOR), LPO is the most abundant enzyme in milk (Kussendrager and 
van Hooijdonk, 2000). It accounts for about 0.5% of the whey proteins and is 
present at approximately 30 mg/L in milk (de Wit and van Hooydonk, 1996). Hahn 
et al. (1998) reported that the concentration of LPO in milk ranges from 11 to 45 
mg/L, while colostrum contains 13 to 30 mg/L. Korhonen (1977) observed that the 
concentration of LPO in colostrum is low initially but increases rapidly to reach a 
maximum after 3-5 days post partum, followed by a slow decrease until a plateau is 
reached after about 2 weeks. 
Catalase is a haemoprotein which catalyses the decomposition of hydrogen 
peroxide; its activity is higher in colostrum than in milk, and decreases during 
lactation (Farkye, 2002). 
Superoxide dismutase (SOD) scavenges superoxide radicals and is present in milk at 
levels similar, albeit lower, than XOR (Fox and Kelly, 2006b). The concentration of 
SOD in milk ranges from 0.15 to 2.5 mg/L (Farkye, 2002), but is not affected by the 




Plasmin, a serine protease derived from the proenzyme, plasminogen (Bastian and 
Brown, 1996), is the principal indigenous proteinase in milk (Fox and Kelly, 2006 
a,b). Dupont et al. (1998) reported that the concentration of plasmin in colostrum is 
about 10 times higher than in milk, i.e., 0.49 µg/mL and 0.04 µg/mL, respectively. 
Madsen et al. (2004) observed a 2-fold increase in plasmin activity in colostrum 
compared with milk. Similarly, Pyorala and Kaartinen (1988) found a decrease in 
plasmin activity during the transition from colostrum to milk.  
Cathepsin D is a lysosomal proteinase and, as with plasmin, it is part of a complex 
system including inactive precursors (Hurley et al., 2000). Larsen et al. (2006) 
reported that cathepsin D activity is significantly lower in colostrum than in milk. 
Other proteinases which have been identified in bovine milk include cathepsins B, L 
and G, and elastase (Kelly and McSweeney, 2003), but, to best of the authors’ 
knowledge, these enzymes have not been studied in colostrum. 
 
1.2.4.3 Lipases and esterases 
Lipoprotein lipase (LPL) is the principal indigenous lipase in milk (Olivecrona et al., 
1992). Mammary LPL activity increases markedly prior to parturition and remains 
high throughout lactation (Shirley et al., 1973; Liesman et al., 1988). Saito and Kim 
(1995) observed that LPL activity in colostrum is low initially but increases rapidly 
during the first few days of lactation and, thereafter, remains constant for the 
remainder of lactation. Andersen (1982) reported that LPL activity in the serum 
phase of colostrum fell from 45% to 34% during the first 24 h following parturition, 
but, these figures are not representative of total LPL activity in milk as, in milk, 
more than 90% of LPL is associated with the casein micelles (Fox and McSweeney, 
1998). 
In addition to the lipase system, milk contains several other carboxyl ester 
hydrolases, collectively referred to as esterases (Deeth and Fitz-Gerald, 2006). 
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Compared with LPL activity, the total esterase activity in milk is quite low, about ten 
percent (Downey, 1974). Forster et al. (1959) and Marquardt and Forster (1965) 
reported that the concentration of arylesterase in colostrum is higher than in milk. 
Similarly, the level of carboxylesterase activity is higher in colostrum than in milk 
(Fitz-Gerald et al., 1981).  
 
1.2.4.4 Others 
Milk contains several phosphatases, the principal ones being alkaline phosphatase 
and acid phosphatase (Fox and Kelly, 2006b). The concentration of alkaline 
phosphatase is very high in colostrum and decreases to a minimum within 1-2 
weeks of parturition before reaching a constant level after approximately 25 weeks 
(Schlimme and Thiemann, 1992; Shakeel ur-Rehman and Farkye, 2002; Fox and 
Kelly, 2006b). The activity of acid phosphatase in milk is much lower (about 2%) 
than that of alkaline phosphatase and ranges from 2.6 x 10-4 to 2.6 x 10-3 IU/mL 
(Shakeel ur-Rehman and Farkye, 2002). The concentration of acid phosphatase is 
low in colostrum initially, increases to reach a maximum over 5-6 days post partum, 
and then decreases and remains low until the end of lactation (Shakeel ur-Rehman 
and Farkye, 2002). 
Ribonucleases catalyses the cleavage of RNA into smaller components. 
Ribonuclease A, B, C, D and II-1 have all been detected in milk (Bingham and Kalan, 
1967; Bingham and Zittle, 1964). Meyer et al. (1987) reported that colostrum 
contains 10 to 15 times more ribonuclease II-1 than milk and three times more total 
ribonuclease activity. Roman et al. (1990) reported that the concentration of 
ribonuclease in colostrum is highest in the third milking post partum (63 mg/L), 
followed by an abrupt decrease in concentration until  normal levels were reached 
1 month after parturition (14 mg/L).  
Lysozyme is a lysosomal enzyme which catalyses the cleavage of β1,4-linkages 
between muramic acid and N-acetylglucosamine in bacterial cell walls (Fox and 
McSweeney, 1998). Generally, lysozyme activity is higher in colostrum than in milk 
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(Goudswaard et al., 1978; Farkye, 2002). The concentrations of lysozyme in 
colostrum and milk are about 0.14-0.7 and 0.07-0.6 mg/L, respectively (Korhonen, 
1977). 
γ-Glutamyl transferase (γ-GT) is an enzyme that is localised on the outer surface of 
the alveolar cell membrane which catalyses the transport of free amino acids across 
the membrane into the cell (Baumrucker and Pocius, 1978). Hadorn et al. (1997) 
and Ontsouka et al. (2003) reported that the activity of γ-GT is much higher in 
colostrum than in milk. Vacher and Blum (1993) reported 2.5-3 fold higher γ-GT 
activity in colostrum than in milk. 
 
1.2.5 Enzyme inhibitors 
Colostrum and milk contain a number of enzyme inhibitors, the concentration of 
which are highest initially and decrease rapidly with time post partum (Georgiev, 
2008). It is thought that these inhibitors play an important role in the mechanism of 
absorption of immune components by the calf, i.e., protecting Igs from proteolytic 
cleavage and allowing absorption of the intact molecule (Carlson et al., 1980). 
Several authors have reported the presence of trypsin inhibitors in colostrum 
(Laskowski and Laskowski, 1951; Cehova et al., 1971; Pineiro et al., 1978), the 
concentration of which is nearly 100 times greater than in milk (Sandholm and 
Honkanen-Buzalski, 1979; Honkanen-Buzalski, 1981). Quigley et al. (1995) found 
that colostrum contains approximately 560 mg trypsin inhibitor/L and reported a 
positive correlation with IgG, which is in agreement with the study of Pineiro et al. 
(1978).  
Cysteine protease inhibitors form a cystatin superfamily consisting of three 
subfamilies, i.e., family I (the stefins), family II (the cystatins) and family III (the 
kininogens) (Saitoh and Isemura, 1993). Hirado et al. (1984, 1985) reported the 
presence of two types of cysteine protease inhibitors in colostrum, belonging to the 
kininogen and cystatin subfamilies, which have been isolated and well 
characterised. Kirihara et al. (1995) purified a third type of cysteine protease 
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inhibitor from colostrum; however, information relating to its taxonomy was not 
available.  
α2-Macroglobulin is a large plasma glycoprotein (718 kDa) with broad-spectrum 
proteinase inhibitory activity (Barret et al., 1973). The concentration of α2-
macroglobulin in colostrum is higher than that in milk (Honkanen-Buzalski and 
Sandholm, 1981). Perez et al. (1989) reported that the first milking post partum 
contained the highest concentration of α2-macroglobulin (386.7 µg/mL), which 
decreases very rapidly until a plateau is reached during the second week post 
partum (4.5 µg/mL).  
Christensen et al. (1995) reported the presence of seven plasma-derived protease 
inhibitors in colostrum, i.e., α2-macroglobulin, α2-antiplasmin, antithrombin III, C1-
inhibitor, inter-α-trypsin inhibitor, bovine plasma elastase inhibitor and bovine 
plasma trypsin inhibitor. The concentration of these inhibitors was highest in 
colostrum initially and decreased dramatically during the first 3 days post partum, 
at which point stable levels were reached, e.g., the concentration of bovine plasma 
trypsin inhibitor and bovine plasma elastase inhibitor is approximately 200 mg/L in 
colostrum compared with 5-10 mg/L in milk (Christensen et al., 1995).  
 
1.2.6 Nucleotides and nucleosides 
Nucleotides and nucleosides belong to the non-protein-nitrogen (NPN) fraction of 
milk and are present in the sub-milligram range per litre (Schlimme et al., 2000). 
These compounds have important roles in biochemical synthesis, i.e., nucleic acid 
synthesis, enhancement of immune response (Carver et al., 1991; Schaller et al., 
2004), influence metabolism of fatty acids, contribute to iron absorption in the gut 
and improve gastrointestinal tract repair after damage (Carver and Walker, 1995; 
Sanchez-Pozo and Gil, 2002). 
Nucleotides are O-phosphoric acid esters of nucleosides (Schlimme et al., 2002). 
The concentration of nucleotides in colostrum is higher than in milk (Schlimme et 
al., 2002). Initially, the concentration of nucleotides in colostrum is very low, but 
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reaches a maximum 24-48 h after parturition, followed by a gradual decrease as 
lactation continues, up until the third week when levels stabilise (Gil and Sanchez-
Medina, 1981a,b; Sugawara, 1995; Gil and Indyk, 2007a). This pattern is seen for 
nucleoside-5’-monophosphates; 5’-AMP, 5’CMP and 5’UMP, as well as nucleoside-
5’-, di- and tri-phosphates, UDP galactose and UDP glucose (Gil and Sanchez-
Medina, 1981). Generally, the concentration of nucleotides in milk is about one or 
two orders of magnitude higher than the concentration of nucelosides (Gil and 
Sanchez-Medina 1981a; Raezke and Schlimme, 1990; Schlimme et al., 1991).  
Nucleosides are N-glycosides of pyrimidines and purines (Schlimme et al., 2002). 
The concentration of nucleosides is higher in colostrum than in milk; however, 
unlike nucleotides, no distinct maximum is observed during the first two days after 
parturition (Raezke and Schlimme, 1990; Schlimme et al., 1991). The nucleoside 
concentration decreases during the colostral phase and reaches a constant level 
approximately three weeks post partum (Schlimme et al., 2000). The levels of 
pyrimidine nucleosides in milk are higher than for purine nucleosides. The 
concentration of uridine is relatively high in early colostrum but decreases by 
approximately two orders of magnitude during the first few hours post partum, 
whereas the concentration of cytidine reaches a maximum on the second day of 
lactation (Gil and Indyk, 2007b). 
 
1.2.7 Cytokines 
Cytokines are a diverse group of proteins, peptides or glycoproteins which have 
profound biological effects at minute concentrations (10 to 1000 pg/mL) (Gauthier 
et al., 2006). These molecules are principally responsible for modulating the 
immune system (Biswas et al., 2007) and include the interleukins (IL) series, tumour 
necrosis factors (TNF) and interferons (INF). Sacerdote et al. (2013) reported the 
presence of a wide range of cytokines in colostrum, i.e., IL-1β, IL-2, IL-4, IL-6, IL-8, IL-
9, IL-10, IL-12, IL-15, IL-17, IFN-γ and TNF; however, the equivalent concentrations 
in milk were not measured. Hagiwara et al. (2000) reported that the concentrations 
of IL-1β, IL-6, TNF-α, INF-γ and IL-1ra are significantly higher in colostrum than in 
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milk, i.e., mean concentrations of 844, 77, 927, 261 and 5206 ng/mL in the first 
milking post partum, respectively, and 3.4, 0.22, 4.58, 0 and 26 ng/mL in milk, 
respectively. These results are in agreement with the study of Sobczuk-Szul et al. 
(2013), who observed increased levels of IL-1β, IL-6 and TNF-α in colostrum 
compared with milk. Similarly, Goto et al. (1997) reported increased concentrations 
of IL-1β in colostrum compared with milk. 
 
1.2.8 Lipids 
The lipids in milk are present in microscopic globules as an oil-in-water emulsion. 
Both the fat content of milk and its fatty acid composition vary considerably 
depending on factors such as individuality of the animal, diet and stage of lactation, 
e.g., the fat content can vary from 3.0 to 6.0% but typically is in the range 3.5 to 
4.7% (MacGibbon and Taylor, 2006). Triacylglycerols (TAG) represent 97-98% of the 
fat in milk; however, there are also minor amounts of diacylglycerols, 
monoacylglycerols, free (unesterified) fatty acids, phospholipids, sterols and other 
components (Fox and McSweeney, 1998). The composition and structure of milk fat 
has been reviewed extensively (Jensen and Newberg, 1995; Jensen, 2002; 
Vanhoutte and Huyghebaert, 2003; MacGibbon and Taylor, 2006; Palmquist, 2006); 
however, relatively little work has been carried out on changes in the composition 
and structure of milk fat during the transition from colostrum to milk. Generally, 
but not always, the fat content of colostrum is higher than that of milk (Foley and 
Otterby, 1978; Marnila and Korhonen, 2002). Parrish et al. (1950) reported a mean 
fat content of 5.7% in the first milking, followed by a gradual decrease to 4.6% in 
the sixth milking. The same author observed significant variability in the fat content 
of colostrum, not only among different breeds, but also between individual cows of 
the same breed, i.e., the fat content of the first milking post partum ranged from 
0.3% to 18.0%. Tsioulpas et al. (2007) reported that the fat content varied 
throughout the sampling period (0-90 days), but no particular trend was observed. 
Kehoe et al. (2007) reported that the average fat content of the first milking post 
partum ranged from 2.0 to 26.5%, with an average value of 6.7%. Morrill et al. 
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(2012) observed a similar trend, i.e., the fat content of colostrum varied from 1.0 to 
21.7%, with an average value of 5.6%. Abd El-fattah et al. (2012) reported a 
decrease in the fat content of colostrum from 8.04% at parturition to 3.9% after 5 
days.  
Approximately 400 different fatty acids have been identified in bovine milk fat, but 
only about 15 of these are present at or above 1.0% of total lipids (MacGibbon and 
Taylor, 2006). Fatty acids in milk arise from two sources: synthesis de novo in the 
mammary gland and plasma lipids which originate from the feed (MacGibbon and 
Taylor, 2006). Laakso et al. (1996) reported that, during the first week post partum, 
the proportions of stearic acid, oleic acid and short chain fatty acids (C4-C10) in 
colostrum were low and increased thereafter. Similarly, Palmquist et al. (1993) 
observed that the proportion of short-chain fatty acids, with the exception of C4, 
are low in colostrum, but that these fatty acids increase, reaching >90% of 
maximum levels by 8 wk of lactation. Laakso et al. (1996) also reported that the 
relative amounts of C12-C16, in particular myristic and palmitic acid, in colostrum 
were high initially and decreased with time post partum. Several authors have 
reported that colostrum contains high levels of C18:0 and C18:1 (Syrstad et al., 
1982; Lynch et al., 1992; Palmquist et al., 1993). High levels of long-chain fatty acids 
are found in colostrum because, at parturition, cows are in a negative energy 
balance, resulting in mobilisation of adipose fatty acids which are incorporated into 
milk fat (Belyea and Adams, 1990). Concomitantly, high levels of long-chain fatty 
acids inhibits de novo synthesis of short-chain fatty acids (Bauman and Davis, 1974). 
Laakso et al. (1996) observed changes in the TAG distribution during the colostral 
period, i.e., the proportion of molecules with acyl carbon number (ACN) 38-40 
increased and those with ACN 44-48 decreased. Paszczyk et al. (2005) reported that 
colostrum contains a lower content of trans fatty acids and cis-9 trans-11 C18:2 
(CLA) than milk.  
The phospholipids are minor constituents of milk fat and constitute about 1% of 
total lipids in milk (Fox and McSweeney, 1998). They are important structural 
components of the MFGM and are present in five major subclasses: sphingomyelin, 
phosphatidyl choline, phosphatidyl serine, phosphatidyl inositol and phosphatidyl 
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enthanolamine (Palmquist, 2006). Bitman and Wood (1990) reported that the total 
phospholipid content of milk increases from 0.72 to 1.06% of total lipids from the 
third to seventh day of lactation, respectively. The same authors observed that the 
five major subclasses of phospholipids mentioned above are all present at 
significantly lower concentrations in colostrum than in milk.  
Sterols are minor components of milk lipids, at approximately 0.3% of total lipids. 
Cholesterol is the main component of sterols, accounting for approximately 95% 
(MacGibbon and Taylor, 2006). Small amounts of other sterols have also been 
identified in milk, namely campesterol, stigmasterol and β-sitosterol (Minicione et 
al., 1977). Shope and Gowen (1928) reported that the cholesterol content of 
colostrum was highest initially and decreased progressively over 48 h at which point 
a plateau was reached. Precht (2001) observed that the cholesterol content of 
colostrum is significantly higher than of milk, i.e., 327 and 285 mg/100g fat, 
respectively, with colostrum from one cow registering a cholesterol content of 
approximately 600 mg/100g fat immediately after calving.  
 
1.2.9 Minerals 
The mineral components, or milk salts, include the citrates, phosphates and 
chlorides of H+, K+, Na+, Mg2+ and Ca2+, which are present as either as ions in 
solution or as colloidal species complexed with the caseins (Lucey and Horne, 
2009). Potassium, sodium and chloride ions are essentially soluble in milk, while 
calcium, inorganic phosphate and magnesium are partly associated with the casein 
micelles (Gaucheron, 2005). The principal colloidal salt in milk is calcium phosphate; 
the colloidal salts are thus often referred to collectively as colloidal calcium 
phosphate (CCP) (Fox and McSweeney, 1998). Several factors affect the 
concentration of salts in milk, i.e., stage of lactation, mastitis, diet and season, 
whereby the most pronounced changes occur around parturition (Holt, 1985).  
Milk is saturated with respect to calcium and phosphate ions, which exist in a 
dynamic equilibrium with the colloidal forms (Lucey and Horne, 2009). The 
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concentration of calcium and phosphorus in milk is approximately 1200 and 950 
mg/kg, respectively (Fox and McSweeney, 1998). Several authors have reported 
high concentrations of calcium and phosphorus in colostrum; Tsioulpas et al. (2007) 
reported that the concentrations of calcium and phosphorus decreased from 2168 
and 1635 mg/kg, respectively, at parturition, to 1342 and 929 mg/kg, respectively, 
after a 15 days. A similar trend was observed by Garret and Overman (1940), Rook 
and Campling (1965) and Jeong et al. (2009). Abd El-Fattah (2012) observed a 
similar trend for the calcium concentration during the transition from colostrum to 
milk, but, the concentration of phosphorus in colostrum and milk was significantly 
lower than previous reports, i.e., 530 and 520 mg/kg, respectively. On the other 
hand, Kehoe et al. (2007) reported mean concentrations for calcium and 
phosphorus in colostrum of 4716 and 4452 mg/kg, respectively, which are 
approximately 4- and 5-fold higher than the concentrations found in milk. White 
and Davies (1958) reported that the average concentrations of colloidal inorganic 
calcium and colloidal inorganic phosphorus were lower in colostrum than in milk. 
Colloidal calcium and colloidal phosphorus are associated predominantly with 
casein, which, as mentioned earlier, is present in higher concentrations in 
colostrum than in milk (Cerbulis and Farrell, 1975). However, during the colostral 
period, casein micelles are not as mineralised as later in lactation, and so the 
concentrations of colloidal calcium and colloidal phosphorus are not as high as 
expected.  
The concentrations of magnesium and sodium in milk are approximately 120 and 
500 mg/kg, respectively (Fox and McSweeney, 1998). Several authors have reported 
increased concentrations of these elements in colostrum. Jeong et al. (2009) 
reported that the concentrations of magnesium and sodium decreased from 287 
and 761 mg/kg, respectively, at parturition, to 120 and 430 mg/kg, respectively, 
after 4 days. A similar trend was observed by Garrett and Overman (1940), 
Tsioulpas et al. (2007) and Abd El-Fattah et al. (2012). Kehoe et al. (2007) reported 
that the concentrations of magnesium and sodium in colostrum ranged from 230 to 




The concentration of potassium in milk is approximately 1450 mg/kg (Fox and 
McSweeney, 1998). Unlike for calcium, phosphorus, magnesium and sodium, there 
are mixed reports in the literature regarding the concentration of potassium in 
colostrum. Garret and Overman (1939), Toshiyoshi et al. (1982) and Kilmes et al. 
(1986) reported low levels of potassium in colostrum at parturition but a gradual 
increase thereafter. Abd El-Fattah (2012) reported that the concentration of 
potassium in colostrum decreased from 1795 mg/kg at parturition to 650 mg/kg 
after 14 days, which is significantly lower than typically found in milk. No particular 
trends were observed for potassium concentration in the studies of Rook and 
Campling (1965), Ontsouka et al. (2003), Tsioulpas et al. (2007) and Jeong et al. 
(2009). Kehoe et al. (2007) reported that the concentration of potassium in 
colostrum ranges from 983 to 5511 mg/kg, with a mean value of 2845 mg/kg, which 
is significantly higher than other reports in the literature.  
In addition to the macro-elements mentioned above, approximately 20 other 
elements are found in milk in trace amounts, including copper, iron, zinc and 
manganese, which are present in milk at approximately 200, 500, 3500 and 30 
µg/kg, respectively (Fox and McSweeney, 1998). The presence of these trace 
elements in milk has been studied by several authors (Coni et al., 1994, 1995; Ataro 
et al., 2008; Pechova et al., 2008; Pilarcyzk et al., 2013), but, relatively little work 
has been carried out on their concentrations in colostrum and milk during the early 
post partum period. Kehoe et al. (2007) reported that the average concentrations 
of copper, iron, zinc and manganese in colostrum were 340, 5330, 38100 and 100 
µg/kg, respectively, with values ranging from 130 to 640, 1700 to 17500, 11200 to 
83600 and 0 to 360 µg/kg, respectively. The mean values reported by Kehoe et al. 
(2007) are 1.7, 10.7, 10.9 and 3.3 fold higher than values for normal milk. Jeong et 
al. (2009) observed no particular trends in the concentrations of copper and iron in 
colostrum over the first 108 h post partum, with values ranging from 1000 to 1700 
µg/kg for both elements. In the same study, the concentration of zinc was highest 
in the first milking, at 14300 µg/kg, but decreased sharply thereafter, while no 
manganese was detected in colostrum. Abd El-Fattah (2012) reported a general 
decrease in the levels of copper, iron and zinc in colostrum over the first 336 h post 
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partum. The concentration of copper fluctuated during the first 24 h from 1780 to 
2040 µg/kg, but then decreased gradually to 600 µg/kg after 336 h. Similarly, the 
concentrations of iron and zinc decreased from 22100 and 2700 µg/kg, respectively, 
at calving, to 4600 and 1700 µg/kg at 336 h post partum.  
 
1.2.10 Vitamins 
Vitamins are a heterogeneous group of organic chemicals required in extremely 
small amounts for growth and maintenance of normal cells and body function 
(Morrissey and Hill, 2009). Vitamins are generally not synthesised in the body and 
are classified based on their solubility in either water or fat. Water-soluble vitamins 
include the B group vitamins and vitamin C, while the fat-soluble vitamins are A, D, 
E and K (Fox and McSweeney, 1998).  
 
1.2.10.1 Fat-soluble vitamins 
Vitamin A is present in milk as a variety of substances including retinol, retinal, 
retinoic acid, retinyl esters as well as provitamin A carotenoids such as β-carotene 
(Morrissey and Hill, 2009). Retinol and its derivatives are found only in animal 
tissues, whereas β-carotene is found principally in plants (Blomhoff, 1994; Basu and 
Dickerson, 1996). The concentrations of vitamin A and β-carotene in milk is 
approximately 40 µg/100g and 20 µg/100g, respectively (Walstra and Jenness, 
1984). The concentration of vitamin A and carotenoids in milk is strongly influenced 
by the amount of carotenoids in the feed (Jensen et al., 1999), as carotenoids with a 
β-ionone ring (e.g., β-carotene) serve as vitamin A precursors (Fox and McSweeney, 
1998). The concentration of vitamin A in colostrum and milk is also influenced by 
parity, i.e., primiparous cows exhibit significantly higher vitamin A concentrations 
than multiparous cows (Franklin et al., 1998; Kumagai et al., 2001). Several authors 
have reported increased concentrations of vitamin A in colostrum, with values 
ranging from 233 to 369 µg/100g (Drummond et al., 1921; Dann, 1933; French, 
1943; Franklin et al., 1998; Jensen et al., 1999; Debier et al., 2005). The 
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concentration of vitamin A and carotenoids decreases drastically during the first 
few days of lactation and stabilises beyond approximately day 5 (Parrish et al., 
1948; Calderon et al., 2007; Abd El-fattah et al., 2012). 
Vitamin E includes two main groups: tocopherols (α-, β-, γ- and δ-) and tocotrienols 
(α-, β-, γ- and δ-) (Morrissey and Hill, 2009). The transfer of vitamin E into 
colostrum does not appear to occur via a passive mechanism associated with the 
transfer of lipids (Debier et al., 2005) but rather by a mechanism involving low-
density lipoproteins (Schweigert, 1990). The concentration of vitamin E in milk is 
approximately 90 µg/100g (Fox and McSweeney, 1998), while its concentration in 
colostrum is much higher (Hidiroglou, 1989; Schweigert, 1990; Debier et al., 2005; 
Calderon et al., 2007). Kehoe et al. (2007) reported that the concentration of 
vitamin E in colostrum ranges from 60 to 1040 µg/100g, with a mean value of 292 
µg/100g. Parrish et al. (1949) reported that the concentration of vitamin E 
decreased from 84 to 31 µg/g fat over the course of the first six milkings post 
partum, compared with an average vitamin E concentration in milk of 15 µg/g fat. 
The concentration of α-tocopherol in milk ranges from 0.2 to 0.7 mg/L (Renner et 
al., 1989; Jensen et al., 1995). Hidiroglou (1989) reported that the concentration of 
α-tocopherol in colostrum decreased from 1.9 to 0.3 mg/L over the first four days 
post partum. γ-Tocopherol and α-tocotrienol have also been detected in trace 
amounts in colostrum and milk (Barrefors et al., 1995). 
The two major forms of vitamin D are cholecalciferol (vitamin D3), which is 
synthesised by the skin of the cow following exposure to ultraviolet radiation, and 
ergocalciferol (vitamin D2), which is produced by plants following exposure to UV 
radiation (Bulgari et al., 2013). The concentration of vitamin D in milk is quite low, 
ranging from 0.01 to 0.15 µg/100g (Reeve et al., 1982). The most important factor 
affecting the vitamin D content of milk is exposure to sunlight, with higher values 
found in summer (approx. 0.035 µg/100g) than in winter (approx. 0.025 µg/100g) 
(Scott et al., 1984). Henry and Kon (1937) reported a decrease in the vitamin D 
content of colostrum from 1.2 to 0.36 IU/g fat during the first 5 days post partum, 
compared with an average vitamin D content of 0.41 IU/g fat in milk. These results 
are in agreement with the study of Eaton et al. (1947) who reported that the 
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concentration of vitamin D in colostrum ranged from 0.83 to 1.81 IU/g fat. Yan et al. 
(1993) also observed an higher concentration of vitamin D in colostrum compared 
with milk. 
Vitamin K exists in two forms; phylloquinone (vitamin K1) and menaquinones 
(vitamin K2) (Morrissey and Hill, 2009). The concentration of vitamin K in milk is 
quite low, ranging from 0.35 to 1.8 µg/100g (Haroon et al., 1982). Indyk and 
Woolard (1995) reported that the concentration of phylloquinone was higher in 
colostrum than in milk, decreasing from approximately 2 µg/100g in the initial 
colostrum to normal levels (0.4 to 0.66 µg/100g) after five days of lactation.  
 
1.2.10.2 Water-soluble vitamins 
Ascorbic acid (vitamin C) is synthesized in the liver of cows (Chatterjee, 1978), but 
calves do not begin to synthesize endogenous vitamin C until approximately 3 
weeks of age and so are reliant on vitamin C from milk during this period (Palladun 
and Wegger, 1984). The vitamin C content of milk ranges from 1.65 to 2.75 
mg/100g, with a mean concentration of 2.11 mg/100g (Walstra and Jenness, 1984). 
Kon and Watson (1936) reported that the concentration of vitamin C in colostrum is 
slightly higher than that in milk, with vitamin C content in first post partum milkings 
ranging from 1.6 to 3.2 mg/100g and 1.97 to 2.15 mg/100g after 6 days. Hidiroglou 
et al. (1995) reported no differences in the concentration of vitamin C between the 
initial colostrum and milk, but, the concentration of vitamin C was twice as high in 
colostrum (16 µg/mL) as in milk at 2 days after calving (8 µg/mL). 
The B group vitamins are thiamine, riboflavin, niacin, biotin, pantothenic acid, 
folate, pyridoxine (and related substances, such as vitamin B6) and cobalamin (and 
its derivative, vitamin B12). The concentration of thiamine, riboflavin, folate, vitamin 
B6 and B12 are higher in colostrum than in milk, while the levels of pantothenic 
acid and biotin are lower in colostrum and that of niacin approximately the same as 
in milk (Marnila and Korhonen, 2002). Pearson and Darnell (1946) reported that the 
concentrations of thiamin and riboflavin in colostrum were 0.62 and 6.1 µg/mL, 
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respectively, compared with 0.38 and 1.77 µg/mL in milk. These values are in 
agreement with those reported by Kehoe et al. (2007), who reported that the 
concentration of thiamin and riboflavin in colostrum ranged from 0.3 to 2.1 µg/mL 
and 2.4 to 9.2 µg/mL, respectively, with mean values of 0.9 and 4.5 µg/mL. Sutton 
et al. (1947) reported that the concentration of riboflavin in colostrum was 3.3-fold 
higher than in milk, with values decreasing sharply from 6.2 to 3.7 µg/mL between 
the first and second milking, followed by a more gradual decrease from 2.4 to 1.8 
µg/mL from the second to tenth milking. Pearson and Darnell (1946) also reported 
that the concentration of pantothenic acid increased from 2.24 to 3.67 µg/mL 
during the transition from colostrum to milk, while the niacin content of colostrum 
was approximately the same as in milk, i.e., 0.96 and 0.91 µg/mL in colostrum and 
milk, respectively. Both of these trends were also reported by Lawrence et al. 
(1946). In contrast to this, Kehoe et al. (2007) observed that the concentration of 
niacin was lower in colostrum (0.34 µg/mL) than in milk. The level of biotin in milk 
ranges from 21 to 43 ng/ml (Gregory et al., 1958; Causeret, 1971; Higuchi et al., 
2003). Hirano et al. (1991) reported that the biotin content in colostrum was low 
initially (5.1 ng/mL) but increased with the progression of lactation, which is in 
agreement with the findings of Lawrence et al. (1946) and Indyk et al. (2014). 
Cobalamin is present in milk at <1 µg/100g and its level is fairly constant 
throughout lactation, except during the colostral period during which it is very high 
(Nohr and Biesalski, 2009). Anthony et al. (1951) observed that the concentration of 
cobalamin in colostrum decreased from 4.9 to 2.3 µg/mL during the first 24 h after 
parturition, followed by a more gradual decrease thereafter. Kehoe et al. (2007) 
reported that the concentration of cobalamin in colostrum ranged from 0.2 to 1.1 
µg/mL, with a mean value of 0.6 µg/mL, which is significantly lower than reported 
by Anthony et al. (1951). The concentration of pyridoxine in milk is approximately 
0.36 µg/g (Nohr and Biesalski, 2009). Kehoe et al. (2007) reported that the 
concentration of pyridoxine in colostrum ranges from 0 to 0.2 µg/mL, with a mean 
value of 0.04 µg/mL, which is lower than the level found in milk and is not in 
agreement with Marnila and Korhonen (2002). Collins et al. (1950) reported that 
the concentration of folic acid in colostrum decreases abruptly from 0.75 µg/100g 
at parturition to 0.2 µg/100g after 24 h, at which point a plateau was reached.  
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1.3 Physical properties 
1.3.1 pH 
The pH of milk is strongly influenced by temperature (Walstra et al., 2006). At 25°C, 
the pH of milk is usually in the range 6.5 to 6.7, with a mean value of 6.6 (Fox and 
McSweeney, 1998). The main factor influencing the pH of milk is stage of lactation; 
the pH of colostrum is lower and that of late-lactation milk is higher than the pH of 
normal mid-lactation milk (McCarthy and Singh, 2009). McIntyre et al. (1952) 
reported that the pH of colostrum at parturition ranged from 6.0 to 6.61, with an 
average value of 6.32. This value increased with time and reached pH 6.5 after 2 
weeks. Several authors have reported similar trends, whereby the pH of colostrum 
is low initially and increases with time post partum (Klimes et al., 1986; Madsen et 
al., 2004; Tsioulpas et al., 2007; Jeong et al., 2009). The precise reason for the low 
pH of colostrum is unknown. During the pre partum period, there is increased 
permeability of the mammary gland membranes, and thus more blood constituents 
gain access to the milk. Given that colostrum contains significantly more blood 
components than milk, a pH closer to that of blood (pH 7.35 to 7.45) (Nappert and 
Taylor, 2001) should be expected.  Sebela and Klicnik (1977) reported that the low 
pH of colostrum is caused by the increased concentration of protein, dihydrogen 
phosphate, citrate and carbon dioxide. Another possible explanation for the low pH 
is the high ash content, i.e., hydrogen ions are released during the formation of 
colloidal calcium phosphate, which may cause a drop in pH.  
 
1.3.2 Buffering capacity 
The buffering capacity of milk is defined as the resistance to changes in pH on 
addition of acid or base (Fox and McSweeney, 1998). The principal buffering 
components of milk are soluble phosphate, colloidal calcium phosphate, citrate, 
carbonate and proteins (Lucey et al., 1993). McIntyre et al. (1952) reported that the 
buffering capacity of colostrum was greater than that of milk and decreased rapidly 
during the first four milkings. Klimes et al. (1986) also reported a markedly higher 
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buffering capacity of colostrum compared with milk which decreased with 
advanced lactation. Titratable acidity is defined as the buffering capacity of milk 
between its own pH and pH 8.3 (Walstra et al., 2006). Kilmes et al. (1986) reported 
that the titratable acidity of colostrum is approximately 2 to 2.5 times higher than 
that of milk. This was supported by Tsioulpas et al. (2007) and Jeong et al. (2009).  
Tsioulpas et al. (2007) observed a logarithmic relationship between titratable 
acidity and total protein, while Nardone et al. (1997) also observed a higher 
titratable acidity for colostrum than milk, and reported a positive correlation with 
protein content.  
 
1.3.3 Colour 
The colour of milk is typically dominated by the presence of casein micelles and fat 
globules, which scatter light and are responsible for its white/opaque appearance. 
The serum phase of milk is greenish due to the presence of riboflavin, while the 
colour of the lipid phase is dependent on the presence and concentration of fat-
soluble pigments, in particular carotenoids, which are not synthesised by the animal 
but are obtained from plant sources in the animals diet (Fox and McSweeney, 
1998).  Colostrum has a reddish-yellow colour (Edelsten, 1988). This yellow colour is 
due largely to the presence of carotenoids (Edelsten, 1988). It has been observed 
that levels of carotenoids are high in the initial colostrum, in particular the fat 
fraction, but decrease rapidly as the mammary secretions change to normal milk 
(Parrish et al., 1948). Calderon et al. (2007) reported that the concentration of the 
carotenoids lutein, all-trans β-carotene and cis-13 β-carotene in colostrum were 
highest initially and decreased drastically during the first week of lactation. The 
same authors reported a linear relationship between the concentration of β-
carotene and the colour index and stated that β-carotene accounted for 65% of 
variations in the colour index in colostrum. Kehoe et al. (2007) reported that the 
concentration of β-carotene in colostrum ranges from 0.1 to 3.4 µg/g, with an 
average value of 0.68 µg/g. This is significantly higher than the average 
concentration of β-carotene in milk, i.e., 0.2 µg/g (Renner et al., 1989). The reddish 
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colour of colostrum is due to the presence of red blood cells. During the pre partum 
period there is increased permeability of the mammary gland membranes, and 
more blood constituents gain access to the milk. Linzell and Peaker (1975) observed 
that as little as 0.1 mL blood/L can be detected visually and that 0.4 mL/L turns milk 
very pink. Using the CIELAB colour space, Madsen et al. (2004) reported that the 
colour of colostrum changed with time after calving; it became lighter (lightness, L, 
increased over the first six milkings), less red (redness, a, decreased and stabilized 
after the second milking) and less yellow (yellowness, b, decreased over the first 12 
milkings). The same authors reported that the presence of blood in colostrum 
significantly affected the colour, causing the sample to be darker, less yellow and 
more red. These results are in agreement with the study of Espada and Vijverberg 
(2002), who reported that colostrum has a less blue colour than milk.  
 
1.3.4 Density/ Specific gravity 
The density of milk is the mass per unit volume and is usually expressed as kg/m3. 
The density of whole milk at 20°C is about 1030 kg/m3 and ranges from 1027 to 
1033 kg/m3 (Walstra and Jenness, 1984). Density varies with the composition of 
milk, i.e., the density increases with increasing content of solids-not-fat and 
decreases with increasing fat content (Walstra et al., 2006). Madsen et al. (2004) 
reported that the density of colostrum decreased rapidly from 1048 to 1034 kg/m3 
during the first 2 d post partum, followed by a more gradual decrease to 1030 
kg/m3 by 6 d post partum. Strekozov et al. (2008) observed variations in the density 
of colostrum according to parity and season of calving. On average, the density of 
colostrum from first-calf heifers was 1059 kg/m3, compared with 1068 kg/m3 for 
third- and fourth-calf cows. Within these groups, the density of colostrum from 
cows which calved in fall was highest, followed by winter and then spring.  
The density of milk should be distinguished from its specific gravity, i.e., the ratio of 
the density of milk to the density of water, at a specific temperature. Specific 
gravity is a dimensionless quantity and is much less temperature-dependant than 
density. The specific gravity of whole milk at 15.5°C ranges from 1.030 to 1.035, 
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with a mean value of 1.032 (Jenness and Patton, 1959). Parrish et al. (1950) 
reported that the specific gravity of colostrum is highest initially, decreases rapidly 
between the first and fourth milkings and continues to decrease after the fourth 
milking, but at a slower rate. The same authors observed that the lowest specific 
gravity is usually found in secretions from Holstein cows, while marked variations 
were also found in Ayrshire, Jersey and Guernsey cows. Quigley et al. (1994) 
reported that the specific gravity of colostrum is in the range 1.028 to 1.074, with a 
mean value of 1.052. The same authors reported that correlations of total Igs and 
IgG with specific gravity were lower than reported by Mechor et al. (1992) but were 
highly related to total N and protein N. Jeong et al. (2009) observed a similar trend 
to that seen by Parrish et al. (1950), i.e., the specific gravity of colostrum decreases 
rapidly between the first and fourth milking from 1.055 to 1.034 and continues to 
decrease but at a less rapid rate. Similarly, Kertz (2008) reported that the specific 
gravity of colostrum decreases from 1.056 to 1.033 during the first 5 milkings post 
partum. 
 
1.3.5 Thermal properties 
Heat treatment of milk and dairy products is mainly aimed at killing of 
microorganisms and inactivation of enzymes. Pathogens that may be transmitted to 
dairy calves in colostrum include Mycobacterium avium subsp. paratuberculosis, 
Salmonella spp., Mycoplasma spp., Listeria monocytogenes, Campylobacter spp., 
Mycobacterium bovis and Escherichia coli (Elizondo-Salazar and Heinrichs, 2008). 
One strategy to prevent the transmission of infectious diseases to calves is heat 
treatment of colostrum. However, pasteurisation of colostrum using the same time 
temperature combinations as used for milk reduces Ig concentration and increases 
viscosity. Meylan et al. (1996) investigated the effects of batch pasteurisation (63°C 
for 30 min) on colostrum and reported a mean loss of native Ig after pasteurisation 
of 12.3 ± 8.7%. In a similar study, Godden et al. (2003) investigated the effects of 
batch pasteurisation on native IgG concentrations of colostrum and reported that 
pasteurisation reduced native IgG concentration by 58.5 and 23.6% for 95- and 57-L 
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batches, respectively. The same authors observed that the consistency of colostrum 
was mildly thickened following pasteurisation. McMartin et al. (2006) found that 
heating colostrum to 63°C for 120 min resulted in an estimated 34% decrease in 
native IgG concentration and a 33% increase in viscosity. The same authors 
reported no differences in native IgG concentration and viscosity after heating 
colostrum to 60°C for 120 min and, in doing so, identified the critical temperature 
at or below which heating would produce no significant changes in native IgG 
concentration and viscosity. Godden et al. (2006) reported that heating of 
colostrum to 60°C for 120 min was sufficient to reduce the level of viable 
Mycoplasma bovis, Listeria monocytogenes, Escherichia coli O157:H7, Salmonella 
enteritidis and Mycobacterium avium subspecies paratuberculosis below detectable 
limits. Similarly, Donahue et al. (2012) found that heating colostrum at 60°C for 60 
min decreased total plate counts and coliform counts, and did not affect native IgG 
concentration. Johnson et al. (2007) described increased efficiency of IgG 
absorption and, consequently, higher serum IgG concentration in calves fed heat-
treated (60°C for 60 min) compared to raw colostrum. These results are consistent 
with those of Godden et al. (2012) who, in addition, reported that calves fed heat-
treated (60°C for 60 min) colostrum were at significantly lower risk for treatment of 
any illness in the preweaning period compared with calves fed unheated colostrum. 
The precise reason for this remains unclear, but it was hypothesised that the 
presence of bacteria in colostrum could interfere with systemic absorption of Ig 
molecules in the small intestine.  Green et al. (2003), using HTST (high-temperature 
short-time) pasteurisation (72°C for 15 s) of colostrum, reported an average 28.4% 
loss of native IgG, and that all samples congealed into a thick, pudding-like 
consistency during or immediately after pasteurisation. These results are in 
agreement with those of Stabel et al. (2004), who reported a 25% reduction in 






1.3.6 Casein micelle properties 
Casein exists in milk as large colloidal aggregates referred to as casein micelles. 
Micelles have a spherical shape, a diameter ranging from 50 to 500 nm (average 
150 nm) and molecular weight of 106 to > 109 Da (average 108 Da) (Fox, 2003). 
Brooker and Holt (1978) reported that colostrum contains casein micelles several 
micrometres in diameter. These micelles contain closed cavities, suggesting that 
they were formed by aggregation of particles comparable in size to normal casein 
micelles. Walstra et al. (2006) reported that colostrum and early-lactation milk 
contain a small number of very large micelles, reaching diameters of 600 nm. 
Tsioulpas et al. (2007) reported that the average diameter of casein micelles was 
almost constant throughout the first 90 days of lactation, except for the transition 
from day 1 to 2, during which it decreased from 227 to 189 nm. The same authors 
attributed the increased size of casein micelles in colostrum to the high protein 
(casein) and Ca (especially Ca2+) concentrations. The relative proportions of the 
individual caseins in the micelles vary with micelle size. αs- and β-casein decrease 
with decreasing micelle size, while к-casein increases (McGann et al., 1980; 
Donnelly et al., 1983). The relative proportion of glycosylated к-casein is inversely 
related to micelle size (Zbikowska et al., 1992). Kroeker et al. (1985) reported that, 
in terms of the relative percentage of casein, the percentage of αs-casein in 
colostrum fell initially after parturition and remained constant thereafter. The same 
authors observed that the relative percentage of β-casein was low initially and 
increased during the first two months of lactation, while the relative percentage of 
к-casein was unaffected by stage of lactation.  Barry and Donnelly (1980) reported 
that the relative percentage of αs-casein was low in colostrum and increased in 
early lactation, which was not supported by the findings of Kroeker et al. (1985), 
while the relative percentage of β- and γ-caseins varied in a directly inverse 
relationship. Sobczuk-Szul et al. (2013) investigated the relative percentage of 
individual caseins in colostrum over the first 8 milkings post partum and reported 
that the relative percentage of αs-casein increased, the relative percentage of β-
casein remained stable and the relative percentage of к-casein decreased over time 
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after calving.  A decrease in к-casein content and increase in αs-casein content was 
also reported by Wielgosz-Groth (2004).  
 
1.3.7 Ethanol stability 
Ethanol stability is defined as the minimum concentration of added aqueous 
ethanol that causes milk coagulation (Horne and Parker, 1979). Serum phase 
components, in particular ionic calcium, govern the sigmoidal shape and position of 
the ethanol stability/pH profile (Horne and Parker, 1981a,b).  Other factors which 
influence the ethanol stability of milk include salts (calcium, magnesium, 
phosphorus and citrate) (Donnelly and Horne, 1986), ionic strength (Horne, 1987) 
and pH (Horne, 1992). Chavez et al. (2004) reported that milk samples that were 
unstable to ethanol (72%, v/v) had a lower pH, SCC, casein and non-fat-solids 
relative to ethanol stable samples (ethanol at 78%, v/v or more), whereas freezing 
point, chloride, sodium and potassium concentrations were higher in the unstable 
group. Mitamura (1937) observed that colostrum reacts strongly to an equal 
volume of 70% ethanol immediately after parturition but that the degree of 
coagulation weakens gradually and disappears after approximately 10 days. 
Tsioulpas et al. (2007) investigated the stability of colostrum to equal volumes of 
ethanol ranging from 40 to 100% and found that the ethanol stability of colostrum 
was low for the first four days following parturition (54% on average) and only 
achieved 70% by day 5. The same author observed that samples which had poor 
ethanol stability also had low pH values and high ionic calcium concentrations.  
 
1.3.8 Rennet coagulation 
Rennet coagulation of milk occurs in two stages, i.e., enzymatic modification of 
casein micelles and Ca2+-induced aggregation of the rennet-altered micelles (Horne 
and Banks, 2004). In milk, rennet coagulation time increases with increasing pH and 
decreases with increasing protein content and Ca2+ concentration (Fox and 
McSweeney, 1998; Madsen, 2004). Sebela and Klicnik (1975) observed a shorter 
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rennet coagulation time (RCT) for colostrum than for milk and recorded the lowest 
RCT on day 3 following parturition. A similar trend was reported by Klimes et al. 
(1986). Kvapilik et al. (1975) found that the RCT of colostrum from days 2 to 7 was 
more rapid than in subsequent days. Madsen et al. (2004) observed a decrease in 
the RCT of colostrum during the first six milkings, followed by an increase at a 
slower rate. However, curd firmness increased during the first six milkings and then 
decreased. With the exception of the first six milkings, Madsen et al. (2004) 
attributed changes in RCT primarily to changes in pH and casein content. 
Additionally, an elevated SCC was associated with a significant increase in RCT, 
which is in agreement with the study of Politis and Ng-Kwai-Hang (1988a). This is 
most likely due to the lower fat and casein contents of milk with a high SCC (Politis 
and Ng-Kwai-Hang, 1988b). Tsioulpas et al. (2007) reported that the RCT of 
colostrum was high on day 1, decreased sharply on day 2, remained constant for 
the next 3 days, and then increased steadily for the remainder of the study (90 
days). With the exception of day 1, RCT followed a similar pattern to pH. The high 
RCT on day 1 could not be explained, as the colostrum had a low pH and high 
protein content. A possible explanation proposed by Tsioulpas et al. (2007) was a 
delay in the enzymatic phase of coagulation as a result of the high protein to 
chymosin ratio. 
 
1.3.9 Somatic cell count (SCC) 
Somatic cells in milk are of two types: sloughed epithelial cells from the udder and 
leukocytes form the blood (Singh and Ludri, 2001). Several authors have reported 
that the SCC for colostrum is much higher than that of milk (Emanuelson and 
Persson, 1984; Hallberg et al., 1995; Andrew, 2001). In most cases, a high SCC in 
colostrum is not due to a mastitic infection but is of a physiological nature and is 
most likely due to penetration of cells through leaky tight junctions between the 
mammary epithelial cells (Nguyen and Neville, 1998). Miller et al. (1991) reported 
that the SCC was highest during the first 2 wk after calving, with smaller changes 
thereafter. These results were in agreement with Bodoh et al. (1976) who also 
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reported elevated SCC in early lactation. Ontsouka et al. (2003) reported that the 
SCC of colostrum on d 2 was 1,479,000 cells/mL compared with 274,000 cells/mL in 
milk. Madsen et al. (2004) found that the SCC of colostrum decreased from 
approximately 1,000,000 cells/mL for milkings 1 and 2 to < 100,000 at milking 12. 
Jeong et al. (2009) reported that the SCC of colostrum was highest initially and 
decreased gradually from approximately 2,454,708 cells/mL at parturition to 
645,654 cells/mL after 132 h. The same author observed no differences in the SCC 
of colostrum from cows of different parities. 
 
1.3.10 Osmotic pressure 
The osmotic pressure of milk is a colligative property which is closely related to its 
freezing and boiling point. Natural variation in the osmotic pressure of milk (and 
hence freezing point) is limited by the physiology of the mammary gland and so 
remains relatively constant (Fox and McSweeney, 1998). Very little work has been 
carried out on the osmotic pressure of colostrum. McIntyre et al. (1952) reported 
that the average osmotic pressure of colostrum decreased rapidly in the first four 
milkings post partum and only relatively small changes were noted thereafter. The 
osmotic pressure of the 28th milking was about two-thirds of the initial colostrum. 
The high osmotic pressure of colostrum was attributed to its high mineral content. 
In contrast to this, Ontsouka et al. (2003) reported that the osmolarity of colostrum 
on d 2 was numerically, but not statistically, higher than milk.  
 
1.3.11 Other properties 
In addition to the properties discussed above, other physical properties of milk 
include ionic strength, redox potential, interfacial tension and various rheological 






Colostrum is a secretion of the mammary gland produced immediately after 
parturition which is tailored to meet the unique nutritional and physiological 
requirements of the neonate. In particular, colostrum confers passive immunity to 
the newborn calf through its high concentration of IgG. The composition of 
colostrum differs markedly from milk, reflecting a difference in the biological 
function of the two materials. Its composition and physical characteristics vary with 
a number of factors including individuality, breed, parity, prepartum ration, length 
of dry period of cows and time post partum.  
Colostrum has a much higher total solids content than milk, reflected mainly by a 
significantly higher protein content. The concentration of casein is higher in 
colostrum than in milk and the relative proportions of the individual caseins vary, 
i.e., colostrum contains reduced proportions of αs-casein and elevated proportions 
of к-casein, while the proportion of β-casein is constant.  The proportion of whey 
proteins is substantially higher in colostrum than in milk. The predominant protein 
fraction in colostrum is the immunoglobulins (IgG, IgM, IgA), but colostrum also 
contains elevated levels of β-lg, α-la, serum albumin and lactoferrin. Additionally, 
certain proteins associated with the milk fat globule membrane are present in 
higher concentration in colostrum than in milk, i.e., apolipoprotein A1, 
apolipoprotein E and clusterin. The concentration of certain growth factors (IGF-I, 
IGF-II, EGF, TGF-β1, TGF-β2), antioxidants (lactoperoxidase, catalase, superoxide 
dismutase), proteinases (plasmin, cathepsin D), lipases (lipoprotein lipase) and 
esterases (arylesterase, carboxylesterase) are higher in colostrum than in milk, as 
are the concentrations of other enzymes including alkaline phosphatase, 
ribonuclease, lysozyme and γ-glutamyl transferase. Similarly, the concentrations of 
various enzyme inhibitors are higher in colostrum than in milk, i.e., cysteine 
protease inhibitors, α2-macroglobulin, α2-antiplasmin, antithrombin III, C1-
inhibitor, inter-α-trypsin inhibitor, bovine plasma elastase inhibitor and bovine 
plasma trypsin inhibitor. The concentrations of nucleotides, nucleosides and 
cytokines are higher in colostrum than in milk. Lactose concentration is reduced in 
colostrum and is inversely related to other constituents such as solids, protein and 
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ash; a lactose concentration as low as 1.2% has been reported in colostrum. The 
concentrations of oligosaccharides, mostly acidic but also neutral, are higher in 
colostrum than in milk. Generally, but not always, the fat content of colostrum is 
higher than that of milk. Reported values range from 0.3 to 26.5%, with a mean 
value of approximately 6.5%. The proportion of short-chain fatty acids is low in 
colostrum, while the proportion of long chain-fatty acids in colostrum is high 
initially and decreases with time post partum. The concentration of phospholipids is 
significantly lower in colostrum than in milk, while the concentration of cholesterol 
is higher. Colostrum contains higher concentrations of calcium, phosphorus, 
magnesium, sodium, copper, iron, zinc and manganese than milk, while there are 
mixed reports in the literature regarding the concentration of potassium. For the 
most part, the concentrations of both fat-soluble (vitamin A, E, D, K) and water-
soluble (vitamin C, B) vitamins are higher in colostrum than in milk. 
The high compositional variability of colostrum has pronounced effects on its 
physical properties. The pH of colostrum is low initially and increases with time post 
partum, the precise reason for which is unknown. The buffering capacity and 
titratable acidity of colostrum are greater than that of milk due to increased levels 
of protein, soluble phosphate, colloidal calcium phosphate, citrate and carbonate. 
Colostrum has a reddish-yellow colour due to the presence of carotenoids and red 
blood cells. The density and specific gravity of colostrum are greater than that of 
milk due to higher a higher content of solids-not-fat. Colostrum has poor heat 
stability to typical pasteurisation or UHT treatments, but can be heated at 60°C for 
up to 120 min without affecting native IgG concentration or viscosity. The casein 
micelles are larger in the initial colostrum than in subsequent milkings. Colostrum 
has poor ethanol stability due to low pH, high SCC and increased concentrations of 
casein and non-fat-solids. There are mixed reports in the literature relating to the 
RCT of colostrum but, in general, the RCT of colostrum is lower than that of milk. 
The SCC of colostrum is much higher than that of milk, most likely due to 
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The aim of this study was to analyse the secretions from the first six post partum 
milkings from six individual Holstein-Friesian cows to investigate how composition 
and physico-chemical properties change throughout the early lactation period. 
Properties, including pH, casein micelle size, viscosity, colour, rennet coagulation 
time (RCT), acid-induced gelation, rheology of rennet- and acid-induced gels, heat 
coagulation time, isoelectric precipitability, and ultracentrifugal sedimentability 
were analysed, together with some compositional factors, such as carbohydrates, 
minerals, total protein, casein protein and whey protein. In general, pH increased 
with increasing time post partum, while total protein content decreased with time, 
due to a decrease in the level of whey proteins. Casein micelles in all first milkings 
were larger than at subsequent milkings. Heat stability increased with increasing 
time post partum, most likely due to decreasing levels of whey proteins. Viscosity 
and RCT of colostrum samples and G’ values of rennet gels decreased with 
increasing time post partum. G’ values for acid gels from colostrum were low 
compared with those from mature milk, but no particular trend was observed. Total 
Na, Mg, P, K and Ca were high initially and decreased with time post partum. The 
concentration of lactose was low initially and increased with time post partum. 
Colostrum samples contained elevated levels of oligosaccharides and low levels of 
monosaccharides. The colour of colostrum samples was highly variable, presumably 
due to the presence of carotenoid and blood pigments. Caseins did not precipitate 
at pH 4.6 in several colostrum samples; altering the serum mineral composition and 
increasing the level of certain whey proteins had no effect on isoelectric 
precipitation, but reducing the pH below 4.6 restored precipitability, as did dilution 
with distilled water. Reversing the serum phase of colostrum and mature milk also 
resulted in precipitation of the caseins at pH 4.6. The results described in this study 
expand on current knowledge of the composition and physico-chemical properties 






Colostrum is usually defined as the mammary secretion produced in the first five to 
six post partum milkings, the composition of which changes drastically during the 
transition from colostrum to early lactation milk (Christiansen et al., 2010). 
Colostrum is a complete source of protein, carbohydrates, fat, vitamins and 
minerals, and is also rich in biologically active constituents. Colostrum plays an 
important role in development of immunological, metabolic, hormonal and 
haematological traits, and in growth performance in neonatal calves (Rauprich et 
al., 2000; Blattler et al., 2001). Its composition and physical properties depend on 
various factors, including individuality, breed, parity, pre partum ration, length of 
dry period of cows, and time post partum (Foley and Otterby, 1978).  
Bovine milk is classified as mature milk 72 h after parturition (Sgarbieri, 2004). 
Mature milk contains about 3.5% protein, of which approximately 80% are caseins, 
a heterogeneous group of proteins which are insoluble at their isoelectric point (pH 
4.6). The casein fraction can be subdivided into four groups: αS1, αS2, β and к, which 
occur in milk as a micellar complex in the approximate proportions 4:1:4:1, 
respectively (Visser et al., 1991). The remaining 20% of milk proteins are the whey 
proteins (soluble at pH 4.6), of which there are over 200 different types, with β-
lactoglobulin (β-Lg), α-lactalbumin (α-La), bovine serum albumin (BSA) and 
immunoglobulins (Igs) being the major constituents. The natural function of milk 
proteins is to provide young mammals with amino acids and calcium, both of which 
are necessary for growth. Casein micelles serve both functions as, in addition to 
protein, they provide the neonate with high levels of calcium and phosphate, which 
are required for bone growth (Fox and McSweeney, 1998). Madsen et al. (2004) 
found that colostrum contains a higher concentration of casein than mature milk. 
Colostrum has a distinctive whey protein composition, which includes elevated 
levels of IgG, IgA and IgM (Smolenski et al., 2007). The composition and physical 
properties of Igs in colostrum have been studied extensively (Mechor et al., 1992; 
Quigley et al., 1993; Levieux and Ollier, 1999; Elfstrand et al., 2002; Gapper et al., 
2007; Yonghao et al., 2008;  Zang et al., 2011; Golinelli et al., 2011). For ruminants, 
Igs in colostrum are of particular importance to the neonate, as the transfer of 
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passive immunity from the mother to the neonate occurs through colostrum and 
not via the placenta. Passive transfer of Igs is important in protecting the neonate 
from infectious disease (Elizondo-Salazar and Heinrichs, 2008). Colostrum has a 
high concentration of bioactive components, e.g., growth factors, especially insulin-
like growth factor-1 (IGF-1), transforming growth factor beta-2 (TGF-β2) and growth 
hormone (GH), as well as lysozyme and lactoperoxidase (Elfstrand et al., 2002). The 
concentration of growth factors in colostrum is highest during the first hours after 
calving and generally then declines sharply in a time-dependant manner (Gauthier 
et al., 2006). Growth factors control some fundamental life processes such as cell 
division, cell differentiation or apoptosis, and stimulate the growth and 
development of the gastrointestinal tract of new-born animals (Elfstrand et al., 
2002). Proteins secreted by the mammary gland, such as β-Lg, α-La, lactoferrin (LF), 
proteinase inhibitors and some enzymes, are present at higher concentrations in 
colostrum than in mature milk (Levieux and Ollier, 1999). Proteins derived from the 
blood, such as albumin, α2-macroglobulin, and transferrin are also present at high 
concentrations in colostrum (Levieux and Ollier, 1999).  
The predominant carbohydrate in bovine milk is lactose (Nakamura et al., 2003). 
Lactose concentration is low in colostrum and changes inversely to other 
constituents, such as total solids, protein, fat and ash (Kehoe et al., 2007; Tsioulpas 
et al., 2007a). In addition to lactose, the carbohydrate and carbohydrate-containing 
components of bovine colostrum include oligosaccharides, glycoproteins and 
glycolipids. The oligosaccharide content of bovine colostrum is lower and less 
complex than that of human milk, but there is a close homology between the major 
acidic oligosaccharides in both species (Gopal and Gill, 2000; Urashima et al., 2009). 
Oligosaccharides are considered to be some of the most important bioactive 
components in milk, and their primary role seems to be to provide protection 
against pathogens by acting as competitive inhibitors for binding sites on the 
epithelial surfaces of the intestine (Gopal and Gill, 2000). Colostrum contains much 
higher concentrations of oligosaccharides and other glycoconjugates than mature 
milk (Nakamura et al., 2003; Urashima et al., 2013).  
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Bovine milk typically contains 3.5% fat, but the level varies widely. Of the common 
European breeds, milk from Holstein/Friesian cows, which were used in the current 
study, contain the lowest level of fat (Fox and McSweeney, 1998). Parrish et al. 
(1950) and Kehoe et al. (2007) reported an elevated fat level in colostrum 
compared to mature milk. Differences between the lipids in bovine colostrum and 
milk have not been studied in great detail, but Precht (2001) reported a higher 
cholesterol content in bovine colostrum than in milk. 
Kilmes et al. (1986) and Tsioulpas et al. (2007a) found that concentrations of Ca, 
Mg, P, Na and K were much higher in colostrum than mature milk. Elevated levels of 
minerals have a pronounced effect on the technological properties of milk, e.g., 
renneting, fouling on heat exchangers, gelation and sedimentation (Tsioulpas et al., 
2007b). 
Several authors have studied changes in the physico-chemical properties of bovine 
milk from the colostrum period to early lactation (Ontsouka et al., 2003; Madsen et 
al., 2004; Tsioulpas et al., 2007a), but relatively little work has been carried out on 
the composition of bovine colostrum. Foley and Otterby (1978) reviewed the 
literature, but no comprehensive research on colostrum composition has been 
published since. Most research on colostrum focuses narrowly on IgG and ignores 
other Igs and nutrients.   
The aim of this study was to investigate the composition and physico-chemical 









2.2 Materials and Methods 
 
2.2.1 Collection of milk samples 
Milk samples were obtained from Teagasc – Animal and Grassland Research and 
Innovation Centre, Moorepark, Fermoy, Co. Cork.  The first six post partum milkings 
from six individual Holstein-Friesian cows, referred to as samples 1 to 6 from cows 
A to F, were obtained. Of the six cows, one was a heifer, four were in second 
lactation, and one was in third lactation. Three bulk mature milk samples (bulk 1 to 
3) from a herd of cows in mid-lactation were also obtained for purposes of 
comparison.  
 
2.2.2 Carbohydrate and protein analysis 
The lactose, glucose, galactose and oligosaccharide content of milk samples was 
determined by HPLC using a method modified from those of Biggs and 
Szijarto (1963), Brons and Olieman (1983), and Koops and Olieman (1985). The 
HPLC system was equipped with an ERC-7510 refractive index detector (Erma 
Optical Works, Ltd., Tokyo, Japan), a mixed-bed guard column and an Aminex HPX-
87P column (300 x 7.8mm, Bio-Rad, Hercules, CA, USA) in series, an LC-10ATvp 
pump, a SIL-10ADvp autosampler and a CTO 6A column oven set at 80⁰C (Shimadzu, 
Kyoto, Japan).  A 25 µL sample was injected and sugars were eluted at a flow rate of 
0.40 mL/min using an isocratic mobile phase of ultrapure MilliQ water (Millipore 
Corporation). Lactose, glucose and galactose were identified using appropriate 
standards. 
Protein content was determined by the macro-Kjeldahl method (IDF, 1986). The 






The viscosity of whole milk and colostrum samples was measured using a rotational 
viscometer (Haake Roto Visco 1, Thermo Fisher Scientific, Waltham, MA, USA). For 
each sample, the shear rate was increased from 0 to 100/s, spaced at equal 
logarithmic intervals, over 2 min. Torque measurements were taken at a constant 
shear rate of 100/s over 2 min. The shear rate was then decreased from 100 to 0/s, 
spaced at equal logarithmic intervals, over 2 min. The sample cup (DG43 Series 1) 
was maintained at either 5oC or 20oC using a circulating waterbath (Haake K15 with 
SC150 temperature controller; Haake Mess-Technik GmbH, Karlsruhe, Germany). 
The instrument was checked prior to analysis using Milli-Q® water. 
 
2.2.4 pH 
The pH of skimmed milk and colostrum samples was measured at room 
temperature using a Meterlab standard pH meter PHM210 (Radiometer, 
Copenhagen, Denmark). The meter was calibrated using standard phosphate 
buffers (pH 4.01 and 7.00, Radiometer, Copenhagen, Denmark) and the electrode 
was washed with distilled water between measurements. 
 
2.2.5 Colour  
The colour of whole milk and colostrum samples was measured on three replicates 
of each sample at 20oC using a Minolta CR-400 colorimeter (Minolta Corp., Osaka, 
Japan). The CIE L*a*b* (CIE, 1976) standard measurement system, which measures 
colour using 3 coordinates, L*, a*, and b*, was used. The instrument was calibrated 
with a white tile (standard tristimulus values: Y = 92.4; x = 0.3161; y = 0.3325) 
supplied by Minolta, prior to measurement and at regular intervals throughout. 




2.2.6 Casein micelle size 
Dynamic light scattering was used to determine the average size of the casein 
micelles using a Zetasizer Malvern System ZS (Malvern Instruments Ltd., Malvern, 
UK). Samples were skimmed by centrifugation at 3,000 x g for 30 min at 4°C before 
analysis. Skimmed milk was diluted 50-fold with synthetic milk ultrafiltrate 
prepared according to the method of Jenness and Koops (1962), placed in a plastic 
cuvette and analysed. 
 
2.2.7 Rennet coagulation 
2.2.7.1 Rennet coagulation time 
The rennetability of milk samples was studied in triplicate using a modification of 
the Berridge method (IDF, 1987).  Two mL of skim milk (at either natural pH or at 
pH 6.6) were placed in thin-walled glass tubes and tempered for 15 min at 30oC in a 
thermostatically controlled waterbath. Ten µL/mL of a 1:10 (v/v) aqueous dilution 
of fermentation-produced chymosin (Maxiren 180, 180 international milk-clotting 
units (IMCU) per mL; DSM Food Specialists, Delft, the Netherlands) were added and 
the tubes were oscillated gently on a rocking platform in the waterbath. Rennet 
coagulation time was recorded as the first sign of flocculation, i.e., when visible 
curd flocs appeared on the wall of the tube. 
 
2.2.7.2 Rheology of rennet-induced gels 
Milk gels are viscoelastic and their rheological properties can be characterised by 
measuring both their elastic (G’) and viscous (G’’) moduli (Lucey, 2002). Dynamic 
oscillatory analysis (low-amplitude oscillatory measurement) of renneted skim milk 
samples was performed using a controlled shear stress AR-G2 rheometer equipped 
with a peltier concentric cylinder system and a conical rotor (diameter 28.02 mm x 
length 42.01 mm; TA Instruments, Waters LLC, Leatherhead, Surrey, UK). Twenty 
five mL of each milk sample were pre-warmed in a waterbath at 30oC for 15 min 
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and 250 µL of a 1:10 (v/v) dilution of Maxiren 180 were added.  The fifth milking 
from cow C and the first milking from cow F did not coagulate under these 
conditions, and so, 750 µL of a 1:10 (v/v) dilution of Maxiren 180 were added. The 
storage modulus, G’, of the sample was recorded continuously at a low-amplitude 
shear strain (0.01) over 90 min at a frequency of oscillation of 0.6283 rad/s. Analysis 
was carried out in triplicate. 
 
2.2.8 Glucono- δ-lactone-induced acidification of colostrum and mature milk 
Skimmed milk and colostrum were acidified using varying levels of glucono-δ-
lactone (GDL). GDL converts to gluconic acid in water and slowly releases H+ over 
time, lowering the pH of milk and providing a simplified and controlled model of 
milk fermentation (Lucey, 2002; Girard and Schaffer-Lequart, 2007). The 
concentration of GDL required to reach pH 3.9 ranged from 2.2 to 3.5%, depending 
on the protein content and buffering capacity of each sample. Addition of sufficient 
GDL to milk ensures that all the colloidal inorganic phosphate is solubilised in 90 
min and that calcium is completely removed from the casein micelles (Heertje et 
al., 1985). Acidification to pH 3.9 took ~90 min. GDL was added to milk samples, 
previously warmed to 30°C, maintained at this temperature for 20 min, and stirred 
vigorously for 1 min to ensure complete dissolution. In tandem with rheological 
measurements, the pH of a sub-sample of GDL-treated milk was monitored and 
recorded continuously. Dynamic oscillatory analysis (small amplitude oscillatory 
measurement) of acidified milk was performed as described in Section 2.2.7.2, with 
some modifications; 25 mL of each milk sample were pre-warmed in a waterbath at 
30°C for 15 min, GDL was added, and the sample was placed immediately in the 
pre-heated cup (30°C) of the rheometer. 
 
2.2.9 Heat stability 
The heat stability of skimmed milk and colostrum was determined in an oil bath at 
temperatures ranging from 70 to 140°C by the subjective method of Davies and 
92 
 
White (1966). Three mL aliquots were placed in glass tubes (length, 130 mm; 
internal diameter, 7.5 mm; wall thickness, 1.6 mm), sealed with silicone rubber 
stoppers; tubes were heated in an oscillating oil bath until visual coagulation of 
protein particles was observed.  
 
2.2.10 Ultracentrifugal sedimentation 
The level of sedimentable and non-sedimentable protein in skimmed colostrum 
samples was measured by ultracentrifugation at 100,000 g for 60 min at 4 or 20°C 
in a Beckman Optima LE-80K Ultracentrifuge and the associated Beckman 50.2 Ti 
rotor (Beckman Instruments Inc., Palo Alto, CA, USA). Aliquots of skimmed milk 
were transferred to tared centrifuge tubes (Optiseal, polyallomer centrifuge tubes, 
Beckman Coulter Inc., Brea, CA, USA) and ultracentrifuged. The supernatant was 
removed carefully from the pellets, weighed, and its protein content determined. 
The supernatants were also analysed by RP-HPLC, as described in Section 2.2.12. 
Samples were diluted before analysis, using a suitable dilution factor based on 
protein concentration. These dilution factors were taken into account when 
correcting for peak areas.  
 
2.2.11 Isoelectric precipitation of casein 
Skimmed milk and colostrum samples were adjusted to pH 4.6 according to the 
method of Kuchroo and Fox (1982) with slight modifications. Prior to pH 
adjustment, samples were diluted 1:1, 1:2, 1:3 or 1:4 with distilled water. Undiluted 
samples were also analysed. Samples were adjusted to pH 4.6 with 1 N HCl and held 
at room temperature. After 30 min, pH was re-checked and re-adjusted if 
necessary. Samples were placed in a waterbath at 40°C for 1 h followed by 
centrifugation at 3000 g for 30 min at 4oC. The resulting supernatant was filtered 
through glass wool and Whatman no. 113 filter paper. The filtrate was stored at -
20oC for further analysis. 
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2.2.11.1 Effect of varying pH on isoelectric precipitation of casein  
The pH of skimmed colostrum from cow F, 1st and 2nd milking, was adjusted to 
different values ranging from 4.0 to 5.0 according to the method of Kuchroo and 
Fox (1982) with slight modifications. Briefly, the pH of the colostrum was adjusted 
to different values ranging from 4.0 to 5.0 using 1 N HCl and held at room 
temperature. After 30 min, the pH was re-checked and re-adjusted if necessary. 
Samples were placed in a waterbath at 40°C for 1 h followed by centrifugation at 
3000 g for 30 min at 4oC. The resulting supernatant was filtered through glass wool 
and Whatman no. 113 filter paper. The filtrate was stored at -20oC for further 
analysis. 
 
2.2.11.2 Interchange of serum phase minerals between colostrum and mature milk 
and its effect on isoelectric precipitation of casein 
The serum phase minerals of skimmed milk and colostrum were interchanged by 
equilibrium dialysis. Briefly, 1 volume of skimmed colostrum was dialysed against 
6.5 volumes of skimmed milk at 4°C for 24 h using a 3500 Da dialysis membrane 
(Medicell International, London). This was carried out in triplicate to bring the total 
dialysis time to 72 h. The same was done for the skimmed milk where 1 volume was 
dialysed against 6.5 volumes of skimmed colostrum under the same conditions as 
above. The dialysed colostrum and mature milk were then adjusted to pH 4.6 
according to the method of Kuchroo and Fox (1982), as described in Section 2.2.11. 
 
2.2.11.3 Addition of lactoferrin to mature milk and its effect on isoelectric 
precipitation of casein 
The lactoferrin content of skimmed milk was modified by direct addition of 0 to 
25.6 mg/mL lactoferrin (NIZO Food Research, Ede, the Netherlands). The addition 
was made at ambient temperature with stirring. Modified milk samples were 
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equilibrated overnight at 4°C and adjusted to pH 4.6 according to the method of 
Kuchroo and Fox (1982), as described in Section 2.2.11. 
 
2.2.11.4 Purification of immunoglobulins from colostrum 
Colostrum was defatted by centrifugation at 3,000 g for 30 min at 4°C. Skimmed 
colostrum was adjusted to pH 4.6 according to the method of Kuchroo and Fox 
(1982), as described in Section 2.2.11, with the slight modification in which samples 
were diluted 1:2 with distilled water before pH adjustment. Equal volumes of the 
pH 4.6-soluble fraction of colostrum and saturated ammonium sulphate were 
mixed and allowed to equilibrate for 30 min. Addition of ammonium sulphate 
compressed the solvation layer and increased protein-protein interactions. As the 
ammonium sulphate concentration of the solution was increased, the charges on 
the surface of the protein interacted with the ammonium sulphate, not the water, 
thereby exposing hydrophobic patches on the protein surface and causing the 
protein to aggregate and precipitate. The solution was centrifuged at 3,000 g for 30 
min at 20°C. The precipitate was taken, dissolved in 0.01 M NaCl and allowed to 
hydrate overnight at 4°C. The solution was dialysed for three 24 h periods against 
20 volumes of distilled water using a 12,000 – 14,000 Da dialysis membrane 
(Medicell International, London), and dialysis retentate was lyophilised. 
 
2.2.11.5 Addition of a colostral Ig preparation to mature milk and its effect on 
isoelectric precipitation of casein  
The Ig content of skim milk was modified by addition of 25, 50, 100 or 150 mg/mL 
of the Ig preparation, prepared as described in Section 2.2.11.4. The addition was 
performed at ambient temperature with stirring. Modified milk samples were 
equilibrated overnight at 4°C and adjusted to pH 4.6 according to the method of 




2.2.11.6 Reversal of serum phase of colostrum and mature milk and its effect on 
isoelectric precipitation of casein 
Casein from bulk mature milk samples, 1 to 3, was sedimented by 
ultracentrifugation at 100,000 g x 1 h at 20ºC and lyophilised. The serum phase of 
the first milking from cow E and bulk mature milk sample 1 were prepared by 
ultracentrifugation at 100,000 g x 1 h at 20ºC to remove casein. Sedimented mature 
milk casein was dispersed (3%, w/v) in the serum phase of the first milking from 
cow E or bulk mature milk 1, at ambient temperature with stirring. Samples were 
equilibrated overnight at 4ºC and adjusted to pH 4.6 according to the method of 
Kuchroo and Fox (1982), as described previously in Section 2.2.11.   
 
2.2.12 Reversed phase-high performance liquid chromatography 
Clarified samples were obtained by mixing skimmed milk or colostrum (1:1, v/v) 
with a buffer containing 0.1 M bis(2-hydroxymethyl)amino-
tris(hydroxymethyl)methane, 8 M urea, 0.3% mercaptoethanol (ME) and 1.3% 
trisodium citrate dehydrate (pH 7); in some experiments, ME was omitted from the 
buffer. After standing at room temperature for 1 h, the mixture was diluted with 
solvent A (acetonitrile-water-trifluoroacetic acid, 100:900:1 v/v/v) containing 6 M 
urea.  
The HPLC equipment consisted of two M 6000A pumps (Waters Association, 
Milford, MA, USA), an ISS-100 automatic sample injector (Perkin-Elmer, Waltham, 
MA, USA), a Kratos Model 783G UV detector and a Waters Type 680 automated 
gradient controller. The equipment was linked to a data acquisition and processing 
system (Waters Maxima 820). A 250 mm x 4.6 mm I.D. HiPore RP-318 column (Bio-
Rad, Hercules, California, USA) was used with a C18 cartridge (Bio-Rad, Hercules, 
California, USA) as a guard column. Solvent A was acetonitrile-water-trifluoroacetic 
acid (100:900:1 v/v/v) and solvent B had the same composition with the 
proportions 900:100:0.7 (v/v/v). The solvent gradient reported for casein 
separation (Visser et al., 1986) was adapted in the current study for genetic casein 
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variants and whey proteins: starting from 26% of solvent B (equilibration buffer) a 
gradient was generated immediately after injection by increasing this proportion at 
0.60%/min (15 min), 0%/min (7 min), 0.67%/min (3 min), 0%/min (12 min), 
0.44%/min (18 min), 12.5%/min (2 min) and 0%/min (5 min), before returning to 
starting conditions in 5 min. The column temperature was 30°C, peak detection was 
at 220 nm, the flow-rate was 0.8 mL/min, and the system pressure was 10.3 MPa. 
 
2.2.13 SDS- polyacrylamide gel electrophoresis 
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) was 
carried out using a Protean II xi vertical slab-gel unit (Bio-Rad Laboratories Ltd., 
Watford, Herts., UK) according to the method of Laemmli (1970) using a 15%, w/v, 
acrylamide separating gel and a 3%, w/v, stacking gel, both containing 0.1%, w/v, 
SDS. Milk samples were prepared in 0.0625 M Tris-HCl buffer (pH 6.8) containing 
2%, w/w, SDS, 5%, w/w, mercaptoethanol and 0.012%, w/w, bromophenol blue and 
heated at 95oC for 4 min prior to loading into gel slots. Electrophoresis was carried 
out at a constant voltage (200 V) for 8 h using a tris-glycine buffer (pH 8.3) 
containing 0.125%, w/w, SDS. The gel was removed from the electrophoresis unit, 
fixed in 50:10:40 methanol:acetic acid:water; and stained with Coomassie Brilliant 
Blue R-250 to visualize the proteins. Images of gels were captured using the Epson 
Perfection 4180 Scanner (Epson, Suwa, Nagano, Japan) with Total Lab Quant 
software (Newcastle, UK). Image resolution was set at 600 dots per inch (dpi). 
 
2.2.14 Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) 
Colostrum and mature milk samples were standardised to approximately equal  
total solids in order to avoid matrix effects between samples. Samples were then 
digested in 70% nitric acid in closed digestion vessels using a MARSXpress 
microwave digester (CEM, Matthews, NC, USA). When the samples were fully 
digested, the contents were carefully washed into a 100 ml volumetric flask and 
brought up to volume with ultrapure water from a Milli-Q system (Millipore, 
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Bedford, MA, USA). Further dilutions were made as necessary. All samples were run 
on an Agilent 7700x series (Agilent Technologies, Tokyo, Japan) with Octopole 
Reaction System (ORS) and MassHunter software. Argon was used as the carrier gas 
and helium as the collision gas. External standards of known mineral composition 
(Reagecon, Co. Clare, Ireland) were run and a multipoint calibration graph was 
prepared for each element. R2 was >0.99% in all cases. Internal standards were run 
for all elements (Agilent Technologies, Santa Clara, CA, USA). A certified standard of 
known composition (BCR -IRMM, Geel, Belgium) was run as a QC check for each 
batch.  
 
2.2.15 Statistical analysis 
Statistical analysis was carried out using Minitab version 16 (Minitab Inc., State 
College, PA, USA). Five separate statistical tests were carried out.  
General linear model analysis of variance (GLM ANOVA) was used to assess the 
effect of cow to cow variation (A to F) and time of milking (1st to 6th milking post 
partum) on the composition and physico-chemical properties of colostrum, of 
which 22 parameters were measured (referred from herein as variables): L*, a*,b*, 
pH, protein concentration, non-sedimentable protein at 4 and 20oC, sedimentable 
protein at 4 and 20oC, minerals (Na, Mg, P, K, Ca), casein micelle diameter, viscosity 
at 5 and 20oC, soluble protein at pH 4.6 (undiluted, 1:1 dilution, 1:2 dilution), rennet 
coagulation time and storage modulus (G') after rennet addition. Plots of residuals 
from GLM ANOVA were examined initially to satisfy the requirement that they be 
normally distributed and thus confirm the validity of the statistical test. Plots of 
residuals versus fits and residuals versus order were examined to identify potential 
patterns in the residual error and highlight any outliers in the data from each 
parameter. Data from Sections 2.3.2, 2.3.3, 2.3.4, 2.3.5, 2.3.7 and 2.3.10 were not 
included in the statistical analysis as replication of analysis was not consistent with 
other variables measured. The assumption in this study was that the six cows 
selected represented variability across a herd and, thus, individual cows were 
treated as random factors. GLM ANOVA allows the use of random factors, unlike 
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two-way ANOVA, which only allows the use of fixed factors. Initial models for GLM 
ANOVA were identified by graphically plotting the responses for the six cows over 
time.  Scatter-plots helped to identify possible quadratic time effects in several 
cases.  Where linear or quadratic effects seemed to be appropriate functions for 
the response over the effects of milking number, sample milking numbers were 
included as covariates.  In a few models, the milking numbers did not fit a linear 
effect, and thus milking number was considered a separate level for GLM ANOVA.  
Because GLM ANOVA does not run multiple comparison tests on factors that 
interact with random factors, or on covariates, principal component analysis (PCA) 
was carried out to reduce and interpret the large multivariate dataset using 
underlying linear structures, and to determine if there were any interactions 
between samples over time, based on the 22 variables described above. For PCA 
computation, measurements were standardized using a correlation matrix as 
variables were measured on different scales. Outliers were determined as 
Mahalanobis distances for each observation, which took into account the variance 
of each variable and the covariance between variables, and was useful in identifying 
and gauging similarities in the dataset and pinpointing any obvious outliers. For 
clarity of presentation and interpretation of results, loading and score plots were 
plotted separately. The former is a plot of the loadings of PC2 (y-axis) versus the 
loadings of PC1 and a line is drawn from each loading to the (0,0) point. The latter is 
a plot of the scores for PC2 (y-axis) versus the scores for PC1 (x-axis). Finally, a 
biplot was constructed which is an overlay of the score and loading plots for PCs 1 
and 2. 
GLM ANOVA, using the ‘comparisons with a control function’, was repeated on the 
dataset for the 22 measured variables, but milking number was excluded, while 
results for bulk mature milk (which were not measured at each time point) were 
included in the analysis. Dunnett’s multiple comparison test was used to compare 
the mean of each factor level (i.e., measured parameter) with that of the control 
bulk mature milk samples. This test resulted in a grouping table and a set of 
confidence intervals for the difference between the mean of the control level and 
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the other sample level means. Unusual observations were noted for observations 
where standardized residuals differed from zero by more than 2.00. 
One-way ANOVA was used in Section 2.3.11.3 to determine if there were any 
significant differences between mean values for protein solubility at pH 4.6 of 
colostrum and mature milk after interchanging the serum salts by equilibrium 
dialysis. One-way ANOVA was also carried out on data investigating the effect of 
addition of lactoferrin to mature milk on the isoelectric precipitation of casein 
(Section 2.3.11.4). Initially, the data for all parameters measured were examined for 
normality using the Anderson-Darling normality test at a significance level, α, of 0.1; 
when calculated p values were found to be > 0.1, it was assumed that the data 
were normally distributed. As all data were normally distributed (p > 0.1), one-way 
ANOVA was carried out using a significance level, α, of 0.05. Where significant 
differences occurred between sample means, Tukey’s paired multiple comparison 
test was used to compare all possible pairs of level means for the factors specified 
at a significance level, α, of 0.05. The grouping information table generated by 
Tukeys test was used to group factor level means that were not significantly 
different. 
Two-way ANOVA at a significance level, α, of 0.05 was used to assess the effect of 
pH on the precipitation of casein for the first and second milking of cow F (Section 
2.3.11.3). Unusual observations in the statistical analysis were recorded where 









2.3 Results and Discussion 
 
2.3.1 Physical properties and composition 
 
Average values for physical properties and composition of the first six milkings post 
partum from six individual cows and three bulk mature milk samples are presented 
in Table 2.1. In general, changes were substantial over the first six milkings, most 
notably during the first two milkings.  
The pH of mature milk at 25°C is between 6.5 and 6.7, with pH 6.6 being the most 
commonly reported value (McCarthy and Singh, 2009). The main factor influencing 
the pH of milk is stage of lactation; the pH of colostrum is lower, and that of late-
lactation milk is higher (may be up to 7.5), than the pH of normal mid-lactation milk 
(McCarthy and Singh, 2009). The pH of colostrum samples in the current study was 
very low initially and increased with time post partum; in almost all cases, the pH 
did not reach the normal value by the sixth milking (on average, pH increased from 
6.35 to 6.49 during the first six milkings post partum). Klimes et al. (1986) and 
Tsioulpas et al. (2007a) observed a similar trend for pH values, although their 
average pH value for the first milking was slightly lower than that found in the 
current study. The pH of the initial colostrum ranged from 6.28 to 6.39, while the 
pH of mature milk samples 1 to 3 varied from 6.62 to 6.66. The lowest pH was 
observed in the first milkings from cows A and D (6.31 and 6.28, respectively). 
McIntyre et al. (1951) reported that the pH of colostrum at the first milking ranged 
from 6.00 to 6.61, with a mean value of 6.32.  
The reason for the low pH value of early colostral milkings is unknown. During the 
pre partum period, there is increased permeability of the mammary gland 
membrane and thus more blood constituents gain access to the milk. Given that 
colostrum contains significantly more blood components than mature milk, a pH 
value closer to that of blood (pH 7.35 to 7.45) (Nappert and Naylor, 2001) would be 
expected. A possible explanation for the low pH is the high mineral content of 
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colostrum (see Section 2.3.8), i.e., hydrogen ions are released during the formation 
of colloidal calcium phosphate (CCP), which may cause a drop in pH.  
By the sixth milking, pH values ranged from 6.37 to 6.67, with a mean value of 6.49. 
According to Edelsten (1988), a pH value less than 6.5 in milk indicates the presence 
of colostrum, although a low pH value may also be caused by bacterial 
contamination (Tsioulpas et al., 2007a), while a value greater than 6.7 is usually 
observed in late-lactation milk or denotes a mastitis infection. Therefore, results 
from the present study indicate that, at the sixth milking post partum, milk may still 
be considered as colostrum and may be unsuitable for certain dairy processing 
operations.  
Mature bovine milk contains ~3.5% (w/v) protein, which is made up of 
approximately 80% casein and 20% whey protein (Golinelli et al., 2011). The protein 
concentration in colostrum samples was highly variable and ranged from 4.0 to 
24.9% over the first six milkings post partum (Table 2.1). The average value for total 
protein decreased rapidly, from 14.4% at the first milking to 8.3% at the second 
milking and then continued to decrease until the sixth milking, at which time it still 
had not reached normal levels. Foley and Otterby (1978) and Tsioulpas et al. 
(2007a) observed a similar trend for protein concentration; however, average 
values in those studies did not reflect the high variability in protein concentration 
between individual cows. The total protein level at the first milking from cows A to 
F ranged from 6.6 to 24.9%. This variability decreased with time post partum and, 
by the sixth milking, total protein from cows A to F ranged from 4.0 to 5.2%. 
Samples from cow D had the highest concentration of total protein over the first six 
milkings post partum: 24.9% at the first milking, 15.0% at the second milking and 
5.2% at the sixth milking. In contrast, total protein concentration at the first six 
milkings post partum from cow C were much lower, albeit still higher than mature 
milk: 6.6% at the first milking, 5.3% at the second milking, and 4.4% at the sixth 
milking. High levels of total protein in colostrum have been reported by several 
authors (Oyeniyi and Hunter, 1977; Levieux and Ollier, 1999; Madsen et al., 2004; 
Tsioulpas et al., 2007a; Abd El-Fattah et al., 2012); this high level of total protein is 
due mainly to elevated levels of whey proteins, in particular Ig. The major Ig in 
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colostrum is IgG, with IgG1 representing more than 90% of Igs (Elfstrand et al., 
2002). Proteins secreted by the mammary gland, such as β-Lg, α-La, LF, proteinase 
inhibitors and some enzymes, are present at high concentrations in colostrum 
compared to mature milk (Levieux and Ollier, 1999). Proteins derived from the 
blood such as serum albumin, α2-macroglobulin, and transferrin are also present at 
higher concentrations in colostrum (Levieux and Ollier, 1999).  
Large variations were seen in the level of protein sedimentable at 100,000 g 
(casein) and, in particular, non-sedimentable protein in colostrum samples. The 
concentration of non-sedimentable protein ranged from 8.2 to 171.3 g/L. Average 
levels of non-sedimentable protein decreased rapidly from 89.6 g/L at the first 
milking to 39.3 g/L at the second milking and then continued to decrease until the 
sixth milking, at which time they still had not reached normal levels, i.e., average 
value of 8.45 g/L for bulk mature milk samples. Variations were also seen in the 
level of sedimentable protein, which ranged from 31.8 – 77.7 g/L. Madsen et al. 
(2004) reported average values for casein concentration in first colostral milkings of 
92.4 g/L, which is higher than that found in the current study. However, as 
discussed in Section 2.3.6., a significant proportion of casein was non-sedimentable 
at 100,000 g, which may have caused the underestimation of the concentration of 
casein in colostrum. A similar trend to that seen for changes in the level of non-
sedimentable protein in colostrum samples was observed for sedimentable protein, 
which decreased from an average value of 54.8 g/L at the first milking to 43.5 g/L at 
the second milking and then continued to decrease until the sixth milking, at which 
time they still had not reached normal levels. These results agree with those of 
Parrish et al. (1948), who reported that the concentration of protein components in 
colostrum, including casein, albumins and globulins, decrease as it changes to 
normal milk.  
Casein exists in milk as large colloidal aggregates referred to as casein micelles, 
which have a spherical shape, a diameter ranging from 50 to 500 nm (average 150 
nm) and molecular mass of 106 to > 109 Da (average 108 Da) (Fox, 2003).  The 
average diameter of casein micelles in colostrum was found to be almost constant 
throughout the study, except for the transition from the first to second milking, 
103 
 
during which time it decreased, on average, from 235.5 to 192.8 nm (Table 2.1). No 
particular trends were observed in casein micelle diameter from the second milking 
onwards. Tsioulpas et al. (2007a) reported a similar result, where the average 
diameter of casein micelles was almost constant throughout the first 90 days of 
lactation except for the transition from day 1 to day 2, during which time it 
decreased from 227 to 189 nm. Casein micelle diameter across all colostrum 
samples ranged from 173.3 to 266.9 nm. The average diameter of casein micelles in 
bulk mature milk samples was 195 nm, which is in agreement with reported values 
(Walstra, 1990).  It is known that micelles of different sizes contain different 
proportions of the individual caseins, with smaller micelles containing a larger 
proportion of к-casein (Dalgleish et al., 1981), and the relative amounts of β-casein 
and αS2-casein decrease with decreasing micelle size (Davies and Law, 1983). This 
disagrees with the results of the current study, in which the proportion of к-casein 
as a function of total casein was found to be high in early milkings (see Table 2.3). 
The viscosity of milk is affected by the state and concentrations of fat and protein, 
temperature, pH and age of the milk (Jenness and Patton, 1959). Under most 
conditions, milk behaves as a Newtonian liquid with shear stress proportional to 
shear rate (Walstra et al., 1999). In general, large variations in the viscosity of 
colostrum samples were observed. This was most evident during the transition 
from the first to second milking, in particular for cows D, E and F. This is most likely 
due to high levels of total solids, of which protein was the major constituent, in 
early colostral milkings. Alcantara et al. (2012) reported that the viscosity of milk 
decreased as temperature increased and total solids decreased, and increased as 
fat, lactose, protein and minerals increased. This is consistent with the results of the 
current study, as early colostral milkings with the highest viscosities also had the 
highest concentrations of protein and minerals. There may also be a correlation 
between the viscosity of colostrum and the lactose concentration.  Lactose in milk 
acts as an osmoregulator, and thus a low level of lactose causes the production of 
milk which is extremely viscous (Bleck et al., 2009). In the current study, colostrum 
samples with the highest viscosity (Table 2.1) also contained the lowest 
concentrations of lactose (see Table 2.4). The average viscosity of bulk mature milk 
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at 20°C was found to be 3.2 mPa s. This value was higher than the value of                   
2.1 mPa s reported by Jenness and Patton (1959). In general, the viscosity of 
colostrum from the first 3 milkings of cows A to F were greater than that of the bulk 
mature milk samples; these values decreased with time post partum and fell below 
the value for mature milk by the sixth milking. 
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Table 2.1 Mean values (± S.D., n=3) of pH, total protein, non-sedimentable protein, sedimentable protein, viscosity, and casein micelle diameter of colostrum samples from the first 
six milkings of cows A to F and bulk mature milk samples 1 to 3. Values without an asterisk (*) were significantly different (p < 0.05) from control bulk milk samples. 
 
Sample
A1 6.31 ± 0.01 115.00 ± 1.27 70.21 ± 0.71 44.79 ± 0.71 219.6
*
± 7.89 14.72 ± 0.32 6.52 ± 0.21
A2 6.37 ± 0.01 71.00 ± 0.71 34.39 ± 0.30 36.61 ± 0.30 187.8
*
± 2.75 10.73 ± 0.32 5.17
*
± 0.19














A5 6.44 ± 0.01 46.00
*









































± 0.30 6.28 ± 1.14













































C6 6.50 ± 0.03 44.00
*







D1 6.28 ± 0.01 249.00 ± 0.35 171.34 ± 0.71 77.66 ± 0.08 240.6 ± 12.21 271.20 ± 3.10 65.52 ± 0.50
D2 6.25 ± 0.00 150.00 ± 1.84 96.63 ± 0.09 53.37 ± 0.09 215.6
*
± 6.62 29.81 ± 0.50 14.25 ± 0.29
D3 6.39 ± 0.00 107.00 ± 0.07 58.07 ± 0.01 48.93 ± 0.01 200.1
*
± 6.47 11.56 ± 0.20 8.87 ± 0.19

























(mg/mL) (mg/mL) (mg/mL) d.nm 5°C 20°C
pH Protein Non-sedimentable protein Sedimentable protein Micelle Size Viscosity (mPa s)
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Table 2.1 (continued) 
 
Sample
E1 6.39 ± 0.02 185.00 ± 8.98 130.62 ± 0.59 54.38 ± 0.59 266.9 ± 11.25 107.13 ± 2.08 37.67 ± 0.63

































F1 6.35 ± 0.00 173.00 ± 2.40 109.76 ± 0.49 63.24 ± 0.49 237.1 ± 7.46 66.49 ± 0.91 25.36 ± 0.49











































Bulk 1 6.66 ± 0.00 39.00 ± 0.42 8.26 ± 0.07 30.74 ± 0.17 192.3 ± 2.06 5.78 ± 0.24 4.80 ± 0.15
Bulk 2 6.62 ± 0.03 38.00 ± 0.71 7.87 ± 0.14 30.13 ± 0.31 198.3 ± 7.82 6.85 ± 0.27 1.95 ± 0.27
Bulk 3 6.66 ± 0.01 40.00 ± 2.19 9.23 ± 0.00 30.77 ± 0.13 194.5 ± 6.29 5.20 ± 0.29 2.95 ± 0.15
1st milking (average) 6.35 ± 0.04 144.33 ± 70.47 89.57 ± 57.96 54.76 ± 13.97 235.5 ± 31.47 78.55 ± 102.68 23.48 ± 24.92
2nd milking (average) 6.36 ± 0.08 82.83 ± 35.11 39.33 ± 30.10 43.50 ± 6.39 192.8 ± 13.13 10.67 ± 9.65 5.67 ± 4.28
3rd milking (average) 6.38 ± 0.09 64.17 ± 21.42 24.39 ± 16.72 39.77 ± 5.87 190.7 ± 6.35 6.44 ± 3.02 4.24 ± 2.35
4th milking (average) 6.46 ± 0.09 55.33 ± 8.71 16.42 ± 6.77 38.91 ± 4.10 187.9 ± 6.78 6.86 ± 1.87 3.75 ± 1.52
5th milking (average) 6.48 ± 0.12 48.67 ± 5.05 12.48 ± 3.40 36.18 ± 2.60 185.2 ± 7.34 4.70 ± 1.64 2.42 ± 0.72
6th milking (average) 6.49 ± 0.10 46.50 ± 4.97 11.54 ± 4.30 34.96 ± 3.63 187.2 ± 7.74 5.14 ± 1.25 2.79 ± 0.77
Viscosity (mPa s) Viscosity (mPa s)
(mg/mL) (mg/mL) (mg/mL) d.nm 5°C 20°C
pH Protein Non-sedimentable protein Sedimentable protein Micelle Size 
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2.3.2 Reversed phase-high performance liquid chromatography of protein 
 
RP-HPLC chromatograms of the colostrum from the first six milkings from cows A to 
F and bulk mature milk samples 1 to 3 are shown in Figures 2.1 and 2.2. Samples 
were loaded on an equal protein basis. The proportion of each individual protein, as 
a percentage of total casein or whey protein, is shown in Table 2.2. Quantification 
of αS2-casein was not possible in the current study, as complete elution of αS2-
casein could not be achieved (Thom Huppertz, personal communication). 
It was found that, in early colostrum, the proportion of к-casein as a percentage of 
total casein (excluding αS2-casein) was high (Table 2.2). In colostrum, к-casein 
accounted for between 18.7 and 21.6% of total casein in first milkings from cows A 
to F. In all cases, these values decreased with time post partum, but did not reach 
normal levels by the sixth milking. On average, к-casein in mature milk accounted 
for 12.7% of total casein, which is significantly lower than was found for colostrum. 
к-Casein is a phosphoglycoprotein, containing up to 15% (w/w) carbohydrate 
(Robitaille et al., 1991). In milk, a significant proportion of к-casein molecules are 
carbohydrate-free, with the remainder being glycosylated to varying degrees 
(Robitaille et al., 1990). Variations in the degree of glycosylation of к-casein were 
observed in the current study by comparison of RP-HPLC chromatograms. к-Casein 
eluted within the 8 to 11 min region in the chromatograms (Figure 2.1 and 2.2). The 
first-eluting protein peaks represent a mixture of carbohydrate-rich к-casein A and 
B. Following this, к-casein elutes in order of decreasing degree of glycosylation. The 
genetic variants of carbohydrate-free к-casein elute at different positions and can 
be distinguished from each other. Minor peaks at intermediate positions originate 
from partly glycosylated к-casein A or B. In early colostrum, the proportion of 
glycosylated к-casein as a percentage of total к-casein was high and decreased with 
time post partum. The degree of glycosylation of к-casein has been shown to affect 
the technological properties of milk in several ways. Cases et al. (2006) reported 
that removal of sialic acid groups from the carbohydrate moieties of к-casein 
enhances the acid coagulability of milk by reducing the net negative charge of the 
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casein micelle. Glycosylation of к-casein is inversely correlated with micelle size, 
which, during rennet coagulation of milk, can potentially increase the rate of 
firming and curd firmness, as reported by Robitaille et al. (1993). 
In general, the proportion of αS1-casein as a percentage of total casein (excluding 
αS2-casein), was low in early colostrum and increased with time post partum (Table 
2.2).  There are eight genetic variants of αS1-casein, the two most common being B 
and C (Luhken et al., 2009).  The αS1-casein B variant and to a lesser extent the C 
variant were predominant in samples analysed in the current study. No separation 
of the B/C variant (Glu – Gly at position 192) was achieved, as they gave rise to a 
double peak, due to a difference in the degree of post-translational 
phosphorylation. 
The proportion of β-casein, as a percentage of total casein, showed no particular 
trend over the first six milkings, although values were slightly lower than those 
obtained for mature milk samples (Table 2.2). There are 12 genetic variants of β-
casein (Martin et al., 2013) which occurs mainly as its A1, A2 and, to a lesser extent, 
its B variant (Farrell et al., 2004). The A1 and A2 variants of β-casein differ at 
position 67, where proline in variant A2 is substituted by histidine in variant A1 
(Kaminski et al., 2007). In the current study, three cows (A, C and F) were found to 
contain variants A1 and A2, while cows B, D and E were found to contain the A2 
variant only. Mature milk samples contained variants A1 and A2, but at a differing 
ratio to that in cows A, C and F.  
There are eleven known genetic variants of bovine β-Lg (Ganai et al., 2009). The 
most abundant are variants A and B (Farrell et al., 2004), which differ by two amino 
acid substitutions: Asp-64-Gly and Val-118-Ala, respectively. Colostrum samples 
were found to contain differing levels of variants A and B. Four cows (A, C, E and F) 
contained both variants. One cow (B) contained the A variant only and one cow (D) 
contained the B variant only. Mature bulk milk samples contained both variants. β-
Lg variants A and B are associated with different amounts of β-Lg in milk: milk 
containing variant A has a higher β-Lg content than variant B (Hill, 1993). This 
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correlation could not be investigated in colostrum samples as the protein 
concentration was highly variable.  
The level of α-La, as a percentage of total β-Lg and α-La, was found to be very low 
in certain colostrum samples (D1, D2, D3, E1, F1), as shown in Table 2.2. This has 
important implications for the carbohydrate profile of colostrum samples, as shown 
in Table 2.4, as α-La is an important component in the lactose synthesis pathway. 




















































































Figure 2.1 RP-HPLC chromatograms of skimmed samples of colostrum from the first ( ), second ( ), third ( ), fourth ( ), fifth ( )
and sixth ( ) milkings from cows A to D.










































































































Figure 2.2 RP-HPLC chromatograms of skimmed samples of colostrum from the first ( ), second ( ), third ( ), fourth ( ), fifth ( )
and sixth ( ) milkings from cows E and F and bulk mature milk samples 1 to 3.
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Table 2.2 Calculated levels of αS1-, β-, and к-casein as a % of total casein (excluding 
αs2-casein) and levels of α-lactalbumin (α-La) and β-lactoglobulin (β-Lg) as a % of 
total α-La and β-Lg for the first six milkings from cows A to F and bulk mature milk 
samples 1 to 3.  
 
Sample/
Milking αS1-casein β-casein к-casein α-La β-Lg
A1 39.1 39.3 21.6 18.3 81.7
A2 40.5 39.8 19.7 26.1 73.9
A3 41.7 40.7 17.6 31.7 68.3
A4 43.2 40.4 16.4 29.3 70.7
A5 43.2 40.8 16.0 30.0 70.0
A6 43.7 41.0 15.4 29.9 70.1
B1 41.6 39.6 18.8 35.9 64.1
B2 42.0 41.5 16.5 37.3 62.7
B3 41.5 42.0 16.5 37.3 62.7
B4 42.4 41.9 15.8 34.1 65.9
B5 42.7 42.9 14.4 33.0 67.0
B6 47.5 36.5 16.0 31.6 68.4
C1 39.3 41.4 19.3 24.1 75.9
C2 42.1 41.8 16.1 28.0 72.0
C3 44.6 39.2 16.2 25.0 75.0
C4 42.5 42.6 14.8 28.3 71.7
C5 44.2 41.6 14.2 24.7 75.3
C6 44.0 41.6 14.4 27.9 72.1
D1 41.7 37.5 20.8 3.7 96.3
D2 38.6 41.3 20.1 7.0 93.0
D3 39.3 41.3 19.4 10.0 90.0
D4 41.9 40.4 17.8 15.9 84.1
D5 42.5 41.1 16.4 17.2 82.8
D6 43.5 40.8 15.6 19.9 80.1
E1 39.3 42.0 18.7 9.8 90.2
E2 38.7 43.4 17.9 20.2 79.8
E3 40.9 42.3 16.9 26.8 73.2
E4 42.2 42.4 15.4 22.9 77.1
E5 44.7 40.5 14.8 26.1 73.9
E6 44.6 42.0 13.5 21.8 78.2
F1 38.2 42.0 19.8 9.8 90.2
F2 38.4 41.9 19.7 17.5 82.5
F3 40.5 40.7 18.8 22.5 77.5
F4 41.5 40.5 17.9 24.5 75.5
F5 43.3 39.7 17.0 25.4 74.6
F6 44.4 39.1 16.5 25.0 75.0
Bulk 1 42.6 44.6 12.8 21.6 78.4
Bulk 2 41.9 45.4 12.7 22.1 77.9
Bulk 3 41.9 45.1 12.9 22.4 77.6
% of total casein % of total α-La and  β-Lg
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2.3.3 Gel electrophoresis 
 
SDS-PAGE electrophoretograms of the first six milkings from cows A to F and bulk 
mature milk samples 1 to 3 are shown in Figure 2.3. Samples were loaded on an 
equal protein basis under reducing conditions. In colostrum samples, the levels of 
αS1-, αS2-, β- and к-caseins, as a percentage of total protein, were low initially but 
increased with time post partum. This was due to elevated levels of whey proteins, 
and not reduced levels of casein. By the sixth milking, the casein:whey protein ratio 
had reached normal levels of approximately 80:20; however, it should be noted 
that total protein concentration remained elevated at this point. The caseins are all 
in the approximate size range 20 – 25 kDa and so do not separate well by SDS-
PAGE: For this reason, densitometric analysis was not carried out on the individual 
caseins, however, proportions of the individual caseins were studied by RP-HPLC, as 
described in Section 2.3.2. As already discussed, the major Ig present in colostrum is 
IgG, in particular IgG1, but IgA and IgM are also found. According to Elfstrand et al. 
(2002), IgG1 represents approximately 90% of total Ig found in bovine milk. IgG is a 
monomeric glycoprotein consisting of two heavy and two light polypeptide chains 
that are linked by disulfide bonds (Gapper et al., 2007). Under reducing conditions, 
the disulfide bonds linking the heavy and light chains are broken. The heavy chains 
are approximately 50 kDa and are well resolved on the SDS gel in Figure 2.3. The 
light chains are approximately 25 kDa in mass and so are located in the same region 
as the caseins, which makes analysis difficult.  
Quantitation of Lf, Ig, β-Lg and α-La was carried out by densitometric analysis of 
representative SDS profiles (Table 2.3). Briefly, the intensities of specific bands, 
corresponding to the proteins of interest, were measured and expressed as a 
percentage of total band intensity, which was then converted to mg/mL protein. 
The concentrations of LF, Ig and β-Lg were high initially, but decreased with time 
post partum.  
On average, the concentration of IgG1 (heavy chain) in mature milk was 0.64 mg/mL 
(Table 2.3). The concentration of IgG1 (heavy chain) in first colostrum from cows A 
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to F ranged from 9.88 to 41.59 mg/mL, which is between 15 and 65 times that 
found in mature milk (Table 2.3).  These values decreased with time post partum, 
but did not reach normal levels by the sixth milking.  Similarly, elevated levels of 
lactoferrin were found in colostum. Lactoferrin is an 80 kDa iron-binding 
glycoprotein of the transferrin family which has anti-microbial, anti-inflammatory 
and anti-cancer activities (Lonnerdal and Suzuki, 2013). On average, the 
concentration of LF in mature milk was found to be 0.69 mg/mL (Table 2.3). The 
concentration of LF in first colostrum from cows A to F ranged from 3.43 to 14.29 
mg/mL, which is between 5 and 21 times that found in mature milk. These values 
decreased with time post partum, but did not reach normal levels by the sixth 
milking (with the exception of cows B and C). The concentration of β-Lg was high 
initially, ranging from 6.9 to 29.7 mg/mL in first colostral milkings. These values 
decreased with time post partum and reached normal levels by the sixth milking 
(with the exception of cow D). In general, colostrum samples were found to contain 
elevated levels of α-La compared to mature milk, which contained, on average, 1.89 
mg/mL. No particular trend for α-La concentration was observed in the first six 
milkings from cows A to F, but some initial milkings were found to contain the 
highest concentrations, in particular the first milkings from cows B and E (4.07 and 
4.36 mg/mL. respectively). It is important to note that the values above were 
obtained by densitometric analysis and so are relative and not absolutely 
quantitative. These values should not be confused with those described in Section 
2.3.2, whereby the level of α-la, as a percentage of total α-la and β-lg, was 
calculated, as quantitation by RP-HPLC was not possible. In some colostrum 
samples and all mature milk samples, a band was evident in the molecular mass 





Figure 2.3 Sodium dodecyl sulphate-polyacrylamide gel electrophoretograms of colostrum from the first six milkings from cows A to F
and bulk mature milk samples 1 to 3. Fifty µg protein was loaded for each sample. Also shown are whey protein isolate (WPI) and
lactoferrin (Lf) standards.
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Table 2.3 Concentration of lactoferrin (Lf), immunoglobulin G heavy chain (Ig), beta-
lactoglobulin (β-Lg), and alpha-lactalbumin (α-La) in the first six milkings from cows 
A to F and bulk mature milk samples 1 to 3, as calculated using densitometric 
analysis (results shown are based on a single analysis). Total protein values are 
taken from Table 2.1. 
 
Sample total protein Lf Ig β-Lg α-La
mg/ml mg/ml mg/ml mg/ml mg/ml
A1 115 7.99 27.54 10.98 2.26
A2 71 3.10 12.55 7.82 2.69
A3 50 1.32 4.59 6.14 2.97
A4 48 1.05 2.46 6.42 2.78
A5 46 1.03 2.13 5.99 2.55
A6 40 0.87 1.43 5.19 2.22
B1 78 3.43 9.88 6.89 4.07
B2 58 1.45 3.42 5.57 3.23
B3 57 1.44 3.60 5.68 3.30
B4 59 1.15 3.10 6.14 2.70
B5 51 1.12 2.22 6.12 2.70
B6 52 0.77 1.94 5.82 2.49
C1 66 3.47 11.81 7.16 2.12
C2 53 0.94 5.61 6.70 2.72
C3 51 0.74 3.84 7.02 2.91
C4 48 0.89 3.50 6.61 2.82
C5 46 0.73 2.64 6.64 2.66
C6 44 0.68 2.29 6.02 2.40
D1 249 13.45 32.26 29.69 1.73
D2 150 10.21 32.79 19.17 1.36
D3 107 6.48 22.03 14.15 1.05
D4 71 3.35 11.91 10.19 2.18
D5 58 1.59 6.84 8.72 2.22
D6 52 1.02 4.21 7.95 2.02
E1 185 12.73 41.59 19.17 4.36
E2 81 4.26 15.22 9.15 2.49
E3 60 2.46 7.79 7.15 3.18
E4 54 1.95 5.17 6.69 2.56
E5 46 1.48 3.44 5.88 2.60
E6 48 1.42 2.99 6.03 2.05
F1 173 14.29 30.06 16.53 3.86
F2 84 5.32 12.32 9.25 3.59
F3 60 2.82 6.86 6.87 2.75
F4 52 1.86 4.04 6.55 2.55
F5 45 1.58 2.51 6.03 2.35
F6 43 1.17 1.83 6.02 2.29
Bulk 1 39 0.77 0.69 6.21 1.90
Bulk 2 38 0.67 0.64 6.01 1.85
Bulk 3 40 0.64 0.58 6.07 1.93
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2.3.4 Carbohydrate analysis 
 
Average levels of lactose, glucose and galactose for the first six milkings from cows 
A to F and bulk mature milk samples 1 to 3 are shown in Table 2.4. Lactose is a 
reducing disaccharide, composed of galactose and glucose linked by a β (1-4) 
glycosidic bond, the concentration of which in mature bovine milk is approximately 
4.8% (Fox, 2009).  Several factors influence the lactose content of milk, i.e., breed of 
cow, individuality factors, mastitis and, in particular, stage of lactation (Fox and 
McSweeney, 1998). Lactose concentration is reduced in colostrum and is inversely 
correlated with other constituents such as solids, protein, and ash (Kehoe et al., 
2007). In the current study, the level of lactose was found to be low initially and 
increased with time post partum (Table 2.4). Several authors reported a similar 
trend (Parrish et al., 1950; Klimes et al., 1986; Kehoe et al., 2007; Tsioulpas et al., 
2007a). In the current study, the concentration of lactose reached normal levels by 
the sixth milking post partum. This is in agreement with Klimes at al. (1986), but 
Tsiuolpas et al. (2007a) reported that the lactose concentration in colostrum and 
milk did not reach normal levels until 60 d post partum. Lactose is important in 
maintaining osmotic pressure in the mammary system and thus any increase or 
decrease in lactose is correlated with an increase or decrease in soluble salts (Holt, 
1985). This is consistent with the current study, i.e., colostrum samples with a low 
level of lactose contained an elevated level of certain minerals (Table 2.9). In the 
mammary gland, α-La forms a complex with the enzyme galactotransferase to form 
lactose synthase, which is responsible for lactose production (Neville, 2009). 
Decreasing levels of α-La during lactation have been correlated with decreasing 
levels of lactose (Larson, 1985). A positive correlation between the concentration of 
lactose and the relative proportion of α-La (as a percentage of total β-Lg and α-La) 
was found in the current study (Table 2.4). 
Milk contains several carbohydrates in addition to lactose. In the current study, 
large variations in the levels of free glucose and galactose were found. In general, 
no apparent trends were observed for glucose concentration in colostrum; 
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however, values were significantly lower than those found for mature milk (Table 
2.4). On average, mature milk samples contained 225.8 mg/L glucose (Table 2.4); 
Walstra (1999) and Cataldi et al. (2003) reported that mature bovine milk contains 
18.0 and 25.2 mg/L glucose, respectively, which is much lower than was found in 
the current study. The glucose content of colostrum samples was also elevated, 
compared to levels in mature milk, as reported by Walstra (1999) and Cataldi et al. 
(2003); however, they were not as high as those in mature milk samples. Galactose 
levels were low compared to mature milk samples, with the exception of the first 
milking of cows D and F. The galactose content of colostrum samples was high 
initially and decreased with time post partum. On average, the mature milk 
contained 133.7 mg/L galactose (Table 2.4). Walstra (1999) and Cataldi et al. (2003) 
reported that mature bovine milk contains 36.0 and 40.4 mg/L galactose, 
respectively, which, as for glucose, was a significantly lower level than was found in 















Table 2.4 Concentrations of lactose, glucose and galactose for the first six milkings 
from cows A to F and bulk mature milk samples 1 to 3, as determined by HPLC 
(results shown are based on a single analysis). α-La (as a % of total α-la and β-lg) 
values are taken from Table 2.2. 
 
Sample Lactose Glucose Galactose α-La
[g/L] [mg/L] [mg/L] (% of total α-La & β-Lg)
A1 29.8 49.7 116.1 18.28
A2 39.1 33.5 56.3 26.10
A3 42.4 34.2 36.5 31.71
A4 45.5 30.1 25.5 29.25
A5 45.3 34.3 27.9 30.03
A6 45.4 45.0 30.4 29.89
B1 35.8 62.1 119.7 35.89
B2 40.8 39.3 52.4 37.26
B3 44.2 51.3 55.6 37.29
B4 44.5 71.8 48.4 34.11
B5 47.9 73.9 39.9 32.98
B6 45.9 71.9 38.6 31.61
C1 21.9 16.1 24.3 24.10
C2 43.7 28.8 28.8 27.98
C3 44.7 33.5 28.3 24.99
C4 45.0 34.7 32.4 28.27
C5 45.6 35.1 22.1 24.69
C6 46.8 60.5 52.9 27.90
D1 8.1 19.1 248.4 3.74
D2 28.0 21.7 91.9 7.03
D3 34.3 29.3 86.7 9.98
D4 39.9 29.1 54.9 15.94
D5 40.8 23.3 35.1 17.22
D6 45.1 28.4 31.2 19.95
E1 22.7 61.9 136.4 9.76
E2 38.6 23.8 54.6 20.23
E3 40.9 19.0 42.0 26.82
E4 41.7 16.9 27.2 22.89
E5 45.4 8.4 23.0 26.15
E6 44.4 24.4 27.1 21.78
F1 23.1 45.6 155.0 9.78
F2 37.6 18.9 52.2 17.53
F3 43.3 21.0 44.6 22.49
F4 47.0 22.9 46.2 24.46
F5 48.1 51.7 45.9 25.41
F6 48.5 64.7 40.4 24.99
Bulk 1 48.4 226.6 132.8 21.58
Bulk 2 48.8 229.9 135.2 22.11
Bulk 3 48.6 221.0 133.0 22.45
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Lactose is the predominant carbohydrate in mature bovine milk, but colostrum 
contains less lactose and much higher concentrations of oligosaccharides than 
mature milk (Nakamura et al., 2003; Urashima et al., 2009). The oligosaccharides in 
milk can be divided into two broad classes, neutral and acidic. Nearly 40 
oligosaccharides are present in bovine milk, of which 70% are sialylated (Tao et al., 
2008). The concentration of oligosaccharides in bovine colostrum is approximately 
0.7 to 1.2 g/L (Veh et al., 1981), whereas mature milk contains only trace amounts 
(Gopal and Gill, 2000). In the current study, the level of oligosaccharides in 
colostrum varied with time post partum (Figure 2.4). Early colostral milkings 
contained significantly higher levels of oligosaccharides than later milkings and 
mature milk samples. This is in agreement with the studies of Gopal and Gill (2000), 











































































































































Figure 2.4 RP-HPLC chromatograms of the change in peak area of sialic acid and oligosaccharides in the first ( ), second ( ), third ( ), fourth








Table 2.5 presents L*a*b* values for the first six post partum milkings from cows A 
to F and bulk mature milk samples 1 to 3. The colour of milk is typically dominated 
by the presence of casein micelles and fat globules, which scatter light and are the 
reason for the white/opaque appearance of milk (Fox and McSweeney, 1998). 
Colostrum has a reddish-yellow colour (Edelsten, 1988). The yellow colour is due to 
the presence of carotenoid pigments (Edelsten, 1988), which are not synthesised by 
the animal but are obtained from feed sources. It has been reported that levels of 
carotenoid pigments are high in the initial colostrum, in particular the fat fraction, 
but decrease rapidly as the mammary secretions change to normal milk (Parrish et 
al., 1948). The red colour is due to the presence of red blood cells. During the pre 
partum period there is increased permeability of the mammary gland membranes, 
and thus more blood constituents gain access to the milk. Linzell and Peaker (1975) 
observed that as little as 0.1 mL blood/L of milk can be detected visually and that 
0.4 mL/L turns milk very pink.  
As can be seen from Table 2.5, large variations in L*a*b* values were found. In 
general, colostrum samples were darker (lightness, L*, was low initially and 
increased over the six milkings), more red (redness, a*, high initially and decreased 
over the six milkings) and more yellow (yellowness, b*, was high throughout the 
first six milkings), compared to mature milk samples. Madsen et al. (2004) analysed 
the colour of colostrum and mature milk over 14 d. Results of the two studies are 
not comparable, as Madsen et al. (2004) used a black capsule when measuring 
colour, which greatly affected L* values, but the trends in L*a*b* values over the 
first 6 milkings were consistent with those of the current study: L* values were low 
initially but increased over time, while a* and b* values decreased over time. The 
initial colostrum from cow E, and in particular cow F, had a very low L* value (71.03 
and 53.24 for the first milking from cow E and F, respectively) and high a* value       
(-1.75 and 14.72 for the first milking from cows E and F, respectively). This suggests 
that colostrum contained relatively high levels of red blood cells. The first milkings 
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from cows A, D and, in particular cow E, were very yellow, which is reflected by very 
high b* values (35.95, 37.22, 31.91, respectively). This suggests that these 
colostrum samples contained high levels of carotenoid pigments. 
Table 2.5 Mean values (± S.D., n=3) of colour (lightness-blackness, L; greenness-
redness, a; and blueness-yellowness, b) for the first six milkings from cows A to F 
and bulk mature milk samples 1 to 3. Values without an asterisk (*) were 
significantly different (p < 0.05) from control bulk milk samples. 
 
Sample
A1 75.49 ± 0.03 -3.45
*
± 0.01 35.95 ± 0.09
A2 78.28
*
± 0.05 -1.57 ± 0.04 35.95 ± 0.01





± 0.03 18.94 ± 0.01
A5 81.75
*





± 0.11 -3.83 ± 0.01 9.96 ± 0.01
B1 79.94 ± 0.07 -4.30 ± 0.01 18.79 ± 0.03
B2 80.79 ± 0.08 -4.90 ± 0.03 17.56 ± 0.17
B3 80.86 ± 0.02 -4.90 ± 0.01 17.43 ± 0.04
B4 81.22 ± 0.03 -3.30 ± 0.03 25.60 ± 0.01
B5 80.68 ± 0.01 -4.38 ± 0.02 16.21 ± 0.05
B6 81.82
*
± 0.04 -3.60 ± 0.02 19.95 ± 0.03
C1 79.28 ± 0.15 -3.83 ± 0.02 21.01 ± 0.15





± 0.02 13.39 ± 0.02
C4 81.47
*
± 0.05 -3.28 ± 0.01 20.66 ± 0.06
C5 81.84
*








D1 73.43 ± 0.03 -1.02 ± 0.04 37.22 ± 0.08
D2 76.25 ± 0.09 -3.25 ± 0.03 27.19 ± 0.10
D3 79.63 ± 0.01 -3.03 ± 0.06 26.45 ± 0.03
D4 79.99 ± 0.11 -3.47
*
± 0.04 23.00 ± 0.29
D5 80.49 ± 0.09 -3.43
*
± 0.04 19.00 ± 0.07
D6 81.15 ± 0.02 -3.84 ± 0.02 14.74 ± 0.03
E1 71.03 ± 0.01 -1.75 ± 0.03 31.91 ± 0.06
E2 73.54 ± 0.09 3.80 ± 0.01 18.69 ± 0.11
E3 77.43 ± 0.21 0.27 ± 0.03 21.02 ± 0.10
E4 79.50 ± 0.02 -2.46 ± 0.07 19.83 ± 0.02
E5 80.21 ± 0.03 -3.46
*
± 0.03 15.04 ± 0.09
E6 81.15 ± 0.32 -3.26 ± 0.03 13.78 ± 0.08
F1 53.24 ± 0.04 14.72 ± 0.01 18.67 ± 0.03
F2 64.26 ± 0.05 6.32 ± 0.04 14.21 ± 0.03
F3 71.92 ± 0.16 0.70 ± 0.02 14.39 ± 0.03
F4 76.51 ± 0.06 0.95 ± 0.02 16.93 ± 0.03
F5 79.44 ± 0.06 -2.44 ± 0.01 13.96 ± 0.03
F6 74.90 ± 0.02 0.04 ± 0.03 15.94 ± 0.02
Bulk 1 81.84 ± 0.01 -2.91 ± 0.01 8.82 ± 0.01
Bulk 2 77.89 ± 0.08 -3.14 ± 0.02 10.26 ± 0.00




2.3.6 Ultracentrifugal sedimentation 
 
 Casein exists in milk as large colloidal micelles, most (90-95%) of which may be 
sedimented by centrifugation at 100,000 g for 1 h (O’Mahony and Fox, 2013). Mean 
values for non-sedimentable protein after ultracentrifugation (100, 000 g x 1 h) of 
the first six milkings form cows A to F and bulk mature milk samples 1 to 3 are 
shown in Table 2.6. The concentration of sedimentable and non-sedimentable 
protein has been discussed in Section 2.3.1. Briefly, the level of sedimentable, and, 
in particular, non-sedimentable protein, were very high initially and decreased with 
time post partum, but in general did not reach normal levels by the sixth milking. 
The non-sedimentable material was analysed by RP-HPLC (Section 2.3.6) and the 
proportions of individual caseins (к-, αS1- and β-caseins) in ultracentrigugal 
supernatants, as a percentage of total casein (excluding αS2-casein), was calculated 
(Table 2.7). It is clear from Table 2.7 that a significant proportion of the casein, in 
particular in early milkings, was non-sedimentable. The range of non-sedimentable 
casein, as a percentage of total casein, for the first milkings of cows A to F at 20°C, 
was 11.3 to 86.8%. These values decreased with time post partum and in all cases 
reached normal levels by the sixth milking. The most likely explanation for the poor 
sedimentability of the casein micelles in colostrum was the high viscosity of certain 
samples (Table 2.1). The relationship between sedimentation of particles and 
viscosity is described by the equation: 
V = (2r2 [ρ1-ρ2]/9η) x ω2r 
where V is sedimentation velocity (svedberg), r is the radius of the particle (m), ρ1 is 
the density of the continuous phase (kg/m3), ρ2 is the density of the dispersed 
phase (kg/m3), η is the viscosity (Pa s) and ω2r is centrifugal acceleration. A 
correlation existed between the high viscosity of some early milkings (Table 2.1) 
and poor sedimentability of casein micelles in colostrum (Table 2.6 and 2.7). 
However, this was not true in all cases, e.g., the first milking from cow C had a 
viscosity of 2.5 mPa s (Table 2.1) and 11.3% of casein did not sediment at 20°C 
when centrifuged at 100,000 g x 1 h (Table 2.7) whereas, for  bulk mature milk 
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sample 1, which had a higher viscosity than the first milking from cow C (4.8 mPa s), 
only 3.42% of casein did not sediment at 20°C when centrifuged at 100, 000 g x 1 h. 
Of the individual caseins which did not sediment at 100,000 g, к-casein was present 
in the highest proportion, relative to the initial concentration of each individual 
casein. The stability of casein micelles in an aqueous system is due primarily to 
steric and electrostatic interactions, caused by the hairs of к-casein (Walstra, 1990); 
De Kruif (1999) described к-casein as a polyelectrolyte brush which sterically 
stabilises the casein micelles and maintains solvency. Another possible explanation 
for the poor sedimentability of casein micelles in certain colostrum samples is the 
high level of glycosylated к-casein, which may lead to enhanced steric and 
electrostatic interactions, thereby increasing solvency. Also, salts in the serum 
phase of milk have the ability to increase micellar solubility by stabilisation of the 
hydrophilic end of к-casein through ionic bonding (Roach and Harte, 2008). This 
may also be a contributory factor to the poor sedimentability of casein micelles, as 
colostrum samples contained high salt levels (Table 2.9). The same trend was 
observed for non-sedimentable protein at 4°C, but significantly more casein was 
non-sedimentable at 4°C than at 20°C. This is because, at low temperatures, casein 
dissociates from the micelles, and β-casein is the predominant protein released 
(Post et al., 2012; Liu et al., 2013). Several authors have reported that the solubility 
of β-casein increases as the temperature is reduced (Bingham, 1971; Post et al., 
2012). The range of non-sedimentable casein, as a percentage of total casein, for 
the first milkings of cows A to F at 4°C, was 24.9 to 99.3%. Once again, these values 
decreased with time post partum and in all cases reached normal levels by the sixth 
milking (Table 2.7). The average level of non-sedimentable casein, as a percentage 








Table 2.6 Mean levels (± S.D., n=3) of protein not sedimented by 
ultracentrifugation at 100,000 g x 1h at 4°C or 20°C for the first six milkings from 
cows A to F and bulk mature milk samples 1 to 3. Values without an asterisk (*) 
were significantly different (p < 0.05) from control bulk milk samples. 
 
Sample
A1 77.46 ± 0.87 67.35 ± 0.75 70.21 ± 0.71 61.05 ± 0.62
A2 41.58 ± 0.30 58.57 ± 0.42 34.39 ± 0.30 48.44 ± 0.42
A3 19.40 ± 0.11 38.80 ± 0.23 16.86 ± 0.17 33.72 ± 0.35
A4 17.29 ± 0.05 36.02 ± 0.11 13.55 ± 0.45 28.24 ± 0.93
A5 13.89 ± 0.07 30.20
*












B1 35.37 ± 0.65 45.35 ± 0.83 28.34 ± 0.14 36.34 ± 0.17
B2 18.93 ± 0.27 32.64
*
± 0.47 13.12 ± 0.03 22.62
*
± 0.05
B3 18.97 ± 0.23 33.29
*
± 0.40 13.58 ± 0.12 23.82
*
± 0.22
B4 20.12 ± 0.14 34.11
*
± 0.23 13.25 ± 0.01 22.46
*
± 0.01
B5 16.09 ± 0.58 31.54 ± 1.15 11.19 ± 0.20 21.94
*
± 0.40
B6 16.04 ± 0.27 30.85 ± 0.52 10.99 ± 0.09 21.13
*
± 0.18
C1 31.27 ± 0.29 47.38 ± 0.44 27.18 ± 0.17 41.17 ± 0.25
C2 19.59 ± 0.44 36.97 ± 0.84 16.34 ± 0.39 30.83 ± 0.73
C3 19.72 ± 0.08 38.67 ± 0.15 16.59 ± 0.09 32.53 ± 0.18
C4 15.78 ± 0.16 32.88
*
± 0.34 12.67 ± 0.06 26.40 ± 0.12
C5 17.05 ± 0.35 37.06 ± 0.76 12.79 ± 0.15 27.80 ± 0.33
C6 14.69 ± 0.33 33.38 ± 0.75 10.98 ± 0.15 24.94 ± 0.34
D1 180.26 ± 1.15 72.39 ± 0.46 171.34 ± 0.71 68.81 ± 1.06
D2 106.25 ± 0.15 70.83 ± 0.10 96.63 ± 0.09 64.42 ± 0.06
D3 67.88 ± 0.34 63.44 ± 0.32 58.07 ± 0.01 54.27 ± 0.01
D4 35.36 ± 0.52 49.80 ± 0.74 30.06 ± 0.03 42.34 ± 0.04
D5 22.94 ± 0.19 39.56 ± 0.33 19.07 ± 0.19 32.88 ± 0.33
D6 26.53 ± 0.94 51.02 ± 1.81 19.98 ± 1.41 38.43 ± 1.56
E1 132.51 ± 0.64 71.63 ± 0.35 130.62 ± 0.59 70.61 ± 0.32
E2 44.19 ± 0.48 54.56 ± 0.59 38.21 ± 0.21 47.17 ± 0.26
E3 26.06 ± 0.73 43.43 ± 1.22 19.69 ± 2.33 32.82 ± 0.39
E4 21.46 ± 0.03 39.74 ± 0.05 15.82 ± 0.01 29.30 ± 0.03
E5 14.66 ± 0.13 31.86
*
± 0.27 11.20 ± 0.19 24.34 ± 0.40
E6 16.17 ± 0.05 33.69
*
± 0.11 10.45 ± 0.10 21.76
*
± 0.21
F1 124.19 ± 0.71 71.79 ± 0.41 109.76 ± 0.49 63.44 ± 0.28
F2 43.20 ± 0.03 51.43 ± 0.04 37.30 ± 0.39 44.41 ± 0.46
F3 24.52 ± 0.39 40.86 ± 0.65 21.57 ± 0.28 35.96 ± 0.46
F4 16.67 ± 0.00 32.06
*














± 0.01 20.23 ± 0.10
Bulk 1 10.30 ± 0.01 26.41 ± 0.02 8.26 ± 0.07 21.18 ± 0.13
Bulk 2 12.73 ± 0.06 33.50 ± 0.15 7.87 ± 0.14 20.71 ± 0.03
Bulk 3 11.33 ± 0.20 28.33 ± 0.49 9.23 ± 0.00 23.06 ± 0.42
protein (g/L) (as a % of total protein) protein (g/L) (as a % of total protein)
4°C 20°C
non-sedimentable soluble protein non-sedimentable soluble protein
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Table 2.7 Percent of total casein in skimmed colostrum which was non-
sedimentable on ultracentrifugation at 100, 000 g x 1 h at 4°C or 20°C for the first 
six milkings from cows A to F and bulk mature milk samples 1 to 3. Also shown is 
the proportion of individual caseins (к-, αS1- and β-caseins) present in 
ultracentrifugal supernatants. Values were calculated based on peak areas from RP-
HPLC chromatograms (not shown). 
 
Sample
non-sedimentable casein αS1-casein β-casein к-casein non-sedimentable casein αS1-casein β-casein к-casein
as a % of total casein as a % of total casein
A1 45.73 32.92 34.49 32.59 36.44 30.38 33.45 36.17
A2 48.50 33.63 39.90 26.47 26.59 28.13 37.70 34.17
A3 27.00 30.84 41.30 27.87 14.28 25.64 38.04 36.32
A4 26.65 31.65 45.03 23.32 10.93 24.96 41.78 33.27
A5 19.84 32.44 44.24 23.32 6.19 18.85 45.10 36.05
A6 13.33 29.92 48.11 21.96 0.89 10.81 34.36 54.83
B1 45.92 37.91 32.56 29.52 20.63 34.88 24.78 40.34
B2 23.84 31.68 39.21 29.12 7.67 22.60 34.77 42.63
B3 25.33 31.51 40.84 27.65 8.87 22.75 35.53 41.72
B4 31.12 34.26 42.81 22.94 8.94 25.06 37.75 37.20
B5 21.31 31.48 46.75 21.78 5.26 22.07 43.17 34.77
B6 19.14 42.32 33.75 23.93 4.01 55.87 13.94 30.18
C1 24.85 32.82 33.71 33.47 11.31 26.32 33.41 40.27
C2 23.62 28.10 44.14 27.76 7.11 24.12 27.82 48.06
C3 25.13 32.44 39.71 27.85 4.97 32.88 15.01 52.11
C4 18.69 28.24 47.72 24.05 6.21 21.46 44.21 34.33
C5 25.79 31.94 47.34 20.72 7.13 27.94 36.01 36.06
C6 20.11 32.22 45.09 22.69 5.29 21.85 36.99 41.16
D1 86.44 39.58 36.70 23.72 86.79 42.37 33.82 23.82
D2 67.27 35.01 39.15 25.85 46.68 36.23 39.33 24.44
D3 55.82 32.99 39.81 27.19 25.44 29.85 34.09 36.07
D4 29.67 32.56 39.15 28.30 11.33 31.36 30.24 38.40
D5 28.17 30.13 45.14 24.72 9.36 26.59 35.71 37.70
D6 15.55 28.68 43.73 27.59 3.64 32.51 22.60 44.90
E1 99.30 37.97 37.17 24.86 62.88 38.86 36.00 25.13
E2 47.24 31.46 40.69 27.85 15.40 29.76 33.72 36.52
E3 28.54 30.90 38.62 30.48 9.18 27.57 26.50 45.93
E4 31.81 30.32 43.70 25.98 7.09 27.54 30.00 42.46
E5 16.11 33.98 36.82 29.20 3.88 29.02 21.38 49.59
E6 25.86 30.17 47.03 22.80 1.87 18.53 14.93 66.54
F1 80.30 34.71 39.71 25.58 40.02 35.06 35.67 29.27
F2 36.46 29.36 39.79 30.84 16.27 28.98 34.18 36.84
F3 26.06 29.87 40.56 29.57 13.34 31.84 31.31 36.86
F4 19.45 26.30 47.88 25.82 3.39 26.62 20.02 53.36
F5 11.86 28.20 44.59 27.21 0.74 0.00 0.00 100.00
F6 23.57 34.01 43.18 22.81 0.86 0.00 12.71 87.29
Bulk 1 16.34 24.91 50.84 24.25 3.42 24.31 27.08 48.62
Bulk 2 24.36 30.18 48.94 20.88 2.93 21.44 30.11 48.45
Bulk 3 18.75 25.86 49.54 24.60 6.78 29.55 35.58 34.87
as a % of non-sedimentable casein as a % of non-sedimentable casein
Ultracentrifugal supernatant (20°C)Ultracentrifugal supernatant (4°C)
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2.3.7 Heat-induced coagulation  
 
The heat stability of milk refers to the ability of milk to withstand high processing 
temperatures without visual signs of coagulation or gelation (Singh, 2004). Mature 
milk is a very heat-stable system, which allows it to be subjected to severe heat 
treatments with relatively minor changes (Fox, 1982). The heat coagulation time 
(HCT) of mature milk is affected by a number of factors, pH being the most 
important (Singh, 2004). Generally, in mature milk, HCT increases with increasing 
pH from 6.4 to 6.7 but decreases sharply below pH 6.4 (Fox and McSweeney, 1998). 
The proteins in milk are probably the constituents most affected by heating. This is 
especially true for colostrum, due to its elevated whey protein content. The whey 
proteins, which in colostrum represent up to 70% of total protein (Table 2.1), are 
globular proteins with high levels of secondary and tertiary structures, and are 
therefore susceptible to denaturation by heating (Fox and McSweeney, 1998). 
Table 2.8 presents the heat coagulation times of the first six milkings from cows A 
to F and bulk mature milk samples 1 to 3, measured at the natural pH of each 
sample, at temperatures ranging from 70 to 140°C. It was found that mature milk 
samples did not coagulate in 15 min, even when heated to 140°C, while early 
colostrum samples were the most susceptible to heat-induced coagulation. This is 
most likely due to a combination of early colostrum samples containing the highest 
concentrations of whey proteins (Table 2.1) and also having the lowest pH (Table 
2.1). Oldfield et al. (2005) observed a similar trend where the rate of whey protein 
denaturation and aggregation in mature milk increased with increasing whey 
protein concentration. In all cases, there was an increase in the heat coagulation 
time of colostrum with time post partum. This was due to decreasing levels of whey 
proteins and increasing pH with time post partum. The first milking from cows A to 
F coagulated at 70°C. Large variations in HCT between individual cows were 
observed, for reasons discussed above. For cow D, colostrum from the first four 
milkings coagulated at 70°C. In contrast to this, the second to fifth milkings from 
cow B required heating to 140°C for coagulation. It is clear from the current study  
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Table 2.8 Heat stability of samples from the first six milkings from cows A to F and 
bulk mature samples 1 to 3 measured at natural pH values 
 
x indicates samples did not coagulate in 15 min 
that, even at the sixth milking, colostrum samples are relatively heat-labile 
compared to mature milk. 
Sample 70°C 80°C 90°C 100°C 120°C 140°C
A1 3.98
A2 6.16
A3 x x 9.35
A4 x x x x x 5.13
A5 x x x x x 12.22
A6 x x x x x 12.78
B1 8.37
B2 x x x x x 9.50
B3 x x x x x 10.07
B4 x x x x x 8.85
B5 x x x x x 14.62
B6 x x x x x 14.98
C1 11.32
C2 x x 4.95
C3 x x 10.25
C4 x x x x x 7.50
C5 x x x x x 4.50











E5 x x x x 10.22





F5 x x x 11.10
F6 x x x x 6.66
Bulk 1 x x x x x x
Bulk 2 x x x x x x
Bulk 3 x x x x x x





Average values for the mineral composition of colostrum from the first six milkings 
of cows A to F and bulk mature milk samples 1 to 3 are shown in Table 2.9. The salts 
in milk exist in a dynamic equilibrium between the soluble and colloidal phases, and 
play an important role in the stability of the proteins. The mineral content has a 
profound effect on the technological properties of milk, as it affects its heat stability 
and susceptibility to renneting, gelation and sedimentation (Tsioulpas et al., 2007b). 
The composition of milk salts is influenced by several factors, especially by the 
stage of lactation (Holt, 1985). Klimes et al. (1986) and Tsioulpas et al. (2007a) 
found that concentrations of Ca, Mg, P, Na and K were highest in colostrum at the 
first milking post partum. In the current study, large variations in mineral 
concentrations were observed but, in general, colostrum samples contained 
elevated levels of Na, Mg, P, K and Ca, which decreased with time post partum 
(Table 2.9). 
Calcium partitions between the colloidal and serum phases and is in 
electrochemical equilibrium with several major milk components (Silanikove et al., 
2003). The distribution of Ca between the colloidal and serum phases in milk is 
governed by the level of casein in the milk (Holt and Jenness, 1984). The mature 
milk samples contained, on average, 1396 mg/L Ca (Table 2.9), which is in 
agreement with reported values (Fox and McSweeney, 1998).  In general, the total 
Ca content was very high in colostrum samples. This was most evident for the first 
milkings from cows D, E and F. Cow F contained the highest level of total Ca; the 
concentration of Ca at the first milking was 2991 mg/L, and declined to 2157 mg/L 
at the second milking, and to 1667 mg/L by the sixth milking. Tsioulpas et al. 
(2007a) observed a similar trend over the first 3 days post partum, at which time 
total Ca varied from 2172 to 1551 mg/L. Similar trends were seen for the first six 
milkings from cows D and E, in which the Ca concentration decreased from 2300 to 
1412 mg/L and 2964 to 1513 mg/L, respectively. The high concentration of Ca in 
colostrum is most likely due to elevated levels of casein (Table 2.1), which act as a 
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Ca carrier in milk (Little and Holt, 2004).  The colostrum from Cow B contained an 
elevated level of Ca, especially in early milkings, but this figure reached normal 
levels by the sixth milking. All milkings from cows A and C, with the exception of the 
first milking from cow A, contained average concentrations of calcium, i.e. 
approximately 1200 mg/L. Tsioulpas et al. (2007a) reported that the Ca2+ levels in 
milk increased as the pH decreased. Ca2+ was not measured in the current study, 
but it is speculated that colostrum samples would contain high levels of Ca2+, due to 
the combined effect of low pH (Table 2.1) and high Ca level (Table 2.9).  
Phosphorus in milk exists in several forms, e.g., free inorganic orthophosphate in 
solution, colloidal phosphate associated with Ca in micellar Ca phosphate (CCP) and 
the ester phosphate of various proteins and phospholipids (Lucey and Horne, 2009). 
Total phosphorus was measured in the current study (Table 2.9). Mature milk 
samples were found to contain, on average, 1029 mg/L P, which is in agreement 
with reported values (Fox and McSweeney, 1998). In general, the total P content 
was very high in colostrum. This was most evident for the early milkings from cows 
B, E and F. Cow E contained the highest levels of total P, i.e., 2564 mg/L at the first 
milking, declined to 1968 mg/L at the second milking and 1865 mg/L by the sixth 
milking. Similar trends were seen for the first six milkings from cows B and F, in 
which the P concentration over the first six milkings ranged from 1804 to 1133 mg/L 
and 2127 to 1345 mg/L, respectively.  
The concentration of Na in colostrum was not as elevated as that of Ca and P. In the 
current study, the average concentration of Na in mature milk was 500 mg/L (Table 
2.9), which is in agreement with reported values (Fox and McSweeney, 1998). 
Colostrum from cows D, E and F contained the highest concentrations (mg/L) of Na, 
ranging from 713-557, 914-549 and 935-527 mg/L, respectively. Na concentrations 
in the first six milkings from cows A, B and C were slightly lower than average levels 
found in mature milk.  
The concentration of Mg in colostrum samples was found to be very high, especially 
in early milkings. The average concentration of Mg in mature milk in the current 
study was found to be 131 mg/L (Table 2.9), which is in agreement with reported 
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values (Fox and McSweeney, 1998).  Colostrum from cows D, E and F contained the 
highest concentrations of Mg, ranging from 527-132, 610-143 and 477-150 mg/L, 
respectively. Mg concentrations in milkings from cows A, B and C were found to be 
high initially, but decreased rapidly and fell below average levels by the third 
milking.  
Mature milk contains approximately 1450 mg/L K (Fox and McSweeney, 1998). The 
average concentration of K in mature milk samples in the current study was found 
to be 1773 mg/L (Table 2.9), which is higher than reported values. No particular 
trend was found regarding K concentration, which ranged from 2991 to 941 mg/L 
across all colostrum samples. This is in agreement with the study of Tsioulpas et al. 





















Table 2.9 Mean values (± S.D., n=3) for concentration of Na, Mg, P, K and Ca for the 
first six milkings from cows A to F and bulk mature milk samples 1 to 3. Values 
























































± 3 192 ± 1 1804 ± 20 1785
*










± 0 1712 ± 22 1969
*







































± 0 1293 ± 10 1749
*





± 1 1355 ± 10 1751
*























± 54 1165 ± 33
D1 670 ± 31 527 ± 22 1694 ± 81 1134 ± 66 2085 ± 95
D2 592
*
± 5 387 ± 5 2049 ± 45 2028
*
± 37 2300 ± 40
D3 557
*
± 23 261 ± 9 1648 ± 44 1900
*
± 80 1682 ± 51
D4 713 ± 16 210 ± 5 1715 ± 42 2291 ± 54 1799 ± 41
D5 682 ± 61 136
*





D6 667 ± 1 132
*





E1 914 ± 49 610 ± 32 2564 ± 159 1723
*
± 104 2964 ± 13
E2 645 ± 9 264 ± 4 1968 ± 41 2005
*
± 38 2106 ± 35





± 15 1771 ± 17 2017
*














± 1 1815 ± 8 2177 ± 15 1812
*
± 16
F1 935 ± 133 477 ± 62 2127 ± 31 1538
*
± 23 2991 ± 41
F2 645 ± 54 279 ± 22 1984 ± 17 2039
*
± 18 2157 ± 18
F3 623
*





± 3 1513 ± 35 1779
*





± 19 1391 ± 21 1752
*





± 6 1345 ± 35 1798
*
± 69 1667 ± 70
Bulk 1 468 ± 10 126 ± 27 976 ± 24 1652 ± 39 1345 ± 30
Bulk 2 519 ± 8 136 ± 2 1068 ± 4 1775 ± 13 1486 ± 16
Bulk 3 512 ± 6 131 ± 16 1044 ± 53 1893 ± 36 1357 ± 57
Na Mg P K Ca
mg/L mg/L mg/L mg/L mg/L
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2.3.9 Rennet coagulation time (RCT) and rheology of rennet-induced gels 
 
RCT values, measured at both the natural pH and at pH 6.6, for the first six milkings 
from cows A to F and bulk mature milk samples 1 to 3 are shown in Table 2.10. The 
main factors affecting the rennet clotting of milk are enzyme concentration, 
temperature, pH and concentration of Ca2+ (Najera et al., 2003). The enzyme 
concentration and temperature used in the current study did not vary and so will 
not be discussed. It is well known that reducing the pH of milk from 6.7 to 5.8 
causes a decrease in clotting time (Dalgleish., 1993; Fox and McSweeney, 1998; 
Daviau et al., 2000; Madsen et al., 2004), due to a combination of factors, including 
increased rennet activity as the enzyme moves towards its pH optimum, a 
reduction in the electrostatic repulsion between micelles as a result of increased 
Ca2+ activity, and flocculation at a lower degree of к-casein hydrolysis (Walstra, 
1993). In general, it was found that the RCT of colostrum, measured at its natural 
pH, decreased with time post partum. This decrease in RCT was inversely related to 
an increase in the natural pH of colostrum, which is not in agreement with the 
behaviour of mature milk, as reported by Dalgleish (1993), and cannot be 
explained; an increase in RCT with increasing pH was expected. Colostrum samples, 
in particular early milkings, contained high concentrations of calcium (Table 2.9), 
which decreased with time post partum. Addition of Ca2+ causes a decrease in RCT 
due to the neutralization of negatively charged residues on caseins, which increases 
the aggregation of renneted micelles (Lucey and Fox, 1993). In general, the 
opposite effect was seen here, where RCT decreased with decreasing calcium 
concentration. Madsen et al. (2004) reported that RCT decreases with increasing 
protein concentration. The opposite effect was found in the current study, where 
RCT values decreased with decreasing protein concentration. The exception to 
these irregularities was cow C, where RCT values increased with increasing pH and 
decreasing protein concentration.  
In most cases, increasing the natural pH of colostrum to pH 6.6 resulted in a 
significant increase in RCT. At pH 6.6, RCT of colostrum from cows A and B was high 
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initially and decreased with time post partum. In general, at pH 6.6, the RCT of 
colostrum, in particular in early milkings, was higher than that of bulk mature milk. 
Other factors which may have affected the RCT of colostrum were viscosity and the 
presence of protease inhibitors. The high viscosity of colostrum may have caused an 
increase in RCT by limiting diffusion of para-к-casein resulting in slower aggregation 
of casein micelles. Colostrum contains a number of enzyme inhibitors, all of which 
originate from the blood (Kelly et al., 2006), the concentration of which is highest 
initially and decreases with time post partum (Georgiev, 2008). Huppertz et al. 
(2006) reported that protease inhibitors present in blood serum can significantly 
reduce chymosin activity, which could lead to an increase in the RCT of milk. 
Table 2.10 Mean values (± S.D., n = 3) for pH, RCT at natural pH, and RCT at pH 6.6 
for colostrum from the first six milkings from cows A to F and bulk mature milk 
samples 1 to 3. Values without an asterisk (*) were significantly different (p < 0.05) 
from control bulk milk samples. 
 
Sample pH
A1 6.31 5.10 ± 0.09 7.89 ± 0.02
A2 6.37 4.56 ± 0.06 7.26 ± 0.05
A3 6.40 4.73 ± 0.04 8.07 ± 0.14
A4 6.47 4.40 ± 0.03 5.10 ± 0.04
A5 6.44 3.20 * ± 0.02 4.35 ± 0.02
A6 6.46 3.28 * ± 0.03 4.20 ± 0.06
B1 6.37 2.89 ± 0.02 4.33 ± 0.03
B2 6.32 2.57 ± 0.02 4.16 ± 0.01
B3 6.32 3.50 * ± 0.01 4.15 ± 0.01
B4 6.36 2.43 ± 0.03 3.30 * ± 0.01
B5 6.40 3.10 ± 0.01 3.08 ± 0.04
B6 6.47 3.27 * ± 0.02 3.02 ± 0.01
C1 6.39 2.36 ± 0.03
C2 6.44 4.18 ± 0.01
C3 6.51 4.10 ± 0.02
C4 6.54 5.68 ± 0.02
C5 6.48 7.57 ± 0.01
C6 6.50 5.10 ± 0.01
D1 6.28 0.46 ± 0.12
D2 6.25 4.04 ± 0.11 6.92 ± 0.07
D3 6.39 1.50 ± 0.04
D4 6.51 1.83 ± 0.08
D5 6.68 3.20 * ± 0.02
D6 6.67 2.97 ± 0.02
E1 6.39 3.90 * ± 0.21
E2 6.47 3.58 * ± 0.20
E3 6.42 2.80 ± 0.08
E4 6.53 1.21 ± 0.04 3.41 * ± 0.02
E5 6.52 1.64 ± 0.02
E6 6.44 3.92 * ± 0.02
F1 6.35 8.20 ± 0.01
F2 6.33 3.90 * ± 0.01 5.63 ± 0.03
F3 6.26 3.00 ± 0.02
F4 6.34 2.30 ± 0.01 4.20 ± 0.03
F5 6.35 2.72 ± 0.02 3.23 ± 0.04
F6 6.37 2.22 ± 0.02
Bulk 1 6.66 3.79 ± 0.01
Bulk 2 6.62 3.37 ± 0.01
Bulk 3 6.66 3.62 ± 0.03
RCT RCT 
natural pH pH 6.6
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Small-amplitude oscillatory rheology was used to characterise the rheological 
properties of rennet-induced gels without damaging the gel network (Table 2.11 
and Figure 2.5). Gel properties were studied for 90 min after rennet addition; 
however, it should be noted that G’ values presented in Table 2.11 were not the 
final G’ values in all cases, i.e., for some samples, the G’ value was still increasing 
after 90 min (Figure 2.5). In general, G’ of gels formed at the natural pH value was 
very high initially and decreased with time post partum, but, in most cases, did not 
reach normal levels by the sixth milking. On average, the G’ value of bulk mature 
milk was found to be 87.1 Pa. G’ values of the first milkings from cows D and E were 
over five times greater than this, i.e., 495.9 and 495.8 Pa, respectively. The high G’ 
values in colostrum samples are probably due to a combination of factors, e.g., low 
pH, high levels of casein and calcium. As a result, both bond formation between 
casein particles, and particle fusion, are likely to proceed faster, resulting in higher 
G’ values. Daviau et al. (2000) observed that increasing the concentration of casein 
in skim milk led to a reduction in RCT and an increase in G’. The same authors found 
that decreasing pH in the range 6.4 to 6.0 resulted in an increased firming rate. In 
general, the opposite was seen for G’ values, measured at a fixed pH value of 6.6, 
where the G’ value of colostrum samples increased with time post partum.   
The effect of interchanging the serum phase of colostrum and bulk mature milk on 
the rheology of rennet-induced gels was investigated (Table 2.11). The serum phase 
of colostrum and bulk mature milk was prepared by ultracentrifugation at 100,000 
g x 1 h at 20°C. The average G’ value of bulk mature milk 3 was 90.27 Pa; however, 
interchanging the serum phase of this sample with either the first milking from cow 
B or the second milking from cow F resulted in an increase in the G’ value of bulk 
mature milk 3 (138.71 and 122.99 Pa, respectively). This increase in G’ was most 
likely because of the high proportion of casein in colostrum which was non-
sedimentable at 100,000 g x 1 h (Table 2.7), thereby increasing the concentration of 
casein in bulk mature milk 3. Another explanation for the increase in G’ was the 
effect of pH; the pH of colostrum was lower than that of bulk mature milk (Table 
2.1), and so, interchanging the serum phase of colostrum with bulk mature milk 
would reduce the pH of bulk mature milk, thereby reducing the RCT and increasing 
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G’. The opposite effect was observed after interchanging the serum phase of the 
first milking from cows B or F with that of bulk mature milk 3, i.e., G’ values 
decreased from 406.61 and 111.11 Pa to 143.99 and 47.93 Pa, respectively. As 
before, this decrease in G’ was most likely because of the high proportion of casein 
in colostrum which was non-sedimentable at 100,000 g x 1 h (Table 2.7), thereby 
reducing the concentration of casein in the first milkings of cows B and F. Also, 
interchanging the serum phase of colostrum with bulk mature milk would increase 
the pH of colostrum, thereby increasing the RCT and reducing G’ values. 
Table 2.11 Mean values (± S.D., n = 3) for pH, G’ values at the natural pH, and G’ 
values at pH 6.6, of rennet-induced gels for colostrum from the first six milkings 
from cows A to F and bulk mature milk samples 1 to 3. Values without an asterisk 
(*) were significantly different (p < 0.05) from control bulk milk samples. 
Sample pH
A1 6.31 112.56 * ± 8.33 29.04 ± 1.87
A2 6.37 16.30 ± 2.11
A3 6.4 139.90 ± 7.90 47.72 ± 3.34
A4 6.47 149.96 ± 4.13
A5 6.44 153.54 ± 6.11 132.32 ± 3.98
A6 6.46 142.66 ± 5.97
B1 6.37 406.61 ± 11.49
B2 6.32 301.61 ± 13.02 191.70 ± 9.22
B3 6.32 257.71 ± 12.68
B4 6.36 281.10 ± 12.00 226.06 ± 10.13
B5 6.4 271.75 ± 8.78
B6 6.47 268.66 ± 6.33
C1 6.39 204.49 ± 10.22
C2 6.44 118.61 * ± 7.18
C3 6.51 99.88 * ± 5.49
C4 6.54 59.98 * ± 4.19
C5 6.48 14.03 ± 2.06
C6 6.5 77.24 * ± 6.20
D1 6.28 495.92 ± 21.21
D2 6.25 405.09 ± 18.98 212.90 ± 9.26
D3 6.39 260.56 ± 4.54
D4 6.51 134.16 * ± 6.13
D5 6.68 107.34 * ± 7.22
D6 6.67 140.50 ± 9.01
E1 6.39 495.76 ± 33.16
E2 6.47 260.03 ± 5.29
E3 6.42 202.39 ± 4.11
E4 6.53 124.78 * ± 5.05
E5 6.52 130.79 * ± 5.82
E6 6.44 187.64 ± 6.11
F1 6.35 111.11 * ± 3.49 23.42 ± 2.11
F2 6.33 274.49 ± 10.09 89.45 * ± 6.49
F3 6.26 258.10 ± 9.86 110.12 * ± 5.26
F4 6.34 253.13 ± 6.99 224.88 ± 9.04
F5 6.35 259.98 ± 6.43
F6 6.37 175.58 ± 3.08 67.78 * ± 1.38
Bulk 1 6.66 102.22 ± 1.34
Bulk 2 6.62 68.75 ± 5.82
Bulk 3 6.66 90.27 ± 3.99
Bulk 3 & B1 serum 6.53 138.71 ± 2.22
Bulk 3 & F2 serum 6.59 122.99 ± 2.69
B1 & bulk 3 serum 6.64 143.99 ± 5.42
F1 & bulk 3 serum 6.74 47.93 ± 1.08
G'







































































Figure 2.5 Effect of renneting (at 30oC and unadjusted pH) with 10 µL/mL of 1:10 (v/v) diluted Maxiren 180 on the storage modulus, G΄,
of the first six milkings from cows A to F ( ─ 1st, ─ 2nd, ─ 3rd, ─ 4th, ─ 5th, ─ 6th) and bulk mature milk (─). For clarity, the result from




2.3.10 Acidification of colostrum samples 
 
GDL can be hydrolysed to gluconic acid in aqueous solution, which results in a 
reduction in the pH of milk, typically to pH 4.6. At this pH, gelation occurs as a result 
of the aggregation of casein particles. The influence of acidification by GDL on the 
storage modulus, G’, of colostrum samples was measured using small-amplitude 
oscillatory rheology, and the results are shown in Table 2.12 and Figure 2.6. G’ 
describes the elastic properties of a gel. GDL was added to colostrum samples at 
concentrations which caused the pH to decrease to 3.9 in 90 min. This pH value was 
selected because, in certain colostrum samples, casein did not precipitate at pH 4.6, 
as described in Section 2.3.11. Varying levels of GDL were required to reach pH 3.9 
due to the highly variable protein and mineral content, and consequently highly 
variable buffering capacity, of colostrum samples. The G’ value of the gel formed 
from mature milk was 198.2 Pa. In all cases, the G’ value of acid gels formed from 
colostrum was significantly lower than that from mature milk. No gelation was 
observed for the sixth milking from cows B and E, the first and third milking from D 
and the first milkings from cows E and F. The range of G’ values for the remaining 
colostrum samples was 3.7 to 56.7 Pa, but no apparent trends were observed.  
The formation and physical properties of acid milk gels have been reviewed by 
Lucey and Singh (1998). Protein fortification is one of the most important 
processing parameters which affects the textural properties of acid milk gels. 
Addition of whey protein concentrate (WPC) to milk has been shown to increase 
the firmness and viscosity of yogurt (Robinson and Tamine, 1986), but only when 
the mixture is heat-treated. Lucey and Singh (1998) suggested that cross-linking or 
bridging by denatured whey proteins within gels made from heated milk was 
responsible for the increase in G’. Lucey et al. (1999) found that addition of native 
(unheated) whey proteins to milk results in a reduction in G’ and suggested that 
they act as an inert filler in acid milk gels. This may be the case in the current study, 
where colostrum samples with high levels of native whey proteins (Table 2.1) had 
poor acid coagulation properties. Colostrum samples with the highest 
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concentration of whey protein (D1, E1 and F1) did not form a gel on acidification. 
The studies mentioned previously (Robinson and Tamine, 1986; Lucey et al., 1999) 
used WPC as the whey protein source. WPC is produced from mature bovine milk 
and contains predominantly β-Lg and α-La. As already discussed in Section 2.3.3, 
colostrum has high levels of Ig, LF, and BSA; to the best of our knowledge, no work 
has been reported on the effect of these proteins on acid-induced gelation of milk.  
 
Table 2.12 Mean initial pH values, amount of glucono-δ-lactone (GDL; % w/v) 
required to acidify colostrum to pH 3.9, and G’ values of the first, third and sixth 
milking from cows A to F and bulk mature milk sample 1. 
 
 
Sample Initial pH GDL (% w/v) G'
A1 6.31 3.5 23.5
A3 6.4 3.5 47.1
A6 6.46 3 22.0
B1 6.37 3 38.6
B3 6.32 3 56.7
B6 6.47 3.5 no gel
C1 6.39 3 34.7
C3 6.51 3 34.3
C6 6.5 3 no gel
D1 6.28 3.5 no gel
D3 6.39 3.5 no gel
D6 6.67 3 54.6
E1 6.39 3.5 no gel
E3 6.42 3 36.7
E6 6.44 3.5 32.4
F1 6.35 3.5 no gel
F3 6.26 3 3.7
F6 6.37 3 27.7





















































































Figure 2.6 Influence of acidification to pH 3.9 by glucono-δ-lactone (GDL) at 30
 
C on the storage modulus, G’, of the first ( ), third ( )


















2.3.11 Isoelectric precipitation of casein 
 
Table 2.13 presents average values for protein solubility of the first six milkings post 
partum from cows A to F and bulk mature milk samples 1 to 3, after adjustment to 
pH 4.6. In this case, protein solubility is defined as the percentage of total protein 
which remained soluble after adjustment to pH 4.6. Colostrum samples were 
diluted with distilled water to investigate the effect of dilution on the isoelectric 
precipitation of casein. Results shown include those for undiluted colostrum, and 
those for a 1:1 and 1:2 dilution of colostrum with distilled water before pH 
adjustment. Colostrum was also diluted 1:3 and 1:4, but no further change occurred 
above a 1:2 dilution and so the results are not shown. Mature bovine milk has a pH 
of approximately 6.7, at which value the casein micelles have a net negative charge. 
The stability of casein micelles against precipitation is complex; it involves 
neutralising the electrostatic repulsion of the charged protein molecules by 
decreasing the pH to the pI of the caseins (pH 4.6). Adjusting the pH of milk to 4.6 
neutralises the outer surface of the micelles, followed by irreversible destruction of 
the micellar structure and precipitation of the caseins (Fox, 2003).  
In the current study, it was found that casein did not precipitate at pH 4.6 in 10 out 
of a total of 36 colostrum samples. Of these ten samples, five were first milkings, 
three were second milkings, one was third milking, and one was fourth milking. For 
all cows, with the exception of cow C, casein did not precipitate at pH 4.6 in the first 
milking. Cows A and B followed a similar trend, i.e., casein did not precipitate at pH 
4.6 in the first milking, but did for the subsequent five milkings. A 1:1 dilution of 
colostrum with distilled water restored acid precipitability in five out of ten samples 
and a 1:2 dilution with distilled water restored acid precipitability in all cases. In the 
case of the first milking from cows A and B, a 1:1 dilution with distilled water 
resulted in casein precipitating at pH 4.6. For cow C, casein precipitated at pH 4.6 
for all six milkings. For cow D, casein did not precipitate at pH 4.6 for the first four 
milkings. In the first and second milking from cow D, a 1:1 dilution with distilled 
water had no effect on precipitability at pH 4.6, but a 1:2 dilution resulted in casein 
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precipitating at pH 4.6. For the third and fourth milking from cow D, a 1:1 dilution 
with distilled water resulted in casein precipitating at pH 4.6. Cows E and F followed 
a similar trend, i.e., casein did not precipitate at pH 4.6 in the first two milkings, but 
did in the subsequent four milkings. In the case of the first milking from cows E and 
F, a 1:2 dilution with distilled water was required to cause precipitation at pH 4.6. 
For the second milking from cows E and F, a 1:1 dilution with distilled water was 
sufficient. To the best of our knowledge, non-precipitability of casein in colostrum 























Table 2.13 Mean values (± S.D., n=3) for protein solubility of undiluted, 1:1 and 1:2 
dilution of the first six milkings from cows A to F and bulk mature milk samples 1 to 
3, after adjustment to pH 4.6. Values without an asterisk (*) were significantly 
different (p < 0.05) from control bulk milk samples. 
 
Sample precipitation at pH 4.6 precipitation at pH 4.6 precipitation at pH 4.6
yes/no yes/no yes/no
A1 N 96.1 ± 0.33 y 54.1 ± 0.76 y 56.3 ± 0.23
A2 Y 35.8 ± 0.05 y 39.0 ± 0.17 y 38.6 ± 0.29
A3 Y 21.2
*





± 0.06 y 23.9
*





± 0.09 y 22.5
*





± 0.70 y 22.5
*
± 0.69 y 22.1
*
± 0.57
B1 N 84.1 ± 0.56 y 31.7 ± 0.15 y 32.3 ± 0.65
B2 Y 15.9 ± 0.62 y 19.0
*





± 0.00 y 21.5
*
± 2.17 y 20.9
*
± 0.34
B4 Y 15.4 ± 0.84 y 18.6
*





± 1.84 y 20.5
*





± 0.82 y 19.9
*
± 0.24 y 21.2
*
± 0.32
C1 Y 50.9 ± 3.06 y 44.6 ± 0.38 y 40.4 ± 2.85
C2 Y 24.9
*
± 1.13 y 27.3 ± 0.24 y 27.5 ± 0.00
C3 Y 23.7
*
± 0.22 y 23.2
*





± 0.34 y 22.7
*





± 0.84 y 23.2
*





± 0.12 y 17.6
*
± 0.57 y 20.2
*
± 0.45
D1 N 89.0 ± 0.23 N 87.8 ± 0.59 Y 80.1 ± 0.93
D2 N 96.3 ± 2.07 N 93.4 ± 2.01 Y 52.3 ± 4.50
D3 N 93.7 ± 0.14 Y 57.3 ± 3.89 Y 55.1 ± 0.95
D4 N 91.4 ± 0.20 Y 36.1 ± 0.17 Y 39.4 ± 0.81
D5 Y 22.7
*
± 1.21 Y 29.8 ± 0.43 Y 29.7 ± 0.66
D6 Y 20.5
*
± 0.19 Y 20.3
*
± 0.46 Y 21.8
*
± 0.00
E1 N 90.7 ± 0.16 N 91.0 ± 0.23 Y 77.4 ± 4.55
E2 N 94.4 ± 0.45 Y 44.1 ± 1.77 Y 44.2 ± 3.12
E3 Y 22.1
*
± 1.30 Y 30.6 ± 0.37 Y 32.1 ± 0.29
E4 Y 22.5
*
± 0.00 Y 21.2
*





± 0.57 Y 23.5
*





± 0.00 Y 19.3
*
± 0.26 Y 15.8
*
± 1.59
F1 N 87.7 ± 0.29 N 90.9 ± 4.17 Y 71.4 ± 0.45
F2 N 89.8 ± 0.43 Y 39.1 ± 0.40 Y 40.9 ± 2.23
F3 Y 32.6 ± 0.74 Y 32.1 ± 0.20 Y 31.7 ± 0.00
F4 Y 21.8
*
± 0.28 Y 24.6
*
± 0.48 Y 14.3 ± 1.13
F5 Y 17.4
*
± 0.21 Y 20.2
*





± 0.13 Y 23.5
*
± 1.51 Y 22.5
*
± 1.87
Bulk 1 Y 18.7 ± 0.16 Y 17.5 ± 0.33 Y 19.6 ± 1.02
Bulk 2 Y 20.3 ± 0.11 Y 19.6 ± 0.35 Y 20.9 ± 0.00
Bulk 3 Y 22.5 ± 0.11 Y 21.9 ± 0.77 Y 21.8 ± 0.54
soluble at pH 4.6 soluble at pH 4.6 soluble at pH 4.6
No dilution 1:1 dilution 1:2 dilution
% of total protein % of total protein % of total protein
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2.3.11.1 Effect of pH on the precipitation of casein  
 
The pI is the point in a titration curve corresponding to the pH in solution at which 
the net surface charge, and thus the electrophoretic mobility, of a protein is zero 
(Righetti, 2004). The effect of varying the pH of acidification of colostrum on the 
solubility of the caseins was investigated, as shown in Table 2.14 and Figure 2.7. 
Two colostrum samples in which casein did not precipitate at pH 4.6 were selected; 
these were the first two milkings from cow F. Samples were adjusted to pH 4.0, 4.2, 
4.4, 4.6, 4.8 or 5.0. For the first milking from cow F, the casein did not precipitate in 
this pH range, as shown in lanes 3-9 (Figure 2.7). However, at pH 4.0 and 4.2, 
samples became very viscous, which suggests that casein was approaching its pI. 
For the second milking from cow F, the casein precipitated at pH 4.0, 4.2, and 4.4, 
which is evident by the absence of casein in lanes 11, 12, and 13, respectively 
(Figure 2.7). This indicates that there was a shift in the pI of casein in certain 
colostrum samples. While the isoelectric point of casein in mammalian milk is pH 
4.6, generally caseins are insoluble over a pH range (3.5 to 5) and so will precipitate 
at values above and below the isoelectric point, e.g., the pH range for precipitation 
of casein in human milk is 4.1 to 4.7 (Khanna et al., 2006). Egito et al. (2001) 
reported that minimal solubility of equine casein is at pH 4.2 instead of pH 4.6, as 
found for bovine casein. Khaldi and Shields (2011) reported that proteins which 
display a dramatic shift in pI are those that are highly glycosylated and 
phosphorylated. Holland et al. (2004) identified multiple forms of к-casein in 
mature milk, with a pI value ranging from 4.47 to 5.81. High levels of к-casein, in 
particular a high proportion of glycosylated к-casein, in colostrum (Table 2.2) may 
cause a shift in pI, to a value below pH 4.6. The proportions of к-casein in colostrum 
of the first two milkings from cow F, as a percentage of total casein (excluding αS2-
casein) were similar, at 20 and 19.7% respectively (Table 2.2), but the first milking 
contained a higher level of glycosylated к-casein as a proportion of total к-casein 




Table 2.14 Mean values (± S.D., n=3) of % protein in samples F1 and F2 soluble at 
pH values in the range of 4.0 to 5.0 
 
 
Figure 2.7 Sodium dodecyl sulphate-polyacrylamide gel electrophoretograms 
obtained under reducing conditions; Lane 1, sodium caseinate; Lane 2, Lactoferrin 
(15 µg); Lanes 3-9, soluble fraction of the first milking from cow F at pH 6.35 
(unadjusted), 4.0, 4.2, 4.4, 4.6, 4.8 and 5.0, respectively; Lanes 10-15, soluble 
fraction of the second milking from cow F at pH 6.33 (unadjusted), 4.0, 4.2, 4.4, 4.6 
and 4.8, respectively. Thirty micrograms of protein were loaded for all samples 
unless otherwise stated. 
Sample adjusted pH precipitate 
yes/no
F1 4 no 89.0 ± 0.34
F1 4.2 no 90.1 ± 1.77
F1 4.4 no 90.9 ± 0.30
F1 4.6 no 91.4 ± 0.65
F1 4.8 no 91.7 ± 1.95
F1 5 no 95.1 ± 2.11
F2 4 yes 24.4 ± 0.16
F2 4.2 yes 27.3 ± 0.22
F2 4.4 yes 26.2 ± 0.41
F2 4.6 no 89.9 ± 0.22
F2 4.8 no 96.9 ± 0.69
F2 5 no 97.8 ± 0.75
soluble protein
at adjusted pH
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2.3.11.2 Effect of reversing the serum phase between colostrum and mature milk on 
the isoelectric precipitation of casein 
 
The effect of the serum phase of colostrum, prepared by ultracentrifugation, on 
isoelectric precipitation of casein from mature milk was investigated (Figure 2.8). 
Sedimented casein micelles (100, 000 g x 1 h) of bulk mature milk 1 were dispersed 
in the serum phase of the first milking from cow E or bulk mature milk 1. In the 
presence of mature milk serum, casein precipitated at pH 4.6, as shown in Figure 
2.8 (lane 6). In the presence of colostral serum, mature milk casein did not 
precipitate at pH 4.6, as shown in Figure 2.8 (lane 9). This suggests that it was a 
constituent of the serum phase of colostrum which was causing non-precipitability 
of casein at pH 4.6. However, as shown in Table 2.7, a significant proportion of 
casein in colostrum samples was non-sedimentable, and thus would account for a 
portion of the serum phase.  
 
Figure 2.8 Sodium dodecyl sulphate-polyacrylamide gel electrophoretograms 
obtained under reducing conditions. Lane 1, sodium caseinate (31.5 µg); Lane 2, 
whey protein isolate (31.5 µg); Lane 3, lactoferrin (15 µg); Lane 5-6, pellet from 
mature milk reconstituted in serum from mature milk and pH 4.6-soluble fraction 
thereof, respectively; Lane 8-9, pellet from mature milk reconstituted in serum 
from colostrum and pH 4.6-soluble fraction thereof, respectively. Samples were not 
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2.3.11.3 Effect of interchanging the serum minerals between colostrum and mature 
milk on the isoelectric precipitation of casein 
  
Large variations in the mineral composition of colostrum samples were observed 
(Table 2.9). The salts in milk play an important role in the stability of the proteins. 
Of most interest is Ca2+, which can significantly influence the negative charge on 
casein micelles, and thus reduce the repulsive forces between them (Tsioulpas et 
al., 2007b). Calcium ions are involved in the internal stability of casein micelles as 
they form linkages between the protein molecules either as CCP or directly bound 
to caseins (Horne, 1998). The effect of reversing the mineral profile of colostrum 
and mature milk by equilibrium dialysis was investigated (Table 2.15 and Figure 
2.9). Equilibrium dialysis works on the principle of diffusion of solutes across a semi-
permeable membrane from an area of high concentration to an area of low 
concentration. The pH of colostrum and mature milk before dialysis was 6.42 and 
6.58, respectively. Following dialysis, the pH of colostrum increased to 6.56, which 
was close to that of milk, and the pH of mature milk decreased to 6.43, close to that 
of colostrum. This is a good indication that dialysis was successful in reversing the 
mineral profiles of colostrum and mature milk; however, it was found that reversal 
of minerals had no effect on isoelectric precipitability, as shown in Table 2.15 and 
Figure 2.9. The casein in colostrum remained non-precipitable at pH 4.6 in the 
presence of the mineral profile of mature milk (lanes 5-8, Figure 2.9) while mature 
milk casein remained precipitable at pH 4.6 in the presence of the mineral profile of 








Table 2.15 Mean values (± S.D., n=3) for total and pH 4.6-soluble protein, in 
dialysed and undialysed, colostrum and mature milk. Values with different 
superscript letters are significantly different (p < 0.05). 
 
 
Figure 2.9 Sodium dodecyl sulphate-polyacrylamide gel electrophoretograms 
obtained under reducing conditions. Lane 1, sodium caseinate (31.5 µg); Lane 2, 
whey protein isolate (31.5 µg); Lane 3, lactoferrin (15 µg); Lanes 5-8, standard milk, 
pH 4.6-soluble fraction of standard milk, dialysed standard milk, pH 4.6-soluble 
fraction of dialysed standard milk, respectively. Lanes 10-13, colostrum, pH 4.6-
soluble fraction of colostrum, dialysed colostrum, pH 4.6-soluble fraction of 
dialysed colostrum, respectively. Thirty micrograms of protein was loaded for all 




Colostrum 6.42 15.86 g ± 0.01 15.28 f ± 0.03
Dialysed colostrum 6.56 15.34 f ± 0.02 14.65 e ± 0.07
Mature milk 6.58 3.39 c ± 0.02 0.96 a ± 0.04
Dialysed mature milk 6.43 3.66 d ± 0.01 1.11 b ± 0.03
soluble at natural pH
protein (mg/mL)
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2.3.11.4 Effect of adding lactoferrin to mature milk on the isoelectric precipitation of 
casein 
 
Lactoferrin (LF) is a non-haem iron-binding protein that is a member of the 
transferrin family, whose function is to transport iron in the blood (Gonzalez-
Chavez et al., 2009). It is an 80 kDa glycoprotein and is strongly cationic with a high 
pI (~8.9) (Anema and de Kruif, 2012a). Recent studies have shown that lactoferrin is 
capable of interacting with casein micelles (Anema and de Kruif, 2011; Anema and 
de Kruif, 2012a,b; Croguennec et al., 2012). At the natural pH of milk, LF carries a 
net positive charge, while casein micelles are negatively charged (pI 4.6), and 
therefore it has been speculated that LF interacts with casein micelles through 
electrostatic interactions (Anema and de Kruif, 2011). In the current study, mature 
milk samples were found to contain, on average, 0.69 mg/mL LF. This value is higher 
than the report of Cheng et al. (2008), who reported that the LF concentration in 
mature milk varies in the range 0.032 – 0.49 mg/mL. In the study of Sobczuk-Szul et 
al. (2013), colostrum was reported to contain 2.65 mg/mL LF.  
In the current study, LF concentration varied widely, in the range 0.77 – 14.29 
mg/mL. LF concentration was very high initially and decreased with time post 
partum. As shown in Table 2.16, all colostrum samples (with the exception of the 
first milking from cow C) in which casein did not precipitate at pH 4.6, contained 
greater than 3.43 mg/mL LF. The range of LF concentration in non-precipitable 
samples was 3.43 to 14.29 mg/mL. To investigate the effect of elevated LF content 
on the isoelectric precipitability of casein in colostrum, LF was added to mature milk 
at a concentration ranging from 0 to 25.6 mg/mL. The results in Table 2.17 and 
Figures 2.10 and 2.11 show that, in all cases, LF had no effect on the isoelectric 
precipitation of casein. This is evident from the absence of casein in the pH 4.6-
soluble supernatants (Figures 2.10 and 2.11); in the pH 4.6-insoluble precipitates, LF 
was present. The binding of LF to the caseins in casein micelles observed in the 
current study is in agreement with the studies of Anema and Kruif (2011) and 
Croguennec et al. (2012).  
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Table 2.16 Approximate concentration of lactoferrin (Lf) (mg/mL) of the first six 
milkings from cows A to F and bulk mature milk samples 1 to 3, as calculated by 
densitometirc analysis of SDS-PAGE gels, in relation to isoelectric precipitability at 
pH 4.6. 
 






































Bulk 1 0.77 Yes
Bulk 2 0.67 Yes
Bulk 3 0.64 Yes
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Table 2.17 Mean values (± S.D., n=3) for pH 4.6-soluble protein for bulk mature milk 
enriched with lactoferrin at 0 to 25.6 mg/mL. Values with different superscript 
letters were significantly different (p < 0.05). 
Lactoferrin addition  precipitate at pH 4.6 soluble protein at pH 4.6 
(mg/ml) yes/no (% of total protein) 
      0 yes 16.48 a ± 0.11 
0.2 yes 16.91 a ± 0.43 
0.4 yes 16.12 a ± 0.11 
0.8 yes 16.76 a ± 0.05 
1.6 yes 18.52 b ± 0.49 
3.2 yes 19.68 c ± 0.70 
6.4 yes 22.65 d ± 0.22 
12.8 yes 28.43 e ± 0.09 
25.6 yes 32.69 f ± 0.46 
 
 
Figure 2.10 Sodium dodecyl sulphate-polyacrylamide gel electrophoretograms 
obtained under reducing conditions. Crude, pH 4.6-soluble and pH 4.6-insoluble 
fractions of mature milk with 0 mg/mL (lanes 1-3, respectively), 0.2 mg/mL (lanes 4-
6, respectively), 0.4 mg/mL (lanes 7-9, respectively), 0.8 mg/mL (lanes 10-12, 
respectively) and 1.6 mg/mL (lanes 13-15) added lactoferrin. Thirty micrograms of 
protein were loaded for crude and pH 4.6-soluble samples, while 31.5 µg protein 















Figure 2.11 Sodium dodecyl sulphate-polyacrylamide gel electrophoretograms 
obtained under reducing conditions. Crude, pH 4.6-soluble and pH 4.6-insoluble 
fractions of mature milk with 2 mg/mL (lanes 1-3, respectively), 6.4 mg/mL (lanes 4-
6, respectively), 12.8 mg/mL (lanes 7-9, respectively) and 25.6 mg/mL (lanes 10-12, 
respectively) added lactoferrin. Thirty micrograms of protein were loaded for crude 
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2.3.11.5 Effect of adding colostral Ig to mature milk on isoelectric precipitation of 
casein  
The solubility of Ig in colostrum varies according to its ionic strength. Based on this 
principle, Ig was purified from colostrum by precipitation with ammonium sulphate. 
A colostrum sample collected immediately after parturition was used because, as 
previously discussed, the concentration of Ig in colostrum is highest initially. Lanes 
3-7 (Figure 2.12) show purified Ig. The first migrating band is IgM, followed by LF, 
IgG heavy chain, IgG light chain, β-Lg, and α-La. Lanes 8-12 show the soluble 
material left after ammonium sulphate precipitation. It can be seen from Figure 




Figure 2.12 Sodium dodecyl sulphate-polyacrylamide gel electrophoretograms 
obtained under reducing conditions; Lane 1, sodium caseinate (30 µg); Lane 2, whey 
protein isolate (30 µg); Lane 3-7, Ig purified from colostrum (10 mg/mL) loaded at 1, 
2, 3, 4, 5 µl, respectively; Lanes 8-12, supernatant of Ig purified from colostrum (10 
















Figure 2.13 Sodium dodecyl sulphate-polyacrylamide gel electrophoretograms 
obtained under reducing conditions. Lane 1, sodium caseinate; Lane 2, whey 
protein isolate; Crude and pH 4.6-soluble fraction of mature milk with 0 mg/mL 
(lanes 4-5, respectively), 25 mg/mL (lanes 6-7, respectively), 50 mg/mL (lanes 8-9, 
respectively), 100 mg/mL (lanes 10-11, respectively), and 150 mg/mL (lanes 12-13, 
respectively) added Ig preparation. All samples were loaded on an equal protein 
basis (30 µg). 
 
As discussed earlier, the principal Ig in colostrum is IgG1, representing more than 
90% of this protein fraction. The effect of elevated levels of IgG on the isoelectric 
precipitability of casein in mature milk was investigated. Colostrum samples were 
found to contain highly variable levels of IgG heavy chain, ranging from 1.43 to 
41.59 mg/mL (Table 2.3). IgG was purified from colostrum and was added to 
mature milk at concentrations ranging from 0 to 15% (w/v); elevated levels of IgG 
had no effect on isoelectric precipitation of casein in this range. This was evident 
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2.3.12 Multivariate statistical analysis 
General linear model analysis of variance (GLM ANOVA) was used to assess the 
effect of individual cow variability (A to F) and time of milking (1st to 6th milking post 
partum) on the composition and physico-chemical properties of colostrum, i.e., L*, 
a*,b*, pH, protein concentration, non-sedimentable protein at 4 and 20oC, 
sedimentable protein at 4 and 20oC, minerals (Na, Mg, P, K, Ca), casein micelle 
diameter, viscosity at 5 and 20oC, soluble protein at pH 4.6 (undiluted, 1:1 dilution, 
1:2 dilution), rennet coagulation time and storage modulus (G') after rennet 
addition. GLM ANOVA used a regression approach to fit data to specified models. In 
this study, models were selected which minimised S (standard distance of data 
values from fitted values, i.e., error of standard deviation) and maximized R2 
(variation in data explained by the results) and adjusted R2 (variation in data 
corrected for degrees of freedom in the error) values. Individual evaluation of each 
variable response made it possible to identify how individuality of each cow and 
time of milking affected the responses, but, not all variable responses behaved in a 
similar manner, which meant that GLM ANOVA models had to be adjusted to 
accommodate the large variability for colostrum samples. For example, 
examination of scatter-plots of pH values of colostrum revealed that pH generally 
increased with time post partum but, the increase was not consistent across cows, 
which made it impossible to identify a consistent linear or quadratic effect, 
therefore, residual versus fits and residual versus order plots showed that the pH of 
colostrum from cow D had some ‘extreme’ values compared with colostrum from 
other cows (although in pH terms this was only a difference of 0.05 pH units). 
Scatter-plots for protein concentration showed the same general effect for all 
samples over time (results not shown), but the protein concentration in the first 
milking from each cow was highly variable, and so GLM ANOVA had to be adjusted 
to accommodate this. 
For all parameters measured, except concentration of K, there was a statistically 
significant effect (p < 0.05) of individual cow and time of milking, and a significant 
interaction (p < 0.05) between each cow and time of milking. Unusual observations 
within responses were noted where standardized residuals differed from zero by 
157 
 
more than 2.00, e.g., a* values of the first and second milking of cows E and F were 
high, as was the viscosity of the first, second and third milking from cow D, 
measured at both 4 and 20°C.   
To simplify the multivariate nature of the data set and find patterns in observations 
for the samples over time, principal component analysis (PCA) was used. PCA is a 
statistical procedure that uses orthogonal transformation to convert a set of 
observations of potentially correlated variables into a set of values of linearly 
uncorrelated variables called principal components. The first principal component 
has the largest possible variance, i.e., accounts for as much of the variability in the 
data as possible, and each succeeding component in turn has the highest variance 
possible under the constraint that it be orthogonal to, i.e., uncorrelated with, the 
preceding components. In the current study, scree plots (eigenvalue profile plots in 
descending order) were examined to judge the relative magnitude of eigenvalues 
and to visually assess which principal components accounted for most of the 
variability in the data. Eigenanalysis of the correlation matrix revealed that the first 
principal component (PC1) accounted for 60% of variation of data and the second 
component (PC2) accounted for 15%, giving a cumulative value of 75%, indicating 
that these two components accounted for a large percentage of the variation in 
data. Thus, most of the structure in the data could be captured with these two 
underlying dimensions.  
The correlations between the original data for each variable and principal 
component were examined in the Minitab output and the loading plot (Figure 
2.14). The first PC was strongly correlated with 13 of the variables measured (L*, 
protein concentration, non-sedimentable protein at 4 and 20oC, sedimentable 
protein at 4 and 20oC, Na, Mg, and Ca concentration, casein micelle diameter, and 
soluble protein at pH 4.6 [undiluted, 1:1 dilution, 1:2 dilution]). All correlations 
were positive except that for L*, which had a large negative correlation with PC1. 
Time of milking increased going from right to left on the loading plot. On the PC1 
scale, moving left, L* increased with milking number while mineral content and 
protein concentration decreased. The largest positive correlation was found for 
protein content.  PC1 increased with these 13 variables, indicating that these 
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criteria were related, e.g., when L* increased, the protein content decreased, as 
would be expected. pH was also negatively correlated with PC1, although its loading 
value was considerably lower. PC2 had a large positive correlation with a*, K and P 
contents, while it was strongly negatively correlated with viscosity at both 4 and 
20oC; the lower a PC2 loading, the higher was sample viscosity.  
The length of a variable line (in blue) on the loading plot is an indication of the 
degree of variability, i.e., longer lines have a higher overall variance. The cosine of 
the angle between lines is an approximate correlation between the variables they 
represent. The closer the angle is to 90 or 270 degrees, the smaller the correlation. 
An angle of 0 or 180 degrees reflects a correlation of 1 or -1, respectively. Rennet 
coagulation times of colostrum showed the least variation throughout the study, as 
indicated by their having the shortest variance line (Figure 2.14). 
 
Figure 2.14 Loading plot from PCA showing the relationship between 22 variables of 
the first six milkings from cows A to F: L*; a*; b*; pH; Prt, protein concentration; 
Non-Sed 4 and Non-Sed 20, non-sedimentable protein at 4 and 20oC, respectively; 
Sed 4 and Sed 20, sedimentable protein at 4 and 20oC, respectively; minerals (Na, 
Mg, P, K, Ca); Size, casein micelle diameter; Vis 5 and Vis 20, viscosity at 5 and 20oC, 
respectively; IP Crude, IP 1:1 and IP 1:2, soluble protein at pH 4.6 (undiluted, 1:1 
dilution, 1:2 dilution), respectively; RCT, rennet coagulation times; and G, storage 






















































Figure 2.15 Score plot from PCA showing the relationship between individual cows 
and milking number. 0, 1st milking; 1, 2nd milking; 2, 3rd milking; 3, 4th milking; 4, 5th 
milking; 5, 6th milking, for cow ●, A; ■, B; ♦, C; ▲, D; ▲, E and ▲, F. Milking number 
increases from right to left. 
 
While the loading plot from PCA can be used to interpret the relationship between 
the 22 variables, the score plot (Figure 2.15) is a summary of the relationship 
among the observations or samples. Grouping by milking number showed how 
observations generally shifted from right to left, which was strongly influenced by 
increasing L* values and decreasing mineral and viscosity values. The greatest 
variation in data occurred at the first milking but, as time progressed, the values 
tended to converge, with significantly less variation. The first milking of cow D 
stands alone in the bottom right of the score plot. The overall pattern on the score 
plot of samples A, B and C is quite similar to one another, as are the patterns for 
samples E and F. The largest overall change in the measured variables over time 
occurred for samples D, E and F, as can be seen from the position of the first milking 
of cows E and F (top right hand corner) and the first milking of cow D (bottom right) 
























































































By comparing the score and loading plots directly in the form of a biplot (Figure 
2.16), some relationships between samples and variables could be identified. An 
overlay of the correlation structure of the variables seen in the loading plot (Figure 
2.14) and clustering of observations was revealed. On a biplot, the closer a sample 
is to each variability line, the more influence that variable has on the sample, e.g., 
the exceptionally high viscosity of early milkings from cow D, measured at both 4 
and 20oC, explains some of the difference between colostrum from cow D with 
colostrum from other cows. Samples positioned to the right on the biplot were 
dominated by variables on the right, while those to the left were dominated by 
variables on the left. Most variables on the biplot were grouped closely together on 
the right, while the sample observations cluster was on the left, with a few samples 
grouped on the right. The strong negative correlation of L* values with the first 
principal component is evident,  as is the negative correlation with pH. In general, 
the biplot shows that colostrum from different cows behaves in a similar trend over 
time, but some have a wider range of movement around the first and second 
principal component. The overall pattern was that the composition and physico-
chemical properties of colostrum, most notably from cows D, E, and F, were highly 
variable, in particular at the first, second and third milkings. 
 
Figure 2.16 Biplot from PCA showing both the loadings and the score for the first 
and second principal components. Blue lines are the variable lines, while red dots 
















































The composition and physico-chemical properties of colostrum over the first three 
days post partum were highly variable, not only compared to mature milk, but also 
between individual cows and consecutive milkings. In general, the highest 
variability was observed between the first and second milking. Most notably, the 
protein concentration in colostrum was very high initially and decreased with time 
post partum. The level of lactose was low initially and increased with time post 
partum, while early colostral milkings contained significantly higher levels of 
oligosaccharides than later milkings and mature milk samples. In general, colostrum 
samples contained elevated levels of Na, Mg, P, K and Ca, which decreased with 
time post partum. 
Several authors have examined differences in the composition between colostrum 
and mature milk, but very little work has been carried out on the physico-chemical 
properties. The pH of colostrum was very low initially; the exact reason for this was 
unknown and warrants further investigation. A significant proportion of the casein, 
in particular in early milkings, was non-sedimentable at 100, 000 g x 1 h, most likely 
due to the high viscosity of colostrum. The colour of colostrum was highly variable, 
especially in early milkings, which had a reddish-yellow colour due to the presence 
of carotenoid pigments and red blood cells. Colostrum had poor heat stability due 
to a low pH and high whey protein content and early milkings were the most heat-
labile. Colostrum had good rennet coagulation properties, i.e., lower RCT and 
higher G’ values than mature milk, but poor acid gelation properties. Casein did not 
precipitate at pH 4.6 in certain colostrum samples, but did at lower pH values, 
indicating a shift in pI, possibly due to high levels of glycosylated к-casein. Further 
work is required to determine the exact cause of non-precipitability of casein at pH 
4.6 in certain colostrum samples.  
Results from the current study indicate that, at the sixth milking post partum, milk 
may still be considered as colostrum and consequently would not be suitable for 
dairy processing due to its highly variable composition and physico-chemical 
properties, i.e., high level of minerals, low level of lactose and poor heat stability, 
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which would lead to problems for many processes, including UHT treatment, 
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The aim of this study was to generate and characterise various fractions of bovine 
colostrum and to test the effect of these fractions on the secretion of pro- and anti-
inflammatory cytokines from a macrophage cell line and bone marrow dendritic 
cells, as well as insulin secretion from a pancreatic beta cell line. Colostrum was 
fractionated into cream, casein, whey, 30 kDa retentate of whey and 30 kDa 
permeate of whey. Casein from colostrum had no inflammatory or insulinotrophic 
properties, while colostrum cream caused a significant reduction in the secretion of 
TNF-α, a central pro-inflammatory cytokine, without compromising macrophage 
cell viability. Colostrum cream was further fractionated to produce buttermilk, 
which was found to significantly reduce the secretion of NF-кB, the key 
transcription factor that regulates the inflammatory response, as well as 
significantly reducing the secretion of the pro-inflammatory cytokines TNF-α, IL-6, 
IL-1β and IL-12. This buttermilk also caused a significant increase in the secretion of 
the anti-inflammatory cytokine IL-10. Buttermilk from colostrum was analysed by 
two dimensional gel electrophoresis and mass spectrometry, and major milk fat 
globule membrane (MFGM) proteins such as xanthine dehydrogenase/oxidase, 
lactadherin, adipophilin and butyrophilin were identified. Colostrum whey, 30 kDa 
retentate of whey and 30 kDa permeate of whey were all found to increase 
significantly insulin secretion when administered to pancreatic beta cells in 
combination with 16.7 mM glucose, at levels similar to that obtained with the 
positive control. Cell viability was not affected by the presence of colostrum 
fractions and increased insulin secretion was not due to the presence of growth 
factors in colostrum. The 30 kDa permeate was the most potent activator of insulin 
secretion in vitro, and the biological activity was found to be most concentrated in 
the 3 kDa permeate of this fraction. Based on the findings of this study, colostrum 
buttermilk and whey may represent novel functional food products with 






The World Health Organization (WHO) reports that at least one billion adults are 
overweight and 300 million are obese and, without intervention, these numbers are 
expected to rise (WHO, 2010). In Europe, >1x106 deaths annually are attributable to 
diseases related to excess bodyweight (WHO, 2006a). Substantial evidence 
indicates that obesity is associated with a state of chronic low-grade inflammation 
characterised by inflamed adipose tissue, with increased infiltration of 
macrophages that produce pro-inflammatory cytokines (McArdle et al., 2013). 
These cytokines directly reduce insulin sensitivity through the insulin-signalling 
pathway (Peraldi et al., 1996) by activation of the mitogen-activated protein kinases 
and the activation of transcription factors such as NF-КB, causing both the down-
regulation and decreased activation of insulin-signalling proteins (McArdle et al., 
2013). The inflammatory trigger in obesity is metabolic and caused by the excess 
consumption of nutrients. Metabolic signals are produced by metabolic cells (such 
as adipocytes), which start the inflammatory response and damage metabolic 
homeostasis (Gregor and Hotamisligil, 2011). Adipose tissue traditionally functions 
in lipid storage, storing triacylglycerides (TAG) following energy excess, and 
mobilizing these stores during periods of nutrient deprivation (Gregoire et al., 
1998). With obesity and insulin resistance there is increased lipolysis; consequently, 
there is an inappropriate spill-over of triacylglycerol (TAG)-derived free fatty acids 
(FFAs) (Sethi and Vidal-Puig, 2007) and these FFAs can activate inflammatory 
pathways and impair insulin signalling. Macrophages are known to be important 
contributors to inflammation; however, adipocytes also demonstrate significant 
intrinsic inflammatory properties (Berg and Scherer, 2005). Adipose tissue acts as 
an endocrine organ, secreting biologically active substances including interleukin 
(IL)-6, IL-1β, TNF-α, leptin and adiponectin (McArdle et al., 2013). Macrophages can 
be classified based on their cytokine secretion profile; M1 macrophages secrete 
pro-inflammatory cytokines TNF-α, IL-1β, IL-6 and IL-12, whereas M2 macrophages 
secrete anti-inflammatory cytokines including IL-10 and IL-1 receptor antagonist 
(Lumeng et al., 2007).  
180 
 
Approaches to modulating the release of pro- and anti-inflammatory cytokines may 
minimise a pro-inflammatory insulin resistance state. Pharmaceutical strategies 
that target inflammation may have some potential. Currently, non-steroidal anti-
inflammatory drugs (NSAIDs) are among the most widely used of therapeutic 
agents (McGettiga and Henry, 2013). They reduce pain and inflammation by 
blocking cyclo-oxygenases (COX) that are needed to produce prostaglandins 
(Cashman, 1996). However, there are a number of safety concerns, as NSAIDs are 
known to have serious adverse effects, including gastrointestinal bleeding, peptic 
ulcer disease, hypertension, edema and renal disease (Dugowson and 
Gnanashanmugam, 2006).  
Recent studies have suggested that the consumption of dairy products is inversely 
associated with low-grade systemic inflammation (Esmaillzadeh and Azadbakht, 
2010; Panagiotakos et al., 2010). Milk proteins may represent a novel alternative to 
pharmaceutical strategies which target inflammation, while they may be less potent 
than some pharmaceutical anti-inflammatory agents, which may be beneficial for 
long-term therapy. The current study focussed on proteins from colostrum as it is 
rich in biologically active constituents, which are also most likely present in mature 
milk but at significantly reduced levels. 
Colostrum is the initial milk secreted by mammals and is typically defined as the 
first five to six milkings post partum. The composition of bovine colostrum is highly 
variable and differs substantially from that of mature milk (Foley and Otterby, 1978; 
Madsen et al., 2004; Tsioulpas et al., 2007). The main factors responsible for 
variation in colostrum composition are: time post partum, individuality of the 
animal, breed, mastitic infection, and feed (Walstra et al., 2006). Colostrum is a 
complete source of nutrients such as protein, carbohydrates, fat, vitamins and 
minerals, but is also rich in biologically active constituents. These include growth 
factors, immunoglobulins, lactoperoxidase, lysozyme, lactoferrin, cytokines, 
nucleosides, vitamins, peptides and oligosaccharides, which are all either not 
present in mature milk or are present at substantially lower concentrations (Wu et 
al., 2011). Hagiwara et al. (2000) demonstrated that colostrum contains 
significantly higher concentrations of the cytokines IL-1β, IL-6, TNF-α, INF-γ and IL-1 
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than mature milk. The natural function of these bioactive components is to provide 
passive immunity to the newborn calf, as well as facilitating the growth and 
immune maturation of the digestive tract (Kelly, 2003).  
Bovine colostrum has a wide range of reported biological activities and clinical uses. 
Products made from bovine colostrum have been marketed for their health 
benefits for many years and are generally regarded as safe (Davis et al., 2007). 
Boosting the natural concentrations of immune components in colostrum through 
vaccination of cows offers great potential in the development of hyperimmune 
colostrum products for prophylactic or therapeutic use in humans (Stelwagen et al., 
2009). A commercial example of a hyperimmune milk product is the range of Stolle 
products (Stolle Milk Biologics Inc., Cincinnati, OH) which contain elevated levels of 
IgG brought about by vaccination of lactating cows with a multivalent killed 
bacterial antigen. Mitra et al. (1995) demonstrated that hyperimmune colostrum 
from cows vaccinated with human rotavirus was an effective therapeutic in 
reducing the severity and duration of rotavirus-caused diarrhea in infants. Tzipori et 
al. (1986) reported that bovine colostrum might be of benefit for the treatment of 
chronic diarrhea among persons with immune deficiency syndromes. Bovine 
colostrum has also been used for the prevention or treatment of infectious diseases 
such as cholera, cryptosporidiosis, Helicobacter pylori, rotavirus and shigellosis 
(Kelly, 2003). Playford et al. (1999) and Playford et al. (2001) reported that bovine 
colostrum prevents non-steroidal anti-inflammatory drug (NSAID) induced gut 
injury.  
The objectives of this study were (1) to generate and characterise various fractions 
of bovine colostrum, (2) to test the effect of these fractions on the secretion of pro- 
and anti-inflammatory cytokines from a murine macrophage cell line and bone 
marrow dendritic cells, (3) to test the effect of these fractions on insulin secretion 





3.2 Materials and Methods 
 
3.2.1 Collection of bovine colostrum 
Colostrum samples were obtained from the Teagasc, Moorepark, Animal and 
Grassland Research and Innovation Centre, Fermoy, Co. Cork.  Colostrum samples 
from either the first or second milking post partum, within 0 to 24 h of calving, were 
collected from three individual Holstein Friesian cows. The colostrum samples were 
mixed and immediately frozen and stored at -20°C. A bulk mature milk sample from 
cows in mid-lactation was also obtained for purposes of comparison. 
 
3.2.2 Processing of colostrum 
Samples were thawed at 4°C overnight. After thawing, the lipid fraction was 
removed by centrifugation at 3,000 g for 15 min at 4°C (Sorvall RC-5C, DuPont, 
Wilmington, DE, USA). The skimmed colostrum was filtered through glass wool and 
Whatman no. 113 filter paper. Colostrum cream and skimmed colostrum were 
immediately frozen and stored at -20°C.  
 
3.2.3 Preparation of pH 4.6-soluble fractions 
Casein and whey were prepared from skimmed colostrum by isoelectric 
precipitation according to the method of Kuchroo and Fox (1982), as described in 
Section 2.2.11. Portions of the pH 4.6-soluble and insoluble material were then 
lyophilised. 
The pH 4.6-soluble fraction was further fractionated by ultrafiltration (20°C, 
regenerated cellulose membrane, 30 kDa nominal molecular weight limit, Merck 
Millipore Ltd, Cork, Ireland) including a 2X diafiltration step using ultra-pure water 
(Elga purelab option-Q, Veolia Water Solutions and Technologies, Marlow, UK). The 
30 kDa retentate and permeate were then separately lyophilised. 
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The lyophilised 30 kDa permeate was reconstituted (4%, w/v) in ultra-pure water 
and left to hydrate overnight at 4°C. The solution was further fractionated by 
ultrafiltration (20°C, regenerated cellulose membrane, 3 kDa nominal molecular 
weight limit, Merck Millipore Ltd, Cork, Ireland) including a 2X diafiltration step 
using ultra-pure water (Elga purelab option-Q, Veolia Water Solutions and 
Technologies, Marlow, UK). The 3 kDa retentate and permeate were then 
separately lyophilised. 
 
3.2.4 Preparation of buttermilk 
Buttermilk was prepared from colostrum by mechanical agitation of raw cream in 
the presence of air. Briefly, an equal volume of distilled water was added to cream 
and heated to 50°C. The solution was cooled and processed into butter at 20°C 
using an overhead stirrer (Kenwood Food Processor, model no. 8910D, Thorn EMI, 
Hants, UK) until fat granules appeared; the granules were kneaded at ca. 20 rpm to 
release the buttermilk. The buttermilk was cooled to 4°C and filtered through 
cheese cloth to remove any residual butter grains. A portion of the filtrate was then 
lyophilised. Buttermilk was prepared from mature milk in the same manner for 
comparison purposes. 
 
3.2.5 Protein content 
Protein content was determined by the macro-Kjeldahl method (IDF, 1986), as 
described in Section 2.2.2. In some cases, the Bradford assay was used. Briefly, a 
standard curve was generated from a 5 mg/mL working solution of bovine serum 
albumin (BSA). BSA standards and samples to be quantified were prepared in 
triplicate. Samples were typically diluted 1:50 with distilled H2O. Diluted (1:5) 
protein assay concentrated dye reagent (200 µl) was added to 10 µL of the BSA 
standards and diluted samples in 96 well plates (Greiner Bio-One Ltd., Stonehouse, 
UK). Following 15 min of incubation at room temperature, the absorbance of each 
sample was read at 595 nm (Varioskan Flash Multimode Reader, Thermo Scientific, 
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Waltham, MA, USA). The protein concentration was then determined from the 
standard curve.   
 
3.2.6 One-dimensional gel electrophoresis 
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) was 
carried out using a Protean II xi vertical slab-gel unit (Bio-Rad Laboratories Ltd., 
Watford, Herts., UK) according to the method of Laemmli (1970), as described in 
Section 2.2.13. 
 
3.2.7 Two-dimensional gel electrophoresis (2-DE) 
2-DE was performed on the pH 4.6-soluble fractions of buttermilk and serum from 
colostrum or mature milk. Lyophilised samples were reconstituted (10% w/v) in 
distilled water. Samples were adjusted to pH 4.6 by adding 30 µL of 33% acetic acid 
to 1 mL sample and vortexing the mixture; after 10 min, 30 µL of 3.3 M-Na-acetate 
was added and the mixture centrifuged for 30 min at 14,000 g at 20°C. After 
centrifugation, the supernatant was carefully removed and used for further 
analysis. Isoelectric focusing (IEF) was carried out using a PROTEAN IEF (Bio-Rad, 
Hercules, CA, USA) according to the manufacturer’s instructions. The pH 4.6-soluble 
fraction of each sample was diluted accordingly with a rehydration buffer (8 M 
urea, 2%  3-[(3-cholamidopropyl) dimethylammonio]-1-propanesulfonate (CHAPS), 
50 mM dithiothreitol (DTT), 0.2% Bio-Lyte 3/10 ampholyte, 0.001% Bromophenol 
Blue) to give a final volume of 125 µL and concentration of 500 µg protein.  Samples 
(125 µl) were loaded on to immobilised pH gradient (IPG) strips (pH 4-7, 7cm, Bio-
Rad) which were then passively hydrated for 8 h, followed by active rehydration for 
8 h. The IPG strips were then focused at 20°C until 20 kV was reached. After 
focussing, the strips were immediately used for second-dimension sodium dodecyl 
sulphate polyacrylamide gel electrophoresis (SDS-PAGE), which was carried out 
under reducing conditions using a 15% acrylamide gel, in a Criterion© Dodeca Cell 
unit (Bio-Rad, USA). The focussed IPG strips were equilibrated with 50 mM Tris/HCl, 
185 
 
pH 8.8, 6 M urea, 30% glycerol, 2% SDS and 130 mM DTT and alkylated in the same 
buffer containing 130 mM iodoacetamide (IAA) instead of DTT. The gels were then 
run at 200 V for 50 min, stained using colloidal Coomassie blue (Chevalier et al. 
2004) and images for stained gels were digitised at 300 dpi using a calibrated GS-
800 densitometer (Bio-Rad Laboratories).  
 
3.2.8 Reversed-phase ultra-performance liquid chromatography (RP-UPLC) 
Colostrum fractions were filtered through 0.22 µm pore filters (Millex, low protein 
binding durapore, syringe driven PVDF membrane; Millipore Ireland Ltd, Tullagreen, 
Carrigtwohill, Co Cork, Ireland). The filtrate was analysed at room temperature 
(21°C) by RP-UPLC using a Waters Acquity UPLC H-Class Core System. The column 
used was an Acquity UPLC BEH C18 column (1.7 µm, 2.1 x 50 mm). The sample was 
eluted for 0.37 min with 100% solvent A (0.1% trifluoroacetic acid [sequencing 
grade; Sigma-Aldrich Ireland Ltd, Arklow, Co Wicklow, Ireland] in ultra-pure water 
[Elga purelab option-Q, Veolia Water Solutions and Technologies, Marlow, UK]), 
then with a linear gradient to 50% solvent B (0.1% trichloroacetic acid in acetonitrile 
[HPLC far UV grade; Labscan Ltd, Dublin, Ireland]) over 6.23 min, maintained at 50% 
B for 0.68 min, then with a linear gradient to 95% B over 0.46 min, maintained at 
95% B for 0.68 min, then with a linear gradient to 100% B over 0.45 min, before 
returning to the original conditions. Eluate was monitored at 214 nm using a 
Waters Acquity UPLC TUV Detector (dual wavelength) interfaced with Empower 3 
software.  The flow rate was maintained at 0.46 mL/min. 
 
3.2.9 Mass Spectrometry 
3.2.9.1 In-gel digestion  
3.2.9.1.1 Manual excision of Coomassie stained protein spots from gels 
Coomassie-stained gels from which spots were to be cut were washed in distilled 
H2O before being placed on a clean level surface protected with a plastic gel bag. 
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Spots of interest were manually excised with a 1.5 mm One Touch Plus Spot Picker 
(Web Scientific, Crewe, Cheshire, UK) using a new pipette tip for each spot. Gel 
plugs were placed in individual eppendorfs and covered with 100 μL of distilled H2O 
in order to prevent dehydration. The samples were stored at 4°C until required. 
 
3.2.9.1.2 Reduction and protection of cysteine residues 
Fifty μL of freshly prepared 10 mM DTT/0.1 M ammonium bicarbonate was added 
to the gel pieces and the samples were incubated at 56°C for 60 min with agitation 
at 500 rpm (Eppendorf Thermomixer Compact, Sigmaaldrich, St. Louis, MO, USA).  
The solution was allowed to cool to room temperature and was removed.  Fifty μL 
of freshly made 50 mM IAA/0.1M ammonium bicarbonate was applied to the gel 
pieces and incubated at 37°C for 30 min in the dark with agitation at 500 rpm.  The 
IAA solution was removed and replaced with 250 μL of 100 mM ammonium 
bicarbonate for 15 min at 37°C with agitation at 300 rpm.  This was removed and 
replaced with 250 μL of 20 mM ammonium bicarbonate/ACN 1:1 for 15 min at 37°C 
with agitation at 300 rpm.  The ammonium bicarbonate/ACN solution was then 
replaced by 100 μL of ACN for 10 min at 37°C with agitation at 300 rpm, followed by 
removal of the ACN solution. 
 
3.2.9.1.3 In-gel tryptic digestion  
The gel pieces were re-suspended in 25 μL of trypsin digestion buffer [8 ng/μL 
sequencing grade modified trypsin (Promega, Madison, WI, USA) in 50 mM 
ammonium bicarbonate].  The samples were incubated overnight at 37°C with 
agitation at 500 rpm (Eppendorf Thermomixer Compact, Sigmaaldrich, St. Louis, 
MO, USA).  
 
3.2.9.1.4 Extraction of peptides  
The eppendorfs containing the samples were briefly spun down and the 
supernatant was taken off and placed in a fresh eppendorf.  Eighty μL of 30% 
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ACN/0.2% TFA was added to each sample and incubated at 37°C for 10 min with 
agitation at 500 rpm (Eppendorf Thermomixer Compact, Sigmaaldrich, St. Louis, 
MO, USA). The samples were spun down briefly and the supernatants pooled with 
their respective original tryptic supernatants.  Eighty μL of 70% ACN/0.2% TFA was 
added to each sample and incubated at 37°C for 10 min with agitation at 500 rpm. 
The samples were spun down briefly and the supernatants combined with their 
respective samples. The pooled supernatants were then dried in a vacuum 
centrifuge (Eppendorf Concentrator 5301, Hamburg, Germany) at 45°C.  
 
3.2.9.2 In-solution digestion 
In-solution digestion of complex protein mixtures (100 µg) was performed as 
described in Sections 3.2.9.1.2 to 3.2.9.1.4. 
 
3.2.9.3 LTQ linear ion trap mass spectrometry 
Samples were analysed by liquid chromatography mass spectrometry (LC-MS) on an 
LTQ linear ion trap mass spectrometer (Thermo Scientific, Waltham, MA, USA) 
connected online to a surveyor chromatography system incorporating an 
autosampler. Dried tryptic samples were re-suspended in 0.1% formic acid and 
separated on a modular CapaLC system (Finnegan) connected directly to the source 
of the LTQ.  Samples were loaded onto a Biobasic C18 PicofritTM column (100 mm 
length, 75 m ID) at a flow rate of 30 nL/min and eluted from the column by an 
increasing acetonitrile gradient. The gradient length for a LC separation is 
dependant upon the complexity of the sample and a 20 min gradient was used for 
2-DE spots. The mass spectrometer was operated in positive ion mode with a 
capillary temperature of 200C, a capillary voltage of 46 V, a tube lens voltage of 
140 V and a potential of 1800 V applied to the frit. Data was collected by the mass 
spectrometer operating in automatic data dependent switching mode.  A zoom 
scan was performed on the 5 most intense ions to determine charge state prior to 
MS/MS analysis. MS/MS spectra were sequence database searched using 
TurboSEQUEST (Xcalibur Software, Thermo Fisher Scientific, Waltham, MA, USA).  
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The MS/MS spectra were searched against the non-redundant UniProt/SwissProt 
(release 6.0) database. Methionine oxidation and cysteine 
carboxyamidomethylation were specified as variable modifications. The precursor-
ion mass tolerance was set at 1.5 Da, fragment ion tolerance was set at 1.0 Da and 
a maximum of 2 missed cleavage sites were allowed.  
 
3.2.9.4 Quadropole time-of-flight (Q-TOF) mass spectrometry 
Samples were analysed by mass spectrometry using a Waters Acquity G2 Q-TOF LC-
MS. This system consisted of a Waters Acquity Nano-Flow LC system coupled to a 
Quadrupole Time-of-flight mass spectrometer. A sample (1 µL) was injected onto a 
Waters Acquity UPLC BEH C18 column (1.7 µm particle size, 100 mm x 75 µm) with 
a flowrate of 300 nL/min. The column temperature was maintained at 30°C while 
samples were refrigerated at 4°C.  The nano-flow system was fitted with a trapping 
column to aid column loading on to the analytical column using 99.5% solvent A 
(0.1% formic acid [sequencing grade; Sigma-Aldrich Ireland Ltd, Arklow, Co 
Wicklow, Ireland] in deionised water [Milli Q System; Millipore Corp]) and 0.5% 
solvent B (0.1% formic acid in acetonitrile [HPLC far UV grade; Labscan Ltd, Dublin, 
Ireland]) with a flow rate of 15 µL/min and a sample loading time of 1 min.  Once 
the sample was transferred from the trapping column to the analytical column, it 
was eluted for 0.1 min with 97% solvent A, then with a linear gradient to 40% 
solvent B over 29 min, then with a linear gradient to 85% B over 2 min, maintained 
at 85% B for 2 min, then with a linear gradient to 3% B over 1 min and maintained 
at 3% B for 15 min.   
Mass spectrometry detection was conducted through electrospray ionization using 
an mse centroid experiment in positive mode in the m/z scan range 50-2000 Da. The 
following MS settings were used in conjunction with the nano-flow ESI source: 
capillary voltage 3.5 kV, sampling cone 20 V, extraction cone 5 V, source 
temperature 100 °C, desolvation temperature 150 °C, desolvation gas flow 600 L/h, 
cone gas flow 50 L/h. The accurate mass of the instrument was initially calibrated 
through direct infusion of a sodium iodide calibrant solution prior to sample 
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analysis. In addition, leucine enkephalin (Leuenk) lockmass solution (2 ng/uL) and 
Glu-fib (1 ng/µL) were infused at 500 nL/min using an auxiliary solvent manager and 
attached to the reference position of the nano-flow source. This reference mixture 
was scanned, but not applied, to verify exact mass, as this correction was 
conducted at the data analysis stage. Masslynx v4.1 software (Waters, Millford, 
Massachusetts) was used to control the instrument while Proteinlynx Global Server 
(PLGS) software (Waters, Millford, Massachusetts) was used to assist data analysis 
and aid in determination of peptides present. Within PLGS, a non-specific or tryptic 
digest was specified and appropriate intensity thresholds of 80 and 20 were used 
for low and elevated energy thresholds, respectively. Lockmass correction was also 
conducted in PLGS rather than during data acquisition. A species specific database 
for Bos taurus was downloaded from the Uniprot website and only reviewed hits 
were included. The analytical data were searched against this database resulting in 
a number of peptides identified within the samples.  
 
3.2.9.5 Matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass 
spectrometry 
Samples were analysed by mass spectrometry with an Axima TOF2 MALDI-TOF mass 
spectrometer (Shimadzu Biotech, Manchester, UK). Aliquots (0.5 μL) of matrix 
solution (-cyano 4-hydroxy cinnamic acid, 10 mg/mL, in 50 % acetonitrile/0.1 % 
(v/v) trifluoroacetic acid) were deposited onto the target and left for 5 seconds 
before being removed. The residual solution was allowed to air-dry and 0.5 μL of 
the sample solution was deposited onto the pre-coated sample spot. Aliquots (0.5 
μL) of matrix solution were added to the deposited sample and allowed to air-dry. 
The sample was subsequently analysed in positive-ion reflectron mode. 
Protein identification was carried out via peptide mass fingerprinting (PMF) using 
the Mascot search engine (http://www.matrix-science.com). The monoisotopic, 
positive ion data +/- 0.25 Da was searched using the following parameters: NCBInr 
database or Swiss Prot, taxonomy mammalian, trypsin digest with one missed 
190 
 
cleavage. Variable modifications including cysteine modified by 
carbamidomethylation, and methionine modified by oxygen were also checked. 
Tandem mass spectrometry (MS/MS) was carried out on peaks from spots that did 
not score well using PMF. The MS/MS positive ion, averaged data +/- 0.8 Da was 
again searched using the Mascot engine (http://www.matrix-science.com) and the 
following parameters: NCBInr database or Swiss Prot, taxonomy mammalian trypsin 
digest with one missed cleavage or semi trypsin with one missed cleavage, variable 
modifications including cysteine modified by carbamidomethylation, methionine 
modified by oxygen and/or acetylated. 
 
3.2.10 Fatty acid analysis 
Following extraction and methylation according to International Organization for 
Standardization (ISO) standards 14156:2001 (ISO, 2001) and 15884:2002 (ISO, 
2002), the fatty acid methyl esters (FAME) of cream from colostrum or mature milk 
were separated using a CP Sil 88 column (100 mm, 30.25 mm i.d., 0.20 mm film 
thickness) (Chrompack, Middelburg, the Netherlands) and quantified using a gas 
liquid chromatograph (Varian 3400 GC, Harbor City, CA, USA). The GLC instrument 
was calibrated using a range of commercial fatty acid methyl ester standards. 
FAMEs were analysed by gas liquid chromatography (GLC) using the parameters 
described by Childs et al. (2008). The GLC instrument was fitted with a flame 
ionisation detector (FID) and helium (2.55 bar) was used as the carrier gas. The 
injector temperature was held isothermally at 225°C for 10 min, and the detector 
temperature was 250°C. The column oven was held at an initial temperature of 
140°C for 8 min, and was then increased at a rate of 8.5°C per min, to reach a final 
temperature of 200°C, which was held for 50 min. The data were recorded and 






3.2.11 Cell culture (inflammation) 
3.2.11.1 Cell lines and reagents 
NIH3T3/NF-κB-luc fibroblasts were purchased from Panomics (Affymetric Inc, Santa 
Clara, California, USA). J774.2 macrophages were purchased from the European 
Collection of Animal Cell Cultures (ECACC, Salisbury, UK). Bone marrow-derived 
mononuclear (BM-MNC) cells were isolated from the femurs and tibia of C57Bl/6 
mice.  
 
3.2.11.2 Cell culture 
NIH3T3/NF-κB-luc fibroblasts, J774.2 macrophages and viable BM-MNC were 
enumerated by a Trypan blue assay according to the method of Strober (1997). 
After enumeration, J774.2 macrophages were re-suspended in Dublecco’s Modified 
Eagle’s Medium (DMEM, Lonza Walkersville Inc, MD, USA) supplemented with 10% 
fetal calf serum (FBS, Gibco®, Invitrogen, Paisley, UK) and 1% 
penicillin/streptromycin. NIH3T3/NF-κB-luc fibroblast were re-suspended in DMEM 
supplemented with 10% fetal calf serum, 1% penicillin/streptromycin and 0.1% 
hygromycin B.  BM-MNCs were re-suspended in DMEM medium containing L929 
conditioned medium and differentiated for 7 days. On day 7, fully differentiated 
macrophages (BMDM) were treated. 
 
3.2.11.3 Preparation of lipopolysaccharide (LPS) 
LPS is a cell wall component of Gram-neagtive bacteria such as Escherichia coli. LPS 
binds to the pattern recognition receptor (PRR) Toll-like receptor–4 (TLR 4) to 
induce a potent inflammatory response and was used in the current study to induce 
inflammation in NIH3T3/NF-κB-luc fibroblasts, J774.2 macrophages and bone 
marrow-derived macrophages (BMDM). E. coli (Serotype 0111:B4) derived LPS 
(Alexis, Enzo Life Sciences, Exeter, UK), at 1 mg/mL, was stored at 4°C and diluted to 
a working concentration prior to use. 
192 
 
3.2.11.4 Treatment of macrophages with milk samples 
BMDM or J774.2 macrophages in log-growth phase were seeded on 24-well tissue 
culture plates (Cell Star®, Greiner Bio-One, Stonehouse, UK) with 1.25x105 cells in 
500 μL of medium and incubated overnight. Following overnight incubation, the 
medium was removed and replaced with fresh medium. The cells were incubated 
with various concentrations of lyophilised colostrum or mature milk samples for 24 
h. Following 24 h incubation the medium was removed and the cells were washed 
gently with phosphate buffered saline (PBS, Gibco®, Invitrogen, Paisley, UK). Fresh 
medium was added to the cells with/without 10 ng/mL LPS (3 h for TNF-α, IL-6 and 
IL-1β analysis; 24 h for IL-10 and IL-12 analysis). Following LPS stimulation, the 
supernatant was collected and stored at -20°C for cytokine analysis. 
 
3.2.11.5 Cytokine secretion 
The supernatant was thawed and centrifuged at 300 x g for 10 min prior to ELISA to 
pellet cell debris. The concentrations of TNF-α, IL-6, IL-1β, IL-10 and IL-12 were 
determined using DuoSet ELISA development systems (R&D Systems Europe, 
Abdingdon, UK).  
 
3.2.11.6 NF-κB-luciferase reporter assay 
Conditioned medium was aspirated and the cells were rinsed gently with 200 μL of 
sterile PBS. After rinsing, 50 μL 1X Reporter Lysis Buffer (Promega Corporation, 
Madison, WI, USA) was added to each well and the plate was gently agitated on a 
shaker table for 5 min at room temperature to lyse cells. Cell lysate (10 μL) was 
transferred to a 96 well fluorescence sterile polystyrene Fluoro Nunc white plate 
(Thermo Fisher Scientific, Waltham, MA, USA). Luciferase Assay Reagent (50 μL) 
was added to the cell lysate and luminescence was measured using a luminometer 




3.2.12 Cell culture (insulin secretion) 
3.2.12.1 Culture of the BRIN-BD11 cell line 
BRIN-BD11 cells were grown and maintained in RPMI 1640 tissue culture medium 
with 10% (v/v) FBS, 0.1% antibiotics (100 units/mL penicillin and 0.1 mg/mL 
streptomycin) and 11.1 mmol/L D-glucose at 37oC in a humidified atmosphere of 
5% CO2 and 95% air using a Thermo HEPA class 100 incubator (Thermo Fisher 
Scientific, Waltham, MA, USA). The cells were gently washed in 10 mL PBS prior to 
detachment from the tissue culture flask by adding 5 mL of pre-warmed 0.025% 
(w/v) trypsin containing 1 mM ETDA, and trypsin was removed before cells began to 
attach. Once detached, cells were re-suspended with 6 mL of pre-warmed tissue 
culture medium. To maintain culture, 1 mL of cell suspension was seeded back into 
a tissue culture flask and supplemented with 50 mL of fresh tissue culture medium. 
For experimental use, cells aliquots of cell suspension (100 L) were stained with 
trypan blue (1:2 dilution) and were counted using a Neubauer haemocytometer 
(Scientific Supplies Co, UK) and were viewed under a phase contrast microscope 
(Olympus CKX 41).  Once the cell count was determined, cells were seeded to the 
required plates and were allowed to attach overnight as monolayers. 
 
3.2.12.2 Acute insulin secretion test  
Acute insulin secretion was induced with a high level of glucose (16.7 mM) plus 
fractions from colostrum or mature milk which are meant to mimic meal conditions 
where there is a starvation period followed by high glucose plus protein. BRIN-BD11 
cells were seeded at a concentration of 1 x 105 cells/well in 1 mL of medium in 24-
well plates for 24 h in RPMI-1640 medium containing 11.1 mM D-glucose.  The 
following day, the tissue culture medium was removed gently and the cells were 
washed with 1 mL warmed PBS.  One mL Kreb’s Ringer Bicarbonate buffer (KRB) (pH 
7.4) (115 mM NaCl, 4.7 mM KCl, 1.28 mM CaCl2.6H2O, 1.2 mM MgSO4.7H2O, 1.2 
mM KH2PO4, 24 mM NaHCO3, 0.1% BSA), supplemented with 1.1 mM D-glucose was 
then added to each well for a 40 min incubation period at 37°C. At the end of the 
incubation period, the buffer was removed and the cells were washed with 1 mL 
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pre-warmed PBS to remove any trace of insulin.  The cells were stimulated with 1 
mL KRB supplemented with 16.7 mM glucose plus 1 mg/mL of colostrum or mature 
milk fractions for precisely 20 min at 37°C. The buffer was removed from each well 
and transferred to eppendorf tubes and samples were centrifuged at 100 x g for 5 
mins to remove cell debris.  The supernatant was collected from each tube and 
stored at -20°C for subsequent insulin determination by ELISA.  Cells were lysed 
with RIPA (1x) and protein content was determined as above. 
 
3.2.12.3 Insulin secretion measurement 
The Mercodia Ultrasensitive Rat Insulin ELISA (Mercodia, Uppsala, Sweeden) was 
used to determine the concentration of insulin in samples.  This is a solid phase 
two-site enzyme immunoassay, which is based on the direct sandwich technique in 
which two monoclonal antibodies are directed against separate antigenic 
determinants on the insulin molecule.  During incubation, insulin in the sample 
reacts with anti-insulin antibodies bound to microtitration wells and peroxidase-
conjugated anti-insulin antibodies.  A washing step removes unbound enzyme 
labeled antibody.  The bound conjugate is detected by reaction with 3, 3’, 5, 5’-
tetramethylbenzidine.  The reaction is stopped by adding acid to give a colorimetric 
endpoint that is read spectrophotometrically at 450 nm.  The exact concentration 
of insulin in each sample was extrapolated from a standard curve.   
 
3.2.12.4 Procedure for insulin secretion measurement 
Standards (50 µl) ranging from 0.02-1.0 µg/L or test samples (colostrum or mature 
milk fractions) were added to separate anti-insulin wells. Conjugate solution (50 
µL), which contains the peroxidase conjugated mouse monoclonal anti-insulin 
antibody in conjugate buffer, was added to each well and the plate was then placed 
on a plate shaker at room temperature for 2 h.  Following incubation, the conjugate 
buffer was removed and the wells were washed 6 times with 350 μL ELISA wash 
buffer.  After the final wash the plate was inverted and tapped firmly against 
absorbent paper. Peroxidase substrate (TMB) (200 μl) was then added and 
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incubated at room temperature for 30 min. To stop the reaction, 50 μL of stop 
solution (1 M H2SO4) was added and mixed on a plate shaker for 5 seconds.  The 
plate was then read at 450 nm using a Molecular Devices Vmax kinetic microplate 
reader (Molecular Devices, Sunnyvale, CA, USA).  Insulin content present in each 
well was extrapolated from the standard curve.   
 
3.2.12.5 Cell proliferation assay - WST-1 
The WST-1 assay is a colorimetric assay for the quantification of cell proliferation 
and cell viability, based on the cleavage of the tetrazolium salt WST-1 by 
mitochondrial dehydrogenases in viable cells. BRIN-BD11 cells (4 x 104) were 
seeded in a 96-well plate in 250 µL of medium and were left to adhere overnight. 
Control wells containing medium alone were also included. Following overnight 
incubation, the medium was removed and the cells were washed with PBS before 
adding 250 μL medium containing the treatment to be analysed, or with medium 
alone as a control. After 24 hours incubation, 25 μL WST-1 reagent was added to 
each well and cells were incubated for a total of 90 min in the incubator, removing 
the plate for a reading at 30, 60 and 90 min.  The cells were shaken for 1 min and 
bubbles were removed prior to reading, and then read at 450 nm using a Molecular 
Devices Vmax kinetic microtitre plate reader (Molecular Devices, Sunnyvale, CA, 
USA). 
 
3.2.13 Data analysis 
Analysis of variance (one-way ANOVA) was conducted using Minitab version 16 
(Minitab Inc., State College, PA, USA). When differences were significant (P ≤ 0.05), 






3.3 Results and Discussion 
 
3.3.1 Colostrum buttermilk 
Buttermilk is defined as the aqueous phase released during the churning of cream 
in butter manufacture (Corredig and Dalgleish, 1997). Mature milk buttermilk 
contains lactose, minerals and skimmed milk proteins in the same proportion as 
skimmed milk (Corredig et al., 1997). It has traditionally been considered a waste 
product; however, in recent years, it has gained considerable attention due to its 
specific composition of proteins and polar lipids from the milk fat globule 
membrane (MFGM). The MFGM is a thin membrane, about 10-20 nm in cross-
section, which surrounds the triglyceride core of fat globules in milk (Dewettinck et 
al., 2008). The MFGM consists of 3 distinct layers: a monolayer of lipid droplet-
associated proteins and polar lipids, an electron-dense proteinaceous coat and a 
bilayer membrane of polar lipids and proteins (Keenan and Mather, 2006). The 
MFGM comprises mainly membrane-specific glycoproteins and polar lipids 
including phospho- and sphingolipids (Fox and McSweeney, 1998).  MFGM can be 
isolated by a four-step procedure in which the fat globules are separated from 
whole milk and washed several times with buffers. The membrane is then released 
from the surface of the globules by physical or chemical means and collected by 
centrifugation (Mather, 2000). The washing step is carried out to remove lactose, 
minerals and skim milk protein. In the current study, colostrum cream was not 
washed before mechanical agitation, which resulted in a large proportion of 
lactose, minerals and skim milk proteins remaining in the buttermilk. An alternative 
method for isolating MFGM is freezing and thawing the washed globules (Keenan, 
1970). In the current study, buttermilk was produced from colostrum which had 
been frozen, which, on thawing, may have resulted in the loss of some MFGM 
material into the serum phase of colostrum. While extensive work has been carried 
out on MFGM proteins in colostrum and mature milk (Mather et al., 2000; 
Reinhardt and Lippolis, 2006; Dewettinck et al., 2008; Vanderghem et al., 2010), to 
the best of our knowledge, very little work has been carried out on the protein 
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composition and biological activities associated with buttermilk produced from 
bovine colostrum.   
The protein profile of the pH 4.6-soluble fraction of (a) colostrum buttermilk and (b) 
mature milk buttermilk were analysed using 2-DE (Figure 3.1). Colostrum buttermilk 
and mature milk buttermilk were adjusted to pH 4.6 according to the method of 
Kuchroo and Fox (1982) in order to remove pH 4.6-insoluble material and improve 
the resolution of whey proteins on 2-DE electrophoretograms. The pH 4.6-insoluble 
fraction of colostrum was shown to have no inflammatory (Figure 3.2) or 
insulinotrophic properties (as discussed later, Figure 3.12). The pH 4.6-soluble 
fraction of colostrum buttermilk contained a higher proportion of high molecular 
weight protein than the pH 4.6-soluble fraction of mature milk buttermilk. This was 
to be expected because, as already mentioned, the protein profile of colostrum 
buttermilk is very similar to that of skimmed colostrum. Colostrum has a distinctive 
whey protein composition, which includes elevated levels of IgG, IgA and IgM 
(Smolenski et al., 2007). Colostrum also has a high concentration of bioactive 
components, e.g., growth factors, especially insulin-like growth factor-1 (IGF-1), 
transforming growth factor beta-2 (TGF-β2) and growth hormone (GH) as well as 
lysozyme and lactoperoxidase (Elfstrand et al., 2002). Proteins secreted by the 
mammary gland such as β-lactoglobulin, α-lactalbumin, lactoferrin, proteinase 
inhibitors and some enzymes are present in higher concentrations in colostrum 
than in mature milk (Levieux and Ollier, 1999). Proteins derived from the blood such 
as albumin, α2-macroglobulin, and transferrin are also present at higher 
concentration in colostrum (Levieux and Ollier, 1999). In addition, colostrum 
contains cytokines and leukocytes, including activated neutrophils, macrophages 
and lymphocytes. The most abundant proteins associated with the bovine MFGM 
are MUC1, xanthine dehydrogenase/oxidase, CD36, butyrophilin, adipophilin, 
periodic acid Schiff 6/7 (PAS 6/7) and fatty-acid-binding protein (Mather, 2000). 
To identify some of the proteins which were abundant in colostrum buttermilk 
compared with mature milk buttermilk, LC-MS was performed on 2-DE excised gel 
spots (Figure 3.1). Identification of the 13 spots analysed are shown in Table 3.1. It 
should be noted that 2-DE is problematic when analysing membrane proteins 
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associated with the MFGM as many are lost due to precipitation at the isoelectric 
point, and these proteins can be difficult to get into solution prior to iso-electric 
focussing (Reinhardt and Lippolis, 2006). The predominant proteins identified in the 
pH 4.6-soluble fraction of colostrum buttermilk by LC-MS of 2-DE gel spots, in 
decreasing order, were immunoglobulin light chain lambda (IGL), immunoglobulin 
light chain kappa (IGK), lactadherin, polymeric immunoglobulin receptor (pIgR), 
serum albumin, lactotransferrin, alpha 1 antiproteinase and zinc alpha 2 
glycoprotein.  
The immunoglobulin (Ig) proteins in milk protect the gut mucosa against pathogenic 
microorganisms. In bovine milk, the predominant species of Ig is IgG, in particular 
IgG1, but IgA and IgM are also found. Colostrum contains 40-300 times the 
concentration of IgG than mature milk (Edwards et al., 2009). All monomeric 
immunoglobulins have the same basic molecular structure, being composed of two 
identical heavy chains and two identical light chains, with a total molecular mass of 
approximately 160 kDa (Hurley et al., 2011). Heavy and light chains are linked 
together by disulphide bonds, resulting in a Y-shape. The number and location of 
disulphide bonds is dependent on the class of immunoglobulin (Mix et al., 2006). 
Under reducing conditions used in 2-DE, the disulphide bonds linking together the 
heavy and light chains are broken. There are two types of light chain, referred to as 
kappa (к) and lambda (λ or L). Of the 13 gel spots analysed, IgL was present in 7 
spots and IgK was present in 6 spots (Table 3.1). Because light chains of the various 
Ig species are identical, there is no way of determining from which particular 
species of Ig these light chains originated.  
Lactadherin (formerly known as PAS-6/7) is a glycoprotein and is an abundant 
peripheral protein associated with the MFGM (Andersen et al., 1997). It is secreted 
by mammary epithelial cells (Butler et al., 1980), epididymal epithelial cells (Ensslin 
et al., 1995), vascular cells (Silvestre et al., 2005) and macrophages (Hanayama et 
al., 2002).  Lactadherin comprises two EGF-like domains and two C-like domains 
found in blood clotting factors V and VIII (Andersen et al., 2000). Lactadherin was 
found in 6 out of 13 gel spots analysed (Table 3.1). Lactadherin has been linked with 
intestinal development. Zhou et al. (2010) demonstrated that lactadherin increases 
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production of IL-10, an anti-inflammatory cytokine, when present in culture 
medium compared with lactadherin-absent culture. Lactadherin-associated glycans 
may also bind to rotaviruses and protect the neonatal gut from infection (Newberg 
et al., 1998). 
Polymeric immunoglobulin receptor (pIgR) is a transmembrane glycoprotein which 
mediates transport of polymeric immunoglobulins (IgA and to a lesser extent IgM) 
across mucosal epithelial cells (Kaetzel, 2005), the pathway of which has been well 
characterised (Mostov et al., 2005). The pro-inflammatory cytokines interferon-γ, 
tumor necrosis factor and interleukin-1, play a key role in upregulation of pIgR 
expression (Kaetzel, 2005). pIgR was found in 5 out of 13 gel spots analysed (Table 
3.1). 
Serum albumin was found in 4 out of 13 gel spots analysed (Table 3.1); this is a 
minor protein in milk which gains entry via leakage from blood serum (Walstra et 
al., 2006). It is a large molecule having three globular domains, resulting in an 
elongated shape, and consists of 9 separate disulphide-bonded loops connected by 
peptide links of 11-26 residues (Beretta et al., 2001). BSA is involved in milk allergy, 
where it represents one of the most important antigens from whey proteins 
(Goldman et al., 1963).  
 
Alpha 1 antiproteinase (also known as alpha 1 antitrypsin or serpin A1) is a 
glycoprotein synthesised in the liver and is composed of a single polypeptide chain 
(Mr, 50 kDa) and three carbohydrate chains (Kurachi et al., 1981). It is an important 
protease inhibitor present in mammalian blood (Kurachi et al., 1981), which has 
also been identified as a low abundance protein in bovine colostrum (Yamada et al., 
2002). Its major physiological function appears to be the inhibition of neutrophil 
elastase; however, it also inhibits many other serine proteinases, including trypsin, 
chymotrypsin, collagenase, thrombin, kallikrein and plasmin (Laurell and Jeppsson, 





Lactotransferrin (also known as lactoferrin) is a monomeric, globular, iron binding 
glycoprotein with a molecular mass of 80 kDa (Edwards et al., 2009). It is present in 
high concentrations in milk, especially colostrum (Sanchez et al., 1988) and was 
found in 3 out of 13 spots analysed (Table 3.1). Lactoferrin possesses numerous 
biological functions, including roles in iron metabolism, cell proliferation and 
differentiation, and antibacterial, antiviral and antiparasitic activity (Adlerova et al., 
2008). Lactoferrin has been shown to reduce the production of pro-inflammatory 
cytokines such as tumor necrosis factor or interleukins IL-1β and IL-6 (Haversen et 
al., 2002) and increase the production of the anti-inflammatory interleukin IL-10. 
Lactoferrin may also prevent the development of inflammation and tissue damage 
by binding components of bacterial cell walls, such as LPS (Adlerova et al., 2008).  
Zinc alpha 2 glycoprotein (ZAG) is a 40 kDa single-chain polypeptide (Burgi and 
Schmid, 1961), the exact function of which is still unknown. ZAG is a 
multidisciplinary protein and is considered an adipokine due to its high sequence 
homology with lipid-mobilizing factor and high expression in cancer cachexia. ZAG 
may also play a role in the immune response as its structural organization and fold 
is similar to MHC class I antigen-presenting molecule (Hassan et al., 2008). ZAG was 






Figure 3.1 Two-dimensional gel electrophoretograms of the pH 4.6-soluble fraction 
of (a) colostrum buttermilk and (b) mature milk buttermilk, separated under 
reducing conditions using a 7 cm pH 4-7 pI range for the first dimension and a 12% 
gradient acrylamide SDS-PAGE gel for the second dimension. Circled and numbered 




















Table 3.1. Identification of spots from a 2-DE gel of the pH 4.6-soluble fraction of colostrum buttermilk, by LC-MS using a LTQ linear 
Spot No. Identified protein Uniprot Mol. mass (Da) % Coverage Peptides Score
Accession Number
1 Actin, cytoplasmic 1 P60712 42052 45.6 18 506
Lactotransferrin P24627 80002 12 7 228
Fibrinogen beta chain P02676 53933 19.2 5 181
Serpin H1 Q2KJH6 46591 16 6 177
Elongation factor 1-alpha 1 P68103 50451 10.6 3 177
Alpha-enolase Q9XSJ4 47639 18.2 4 136
2 Immunoglobulin light chain lambda A5PK49 24919 43.6 29 493
Immunoglobulin light chain kappa Q05B55 26589 12.5 3 124
3 Immunoglobulin light chain lambda A5PK49 24919 43.6 27 507
Immunoglobulin light chain kappa Q05B55 26859 33.3 7 386
4 Immunoglobulin light chain lambda A5PK49 24919 35.5 21 446
Immunoglobulin light chain kappa Q05B55 26589 19.2 4 211
5 Immunoglobulin light chain lambda A5PK49 24910 59.1 27 608
Immunoglobulin light chain kappa Q05B55 26859 45.4 8 274
6 Immunoglobulin light chain lambda A5PK49 24919 40.2 20 432
Immunoglobulin light chain kappa Q05B55 26859 45.4 7 353
7 Polymeric immunoglobulin receptor P812165 83695 40 43 1660
Serum albumin P02679 71244 46.3 27 1427
Lactotransferrin P24627 80002 36 23 1305
Serotransferrin Q29443 79870 37.1 21 1151
CD5L protein A6QNW7 52118 24.6 9 426
Hemopexin Q3SZV7 52974 17.2 7 379
8 Lactadherin Q95114 48520 40.3 15 968
Polymeric immunoglobulin receptor P81265 83695 20.2 12 732
Serum albumin P02679 71244 21.6 10 540
α-1-antiproteinase P34955 46417 20.2 9 395





Spot No. Identified protein Uniprot Mol. mass (Da) % Coverage Peptides Score
Accession Number
9 Lactadherin Q95114 48520 39.8 18 822
Polymeric immunoglobulin receptor P81265 83695 17 9 617
Serum albumin P02679 71244 20.1 9 369
Lactotransferrin P24627 80002 10.9 6 272
Endopin 2C Q32T06 46858 14.7 5 258
FGG protein Q3SZZ9 49763 10.1 3 173
α-2-HS-glycoprotein P12763 39193 11.7 3 161
10 Lactadherin Q95114 48520 27.9 11 635
Polymeric immunoglobulin receptor P81265 83695 13.1 7 478
Immunoglobulin light chain lambda A5PK49 24910 22.6 8 224
Immunoglobulin light chain kappa Q05B55 26589 32.1 4 214
11 Zinc-α-2-glycoprotein B2BX70 34059 55.2 16 970
Lactadherin Q95114 48520 27.4 11 529
Polymeric immunoglobulin receptor P81265 83695 12.4 7 442
Apolipoprotein A-IV Q32PJ2 42991 23.2 9 422
Apolipoprotein E Q03247 36015 28.8 7 409
Actin, cytoplasmin 1 P60712 42052 30.4 8 319
Serum albumin P02679 71244 17 8 312
12 Lactadherin Q95114 48520 44.7 16 910
Alpha-1-antiproteinase P34955 46417 23.8 11 503
Antithrombin-III P41361 52827 23.4 7 449
Serum albumin P02679 71244 16.5 7 376
α-2-HS-glycoprotein P12763 39193 18.4 3 179
Zinc-α-2-glycoprotein B2BX70 34059 10.7 2 71
13 Lactadherin Q95114 48520 32.6 13 652
Immunoglobulin light chain kappa Q05B55 24863 35.5 8 398
Immunoglobulin light chain lambda A5PK49 24910 33.2 7 370
β-lactoglobulin PO2754 20269 26.4 9 330
α-1-antiproteinase P34955 46417 10.6 4 226
Actin, cytoplasmin 1 P60712 42052 18.9 5 201




Unfractionated colostrum buttermilk was analysed by LC-MS using a G2 Q-TOF 
(Table 3.2). As already mentioned, buttermilk contains the same proportion of 
proteins as skimmed milk. Therefore, it is not surprising that the caseins (αS1-, αS2-, 
β- and к-casein) were identified, along with whey proteins such as β-Lg and α-La 
(Table 3.2). Several proteins which were identified from 2-DE gel spots of the pH 
4.6-soluble fraction of colostrum buttermilk by LC-MS using a linear ion trap (Table 
3.1) were also identified using this approach. These include lactadherin, polymeric 
immunoglobulin receptor, serum albumin and lactotransferrin, and will not be 
discussed further. Major MFGM proteins which were identified include lactadherin, 
xanthine oxidoreductase, butyrophilin and adipophilin.  
Xanthine oxidoreductase (XOR) is the second most abundant protein in the MFGM, 
after butyrophilin, comprising approximately 20% of globule-associated protein 
(Fox and Kelly, 2006). XOR is a molybdenum-containing enzyme which comprises a 
homodimer of Mr approximately 300,000 Da (Mather, 1999). XOR exists in two 
forms, xanthine oxidase XO (EC 1.1.3.22) and xanthine dehydrogenase XDH (EC 
1.1.1.204). The most important role of XOR in milk is in the secretion of milk fat 
globules from mammary secretory cells; it is also involved in lipid oxidation, 
atherosclerosis, production of H2O2, purine catabolism and bactericidal activity (Fox 
and Kelly, 2006). XOR has also been linked with the inflammatory process because 
expression of the XOR gene, protein and enzyme activity are induced by cytokines 
and steroids (Pfeffer et al., 1994; Page et al., 1998). Pfeffer et al. (1994) and Page et 
al. (1998) demonstrated that XOR may produce reactive oxygen species, which 
either cause tissue damage and exacerbate inflammation or induce expression of 
genes that modulate tissue healing.  
Butyrophilin is a type 1 transmembrane glycoprotein with a cytoplasmic C-terminal 
tail and is concentrated in the apical plasma membranes of mammary epithelial 
cells (Jack and Mather, 1990). It is the most abundant protein associated with the 
MFGM and constitutes more than 40% by weight of the total protein (Mather and 
Jack, 1993). The exact function of butyrophilin is unclear; however, it, along with 
XOR, is thought to be involved in milk fat globule secretion by linking milk secretory 
granules to the plasma membrane for secretion by interacting with adipophilin at 
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the milk secretory granule surface, facilitating the envelopment of the granule with 
plasma membrane during milk fat droplet formation (Robenek et al., 2006). 
Adipophilin (also known as perilipin-2) is enriched in the MFGM and has a Mr of 52 
kDa (Nielsen et al., 1999). Adipophilin is relatively insoluble in SDS sample buffers 
(Mather, 2000) which may explain why it was not detected by LC-MS identification 
of 2-DE gel spots (Table 3.1). It has been shown that adipophilin, butyrophilin and 
xanthine oxidoreductase are present in constant proportions in high-salt-insoluble 
MFGM material and therefore share physicochemical characteristics (Heid et al., 
1996). Jiang and Serrero (1992) proposed that interactions between butyrophilin, 
xanthine oxidoreductase and adipophilin mediate formation of the protein coat of 
the MFGM. Physiological roles of adipophilin in cytoplasmic lipid droplet 
accumulation and triglyceride metabolism have been established in adipose and 
hepatic tissues (Chang et al., 2006). Recent studies have shown that adipophilin 
might be involved in the inflammatory processes in macrophages (Sarov-Blat et al., 
2007). Chen et al. (2010) showed that adipophilin augmented the secretion of the 
pro-inflammatory cytokines TNF-α, MCP-1 and IL-6 in macrophages. 
Glycosylation-dependant cell adhesion molecule 1 (GlyCAM1) (also known as 
lactophorin/proteose peptone component 3) is a mucin-like endothelial 
glycoprotein that mediates leukocyte-endothelial cell adhesion by presenting 
carbohydrate ligands to the lectin domain of L selectin (Imai et al., 1992). In milk, a 
high molecular weight aggregate of several mucin like glycoproteins that is 
associated with the MFGM has been shown to have antiviral activity against 
rotavirus (Yolken et al., 1992). A similar high molecular weight mucin aggregate in 
milk was shown to inhibit the replication of respiratory syncytial virus (Laegreid et 
al., 1986). 
Clusterin (also known as apolipoprotein J) is a multifunctional protein implicated in 
several immunological and pathological conditions (Sonn et al., 2010). Clusterin is a 
glycoprotein which is expressed in a wide variety of tissues and has been shown to 
play a role in the regulation of inflammation and immunity (Trougakos and Gonos, 
2006). Jeong et al. (2012) showed that clusterin helps prevent the onset of 
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inflammation by maintaining fluid-epithelial interface homeostasis. Sonn et al. 
(2010) presented clusterin as a novel regulator of NK cells via providing co-
stimulation required for cell proliferation and IFN-γ secretion which would have a 
positive effect in chronic inflammatory and autoimmune conditions.  
Angiogenesis is a key process in the pathogenesis of inflammatory arthritis. 
Angiogenin is a heparin-binding 14.1 kDa polypeptide and ribonucleic enzyme 
(Soncin et al., 1997; Shapiro et al., 1986)  and is one of the most active angiogenic 
factor in experimental models in vivo (Liote et al., 2003). Kourtroubakis et al. (2004) 
found that angiogenin may mediate angiogenesis and vascular permeability in the 
mucosa of patients with inflammatory bowel disease, while Liote et al. (2003) 
suggested that angiogenin may mediate local inflammation in arthritis via effects on 
























3.3.2 Fatty acid profile 
Milk fat consists mainly (approximately 96%) of triglycerides, while other milk lipids 
include diacylglycerol (about 2% of the lipid fraction), cholesterol (less than 0.5%), 
phospholipids (about 1%) and free fatty acids (about 0.1%) (Jensen and Newburg, 
1995). In addition, there are trace amounts of ether lipids, hydrocarbons, fat-
soluble vitamins, flavour compounds and compounds introduced by the feed 
(Parodi, 2004). Fatty acids in milk are derived from two sources, the feed and 
Identified Protein Uniprot Mol. mass (Da) % Coverage Peptides PLGS Score
Accession Number
αS1-casein P02662 24513 67.76 31 44615
к-casein P02668 21255 50.53 16 21349
β-lactoglobulin P02754 19870 73.03 25 18422
β-casein P02666 25091 24.55 20 15599
Lactadherin Q95114 47380 54.33 36 14554
α-lactalbumin P00711 16235 45.77 10 11554
αS2-casein P02663 26002 42.34 35 10823
Butyrophilin subfamily 1 member A1 P18892 59238 39.92 21 3768
Glycosylation dependent cell adhesion molecule 1 P80195 17141 43.14 7 3019
Polymeric immunoglobulin receptor P81265 82383 43.59 30 2880
Serum albumin P02769 69248 56.84 33 2488
Polyubiquitin C P0CH28 77522 32.61 18 1903
β-2-microglobulin P01888 13668 10.17 2 989
Apolipoprotein E Q03247 35957 37.97 9 779
Lactotransferrin P24627 78006 44.63 29 767
Xanthine dehydrogenase oxidase P80457 146696 30.03 34 622
Platelet glycoprotein 4 P26201 52906 13.98 6 454
Perilipin 2 Q9TUM6 49337 34.00 11 293
Ribonuclease pancreatic P61823 16450 27.33 2 271
Serotransferrin Q29443 77702 33.24 18 240
Angiogenin 1 P10152 16958 30.41 4 220
Junctional sarcoplasmic reticulum protein 1 Q2YDF7 36931 28.78 10 211
Golgi SNAP receptor complex member 1 Q2TBU3 28523 25.60 5 167
Monocyte differentiation antigen CD14 Q95122 39641 12.60 4 163
UPF0740 protein C1orf192 homolog Q3SZT6 21171 31.63 7 155
Post GPI attachment to proteins factor 3 A7YWP2 36032 23.20 4 148
Clusterin P17697 51081 20.50 9 123
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microbial activity in the rumen of the cow (Parodi, 2004). Bovine milk fat contains 
approximately 400 different fatty acids, making it one of the most complicated 
naturally occurring fats. The fatty acid profile of colostrum cream, colostrum 
buttermilk, mature milk cream and mature milk buttermilk were analysed by GC-
MS (Table 3.3). The most abundant fatty acids across all samples were palmitic acid, 
oleic acid, myristic acid and stearic acid, as reported by Kaylegian and Lindsay 
(1995).  
In general, the fatty acid content of mature milk cream and mature milk buttermilk 
were in line with values reported by Jensen (2002). The fatty acid content of 
colostrum cream and colostrum buttermilk differed in comparison to mature milk 
cream and mature milk buttermilk. Cream and buttermilk from colostrum 
contained lower levels of caproic acid, caprylic acid, pelargonic acid, capric acid, 
lauric acid, myristic acid, myristoleic acid, pentadecanoic acid and oleic acid, and 
higher levels of valeric acid, palmitic acid, palmitoleic acid, margaric acid, stearic 
acid, linoleic acid and arachidonic acid than mature milk cream and buttermilk 
(Table 3.3). Laakso et al. (1996) found that colostrum triglycerides contained less 
oleic acid and more palmitic acid than mature milk fat, which is in agreement with 
the current study; however, the same author found that colostrum triglycerides 
contained less stearic acid and more myristic acid than mature milk fat, which does 
not agree with results from the current study.  
It has been shown that increased concentrations of fatty acids in blood plasma are 
associated with obesity and metabolic syndrome (Reaven et al., 1988), and 
saturated long-chain fatty acids can activate inflammatory and innate immune 
responses in the body (Kennedy et al., 2009). In particular, the saturated fatty acids 
palmitic acid, lauric acid and myristic acid have been shown to activate 
inflammatory genes in adipocytes (Laine et al., 2007; Han et al., 2010). Excess 
consumption of nutrients causes expansion of white adipose tissue and an increase 
in the size and number of adipocytes, leading to adipocyte dysfunction (Lago et al., 
2007). These swollen adipocytes secrete pro-inflammatory agents that promote 
systemic inflammation (Bays et al., 2008). Also, these lipid-engorged adipocytes will 
eventually die and release their contents, resulting in the recruitment of 
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neutrophils and macrophages (Weisberg et al., 2003). Therefore, excess 
consumption of fat is associated with obesity-mediated macrophage recruitment to 
white adipose tissue, resulting in chronic, low-grade inflammation (Kennedy et al., 
2009).  
Table 3.3 Fatty acid composition of colostrum cream, colostrum buttermilk, mature 
milk cream and mature milk buttermilk, measured by GLC and expressed as percent 
by weight of total fatty acids (results shown are based on a single analysis).   
 
Fatty Acid Lipid Number Colostrum Cream Colostrum Buttermilk Mature Milk Cream Mature Milk Buttermilk
% wt % wt % wt % wt
Butyric acid C4:0 1.07 0.81 0.99 0.91
Valeric Acid C5:0 0.17 0.1 0.08 0
Caproic Acid C6:0 1.08 1.1 1.8 1.57
Enanthoic Acid C7:0 0.09 0 0 0.12
Caprylic Acid C8:0 0.72 0.65 1.29 1.37
Pelargonic Acid C9:0 0 0 0.05 0.05
Capric Acid C10:0 1.61 1.52 3.46 3.56
C10:1 0 0 0.27 0.26
C11:0 0 0 0 0.06
Lauric Acid C12:0 2.16 2.13 4.23 4.33
C12:1 0 0 0.06 0.09
C13:0 0 0 0.13 0.15
Iso C14:0 0 0 0.13 0.15
Myristic Acid C14:0 10.43 10.5 12.24 12.6
Myristoleic Acid C14:1 0.93 1.03 1.92 2.02
Pentadecanoic Acid C15:0 1 0.94 1.37 1.4
Iso C16:0 0.15 0.17 0.27 0.26
Palmitic Acid C16:0 35.49 36.26 26.98 27.79
Palmitoleic Acid C16:1 2.77 2.87 2.52 2.25
Margaric Acid C17:0 1.17 1.13 0.84 0.73
C17:1 0.45 0.53 0.38 0.25
Stearic Acid C18:0 11.33 11.62 10.43 10.23
Oleic Acid C18:1 23.83 23.4 24.71 24.17
Linoleic Acid C18:2 1.34 1.35 0.87 0.85
CLA cis-9 trans-11 0 0 1.37 1.05
CLA cis-10 cis-12 0 0 0 0
C18:3 n-6 0.91 0.94 0.7 0.32
C18:3 n-3 0.87 0.84 1.01 0.99
Arachidic Acid C20:0 0.19 0.18 0.2 0.22
C20:1 0 0 0.08 0
C20:2 0 0 0 0
C20:3 n-6 0.09 0.07 0 0
C20:3 n-3 0.06 0.08 0.07 0.06
Arachidonic Acid C20:4 0.14 0.12 0.05 0.05
C20:5 0 0.08 0 0
Behenic Acid C22:0 0 0 0 0
Eruric Acid C22:1 0 0 0 0
C22:2 0.16 0.15 0.14 0.14
C22:4 0.07 0 0.05 0
C22:5 0.33 0.33 0.16 0.13
C22:6 0 0 0 0
Lignoceric Acid C24:0 0.1 0.07 0.06 0
Nervonic Acid C24:1 0 0 0 0
Others 1.27 1.05 1.1 1.85
Total 98.73 98.95 98.9 98.15
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3.3.3 Effect of colostrum fractions on LPS-induced TNF-α secretion  
Tumor necrosis factor (TNF) is among the most studied and central pro-
inflammatory cytokines (Gillett et al., 2010). TNF is a key regulator of the 
inflammatory response whose ligands are known to play a central role in a variety 
of inflammatory conditions, e.g., rheumatoid arthiritis, inflammatory bowel disease, 
multiple sclerosis, diabetes and asthma (Croft et al., 2012). Inhibition of TNF by 
colostrum fractions could potentially lead to suppression of autoimmune and 
inflammatory diseases. TNF-α and its receptors TNFR1/TNFR2 are the major 
members of a gene superfamily which consists of approximately 50 membrane-
bound and soluble proteins (Dhama et al., 2013). TNF-α is predominantly produced 
by activated macrophages and T-lymphocytes and is known to have numerous 
biological properties relating to inflammation, proliferation, differentiation and 
cancer growth (Patil et al., 2011).  
In the current study, murine macrophage cells (J774.2) were isolated, cultured and 
incubated with 5 mg/mL of colostrum cream, casein (pH 4.6-insoluble), whey (pH 
4.6-soluble), 30 kDa retentate of whey or 30 kDa permeate of whey for 24 h before 
inflammation was induced with 10 ng/mL LPS for 3 h. These samples were tested 
for their effect on LPS-induced TNF-α secretion by J774.2 cells (Figure 3.2). LPS is a 
key inflammatory component of Gram-negative bacteria, which induces a 
distinctive pattern of cytokine release that regulates inflammation (Singh and Jiang, 
2003). In the current study, LPS was used to initiate an inflammatory response 
which resulted in increased secretion of TNF-α from J774.2 cells. It can be seen 
from Figure 3.2 that colostrum fractions had an effect on TNF-α secretion from 
J774.2 cells, compared to the positive control; colostrum cream caused the greatest 
reduction in the secretion of TNF-α from J774.2 cells, followed by the  30 kDa 
retentate of whey and unfractionated whey. The colostrum casein had no effect on 
the secretion of TNF-α from J774.2 cells, while the 30 kDa permeate of whey 
increased the secretion of TNF-α. Based on these findings, it was decided to focus 
on colostrum cream as it was the most potent inhibitor of LPS-induced TNF-α 




Figure 3.2 Effect of colostrum fractions on LPS-induced TNF-α secretion by J774.2 
macrophages. Exponentially growing cells were incubated with 5 mg/mL of 
colostrum fractions for 24 h and stimulated with 10 ng/mL of LPS for 3 h. The 
supernatant was removed and the concentration of cytokine quantified using ELISA. 
Data shown represent the mean (± SD, n=3) of data from three independent 




J774.2 cells were isolated, cultured and incubated with various concentrations of 
colostrum cream ranging from 0.01 to 5 mg/mL for 24 h before inflammation was 
induced with 10 ng/mL LPS for 3 h. The dose-response effect of colostrum cream on 
LPS-induced TNF-α secretion by J774.2 cells is shown in Figure 3.3. It can be seen 
that colostrum cream, at concentrations greater than 0.1 mg/mL, significantly 
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Figure 3.3 Effect of colostrum cream on LPS-induced TNF-α secretion by J774.2 
macrophages. Exponentially growing cells were incubated with various 
concentrations (mg/mL) of colostrum cream for 24 h and stimulated with 10 ng/mL 
of LPS for 3 h. The supernatant was removed and cytokine secretion levels were 
quantified using ELISA. Data shown represent the mean (± SD, n=3) of data from 
three independent experiments. Values with different superscript letters were 
significantly different (p < 0.05). 
 
3.3.4 Effect of colostrum cream on macrophage cell viability 
Necrosis occurs as a result of harmful insults such as physical damage, hypoxia, 
hyperthermia, starvation, complement attack and chemical injury and elicits an 
inflammatory reaction in adjacent viable tissue in response to the released cell 
debris (Haanen and Vermes, 1995). To assess the possibility that colostrum cream 
may cause necrosis, its effect on macrophage viability was examined (Figure 4). 
J774.2 cells were isolated, cultured and incubated with various concentrations of 
colostrum cream ranging from 0.01 to 5 mg/mL for 24 h. The effect of colostrum 
cream on J774.2 macrophage cell viability was determined by the MTT (3-(4,5-




























that colostrum cream had no significant effect on J774.2 macrophage cell viability 
when tested in the range 0.01 to 5 mg/mL (Figure 3.4). 
 
Figure 3.4 Effect of colostrum cream on J774.2 macrophage cell viability. 
Exponentially growing cells were incubated with various concentrations (mg/mL) of 
colostrum cream for 24 h. Cell toxicity was determined by an MTT assay. The values 
expressed are normalized to complete (100%) viability of untreated cells. Data 
shown represent the mean (± SD, n=3) of three independent experiments. Values 
with different superscript letters were significantly different (p < 0.05). 
 
3.3.5 Effect of buttermilk from colostrum and mature milk on LPS-induced TNF-α 
secretion  
Colostrum cream was fractionated into butter and buttermilk, as described in 
Section 3.2.4, in an attempt to identify the biologically active component with 
inflammatory potential, i.e., reduced TNF-α secretion. Colostrum butter and 
colostrum buttermilk were both found to have inflammatory potential compared to 
mature milk butter and mature milk buttermilk prepared in the same way (results 
not shown). Prior to cell treatment, reconstituted powders were filtered through 
0.45 µm filters, thereby removing any lipid material in colloidal suspension. For this 























biologically active components present in the soluble fraction of butter would also 
be present in buttermilk. 
 J774.2 macrophages were isolated, cultured and incubated with various 
concentrations of buttermilk from colostrum or mature milk ranging from 0.05 to 5 
mg/mL for 24 h before inflammation was induced with 10 ng/mL LPS for 3 h. The 
dose-response effect of buttermilk from colostrum or mature milk on LPS-induced 
TNF-α secretion by J774.2 macrophages is shown in Figure 3.5. Colostrum 
buttermilk caused a significant reduction in the secretion of TNF-α from J774.2 
macrophages, in a dose-dependent manner, at concentrations greater than 0.05 
mg/mL. Mature milk buttermilk also caused a significant reduction in the secretion 
of TNF-α at concentrations greater than 0.5 mg/mL, but, in all cases, the reduction 
was not as pronounced as that for colostrum buttermilk when tested at equal 
concentrations. This was most evident at higher concentrations of buttermilk from 
colostrum and mature milk. 
 
Figure 3.5 Dose response effect of buttermilk from colostrum or mature milk on 
LPS-induced TNF-α secretion by J774.2 macrophages. Exponentially growing cells 
were incubated with various concentrations (mg/mL) of buttermilk from colostrum 
or mature milk for 24 h and stimulated with 10 ng/mL of LPS for 3 h. The 
supernatant was removed and cytokine secretion levels were quantified using 
ELISA. Data shown represent the mean (± SD, n=3) of three independent 
experiments. Values with different superscript letters were significantly different (p 
< 0.05). 




























3.3.6 Effect of buttermilk from colostrum or mature milk on LPS-induced NF-κB 
luciferase activity 
The transcription factor nuclear factor-kappa B (NF-кB) is an important intracellular 
regulator of many inflammatory responses as it controls the expression of many 
genes involved in the inflammatory process (Ciesielski et al., 2002), and is therefore 
a target for anti-inflammatory treatment. Other transcription factors, such as 
activator protein 1 (AP-1) and the nuclear factor of interleukin-6, are also involved 
in the regulation of inflammatory and immune genes (Stein and Baldwin, 1993). The 
activation of NF-кB causes an increase in the expression of many genes whose 
products mediate inflammatory and immune responses. These include pro-
inflammatory cytokines, chemokines, enzymes that generate mediators of 
inflammation, immune receptors and adhesion molecules that play a key role in the 
initial recruitment of leukocytes to the initial site of inflammation (Barnes and 
Karin, 1997). The pro-inflammatory cytokines interleukin-1β and TNF-α both 
activate and are activated by NF-кB, creating a positive regulatory loop which has 
the potential to amplify and perpetuate a local inflammatory response (Barnes and 
Karin, 1997).  
NIH3T3/NF-κB-luc fibroblasts were isolated, cultured and incubated with various 
concentrations of buttermilk from colostrum or mature milk ranging from 0.05 to 5 
mg/mL for 24 h before inflammation was induced with 50 ng/mL LPS for 6 h. Figure 
3.6 shows the dose response effect of buttermilk from colostrum or mature milk on 
LPS-induced NF-кB luciferase activity. Colostrum buttermilk caused a significant 
reduction in NF-кB luciferase activity, in a dose-dependant manner, at 
concentrations greater than 0.05 mg/mL. Mature milk buttermilk also caused a 
slight reduction in NF-кB luciferase activity; however, the effect was not dose-
dependent. In all cases, the reduction in NF-кB luciferase activity associated with 
colostrum buttermilk was greater than with mature milk buttermilk when tested at 
equal concentrations (Figure 3.6). This was most evident at higher concentrations 





Figure 3.6 Dose response effect of buttermilk from colostrum or mature milk on 
LPS-induced NF-κB luciferase after 24 h pre-treatment. Exponentially growing cells 
were incubated with various concentrations (mg/mL) of buttermilk from colostrum 
or mature milk for 24 h and stimulated with 50 ng/mL of LPS for 6 h. Cell extracts 
were prepared for assessment of luciferase activity. Luciferase activity is expressed 
as the fold change between untreated cells relative to LPS-treated cells. Data shown 
represent the mean (± SD, n=3) of three independent experiments. Values with 
different superscript letters were significantly different (p < 0.05). 
 
 
3.3.7 Effect of buttermilk from colostrum or mature milk on the secretion of the pro-
inflammatory cytokines IL-6 and IL-1β  
Interleukin (IL)-6 is a pro-inflammatory cytokine that is produced at the site of 
inflammation and plays a key role in the acute phase response (Gregor and 
Hotamisligil, 2011). IL-6 dictates the transition from acute to chronic inflammation 
by changing the nature of leukocyte infiltration from polymorphonuclear 
neutrophils to monocyte/macrophages (Gabay, 2006). Furthermore, circulating IL-6 
stimulates the hypothalamic-pituitary-adrenal axis, which is associated with central 
obesity, hypertension, and insulin resistance (Berg and Scherer, 2005).  
































IL-1β is a pro-inflammatory cytokine which mediates its actions through the IL-1 
receptor 1 (IL-1R1) and potentially induces the production of inflammatory 
cytokines including IL-6 (Mc Ardle et al., 2013). IL-1β is not secreted in vivo in a 
biologically active state, i.e., activation is dependent on cleavage of pro-IL-1β by 
capase-1 (Dinarello et al., 2010). Increased concentrations of circulating IL-1β are 
associated with a greater risk of type 2 diabetes (Spranger et al., 2003). 
In the current study, J774.2 macrophages were isolated, cultured and incubated 
with 500 µg/mL of buttermilk from colostrum or mature milk for 24 h before 
inflammation was induced with 10 ng/mL LPS for 3 h and 25 µM ATP for 30 min. 
The effect of buttermilk from colostrum or mature milk on IL-6 and IL-1β secretion 
by J774.2 macrophages is shown in Figures 3.7a and 3.7b, respectively. Buttermilk 
from colostrum was found to decrease significantly the secretion of IL-6 and IL-1β 
from J774.2 macrophages. Buttermilk from mature milk caused a slight decrease in 
the secretion of IL-6 and IL-1β from J774.2 macrophages; however, the effect was 
not as pronounced as with colostrum buttermilk (Figure 3.7a and 3.7b). Buttermilk 
from colostrum or mature milk were also tested in the absence of LPS to investigate 
whether these samples alone induced IL-6 and IL-1β secretion. In the absence of 
LPS, it was found that colostrum buttermilk did induce secretion of IL-6, while no 
effect was observed in the presence of mature milk buttermilk (Figure 3.7a). 
Similarly, in the absence of LPS, buttermilk from colostrum and mature milk had no 






Figure 3.7 Effect of buttermilk from colostrum or mature milk on (a) IL-6 and (b) IL-
1β secretion by J774.2 macrophages after 24 h pre-treatment. Exponentially 
growing cells were incubated with 500 μg/mL of buttermilk from colostrum or 
mature milk for 24 h and stimulated with 10 ng/mL of LPS for 3 h and 25 μM ATP 
for 30 min.  The supernatant was removed and the concentration of cytokine 
quantified by ELISA. Data shown represent the mean (± SD, n=3) of data from three 
independent experiments. Values with different superscript letters were 
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3.3.8 Effect of buttermilk from colostrum or mature milk on the secretion of the pro-
inflammatory cytokine IL-12 
IL-12 is a pro-inflammatory cytokine that is produced mainly by dendritic cells 
(Hamza et al., 2010). IL-12 is a multifunctional cytokine that acts as a key regulator 
of cell-mediated immune responses by inducing T helper 1 differentiation (Del 
Vecchio et al., 2007). In the current study, BMDC were isolated and cultured for 7 d 
and incubated with buttermilk from colostrum or mature milk for 24 h before 
inflammation was induced with 10 ng/mL LPS for a further 24 h. The effect of 
buttermilk from colostrum or mature milk on IL-12 secretion from BMDC is shown 
in Figure 3.8. Colostrum buttermilk significantly reduced the secretion of IL-12 from 
BMDC. Mature milk buttermilk also caused a reduction in the secretion of IL-12; 
however, the effect was not as pronounced as with colostrum buttermilk.  
 
 
Figure 3.8 Effect of buttermilk from colostrum or mature milk on IL-12 secretion 
from BMDC. BMDC from male WT C57Bl/6 mice were cultured for 7 d then seeded 
at a density of 1 x 106 cells/mL and treated for 24 h with buttermilk from colostrum 
or mature milk (1 mg/mL) or H2O vehicle control and then stimulated with LPS (10 
ng/mL) for 24 h. Supernatants were collected and IL-12 concentrations were 
measured by ELISA. Data shown represent the mean (± SEM, n=3) of data from 
three independent experiments. Values with different superscript letters were 


























3.3.9 Effect of buttermilk from colostrum or mature milk on the secretion of the 
anti-inflammatory cytokine IL-10  
IL-10 is an anti-inflammatory cytokine which is produced by numerous immune cells 
including monocytes, macrophages and dendritic cells (Mc Ardle et al., 2013). IL-10 
was first recognized for its ability to inhibit activation and effector function of T 
cells, monocytes and macrophages (Moore et al., 2001). The main function of IL-10 
appears to be in limiting and terminating inflammatory responses (Villalta et al., 
2011). In the current study, J774.2 macrophages were isolated, cultured and 
incubated with 500 µg/mL of buttermilk from colostrum or mature milk for 24 h 
before inflammation was induced with 10 ng/mL LPS for 3 h and 25 µM ATP for 30 
min. The effect of buttermilk from colostrum or mature milk on IL-10 secretion by 
J774.2 macrophages is shown in Figure 3.9. Colostrum buttermilk significantly 
increased the secretion of IL-10 from J774.2 macrophages while mature milk 
buttermilk caused no significant change compared to the LPS-positive control. 
Buttermilk from colostrum or mature milk were also tested in the absence of LPS to 
investigate whether these samples alone induced IL-10 secretion. In the absence of 
LPS, it was found that colostrum buttermilk did induce secretion of IL-10, as shown 








Figure 3.9 Effect of colostrum buttermilk and mature milk buttermilk on IL-10 
secretion by J774.2 macrophages after 24 h pre-treatment. Exponentially growing 
cells were incubated with 500 μg/mL of colostrum buttermilk and mature milk 
buttermilk for 24 h and stimulated with 10 ng/mL of LPS for 24 h.  The supernatant 
was removed and the concentration of cytokine quantified by ELISA. Data shown 
represent the mean (± SEM, n=3) of data from three independent experiments. 












































3.3.10 Characterisation of the serum phase of colostrum 
The protein profile of the pH 4.6-soluble fraction of (a) colostrum and (b) mature 
milk were analysed by 2-DE (Figure 3.10). Skimmed colostrum and mature milk 
were adjusted to pH 4.6 according to the method of Kuchroo and Fox (1982) in 
order to remove pH 4.6-insoluble material and improve the resolution of whey 
proteins on 2-DE electrophoretograms. The whey fraction of mature milk contains 
more than 200 different proteins (Sgarbieri, 2004); however, it is dominated by a 
small number of so-called major proteins, which collectively constitute over 80% of 
whey protein (Tremblay et al., 2003). Of these, β-Lg and α-La are the most 
abundant, as shown in Figure 3.10. As previously discussed (Section 3.3.1), 
colostrum has a distinct whey protein composition which is quite different from 
that of mature milk. The protein composition of colostrum is dominated by the 
presence of immunoglobulins, in particular IgG, whose natural function is the 
transfer of passive immunity from the cow to the calf (Elizondo-Salazar and 
Heinrichs, 2008).  
The pH 4.6-soluble fraction of colostrum contained significantly more high 
molecular weight material in the range 30 – 180 kDa compared with the pH 4.6-
soluble fraction of mature milk (Figure 3.10). To identify some of the proteins which 
were abundant in the pH 4.6-soluble fraction of colostrum compared with the pH 
4.6-soluble fraction of mature milk, LC-MS was performed on 2-DE excised gel 
spots. Identification of the 17 spots analysed are shown in Table 3.4. Despite 
adjustment of skimmed colostrum to pH 4.6 in order to remove caseins by 
isoelectric precipitation, αS1-casein was identified in 2 spots, β-casein was identified 
in 3 spots, and к-casein was identified in 3 spots.  
Spots 7-9 were identified as zinc-alpha-2-glycoprotein (ZAG), which was also 
identified in the pH 4.6-soluble colostrum buttermilk (Table 3.1) and discussed 
briefly in Section 3.3.1. ZAG is a multidisciplinary protein involved in many 
important functions in the human body, including fertilization and lipid mobilization 
(Hassan, et al., 2008). ZAG has previously been reported in bovine milk (Fong et al., 
2008; Golinelli et al., 2011). Bao et al. (2005) reported that human adipocytes 
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express and secrete ZAG, with ZAG expression being regulated particularly through 
TNF-α and the PPARγ nuclear receptor. TNF-α is known to have in vivo effects on 
lipid metabolism and adipose tissue (Beutler and Cerami, 1988). TNF-α has been 
implicated as a causative factor in obesity-associated insulin resistance and the 
pathogenesis of type 2 diabetes (Moller, 2000). Similarly, Barroso et al. (1999) 
reported that PPARγ is associated with severe insulin resistance and diabetes 
mellitus. 
Spot 6 was identified as alpha 1 acid glycoprotein (AGP). Milk-AGP is made up of at 
least two isoforms, a low MW group (44kDa) that is produced in the mammary 
gland, and a higher MW group (55-77 kDa) that is produced by somatic cells 
(Ceciliani et al., 2007). Ceciliani et al. (2005) reported that bovine colostrum 
contains 162 (+/- 63.7) µg/mL and 114.5 (+/- 67.8) µg/mL AGP during the first 12h 
and 24h  post partum, but, AGP was not detectable in mature milk. AGP is a 
lipocalin (Ceciliani et al., 2005) with immunomodulatory and anti-inflammatory 
properties, and plays an important role in the regulation of local inflammatory 
reactions (Tilg et al., 1993). AGP has been shown to reduce the activation state of 
neutrophils and increase the expression of anti-inflammatory cytokines by 
macrophages (Hochepied et al., 2003). Spots 1-4 were identified as serum albumin, 
which was also identified in the pH 4.6-soluble fraction of buttermilk from 










Figure 3.10 Two-dimensional gel electrophoretograms of the pH 4.6-soluble 
fraction of (a) colostrum and (b) mature milk separated under reducing conditions 
using a 7 cm pH 4-7 pI range for the first dimension and a 12% gradient acrylamide 
SDS-PAGE gel for the second dimension. Circled and numbered spots were excised 
and analysed by LC-MS. 





































Table 3.4 Identification of spots from the 2-D gel of pH 4.6-soluble colostrum by 





The pH 4.6-soluble fraction of colostrum, and subsequent fractions, were analysed 
by RP-UPLC, as shown in Figure 3.11 a-e. β-Lg and α-la were the predomainant 
proteins identified in the pH 4.6-soluble fraction of colostrum and 30 kDa retentate, 
but, the concentration of each was greatly reduced in the 30 kDa permeate. The 30 
kDa permeate was further fractionated by ultrafiltration and the products analysed. 
Compared to the 30 kDa permeate, β-Lg and α-La were concentrated slightly in the 
3 kDa retentate; but, both proteins were virtually absent from the 3 kDa permeate. 
Approximately 9 peaks (excluding the injection peak) were observed within the first 
min of each chromatogram in Figure 3.11 a-e. Material eluting in this region is most 
likely hydrophilic peptides or individual amino acids.  
Spot No. Identified Protein Uniprot Mol. mass (Da) Peptides Score
Accession Number
1 Serum albumin PO2769 69248 8 84
2 Serum albumin PO2769 69248 10 95
3 Serum albumin PO2769 69248 9 68
4 Serum albumin PO2769 69248 7 73
5 β-casein PO2666 25091 4 52
6 α-1-acid glycoprotein Q5GN72 23168 6 78
7 Zinc-α-2-glycoprotein B2BX70 33830 11 79
8 Zinc-α-2-glycoprotein B2BX70 33830 17 112
9 Zinc-α-2-glycoprotein B2BX70 33830 12 156
10 αS1-casein B5B3R8 24513 8 65
11 αS1-casein B5B3R8 24513 5 46
12 к-casein PO2668 21256 4 55
13 β-casein PO2666 25091 5 50
14 β-casein PO2666 25091 4 46
15 к-casein PO2668 21256 3 59
16 к-casein PO2668 21256 6 71
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Figure 3.11 Reversed-phase UPLC chromatograms of (a) pH 4.6-soluble colostrum; (b) pH 4.6-soluble colostrum 30 kDa retentate; (c) pH 4.6-soluble colostrum 30 kDa permeate; (d)





The pH 4.6-soluble fraction of skimmed colostrum and subsequent 30 kDa UF 
retentate and permeate, were analysed by LC-MS using a LTQ linear ion trap (Table 
3.5). The most abundant proteins identified, based on the greatest number of 
peptide matches, in the pH 4.6-soluble fraction of colostrum were αS1-, αS2- and β-
casein. Even though colostrum was adjusted to pH 4.6 in order to remove casein by 
isoelectric precipitation, it is not unusual for some casein to remain. However, it is 
unusual that the caseins represented the most abundant proteins in the pH 4.6-
soluble colostrum. This may be explained by Section 2.3.11 of this thesis where it 
was found that casein did not precipitate at pH 4.6 in certain colostrum samples. 
The most abundant proteins in the pH 4.6-soluble 30 kDa retentate were αS1-casein, 
β-Lg and β-casein while the most abundant proteins in the pH 4.6-soluble 30 kDa 
permeate were αS1-casein, β-Lg and αS2-casein. к-Casein was present in a relatively 
high abundance in all three samples. α-La was identified in the pH 4.6-soluble 
colostrum and pH 4.6-soluble 30 kDa retentate but not in the pH 4.6-soluble 30 kDa 
permeate. Serum albumin, which was identified in colostrum buttermilk and 
discussed briefly in Section 3.3.1, was only identified in the pH 4.6-soluble 
colostrum. Polymeric immunoglobulin receptor (pIgR), which was identified in 
colostrum buttermilk and discussed briefly in Section 3.3.1, was found in the pH 
4.6-soluble colostrum and 30 kDa retentate of pH 4.6-soluble colostrum but not in 
the 30 kDa permeate of the pH 4.6-soluble fraction.   
Lactoferrin (also known as lactotransferrin), which was identified in colostrum 
buttermilk and discussed briefly in Section 3.3.1, was found in the pH 4.6-soluble 
fraction of colostrum and pH 4.6-soluble 30 kDa retentate but not in the pH 4.6-
soluble 30 kDa permeate. This was to be expected as lactoferrin is an 80 kDa 
glycoprotein which would not pass through a 30 kDa UF membrane. Lactoferrin is 
known to down-regulate pro-inflammatory cytokine production in cell lines by 
acting via NF-кB (Haversen et al., 2002), which leads to a decrease in the secretion 
of TNF-α and IL-6 in mice (Kruzel et al., 1998). In an insulin-resistance state, pro-
inflammatory cytokines activate several kinases (Gual et al., 2005) which have been 
shown to inhibit insulin action by promoting phosphorylation of serine residues of 
the insulin-signalling pathway (Schenk et al., 2008).  
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Lipoprotein lipase (LPL) was identified in the pH 4.6-soluble fraction of colostrum 
only. LPL is a multifunctional enzyme which is produced by many tissues, including 
adipose tissue, cardiac and skeletal muscle, islets and macrophages (Wang and 
Eckel, 2009).  The main function of LPL is the hydrolysis or core triglycerides and 
very low-density lipoproteins (Eckel, 1989).  Plasma LPL activity has been shown to 
be reduced in insulin-resistance subjects without diabetes (Knudsen et al., 1995) 
and, overall, plasma LPL activity is inversely correlated with insulin resistance in 









using a LTQ linear ion trap
Identified protein Uniprot Mol. mass (Da) % Coverage Peptides Score % Coverage Peptides Score % Coverage Peptides Score
Accession Number
αS1-casein PO2662 24529 41.6 36 464 31.3 22 461 35 15 263
αS2-casein PO2663 26019 20.7 8 310 15.3 3 172 18.9 4 131
β-casein PO2666 25107 54 7 303 33.5 3 156 3.6 1 66
β-lactoglobulin PO2754 19883 33.7 6 198 21.3 6 252 32.6 6 235
Lactotransferrin P24627 78056 5.2 3 115 1.8 1 46 N/A 0 0
NEK4 protein A6QQ15 79280 0.7 2 32 N/A 0 0 N/A 0 0
ACSL4 protein A7E3D9 72659 1.1 2 46 N/A 0 0 N/A 0 0
Serum albumin PO2769 69293 4.4 2 130 N/A 0 0 N/A 0 0
к-casein PO2668 21269 23.7 2 132 28.9 3 119 28.9 3 105
Lipoprotein lipase P11511 53378 6.1 2 73 N/A 0 0 N/A 0 0
Polymeric immunoglobulin receptor P81265 52435 4.4 2 113 5.9 2 51 N/A 0 0
TWF2 protein A2VDX0 39564 1.4 1 31 N/A 0 0 N/A 0 0
Heart fatty acid-binding protein P10790 14779 9.8 1 68 9.8 1 45 N/A 0 0
UPF0488 protein C8orf33 homolog Q2K1D8 20972 4.3 1 30 N/A 0 0 N/A 0 0
Protein kinase C gamma type PO5128 77156 0.9 1 44 N/A 0 0 N/A 0 0
α-lactalbumin P00711 16247 9.9 1 42 9.9 1 55 N/A 0 0
Enterotoxin-binding glycoprotein PP20K Q9TRB9 2266 70 1 66 70 1 54 70 1 62
RecQ-mediated genome instability protein 1 A41F98 70051 1.4 1 37 N/A 0 0 N/A 0 0
Retinoid isomerohydrolase Q28175 60944 0.9 1 28 N/A 0 0 N/A 0 0
RUVBL1 protein A7MBG8 50154 N/A 0 0 3.3 1 32 N/A 0 0
Glycosylation-dependent cell adhesion molecule 1 P80195 17152 N/A 0 0 7.2 1 62 N/A 0 0
Glutamine synthetase P15103 42031 N/A 0 0 2.9 1 30 N/A 0 0
Inter-alpha-trypsin inhibitor heavy chain H1 Q0VCM5 101237 N/A 0 0 N/A 0 0 1.1 1 47
PAX-interacting protein 1 A0JNA8 109167 N/A 0 0 1.3 1 49 N/A 0 0
Protein-glutamine gamma-glutamyltransferase 2 P51176 77112 N/A 0 0 3.8 1 29 N/A 0 0
N/A = not applicable
Table 3.5. Identification of proteins from the ph 4.6-soluble fraction of colostrum, pH 4.6-soluble 30 kDa retentate and pH 4.6-soluble 30 kDa permeate, by LC-MS
pH 4.6-soluble 30 kDa permeatepH 4.6-soluble colostrum pH 4.6-soluble 30 kDa retentate
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3.3.11 In vitro insulinotrophic effects of colostrum fractions  
 
There are two classifications of diabetes; type 1 diabetes is an autoimmune 
condition which is characterised by the destruction of pancreatic β-cells, resulting in 
reduced or complete loss of insulin secretion, while type 2 diabetes is characterised 
by insulin resistance in peripheral tissues (adipose tissue, liver and skeletal muscle) 
which, in some cases, may develop into deficiencies of insulin secretion and β-cell 
dysfunction (Schrezenmeir and Jagla, 2000). The WHO predicts that the incidence of 
type 2 diabetes will increase to 366 million by 2030 (WHO 2006b). The consumption 
of milk proteins has been associated with a reduction in the risk of type 2 diabetes 
(Choi et al., 2005; Tremblay and Gilbert, 2009) by regulating postprandial glycaemia 
and insulin secretion in normoglycemic and type 2 diabetic individuals (Frid et al., 
2005). The objective of this study was to assess the potential of colostrum in 
beneficially modulating insulin secretion by examining their possible insulinotrophic 
properties on pancreatic β-cells in vitro. BRIN-BD11 is a hybrid cell line formed by 
the electrofusion of a primary culture of NEDH rat pancreatic islets with RINm5F (a 
cell line derived from a NEDH rat insulinoma). The cells grow as monolayers with an 
epitheliod morphology and, when confluent, they take on a pavemental pattern 
characteristic of epithelial cells. Figure 3.12 shows the effect of colostrum fractions 
on insulin secretion when administered to the pancreatic β-cells in combination 
with 16.7 mM glucose; 10 mM alanine in combination with 16.7 mM glucose was 
used as a positive control.  
The colostrum lipid and casein fractions had no effect on insulin secretion; 
however, the pH 4.6-soluble, pH 4.6-soluble 30 kDa retentate and pH 4.6-soluble 30 
kDa permeate of colostrum were found to significantly increase insulin secretion in 
pancreatic β-cells, at levels similar to that obtained with the positive control, in the 
order pH 4.6-soluble 30 kDa permeate > pH 4.6-soluble > pH 4.6-soluble 30 kDa 
retentate. However, colostrum fractions were tested on an equal solids and not 
equal protein basis. As can be seen from Table 3.6, the protein content of these 
colostrum fractions varied widely. Assuming that the bioactive component was 
protein-based, it would be fair to assume that, if these samples were tested on an 
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equal protein basis, insulin secretion from pancreatic β-cells in response to the pH 
4.6-soluble 30 kDa permeate would be greatly amplified. These colostrum fractions 
were naturally high in lactose. To rule out the possibility of lactose causing an 
insulinotrophic response, lactose monohydrate was also tested, however, it was 
found to have no effect on insulin secretion (results not shown).    
Table 3.6 Protein concentration of the pH 4.6-soluble fractions of colostrum, as 




Figure 3.12 Acute Insulin secretion in BRIN-BD11 cells. BRIN-BD11 cells (1.5x105) 
were treated with basal levels of glucose with 1.1 mM Glucose Krebs for 40 min, 
followed by treatment with high glucose (16.7 mM krebs) plus colostrum fractions 
which stimulated insulin secretion. Data shown represent the mean (± SD, n=3) of 
data from three independent experiments. Values with different superscript letters 
were significantly different (p < 0.05). 
Colostrum fraction % Protein
pH 4.6-soluble 42.6
pH 4.6 soluble 30 kDa retentate 70.2
pH 4.6-soluble 30 kDa permeate 8.9
pH 4.6-soluble 30 kDa permeate 3 kDa retentate 15.4

























































The addition of colostrum fractions to BRIN-BD11 cells did not affect cell viability 
within the concentration range tested (results not shown). Therefore, BRIN-BD11 
cells were treated with the 30 kDa permeate of the pH 4.6-soluble fraction of 
colostrum at concentrations ranging from 0.1 to 5 mg/mL. The addition of the 30 
kDa permeate of the pH 4.6-soluble fraction of colostrum led to a concentration-




Figure 3.13 Concentration-dependent insulin secretion from BRIN-BD11 cells. BRIN-
BD11 cells (1.5x105) were treated with basal levels of glucose with 1.1 mM glucose 
Krebs for 40 min, followed by treatment with high glucose (16.7 mM Krebs) plus pH 
4.6-soluble colostrum 30 kDa permeate at concentrations of 0.1, 0.5, 1 and 10 
mg/mL which stimulated a dose response insulin secretion. Data shown represent 
the mean (± SD, n=3) of data from three independent experiments. Values with 



































Colostrum is rich in growth factors, especially insulin-like growth factor-1 (IGF-1), 
transforming growth factor beta-2 (TGF-β2) and growth hormone (GH) (Elfstrand et 
al., 2002). Acutely, a high dose of IGF-1 results in hypoglycaemia (Guler et al., 
1987), whereas prolonged IGF-1 therapy has been shown to ameliorate 
hyperglycaemia in type 1 and type 2 diabetes mellitus, as well as in severe insulin-
resistant states (Dunger et al., 1995). A cell proliferation assay was carried out in 
order to determine if growth factors present in colostrum may be causing an 
insulinotrophic response. However, as can be seen from Figure 3.14, no differences 
were observed between the control and colostrum samples, ruling out growth 
factors as a possible cause of insulin secretion.  
 
 
Figure 3.14 Measurement of mitochondrial function reflecting cell proliferation 
following treatment with colostrum fractions as determined by the WST-1 assay. 
BRIN-BD11 cells (4x104) were incubated for 24 h in RPMI-1640 medium 
supplemented with the original pH 4.6-soluble colostrum 30 kDa permeate or a 
regenerated sample at various concentrations ranging from 0 to 2.0 mg/mL. Cell 
viability was determined by the WST-1 assay. Results are relative to control of 
RPMI-1640 medium with no treatment (100%) and expressed at t = 90 min. Data 
shown represent the mean (± SD, n=3) of data from three independent 































Based on the results shown in Figure 3.13 and Table 3.6, it was decided to further 
fractionate the pH 4.6-soluble 30 kDa permeate of colostrum by ultrafiltration to 
produce a 3 kDa retentate and permeate. This step was undertaken in order to 
remove any intact protein material from the pH 4.6-soluble 30 kDa permeate. 
Essentially what was left in the 3 kDa permeate was peptide material, lactose and 
ash. The 3 kDa permeate caused a significant increase in insulin secretion from 




Figure 3.15 Acute insulin secretion from BRIN-BD11 cells. BRIN-BD11 cells (1.5x105) 
were treated with basal levels of glucose with 1.1mM Glucose Krebs for 40 min, 
followed by treatment with high glucose (16.7mM Krebs) plus pH 4.6-soluble 
colostrum 30 kDa permeate 3 kDa retentate or permeate which stimulated insulin 
secretion. Data shown represent the mean (± SD, n=3) of data from three 
independent experiments. Values with different superscript letters were 












































The current study focussed on the characterisation of bovine colostrum and the 
potential anti-inflammatory and insulinotrophic properties of fractions thereof. The 
protein profile of the serum phase of colostrum and colostrum buttermilk were 
analysed by two-dimensional electrophoresis and mass spectrometry. Marked 
differences were observed between the protein profile of colostrum and mature 
milk. GC-MS revealed variations between the fatty acid profiles of colostrum and 
mature milk. 
Based on the results described in the current study, cream and, in particular, 
buttermilk from colostrum, have the potential to modulate immune function, i.e., 
significantly reduce LPS-induced secretion of the transcription factor NF-кB and pro-
inflammatory cytokines TNF-α, IL-6, and IL-1β from J774.2 cells, and IL-12 from 
BMDCs, as well as increasing LPS-induced secretion of the anti-inflammatory 
cytokine IL-10 from J774.2 cells. While several proteins associated with the MFGM 
which were identified in colostrum buttermilk in the current study have reported 
biological activities relating to inflammation and immune function, further work is 
needed to pin-point the specific biological activity of each protein and their precise 
mode of action, in addition to any possible synergistic effects.  
It should be noted that buttermilk from colostrum is a complex fluid which, in 
addition to a very heterogeneous group of proteins, also contains carbohydrates, 
lipids and minor constituents such as vitamins and minerals. The effect of fatty acids 
on inflammation was discussed briefly in Section 3.3.3. One aspect which was not 
investigated in the current study was the effect of the carbohydrate fraction of 
colostrum on inflammation. Compared to mature milk, colostrum contains much 
higher concentrations of oligosaccharides and other glycoconjugates (Nakamura et 
al., 2003; Urashima et al., 2009) which are known to exhibit a range of 
immunological effects, e.g., inhibit immune cell recruitment and adhesion in 
endothelial cells (Bode et al., 2004) and stimulate the production of cytokines in 
blood-borne immune cells (Eiwegger et al., 2004). 
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The serum phase of colostrum caused a significant increase in insulin secretion 
when administered to pancreatic β-cells cells in combination with 16.7 mM glucose. 
Fractionation by ultrafiltration revealed that bioactivity was most concentrated in 
the 3 kDa permeate. 
The consumption of dairy products has been negatively correlated with type 1 
diabetes (Scott, 1991); however, Mensink (2006) reported a protective relationship 
between the consumption of low-fat dairy products and type 2 diabetes. In 
particular, the consumption of milk proteins and milk-derived peptides has been 
associated with a reduction in the risk of type 2 diabetes (Choi et al., 2005; 
Tremblay and Gilbert, 2009) by regulating postprandial glycaemia and insulin 
secretion in normoglycemic and type 2 diabetic individuals (Frid et al., 2005). 
Glucose is the primary stimulus for insulin secretion (Bryan and Aguilar-Bryan, 
1997). Essential amino acids are the primary regulators of the protein-mediated 
insulin response and are heterogeneous in their insulinotropic potency (Floyd et al., 
1996). L-Glutamine, L-leucine and L-arginine are known to regulate insulin secretion 
acutely and chronically from pancreatic β cells in vitro and in vivo (Bratusch-Marrain 
et al., 1980). It is possible that the insulinotrophic properties of the serum phase of 
colostrum is due to the presence of free amino acids. In addition to glucose and 
amino acids, fatty acids are also known to stimulate insulin secretion (Grill and 
Qvigstad, 2000). The presence of free fatty acids in the serum phase of colostrum is 
another possible explanation for its insulinotrophic properties.  
 
Based on the results obtained in this study, colostrum may represent a novel 
treatment for inflammatory- and immune-related disorders; however, the current 
study focused on in vitro experimental approaches. Assuming the bioactivity of 
colostrum was protein-derived, it is likely that, during digestion, enzymatic 
modification of proteins will alter their biological activities. For this reason, further 
work is needed to investigate whether the in vitro bioactive effects can be 
replicated in vivo. This work would help in the formulation of a food product which 
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Mastitis is an inflammation of the mammary gland and is characterised by physical, 
chemical and bacteriological changes in the milk. Gram-negative Escherichia coli is 
among the most common bacteria known to cause mastitis. Lipopolysaccharide (LPS) is 
an endotoxin and is located in the outer membrane of all Gram-negative bacteria. The 
objective of this study was to investigate the early proteomic changes in the milk of 8 
cows in response to infusion with LPS at quarter level in a model mastitic system. In 
addition, the immunological potential of a peptide fraction of this LPS-induced mastitic 
milk was investigated. One udder quarter of each cow was challenged with 200 µg LPS. 
From these quarters, milk samples were obtained after 8 h, while milk samples from 
respective control quarters were obtained prior to LPS infusion. An increase in the SCC 
of milk from infused quarters was observed for all 8 cows. One- and two-dimensional 
SDS-polyacrylamide gel electrophoretograms revealed marked differences in the 
protein profiles of milk samples from LPS-challenged quarters compared with milk 
samples from control quarters, i.e., milk samples from LPS-challenged quarters showed 
hydrolysis of the caseins due to indigenous proteolytic activity. Similarly, reversed 
phase-ultra performance liquid chromatography showed an increase in the quantity of 
pH 4.6-soluble peptide material in milk from LPS-challenged quarters compared with 
milk from control quarters. In addition, these samples were found to contain increased 
concentrations of serum proteins, most notably serum albumin and immunoglobulins, 
due to increased permeability of the blood-milk barrier in response to an elevated SCC. 
Subsequently, the pH 4.6-soluble protein content of milk from LPS challenged quarters 
was found to be greater than that of the corresponding control milk samples, but to 
varying degrees across all 8 cows. A pH 4.6-soluble fraction of bulked milk from LPS 
challenged quarters of all 8 cows was prepared and was found to cause a substantial 
induction in the secretion of the anti-inflammatory cytokine, IL-10, from a murine 
macrophage cell line, while no effects on the secretion of the pro-inflammatory 
cytokine, TNF-α, were observed. Based on the results obtained in this study, milk from 
cows with experimentally induced mastitis may represent a functional food 





Bovine mastitis is defined as inflammation of mammary gland parenchyma and 
most commonly results from a bacterial infection (Seegers et al., 2003, Sharma et 
al., 2011). Gram-positive Staphylococcus aureus and Gram-negative Escherichia coli 
are among the most prevalent bacteria known to cause mastitis (Ibeagha-Awemu et 
al., 2010). Mastitis is one of the greatest influences on milk composition (Kitchen, 
1981; Barbano et al., 2006; Forsback et al., 2010, 2011) and has a negative effect on 
the physico-chemical properties of milk (Cunha et al., 2008). Clinical mastitis is a 
costly disease amongst dairy farmers due to a reduction in milk volume and quality, 
increased culling rates, and the need to discard milk (Oliver and Mitchell, 1984; 
Smith et al., 1985; Oliver, 1988; DeGraves and Fetrow, 1993; Todhunter et al., 
1995). Mastitis has also been shown to have harmful effects on the reproductive 
efficiency of dairy cows (Moore et al., 1991; Ahmadzadeh et al., 2009). Mastitis is 
estimated to cost the New Zealand and US dairy industries €180 million and €1.3 
billion per annum, respectively (Geary et al., 2012).  
Somatic cells are indicators of both resistance and susceptibility of cows to mastitis; 
somatic cell count (SCC) is a predictor of intramammary infection. Somatic cells 
found in healthy milk are primarily leukocytes, which include macrophages, 
lymphocytes and polymorphonuclear neutrophils (PMN) (Sharma et al., 2011). The 
SCC in milk from a healthy mammary gland is usually lower than 1 x 105 cells/mL, 
while bacterial infection causes it to increase to above 1 x 106 cells/mL (Bytyqi et 
al., 2010). Somatic cells contain lysosomes that release active proteolytic enzymes, 
i.e., elastase, collagenase and cathepsins (Kelly and McSweeney, 2003). Several 
authors have correlated increased proteolysis in milk with an elevated SCC (de 
Rham and Andrews, 1982; Andrews, 1983; Le Roux et al., 1995; Moussaoui et al., 
2004; Hinz et al., 2012), due mainly to increased levels of proteases (Larsen et al., 
2006). Previous studies have shown that cathepsin D activity (O’Driscoll et al., 1999) 
and cysteine protease activity were elevated with increasing SCC in milk (Suzuki & 
Katoh, 1990; O’Driscoll et al., 1999). Similarly, previous results have shown 
activation of the plasmin system during experimentally induced E. coli mastitis 
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infections in cows (Grieve and Kitchen, 1985; Saeman et al., 1988; Moussaoui et al., 
2002; Hinz et al., 2012). 
As already mentioned, E. coli is the most prevalent Gram-negative bacterium which 
causes mastitis in cows and is commonly used experimentally to induce mastitis 
(Andrews, 1983; Hirvonen et al., 1999; Moussaoui et al., 2002; Sladek et al., 2002; 
Bannerman et al., 2004; Moussaoui et al., 2004; Schmitz et al., 2004; Sohn et al., 
2007; Hinz et al., 2012). Infections caused by E. coli are usually associated with a 
faster and more dramatic immune response than that due to Gram-positive 
bacteria such as S. aureus (Petzl et al., 2008; Bannerman, 2009) or Streptococcus 
uberis (Rambeaud et al., 2003; Genini et al., 2011). The ability of E. coli to grow in 
mammary secretions and to liberate lipopolysaccharide (LPS) is of crucial 
importance in the pathogenesis of mastitis (Mehrzad et al., 2008). LPS is a part of 
the outer membrane in the cell wall of Gram-negative bacteria (Rietschel et al., 
1994) and is a potent inducer of inflammation and the acute phase response 
(Berczi, 1998).  
In humans, low grade inflammation has been linked with a range of metabolic 
conditions such as obesity, insulin resistance, metabolic syndrome and coronary 
heart disease (Rosa et al., 2012). Bovine milk is known to contain a number of 
biologically active peptides. These peptides are not active within the parent protein 
but can be produced from precursor milk proteins in the following ways: (a) 
enzymatic hydrolysis by digestive enzymes (Korhonen and Pihlanto, 2003), (b) 
fermentation of milk with proteolytic starter cultures (Fugslang et al., 2003), and/or 
(c) proteolysis by enzymes derived from microorganisms or plants (Yamamoto et 
al., 1994).  Immunomodulatory peptides are those which can enhance immune 
function in vivo through stimulation or suppression of the immune system 
(Gauthier et al., 2006). They work by stimulating the proliferation of lymphocytes, 
the phagocytic activities of macrophages (Nagpal et al., 2011), antibody synthesis 
and cytokine expression (Udenigwe and Aluko, 2012).  
The objectives of the current study were to investigate the early proteomic changes 
in the milk of 8 cows in response to infusion with LPS at quarter level. In addition, 
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the effects of a pH 4.6-soluble fraction of the experimentally induced mastitic milk 
on the secretion of the anti-inflammatory cytokine, interleukin (IL)-10, and the pro-
inflammatory cytokine, tumor necrosis factor (TNF)-α, from a murine macrophage 






















4.2 Materials and Methods 
 
4.2.1 Experimental animals 
Eight dairy cows (Holstein Friesian [n=6] and Swiss Fleckvieh [n=2]), referred from 
hereon in as cows A to H, were selected based on their milk having a SCC < 130,000 
cells/mL in all four quarters (morning foremilk samples) for at least 5 days before 
the experiment. Parities ranged from 1 to 5 and none of the udders showed clinical 
signs of mastitis. The cows were housed in tie stall barns during experiments. SCC 
measurements were performed with a DeLaval cell counter (DeLaval International 
AB, Tumba, Sweden).  
 
4.2.2 Experimental procedures 
After the morning milking, one quarter of each cow was challenged with 200 µg of 
E. coli LPS (serotype O26:B6; Sigma-Aldrich), diluted in 10 mL of saline solution, that 
caused mastitis (Yang et al., 2008). Another quarter from each cow was used as a 
control quarter and treated with 10 mL of saline solution. Treated quarters were 
selected randomly (front or rear, left or right) and equally distributed. Milk samples 
were taken by hand from control quarters at 0 h, prior to injection, and from LPS-
challenged quarters at 8 h post challenge.  
 
4.2.3 Determination of protein content  
Protein content of milk samples was determined by the Bradford assay, as 






4.2.4 One-dimensional gel electrophoresis (1-DE) 
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) was 
carried out using a Protean II xi vertical slab-gel unit (Bio-Rad Laboratories Ltd., 
Watford, Herts., UK) according to the method of Laemmli (1970), as described in 
Section 2.2.13. 
 
4.2.5 Two-dimensional gel electrophoresis (2-DE) 
2-DE was performed on the pH 4.6-soluble skimmed milk samples, as described in 
Section 3.2.7, with slight modifications. Immediately after 2-DE, gels were 
immersed in an initial fixing solution (50% methanol, 10% acetic acid) in clean glass 
dishes overnight on a microplate shaker (VWR, Dublin, Ireland). Following this, the 
gels were fixed, pre-treated, stained and developed using the reagents provided by 
the Pierce Silver Stain Kit (Thermo Fisher Scientific, Waltham, MA, USA). Once the 
developing was stopped the gels were washed thoroughly in distilled H2O before 
being scanned. Images of gels were captured using the GS-800 calibrated 
densitometer (Bio-Rad) with quantity one software (Bio-Rad). 
 
4.2.6 Reversed phase-ultra performance liquid chromatography (RP-UPLC) 
Samples were adjusted to pH 4.6 as described in Section 3.2.7. RP-UPLC was 
performed on the pH 4.6-soluble skimmed milk samples, as described in Section 
3.2.8 with slight modifications. The sample was eluted for 0.37 min with 100% 
solvent A (0.1% trifluoroacetic acid [sequencing grade; Sigma-Aldrich Ireland Ltd, 
Arklow, Co Wicklow, Ireland] in deionised water [Milli Q System; Millipore Corp]), 
then with a linear gradient to 50% solvent B (0.1% trifluoroacetic acid in acetonitrile 
[HPLC far UV grade; Labscan Ltd, Dublin, Ireland]) over 6.23 min, maintained at 50% 
B for 2.68 min, then with a linear gradient to 95% B over 0.46 min, before returning 




4.2.7 Preparation of samples for bioassay testing  
The pH 4.6-soluble fraction of milk from LPS challenged quarters and control 
quarters was prepared by isoelectric precipitation of casein according to the 
method of Kuchroo and Fox (1982), as described in Section 2.2.11. A portion of the 
pH 4.6-soluble material was then lyophilised. 
 
4.2.8 Cell Culture 
The effect of the pH 4.6-soluble fraction of milk from control quarters and LPS-
challenged quarters on the secretion of IL-10 and TNF-α by J774.2 macrophages 
was determined as described in Section 3.2.11. 
 
4.2.9 Data analysis 
Analysis of variance (one-way ANOVA) was conducted using Minitab version 16 
(Minitab Inc., State College, PA, USA). When differences were significant (P ≤ 0.05), 












4.3 Results and Discussion 
 
4.3.1 Somatic cell count of milk samples 
The SCC of milk samples collected from control quarters (prior to injection) and 
from LPS challenged quarters (8 h post-challenge) are shown in Table 4.1. In 
general, the SCC of milk samples taken from control quarters were in line with 
reported values for healthy animals, i.e., Eberhart et al. (1979) estimated that 50% 
of uninfected cows had SCC under 100,000 cells/mL and 80% were under 200,000 
cells/mL. The SCC of milk from cow B, taken from a control quarter, was 222,000 
cells/mL, which was slightly higher than expected for a healthy animal. However, 
this result was not necessarily indicative of a bacterial infection. Even though the 
most important factor influencing the SCC of milk is mammary gland infection, 
several other factors have been shown to influence the number of somatic cells, 
i.e., SCC increases with stage of lactation (Dohoo and Meek, 1982), increasing age 
of the animal (Beckley and Johnson, 1966; Blackburn, 1966), advanced parities 
(Skrzypek et al., 2004), elevated stress levels (Smith et al., 1985) and diurnal 
variation (White and Rattray, 1965). With the exception of cow B, SCC of milk from 
control quarters ranged from 22,000 to 125,000 cells/mL, with an average value of 
56,000 cells/mL. Laevens et al. (1997) reported a mean SCC of 49,000 cells/mL for 
44 uninfected cows in their first to third lactation.  
Large increases in SCC were observed in the milk collected from LPS challenged 
quarters from all 8 cows, 8 h after injection. Values ranged from 2.6 x 106 to 5.1 x 
106 cells/mL, with an average value of 3.9 x 106 cells/mL. These values are 
consistent with the studies of Wellnitz et al. (2011) and Hinz et al. (2012). This 
increase in SCC was a result of stimulation of the innate immune system within the 
mammary gland of the cow in response to lipid A, which is the toxic and 
immunomodulating component of LPS that is recognized by the host (Rietschel et 
al., 1987). One of the initial components of the inflammatory response is the influx 
of polymorphonuclear neutrophils (PMN) into the mammary tissue (Paape et al., 
1979; Harmon and Heald, 1982; Nickerson and Pankey, 1984; Craven and Williams, 
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1985), resulting in an increase in the SCC of milk. The level of PMN in somatic cells 
in mastitic milk has been estimated at over 90% (Miller and Paape, 1985; Harmon, 
1994). The European Union Directives (92/46 CEE and 94/71 CEE) set a SCC limit of 
400, 000 cells/mL for raw milk, while some researchers consider a normal SCC of 
milk to be as high as 500, 000 cells/mL.  
 
Table 4.1 Somatic cell count (SCC) of milk from the control quarters and 




4.3.2 Characterisation of the protein component of milk samples 
The protein profile of milk samples collected from control quarters (prior to 
injection) and from LPS-challenged quarters (8 h post challenge) were studied using 
SDS-PAGE (Figures 4.1 to 4.3). Electrophoretograms revealed marked differences in 
the protein profiles of milk samples from control quarters and LPS challenged 
quarters. Milk from control quarters showed little signs of proteolysis (Figure 4.1, 
lane 6, 8, 10, 12; Figure 4.2, lane 6, 8, 10, 12) and were composed predominantly of 
casein, i.e., αS1-, αS2-, β-, к-casein, and the major whey proteins, i.e., β-lactoglobulin 
(β-lg) and α-lactalbumin (α-la). A substantial increase in overall proteolysis was 
observed in milk samples from LPS-challenged quarters. Electrophoretograms 
showed hydrolysis of the caseins, as evident by a decrease in band intensity of αS1-, 
αS2-, and β-casein.  
Cow












In an attempt to increase band intensity and improve resolution of the proteolysis 
products on SDS-PAGE electrophoretograms in the size range 10-15 kDa, samples 
were purposely overloaded (Figure 4.3). Besides α-la and β-lg, up to 7 additional 
bands were present in milk samples from LPS challenged quarters in this region, 
most of which were not present in milk samples from control quarters. This was 
most likely due to an increase in the level of indigenous proteases in milk, which 
has been associated with an elevated SCC (de Rham and Andrews, 1982; Andrews, 
1983; Le Roux et al., 1995; Moussaoui et al., 2004; Hinz et al., 2012). Plasmin is the 
main proteolytic enzyme in normal milk (Grufferty and Fox, 1988; Bastian et al., 
1991; Bastian and Brown, 1996) and is part of a complex system consisting of 
plasmin, its zymogen (plasminogen), plasminogen activators, plasminogen 
inhibitors, and inhibitors of plasminogen activators (Vassalli et al., 1991). Previous 
studies have shown that, during mastitis, the plasminogen activator activity in milk 
is increased, leading to increased plasmin activity (Heegaard et al., 1994; White et 
al., 1995; Zhao and Lacasse, 2008). β-Casein is the milk protein most susceptible to 
plasmin action, followed by αS2- and αS1-casein, while к-casein appears to be quite 
resistant (Fox and McSweeney, 1998). This is consistent with results from the 
current study, in which αS1-, αS2- and β-casein were readily hydrolysed following LPS 
infusion, while, к-casein was not hydrolysed to the same extent. Several authors 
have previously reported that hydrolysis of the caseins in milk from cows suffering 
with mastitis was not exclusively due to plasmin (Saeman et al., 1988; Le Roux et 
al., 1995; Somers et al., 2003; Wedholm et al., 2008; Larsen et al., 2010). Other 
proteases in milk which may have contributed to proteolysis include cysteine and 
aspartate proteases (Suzuki and Katoh, 1990; Bach-Larsen et al., 1993), both of 
which have been reported to be positively correlated with proteolytic activity and 
SCC (O’Driscoll et al., 1999; Somers et al., 2003; Larsen et al., 2006).  
In contrast to the increase in the level of hydrolysis of the caseins in the milk of 
cows following LPS infusion, β-lg appeared quite resistant to proteolysis. In some 
cases, α-la was also resistant to breakdown, but, not to the same extent as β-lg. α-
La is usually resistant to tryptic hydrolysis (Bertrand-Harb et al., 2002), while native 
β-lg is resistant to acidic environments and to proteolytic enzymes (Chobert et al., 
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1995; Dalgalarrondo et al., 1995; Wit, 1998). This may explain the observed 
resistance of these proteins to enzymatic hydrolysis.  
In addition to an increased level of hydrolysis in milk from LPS-challenged quarters, 
elevated levels of high molecular weight proteins were also observed (Figure 4.1, 
lane 7, 9, 11, 13; Figure 4.2, lane 7, 9, 11, 13). This was a result of leakage of blood 
components into milk due to increased permeability of the blood-milk mammary 
epithelial barrier in response to LPS (Burton and Erskine, 2003; Hogarth et al., 
2004). The most notable increase was the level of serum albumin in milk from LPS 
challenged quarters compared with milk from control quarters. This was not 
surprising as serum albumin is the most common protein found in blood serum, i.e., 
the normal serum protein level is 6 to 8 mg/mL, of which albumin constituents 3.5 
to 5 mg/mL (Busher, 1990). This is in agreement with results from the studies of 
Hogart et al. (2004) and Boehmer et al. (2008) who both reported increases in the 
concentration of bovine serum albumin in mastitic bovine whey. The milk from cow 
F appeared to have the highest concentration of serum albumin following LPS 
infusion, followed by the milk from cow H. With the exception of the milk from cow 
B, the milk from all other cows showed a notable increase in the concentration of 
serum albumin following LPS infusion. Immunoglobulin G is the major 
immunoglobulin in the milk of healthy cattle (Butler, 1983), of which the subclass 
IgG1 represents more than 90 % (Elfstrand et al., 2002).  However, in mastitic milk, 
IgG2 becomes the predominant immunoglobulin (Caffin and Poutrel, 1988) as it is 
the main opsonin supporting neutrophil phagocytosis and, therefore, plays a role in 
fighting mastitic pathogens (Burton and Erskine, 2003). In the current study, the 
concentration of Ig in milk followed the same trend as that of serum albumin, i.e., 
the milk from cow F had the highest concentration of Ig following LPS infusion, 
followed by the milk from cow H, while the milk from all other cows, with the 
exception of milk from cow B, showed a notable increase in the concentration of Ig 
following LPS infusion.  
Three additional bands, ranging in size from approximately 70 to 250 kDa, were 
present at various concentrations in milk samples from LPS challenged quarters. Of 
these, one band was estimated to have an MW of approximately 76 kDa. It is likely 
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that this band represents either serotransferrin and/or lactoferrin, both of whose 
concentration has been shown to be elevated in milk during mastitis (Kawai et al., 
1999; Hogarth et al., 2004). It is not clear which proteins the remaining two bands 
represented; however, proteins which have previously been identified within this 
size range in mastitic milk samples include polymeric immunoglobulin receptor, 
complement C3 precursor (Boehmer et al., 2008) and α2-macroglobulin (Perez et 
al., 1989).  
 
 
Figure 4.1 SDS-Polyacrylamide gel electrophoretograms of milk from the control 
quarters and LPS challenged quarters of trial cows. Lane 1, sodium caseinate; Lane 
2, whey protein isolate; Lane 4, molecular mass marker; Lane 6-13, A pre challenge, 
A post challenge, B pre challenge, B post challenge, C pre challenge, C post 






















Figure 4.2 SDS-Polyacrylamide gel electrophoretograms of milk from the control 
quarters and LPS challenged quarters of trial cows. Lane 1, sodium caseinate; Lane 
2, whey protein isolate; Lane 4, molecular mass marker; Lane 6-13, E pre challenge, 
E post challenge, F pre challenge, F post challenge, G pre challenge, G post 
challenge, H pre challenge and H post challenge, respectively.  
 
Figure 4.3 Section of an SDS-polyacrylamide gel electrophoretograms of milk from 
the control quarters and LPS challenged quarters of trial cows. Lane 1-16, A pre 
challenge, A post challenge, B pre challenge, B post challenge, C pre challenge, C 
post challenge, D pre challenge, D post challenge, E pre challenge, E post challenge, 
F pre challenge, F post challenge, G pre challenge, G post challenge, H pre challenge 



























The proteins in bovine milk can be separated into two groups based on their 
solubility at pH 4.6. Caseins are insoluble at pH 4.6 and constitute approximately 
80% of the proteins in mature milk, while whey proteins are soluble at pH 4.6 and 
account for the remaining 20% of milk protein (Fox and McSweeney, 1998). As 
already mentioned, proteolysis increases in bovine milk at elevated SCC, as was 
seen in the current study (Figures 4.1 to 4.3). This increase in proteolysis, mainly of 
the caseins, led to an increase in the quantity of pH 4.6-soluble protein (Figure 4.4).  
An increase in the quantity of pH 4.6-soluble protein in milk from LPS-challenged 
quarters compared with milk from control quarters was seen for all 8 cows. The 
average pH 4.6-soluble protein content of milk from control quarters ranged from 
0.19% to 0.6%, with an average value of 0.45%. These values were slightly below 
average for the whey protein content of mature bovine milk, with a reported 
average value of 0.6% (Fox and McSweeney, 1998). The average pH 4.6-soluble 
protein content of milk from LPS challenged quarters ranged from 0.58% to 3.56%, 
with an average value of 1.42%.  This increase in pH 4.6-soluble protein in milk from 
LPS challenged quarters compared with milk from control quarters was due to a 
combination of increased proteolysis of the caseins, the products of which are 
mostly soluble at pH 4.6, and increased permeability of the blood milk barrier, 
which resulted in an influx of high molecular weight protein into the milk. The 
largest increase in the pH 4.6-soluble protein content of milk following LPS infusion 
was for cow F, in which case an increase of 2.96% was observed, i.e., the pH 4.6-
soluble protein content increased from 0.6% in milk from the control quarter to 
3.56% in milk from the LPS challenged quarter. The lowest increase in the pH 4.6-
soluble protein of milk following LPS infusion was for cow B, where an increase of 
0.07% was observed. The quantity of pH 4.6-soluble protein in the milk of all 8 cows 
following LPS infusion was of the order; cow F > cow H > cow G > cow E >cow C > 
cow D > cow A > cow B. This is in agreement with the observed band intensities of 
the whey proteins in Figures 4.1 and 4.2. No correlation between the pH 4.6-soluble 






Figure 4.4 Mean values (± S.D., n=3) for protein content of the pH 4.6-soluble 
fractions of milk from the control quarters and LPS challenged quarters of cows A to 
H. Values with different superscript letters were significantly different (p < 0.05). 
 
 
The pH 4.6-soluble fraction of milk samples from control quarters and LPS-
challenged quarters were studied by RP-UPLC (Figure 4.5 and 4.6). An increased 
level of proteolysis was observed in milk samples from LPS-challenged quarters 
compared with control quarters for all 8 cows, with the exception of cow B, as 
evident by an increase in the overall peak area on RP-UPLC chromatograms (Figure 
4.5 and 4.6). This is consistent with SDS-PAGE electrophoretograms (Figures 4.1 to 
4.3) and pH 4.6-soluble protein values (Figure 4.4). The amount of peptide material 
present in milk samples from control quarters varied throughout the 8 cows, i.e., 
greater amounts of peptide material were present in the pH 4.6-soluble fraction of 
milk from control quarters of cows B, C, F, G and H than in the corresponding 
samples from cows A, D and E. This was not surprising as bovine milk is known to 
contain naturally occurring indigenous peptide material, e.g., proteose-peptones 













































(Buccioni et al., 2013), several of which are hydrolysis products arising from the 
action of plasmin on β-casein, in addition to glycoproteins and traces of other 
proteins (Andrew, 1978; Innocente et al., 1998). Intact α-la and β-lg eluted at 6.4 
min and 6.8 min on chromatographic profiles, respectively, and were present in 
relatively constant amounts and proportions in milk samples from control quarters. 
The levels of β-lg and α-la in milk samples from LPS infused quarters from cows A, 
B, D and H were virtually identical to those found in milk samples from the 
corresponding control quarters, but, milk samples from LPS-challenged quarters 
from cows C, E and F contained lower levels of β-lg and α-la than milk from control 
quarters.  
In general, the peptide profiles of milk samples from LPS-challenged quarters were 
quite similar for all 8 cows. The majority of peptide material was hydrophobic, 
eluting between 2.5 and 6 min. On average, approximately 35 peaks were observed 
within this range, in milk from LPS challenged quarters. Relative to the overall peak 
area, excluding β-lg and α-la, milk from the LPS challenged quarter of cow G 
contained the greatest amount of peptide material, while milk from cow B 
contained the least. It is clear from the RP-UPLC chromatogram shown in Figure 4.5 
that milk from the control quarter of cow B had already been subjected to 
proteolysis prior to LPS infusion, i.e., milk from the LPS challenged quarter of cow B 
had an identical pH 4.6-soluble profile to milk from the control quarter, indicating 
that the LPS challenge did not cause an increase in proteolysis. This is in agreement 
with SDS-PAGE (Figures 4.1 to 4.3) and pH 4.6-soluble protein values (Figure 4.4). It 
should also be noted that the SCC of milk from the control quarter of cow B prior to 
LPS infusion was 222 x 103 cells/mL, which was, albeit still quite low, significantly 




























































































Figure 4.5 RP-UPLC chromatograms of the pH 4.6-soluble fraction of milk from the control quarters (     ) or LPS-challenged quarters (    ) of cows 
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Figure 4.6 RP-UPLC chromatograms of the pH 4.6-soluble fraction of milk from the control quarters (     ) or LPS-challenged quarters (    ) of cows 






The protein profile of milk samples collected from control quarters (prior to 
injection) and from LPS challenged quarters (8 h post-challenge) were further 
analysed by 2-DE. Representative gels of milk samples from control quarters and 
LPS challenged quarters were chosen to illustrate the protein profiles generated in 
the current study (Figure 4.7 a to f and Figure 4.8 g to l). Samples were adjusted to 
pH 4.6 prior to analysis in order to remove any casein. The resulting protein maps 
demonstrated that infusion with LPS caused a profound change in the protein 
profiles of milk samples from LPS-challenged quarters compared with milk from 
control quarters. In general, β-lg and α-la were the predominant whey proteins 
present in the milk from control quarters; but, some high molecular weight proteins 
were also present, i.e., most likely immunoglobulins, serum albumin and lactoferrin. 
Infusion with LPS at quarter level resulted in an increase in the secretion of high 
molecular weight proteins in milk. These results were consistent with those of Hinz 
et al. (2012) who reported a marked increase in the concentration of serum 
albumin and serotransferrin in milk from infused quarters. As mentioned earlier, 
this was due to increased permeability of the blood milk barrier in response to an 
elevated SCC, which resulted in an influx of serum proteins into milk. Based on 
observed molecular weights, the high molecular weight proteins of the LPS 
challenged milk on 2-DE gels (Figure 4.7 b, d, f; Figure 4.8 h, j, l) were most likely 
serum albumin, immunoglobulins, lactoferrin and serotransferrin. These results 
were consistent with those obtained by SDS-PAGE (Figures 4.1 and 4.2). It should be 
noted that 2-DE gels were silver stained, mainly because of its high sensitivity, i.e., it 
is able to detect less than 1 ng protein (Weis et al., 2009). However, despite the 
improved sensitivity of silver staining (silver staining is reported to be 100-fold 
more sensitive than Coomassie Brilliant Blue (Switzer et al., 1979), the results 








Figure 4.7 Two-dimensional gel electrophoretograms of the pH 4.6-soluble fraction 
of milk from control and LPS-challenged quarters of cows; (a) A pre challenge, (b) A 
post challenge, (c) B pre challenge, (d) B post challenge, (e) C pre challenge, (f) C 
post challenge. The gels show molecular weights (Mr) and isoelectric points (pI) in 




















Figure 4.8 Two-dimensional gel electrophoretograms of the pH 4.6-soluble fraction 
of milk from control and LPS-challenged quarters of cows; (g) D pre challenge, (h) D 
post challenge, (i) E pre challenge, (j) E post challenge, (k) F pre challenge, (l) F post 
challenge. The gels show molecular weights (Mr) and isoelectric points (pI) in the 
























4.3.3 Effect of milk samples on LPS-induced IL-10 secretion 
Interleukin (IL)-10 is an important anti-inflammatory cytokine which is produced by 
many cell populations, i.e., monocytes, macrophages and dendritic cells (McArdle et 
al., 2013). Its main biological function appears to be the limitation and termination 
of inflammatory responses (Villalta et al., 2011) and the regulation of 
differentiation and proliferation of several immune cells such as T cells, B cells, 
natural killer cells, antigen presenting cells, mast cells, and granulocytes (Asadullah 
et al., 2003). In the current study, murine macrophage cells (J774.2) were isolated, 
cultured and pre-treated with 1 mg/mL of the pH 4.6-soluble fraction of milk from 
LPS-challenged quarters and control quarters for 24 h before inflammation was 
induced with 10 ng/mL LPS for 3 h. Samples were also tested for their effect on IL-
10 secretion from J774.2 cells in the absence of LPS. As discussed earlier, LPS is a 
key inflammatory component of Gram-negative bacteria, which induces a 
distinctive pattern of cytokine release that regulates inflammation (Singh and Jiang, 
2003). LPS was used in the current study to initiate an inflammatory response which 
resulted in increased secretion of IL-10 from J774.2 cells (Figure 4.9 a). The effect of 
the pH 4.6-soluble fraction of milk from LPS-challenged quarters and control 
quarters on IL-10 secretion by J774.2 macrophages is shown in Figures 4.9 a and 4.9 
b.  
The pH 4.6-soluble fraction of milk from LPS-challenged quarters was found to 
cause a substantial induction in the secretion of IL-10. This IL-10 induction was seen 
in the absence of LPS (Figure 4.9a) and, when LPS was present, IL-10 secretion was 
amplified to a level which was greater than the effect seen with LPS alone (Figure 
4.9b). No effect on IL-10 secretion was observed with the pH 4.6-soluble fraction of 
milk from control quarters. As shown earlier, milk from LPS-challenged quarters and 
control quarters differed in both their protein and peptide profiles. Milk from LPS-
challenged quarters contained substantially more peptide material and high 
molecular weight proteins compared to milk from control quarters. Therefore, it is 
likely that the induction of IL-10 from J774.2 cells seen in the current study was as a 




Figure 4.9 Effect of the pH 4.6-soluble fraction of milk from control quarters and 
LPS-challenged quarters on IL-10 secretion by J774.2 macrophages. Exponentially 
growing cells were incubated with 1 mg/mL of the lyophilised pH 4.6-soluble 
fraction of milk from LPS challenged quarters or control quarters for 24 h (A), 
followed by stimulation with 10 ng/mL LPS for 3 h (B). The supernatant was 
removed and the concentration of IL-10 quantified by ELISA. Data shown represents 
the mean (± SD, n=3) of data from three independent experiments. Values with 





















































4.3.4 Effect of milk samples on LPS-induced TNF-α secretion 
Tumor necrosis factor (TNF) is among the most studied and central pro-
inflammatory cytokines (Gillett et al., 2010). TNF is a key regulator of the 
inflammatory response whose ligands are known to play a central role in a variety 
of inflammatory conditions, i.e., rheumatoid arthiritis, inflammatory bowel disease, 
multiple sclerosis, diabetes and asthma (Croft et al., 2012). TNF-α is produced 
predominantly by activated macrophages and T-lymphocytes and is known to have 
numerous biological properties relating to inflammation, proliferation, 
differentiation and cancer growth (Patil et al., 2011). In the current study, J774.2 
macrophages were isolated, cultured and incubated with 1 mg/mL of the pH 4.6-
soluble fraction of milk from LPS-challenged quarters and control quarters for 24 h 
before inflammation was induced with 10 ng/mL LPS for 3 h. Samples were also 
tested for their effect on TNF-α secretion from J774.2 cells in the absence of LPS. 
The effect of the pH 4.6-soluble fraction of milk from LPS-challenged quarters and 
control quarters on TNF-α secretion by J774.2 macrophages are shown in Figures 
4.10 a and 4.10 b. The pH 4.6-soluble fraction of milk from LPS-challenged quarters 
did not reduce or induce TNF-α secretion in the presence or absence of LPS. In the 
absence of LPS, the pH 4.6-soluble fraction of milk from control quarters caused a 
substantial induction of TNF-α, albeit at a much lower level than in response to LPS 
alone. This most likely represented the J774.2 cellular response to potentially 









Figure 4.10 Effect of pre and post LPS-challenged milk samples on TNF-α secretion 
by J774.2 macrophages. Exponentially growing cells were incubated with 1 mg/mL 
of the lyophilised pH 4.6-soluble fraction of milk from LPS challenged quarters and 
control quarters for 24 h (A), followed by stimulation with 10 ng/mL LPS for 3 h (B). 
The supernatant was removed and the concentration of TNF-α quantified by ELISA. 
Data shown represents the mean (± SD, n=3) of data from three independent 






















































Intramammary challenge with the endotoxin LPS, from E. coli, induced an immune 
response in vivo, the results of which were seen in the milk of challenged cows, i.e., 
increased SCC, level of hydrolysis, and concentration of serum proteins. These 
changes were due to an increased permeability of the blood-milk barrier in 
response to an elevated SCC. 
A pH 4.6-soluble fraction of bulked milk from LPS challenged quarters and control 
quarters was prepared in order to examine the immunological potential of these 
samples. The pH 4.6-soluble fraction of milk from LPS challenged quarters was 
found to cause a substantial induction in the secretion of the anti-inflammatory 
cytokine, IL-10, from a murine macrophage cell line, both in the presence and 
absence of in vitro LPS stimulation, while, the corresponding control sample had no 
effect. Based on the results of the current study, it was speculated that this 
bioactivity was in response to either the abundant serum proteins and/or the 
proteolysis products which were up-regulated in milk from LPS challenged quarters. 
The pH 4.6-soluble fraction of milk from LPS challenged quarters was found to have 
no effect on the secretion of the pro-inflammatory cytokine, TNF-α; however, the 
corresponding control sample caused a substantial induction of TNF-α in the 
absence of in vitro LPS stimulation. It is thought that this was a cellular response to 
potentially antigenic material.  
The results obtained in the current study represent a useful contribution in 
understanding the immunological response of cows to LPS. In particular, 
correlations between an elevated milk SCC and alterations in the milk proteome 
were further elucidated. Considerable variation in response to LPS was observed 
between individual cows and further investigation is required in this area.  It is not 
known as to whether this milk could be produced on a large scale due to animal 
welfare concerns; however, experimentally induced mastitic milk may represent a 
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Milk is a very heat-stable system; while the whey proteins are easily denatured, 
caseins are remarkably heat-stable and can be heated at 100°C at the natural pH of 
milk for up to 24 h. Despite this, some changes occur on heating under extreme 
conditions, e.g., dephosphorylation, cleavage of peptide bonds and intermolecular 
cross-linking. The aim of this study was to investigate heat-induced hydrolysis of 
sodium caseinate during heating for up to 120 min at pH 7.0 and 130°C, from the 
dual viewpoints of protein breakdown and peptide formation. The formation of 2% 
trichloroacetic acid-soluble peptides was studied using spectrofluorimetry and 
liquid chromatography-mass spectrometry (LC-MS) while sodium dodecyl sulphate 
(SDS)- and urea-polyacrylamide gel electrophoresis (PAGE) were used to study the 
hydrolysis of the caseins. LC-MS and spectrofluorimetry showed an increase in 2% 
trichloroacetic acid-soluble peptides over time, confirming that proteolysis had 
occurred. Similarly, SDS- and urea-PAGE electrophoretograms showed a decrease in 
band intensity for the main caseins over time.  In total, 1023 peptides were 
identified and characterised. Eleven of the most abundant peptides were studied, 
and their production and breakdown modelled as a function of time. Of the eleven 
major peptides, seven came from αS1-casein (six from the C-terminal region, one 
from the N-terminal region), one from β-casein (from its C-terminal region) and 
three from к-casein (two from the C-terminal region, one from the N-terminal 
region). Peptide bonds containing proline, serine, asparagine and/or aspartic acid 
were preferentially hydrolysed during heating. Subsequently, a peptide fraction 
produced by heat-induced hydrolysis of sodium caseinate was tested for its effect 
on lipopolysaccharide (LPS)-induced cytokine secretion from a murine macrophage 
cell line and was found to cause a significant increase in the secretion of the anti-
inflammatory cytokine interleukin-10. The production of peptides in this manner 
may represent a novel alternative to microbial or enzymatic hydrolysis for the 






Heat treatments of milk and dairy products are commonly used in the dairy 
industry, ranging from thermization (65°C for 15 s) to sterilization (120°C for 10-20 
min) or ultra-high temperature (UHT) treatment (typically 135-145°C for several 
seconds). The effect of heat on the milk protein system is an important 
consideration as it can affect both the functional properties and nutritional quality 
of milk. The heat stability of milk has been reviewed by several authors (Davies & 
White, 1966; Robertson & Dixon, 1969; Fox & Morrissey, 1977; Fox & Hearn, 1978; 
O’Connell & Fox, 2003; Singh, 2004) and may be defined as the ability of milk to 
withstand high processing temperatures without visible coagulation or gelation 
(Singh, 2004).  
Milk is a complex biological fluid containing a very heterogeneous mix of proteins, 
carbohydrates, lipids, vitamins and minerals, in soluble, colloidal or emulsified 
states (Fox and McSweeney, 1998). Despite this, the milk protein system is very 
heat-stable and can withstand heating at 140°C for 15-20 min at pH 6.7 (Fox, 1982; 
Singh and Creamer, 1992; McCrae and Muir, 1995). The whey proteins in milk are 
typical globular proteins with well defined secondary and tertiary structures and 
therefore are susceptible to denaturation. They retain their conformation only 
within limited temperature ranges and exposure to extremes of temperatures 
results in denaturation and aggregation of these proteins (Anema, 2009). The order 
of heat stability of the whey proteins, as measured by loss in solubility, is: α-
lactalbumin (α-la) > β-lactoglobulin (β-lg) > blood serum albumin (BSA) > 
immunoglobulins (Ig). Heating β-Lg at neutral pH to 70°C causes dimers to 
dissociate into monomers, and a thiol group and hydrophobic residues become 
exposed. This may lead to heat-induced gelation as aggregates are formed via 
intermolecular thiol-disulphide exchange, thiol-thiol oxidation and noncovalent 
interactions (Hoffmann and van Mill, 1997; McSwiney et al., 1994; Mulvhill and 
Kinsella, 1987). Similarly, α-la can be denatured at temperatures as low as 63°C 
(Jelen and Rattray, 1995).  
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On the other hand, casein is a remarkably heat-stable protein system; sodium 
caseinate can be heated at pH 6.7 at 140°C for at least 40 min before coagulation 
occurs (Fox and Hoynes, 1975). This high heat stability is due largely, in part, to its 
relative lack of secondary and tertiary structures. However, under certain 
conditions of temperature and pH, the colloidal stability of the casein micelles may 
be lost, as evident by visible flocculation, gelation or protein separation (Fox, 1982). 
High heat treatment can lead to an increase in casein micelle size (Mohammad and 
Fox, 1987; McMahon, 1996), intermolecular cross-linking (Singh, 1995) and 
dephosphorylation of the caseins, subsequently disrupting the native micelle 
structure, which is largely held together by calcium phosphate links (Dalgleish et al., 
1987; Singh, 2004). Calcium phosphate present in the serum phase of milk becomes 
less soluble during heat treatment (Holt, 1995) and it is thought that formation of 
insoluble calcium phosphate and its deposition on casein micelles is largely 
responsible for the instability of casein micelles in UHT-treated milks (Wahlgren et 
al., 1990; Dalgleish, 1992). Guo et al. (1999), who studied the effect of heat on the 
functional properties of sodium caseinate, found that, with heating, solubility 
increased, viscosity decreased, as did its foaming and emulsifying capacity, while 
the foam stability increased. 
Severe heat treatment of milk has also been shown to cause proteolysis, but little 
detailed study has been carried out in this area.  White and Davies (1966) showed 
that 10-20% of the total protein nitrogen in milk is converted to non-protein 
nitrogen (NPN) when heated at 135°C for 60 min. Similarly, Saidi and Wrathesen 
(1993) found an 18% increase in the NPN content of milk following typical 
sterilization conditions (120°C for 20 min). Hustinx et al. (1997) found a linear 
increase in pH 4.6- and 2% trichloroacetic acid-soluble peptides on heating a 
sodium caseinate solution at 140oC and pH 7.0 for 100 min; fifteen of the pH 4.6-
soluble peptides were isolated and identified. Gaucheron et al. (1999) related an 
increase in the NPN content of casein micelle suspensions in a salt solution, in milk 
ultrafiltrate and in milk during sterilization (120oC for 10, 20 or 30 min) to an 
increase in proteolysis and subsequently characterised ten peptides. In a later 
study, Gaucheron et al. (2001) studied the effect of pH on the proteolysis of sodium 
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caseinate induced by heating at 120oC and observed an increase in soluble nitrogen 
content with increasing pH (6.0, 7.0, 8.0, 9.0); eighteen low molar mass peptides 
found in the soluble nitrogen fraction were subsequently characterised. Van Boekel 
(1999) studied the kinetics of deamidation, dephosphorylation and protein 
breakdown in heated sodium caseinate solutions; the extent of deamidation was 
related to the extent of amide present in asparagine, while protein breakdown and 
dephosphorylation increased with increasing heating temperature and time.   
Low-grade inflammation has been linked with a range of metabolic conditions such 
as obesity, insulin resistance, metabolic syndrome and coronary heart disease (Rosa 
et al., 2012). Bovine milk is known to contain a number of biologically active 
peptides (Korhonen, 2009). These peptides are not active within the parent protein 
but can be produced from precursor milk proteins in the following ways: (a) 
enzymatic hydrolysis by digestive enzymes (Korhonen and Pihlanto, 2003), (b) 
fermentation of milk with proteolytic starter cultures (Fugslang et al., 2003), and/or 
(c) proteolysis by enzymes derived from microorganisms or plants (Yamamoto et 
al., 1994).  Immunomodulatory peptides are those which can enhance immune 
function in vivo through stimulation or suppression of the immune system 
(Gauthier et al., 2006). They function by stimulating the proliferation of 
lymphocytes, the phagocytic activities of macrophages (Nagpal et al., 2011), 
antibody synthesis and cytokine expression (Udenigwe and Aluko, 2012).  
The aim of this study was to identify some of the peptides produced during heat 
treatment of sodium caseinate at 130°C over a 120 min period, with the aim of 
identifying the most heat-labile bonds in the casein system. In addition, heat-
hydrolysed sodium caseinate was tested for its effect on the secretion of pro- and 
anti-inflammatory cytokines from a murine macrophage cell line, with the view of 
developing a functional food product which targets inflammation in humans. 
Sodium caseinate was chosen in order to avoid numerous other changes that occur 





5.2 Materials and Methods 
 
5.2.1 Sodium caseinate preparation 
Sodium caseinate (Kerry Group, Listowel, Ireland) was made up in distilled water 
(2.5%, w/v) and was allowed to hydrate overnight at 4°C. Following hydration, the 
solution was adjusted to pH 7.0 using 1 N NaOH and dialysed for three 24 hour 
periods against fifty volumes of distilled water using a 3.5 kDa dialysis membrane 
(Medicell International, London, UK). Following dialysis, the pH was re-checked and 
re-adjusted, if necessary, to pH 7.0 using 1 N NaOH.  
 
5.2.2 Heat treatment 
Aliquots of sodium caseinate (3 mL) were placed in glass tubes (length, 150 mm; 
diameter, 15 mm; wall thickness, 2 mm), sealed with silicone rubber stoppers. 
Tubes were heated in an oscillating oil bath at 130°C for up to 120 min. A 2 min 
equilibration time was also allowed. Following heating, the tubes were immediately 
cooled in ice water at 4°C. 
 
5.2.3 Preparation of the pH 4.6-soluble fraction 
Unhydrolysed casein was removed from heat-treated sodium caseinate samples by 
isoelectric precipitation according to the method of Kuchroo and Fox (1982), as 
described in Section 2.2.11. A portion of the pH 4.6-soluble and insoluble material 
were then lyophilised.  
 
5.2.4 Preparation of the 2% trichloroacetic acid (TCA) soluble fraction 
The 2% TCA-soluble fraction of sodium caseinate was prepared by adding 166 µL 
12% TCA to 833 µL sodium caseinate solution and vortexing the mixture; after 10 
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min, the mixture was centrifuged for 30 min at 18,000 g at 20°C. After 
centrifugation, the supernatant was carefully removed and used for further 
analysis. 
 
5.2.5 Spectrofluorimetric measurement 
The relative fluorescence intensity of the 2% TCA-soluble fractions of sodium 
caseinate heated at 130°C for 0 to 120 min were measured at 20°C using a 
luminescence spectrometer (Varioskan Flash, Thermo Scientific, Waltham, MA, 
USA) at excitation and emission wavelengths of 280 and 340 nm, respectively. Slit 
widths were 5 nm. Under these conditions of excitation and emission, fluorescence 
measurement was used to evaluate the release of peptides containing tyrosine 
and/or tryptophan. 
 
5.2.6 Reverse phase-ultra performance liquid chromatography 
RP-UPLC was performed on the 2% TCA-soluble fractions, as described in Section 
3.2.8 with slight modifications. The sample was eluted for 0.5 min with 100% 
solvent A (0.1% formic acid [sequencing grade; Sigma-Aldrich Ireland Ltd, Arklow, 
Co Wicklow, Ireland] in deionised water [Milli Q System; Millipore Corp]), then with 
a linear gradient to 30% solvent B (0.1% formic acid in acetonitrile [HPLC far UV 
grade; Labscan Ltd, Dublin, Ireland]) over 9.5 min, then with a linear gradient to 
50% B over 2 min, then with a linear gradient to 85% B over 0.5 min, maintained at 
85% B for 0.5 min and finally with 0% B over 1.1 min.  
 
5.2.7 Urea–polyacrylamide gel electrophoresis 
Electrophoresis in polyacrylamide gels (12.5% T, 4% C, pH 8.9) was performed using 
a Protean II xi vertical slab-gel unit (Bio-Rad Laboratories Ltd., Watford, Herts., UK) 
according to the method of Andrews (1983) using a 12%, w/v, acrylamide 
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separating gel and a 4%, w/v, stacking gel. Solutions of heated sodium caseinate 
(2.5%, w/v, total solids) were prepared in 0.124 M Tris-HCl buffer containing 49%, 
w/v, urea, 1.4%, v/v, 2-mercaptoethanol and 0.012%, w/w, bromophenol blue. Gels 
were stained directly by the method of Blakeley and Boezi (1977) with Coomasie 
Brilliant Blue G250 for visualization of proteins. 
 
5.2.8 SDS-polyacrylamide gel electrophoresis 
Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) was 
carried out using a Protean II xi vertical slab-gel unit (Bio-Rad Laboratories Ltd., 
Watford, Herts., UK) according to the method of Laemmli (1970), as described in 
Section 2.2.13. In some cases, gels were silver stained using the Pierce® Silver Stain 
Kit (Thermo Scientific, Waltham, MA, USA), as described in Section 4.2.5. 
 
5.2.9 Mass Spectrometry 
5.2.9.1 Identification of 2% TCA-soluble peptides by Quadropole Time-of-flight Mass 
Spectrometry 
TCA-soluble peptides were identified using a Waters Acquity G2 Q-TOF LC-MS. This 
system consisted of a Waters Acquity UPLC system coupled to a Quadrupole Time-
of-flight mass spectrometer. A sample (6.9 µL) was injected onto a Waters Acquity 
UPLC BEH C18 column (1.7 µm, 2.1 x 50 mm) with a flowrate of 0.46 mL/min. The 
column temperature was maintained at ambient temperature (25°C) while samples 
were refrigerated at 4°C.  Sample was eluted for 0.37 min with 100% solvent A 
(0.1% formic acid [sequencing grade; Sigma-Aldrich Ireland Ltd, Arklow, Co 
Wicklow, Ireland] in deionised water [Milli Q System; Millipore Corp]), then with a 
linear gradient to 20% solvent B (0.1% formic acid in acetonitrile [HPLC far UV 
grade; Labscan Ltd, Dublin, Ireland]) over 2.13 min, then with a linear gradient to 
50% B over 7.5 min, then with a linear gradient to 95% B over 0.1 min, maintained 
at 95% B for 1 min, then with a linear gradient to 0% B over 0.1 min before 
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returning to starting conditions.  UV detection was carried using an Acquity PDA 
detector where a scan of 200-450 nm was conducted in parallel to measuring 
aborbance at 214 nm.  
Mass spectrometry detection was conducted through electrospray ionization using 
an mse centroid experiment in positive mode in the m/z scan range 50-2000 Da. The 
following MS settings were used: capillary voltage 3 kV, sampling cone 40 V, 
extraction cone 4 V, source temperature 120 °C, desolvation temperature 450 °C, 
desolvation gas flow 1000 L/h, cone gas flow 50 L/h. The accurate mass of the 
instrument was initially calibrated through direct infusion of a sodium iodide 
calibrant solution prior to sample analysis. In addition, leucine enkephalin (Leuenk) 
lockmass solution (2 ng/uL) and Glu-fib (1 ng/µL) were infused at 5 µL/min in 
parallel to the mobile phase flow, scanned and automatically corrected to verify 
exact mass. Masslynx v4.1 software (Waters, Millford, Massachusetts) was used to 
control the instrument while Proteinlynx Global Server (PLGS) software (Waters, 
Millford, Massachusetts) was used to assist data analysis and aid in determination 
of peptides present. Within PLGS, a non-specific digest was specified and 
appropriate intensity thresholds of 80 and 20 were used for low and elevated 
energy thresholds, respectively. Lockmass correction was also conducted in PLGS 
rather than during data acquisition. A species specific database for Bos taurus was 
downloaded from the Uniprot website and only reviewed hits were included. The 
analytical data were searched against this database resulting in a number of 
peptides identified within the samples.  
 
5.2.9.2 Digestion of protein bands from SDS-PAGE electrophoretograms and 
identification of peptides by Quadropole Time-of-flight Mass Spectrometry 
Protein bands from SDS-PAGE electrophoretograms were digested, as described in 
Section 3.2.9.1. Tryptic peptides were identified using a Waters Acquity G2 Q-TOF 




5.2.10 Cell Culture 
The effect of the pH 4.6-soluble fraction of heat-hydrolysed sodium caseinate on 
the secretion of IL-10 and TNF-α by J774.2 macrophages was determined as 
described in Section 3.2.11. 
 
5.2.11 Data analysis 
Analysis of variance (one-way ANOVA) was conducted using Minitab version 16 
(Minitab Inc., State College, PA, USA). When differences were significant (P ≤ 0.05), 

















5.3 Results and Discussion 
Preliminary experiments were performed on sodium caseinate at pH 1.0, 3.0, 5.0 
and 7.0 to investigate the effect of heating temperature on hydrolysis at these pH 
values. Heat treatment at 140°C resulted in extensive hydrolysis of the caseins (αS1-, 
αS2-, β- and к-casein) over 30 min, as measured by urea-PAGE, SDS-PAGE and RP-
HPLC (results not shown). The degree of protein degradation and peptide formation 
increased with decreasing pH. One of the aims of this study was to identify the 
most heat-labile bonds in the casein system. For this reason, a temperature of 
130°C and pH value of 7.0 were used for all further heat treatment studies, as a 
heating temperature of 140°C and pH values of 1.0, 3.0 and 5.0 proved too severe 
to monitor the early stages of heat-induced hydrolysis of the caseins. 
 
5.3.1 Fluorescence intensity of 2% TCA-soluble peptides 
Heat-induced hydrolysis of sodium caseinate at 130°C and pH 7.0 led to a linear 
increase in the fluorescence intensities, as a function of time, of the 2% TCA-soluble 
fractions during the first 40 min of heating (Figure 5.1). The fluorescence intensity 
continued to increase until 120 min, but, the increase was not linear, i.e., the rate 
of increase in relative fluorescence intensity slowed after 40 min of heating. 
 
5.3.2 SDS-PAGE of heat-treated sodium caseinate 
SDS-PAGE was used to study heat-induced hydrolysis of sodium caseinate at 130°C 
and pH 7.0 over a period of 120 min. SDS-PAGE was carried out under reducing 
(Figure 5.2) and non-reducing (Figure 5.3) conditions to study any disulphide 
protein interactions which may have taken place during heating. The SDS-PAGE 
electrophoretograms in Figure 5.2 showed a decrease in band intensity for the main 
caseins with heating over time, indicating that hydrolysis had occurred. After 60 
min of heating, αS1- and αS2-casein were no longer visible, while low levels of β- and 
к-casein remained. After 120 min of heating, a blank lane was observed, indicating 
extensive hydrolysis with no intact protein or large polypeptide material remaining. 
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Based on the results shown in Figure 5.2, it appears that αS1- and αS2-casein are the 
most heat-labile of the caseins, followed by β- and к-casein. As expected, increased 
protein breakdown was accompanied by an increase in the appearance of peptide 
material in the size range 6.5 - 20 kDa. These results are in agreement with the 
study of Guo et al. (1999), who showed that several peptides were formed after 
heating sodium caseinate (120 and 132°C for 60 min), due to heat-induced 
hydrolysis. Four distinct protein bands were present on the SDS-PAGE 
electrophoretogram (Figure 5.2) in the undialysed sodium caseinate in the size 
range 50-200 kDa. These bands gradually disappeared on heating and were no 
longer visible after 6 min. Some aggregation of protein was observed after 40 and 
60 min of heating, as evidenced by material remaining in the slots of the SDS-PAGE 
electrophoretograms (Figure 5.2). These aggregates were not present after 120 




Figure 5.1 Mean values (± S.D., n=3) of fluorescence intensity of the 2% TCA-soluble 
fractions of sodium caseinate heated at 130°C for 0 to 120 min. The relative 
fluorescence intensity was measured at 20°C using excitation and emission 
wavelengths of 280 and 340 nm, respectively. Values with different superscript 







































Figure 5.2 SDS-PAGE electrophoretograms (Coomassie stain) of sodium caseinate 
heated at 130°C for 0 to 120 min, separated under reducing conditions. Lane 1, 
molecular weight standard; lane 3, undialysed sodium caseinate; lane 4, unheated 
dialysed sodium caseinate; lane 5, heated (2 min come up time) dialysed sodium 
caseinate; lanes 6 – 15, dialysed sodium caseinate heated for a further 2, 4, 6, 8, 10, 
15, 20, 40, 60 and 120 min, respectively.  
 
The SDS-PAGE electrophoretograms in Figure 5.3 show sodium caseinate heated at 
130°C and pH 7.0 over a period of 120 min, separated under non-reducing 
conditions. The protein profile of the heat-hydrolysed sodium caseinate in Figures 
5.2 and 5.3 within the < 30 kDa range were quite similar. However, the protein 
profiles within the > 30 kDa range differ slightly, i.e., the 4 distinct protein bands 
present in Figure 5.2 in the undialysed sodium caseinate in the size range 50-200 
kDa were also present in Figure 5.3, but at greater intensities. As shown in Figure 
5.2, these bands gradually disappeared on heating; however, in Figure 5.3, they 
were present for longer. These bands were most likely к-casein, which, on heating, 




















is known to aggregate due to the presence of free sulfhydryl groups, which allow 
the formation of intramolecular disulphide bonds (Groves et al., 1998). It should be 
noted that disulphide bonds are naturally present within the к-casein structure. 
Another possibility is that these bands were complexes formed between к-casein 
and heat-denatured β-lactoglobulin via disulphide bonds (Cho et al., 2002), as the 
sodium caseinate used in the current study was found to contain a low level of β-
lactoglobulin (results not shown). It is important to note that these bands were 
present in the unhydrolysed sodium caseinate, suggesting that they were not 
formed during heat-induced hydrolysis. However, it is possible that they were 
formed during the manufacture of the sodium caseinate, e.g., as a result of 
exposure to extremes of pH during localised addition of alkali. Irrespective of this, it 
is clear from Figure 5.3 that heating sodium caseinate at 130°C and pH 7 for 120 
min was not a causative factor in protein aggregation but, instead, resulted in the 






Figure 5.3 SDS-PAGE electrophoretograms (Coomassie stain) of sodium caseinate 
heated at 130°C for 0 to 120 min, separated under non-reducing conditions. Lane 1, 
unheated sodium caseinate; lane 2, heated (2 min come up time) sodium caseinate; 
lanes 3 - 12, sodium caseinate heated for  a further 2, 4, 6, 8, 10, 15, 20, 40, 60 and 
120 min, respectively. 
 
 
The most common method for in-gel protein detection is staining with Coomassie 
blue; however, this method sometimes lacks sensitivity. The most sensitive 
colorimetric method for detecting proteins is silver staining; this technique involves 
silver ions interacting with and binding to certain functional groups of proteins, 
which in turn are reduced to metallic silver, resulting in a brown-black colour. The 
SDS-PAGE electrophoretograms of Figure 5.4 show the pH 4.6-soluble fraction of 
sodium caseinate, heated at 130°C and pH 7.0 for up to 120 min, separated under 
reducing conditions in the approximate size range 6 – 30 kDa and stained using the 







silver stain method. The dominant band across all lanes, with the exception of lane 
15 (120 min), was at approximately 27 kDa. This is the region where the main 
caseins would be expected; however, these samples had been adjusted to pH 4.6 
and so it is unlikely that any intact casein would remain. This band was present at a 
relatively constant level over the first 20 min (lanes 3-12), after which its intensity 
was reduced, i.e., 40 and 60 min (lanes 13 and 14). By 120 min (lane 15), only a faint 
band was evident. Eleven additional bands were present on the SDS-PAGE 
electrophoretograms in Figure 5.4. Of these, only one band (A) was consistently 
present at all heating times. Of the remaining bands, four were present in the 
unheated sodium caseinate and subsequently broken down during heating (B, C, D, 




Figure 5.4 Section of an SDS-PAGE electrophoretograms (silver stained) of the pH 
4.6-soluble fraction of sodium caseinate heated at 130°C and pH 7.0 for up to 120 
min, separated under reducing conditions. Lane 1, molecular weight standard; lane 
3, undialysed sodium caseinate; lane 4, unheated dialysed sodium caseinate; lane 5, 
heated (2 min come up time) dialysed sodium caseinate; lanes 6 – 15, dialysed 
























5.3.3 Urea-PAGE of heat-treated sodium caseinate 
Samples of heat-hydrolysed sodium caseinate (130°C, pH 7.0) were analysed by 
urea-PAGE (Figure 5.5). The electrophoretograms were rather streaky, which is 
usually indicative of intermolecular covalent bonds (Hustinx et al., 1997). This is 
supported by the SDS-PAGE electrophoretograms (Figures 5.2 and 5.3) which 
showed some protein aggregation occurring in sodium caseinate after 40 and 60 
min of heating. Hydrolysis was observed in the urea-PAGE electrophoretograms, as 
evident by a decrease in the band intensity of αS1-, αS2-, β-, and к-casein over time. 
After a period of 120 min, no intact αS1-, αS2- or β-casein remained. 
 
 
Figure 5.5 Urea-PAGE electrophoretograms of sodium caseinate heated at 130°C 
for 0 to 120 min. Lane 1, unheated sodium caseinate; lane 2, heated (2 min come 
up time) sodium caseinate; lanes 3-12, sodium caseinate heated for a further 2, 4, 
6, 8, 10, 15, 20, 40, 60 and 120 min, respectively. 
 
 








5.3.4 RP-UPLC of 2% TCA-soluble fractions 
The 2% TCA-soluble fractions of sodium caseinate heated at 130°C, pH 7.0, over 120 
min were analysed by RP-UPLC (Figures 5.6 and 5.7). RP-UPLC showed an increase 
in 2% TCA-soluble peptides on heating, confirming that hydrolysis had occurred. Six 
minor peaks were visible in the unhydrolysed sodium caseinate, i.e., eluting at 2.0, 
3.9, 7.4, 7.8, 8.6 and 9.6 min, indicating some peptide material was naturally 
present in the unhydrolysed sodium caseinate. This peptide material was most 
likely not due to the action of indigenous proteolytic enzymes in milk, as any 
peptide material produced in this manner would have been removed during the 
production of sodium caseinate, in which several washing steps were carried out. 
As previously mentioned, this indigenous peptide material may have been formed 
during the manufacture of sodium caseinate. The majority of peptides produced on 
heating were hydrophobic, i.e., late eluting; however, a substantial minority of 
peptide material eluted in the hydrophilic range. The reproducibility of heat-
induced hydrolysis of sodium caseinate was investigated by repeating the 
experiment and RP-UPLC analysis (results not shown); identical chromatographic 
profiles were obtained, indicating that heat-induced hydrolysis of sodium caseinate 





Figure 5.6 RP-UPLC chromatograms of the 2% TCA-soluble fractions of sodium caseinate (2.5% w/v), pH 7.0, heated at 130°C for 0-8 min;   (a) 0 


















































































Figure 5.7 RP-UPLC chromatograms of the 2% TCA-soluble fractions of sodium caseinate (2.5% w/v), pH 7.0, heated at 130°C for 10-120 min;   

















































































5.3.5 LC-MS identification of peptides 
The 2% TCA-soluble peptides were separated by RP-UPLC and detected by mass 
spectrometry (Figures 5.8 to 5.11). The chromatographic eluent was by-passed 
from the mass spectrometer during the first two minutes after samples injection, in 
order to prevent disturbance in mass spectrometry analysis due to the presence of 
residual TCA, lactose and minerals. In total, 1023 peptides were identified and 
characterised. Of these peptides, 326 originated from αS1-casein (32%) (Figure 5.8), 
125 from αS2-casein (12%) (Figure 5.9), 353 from β-casein (35%) (Figure 5.10) and 
219 from к-casein (21%) (Figure 5.11).  
The 326 peptides identified from αS1-casein were evenly spread throughout its 
entire sequence. Peptides ranged in size from 3 (αS1-casein [f197-199]) to 45 (αS1-
casein [f1-45]) amino acid residues in length. It is highly probable that dipeptides 
and individual amino acids were also produced during heat-induced hydrolysis of 
sodium caseinate, but were not retained on the RP-UPLC column. Based on the 
peptides identified in the current study, the only bonds within αS1-casein which 
were not hydrolysed during heating at 130°C over 120 min were Glu(39)-Leu(40), 
Ile(44)-Gly(45), Ser(48)-Thr(49), Lys(83)-Glu(84), Glu(84)-Asp(85), Tyr(94)-Leu(95), 
Gln(97)-Leu(98), Arg(100)-Leu(101) and Leu(101)-Lys(102). It is interesting to note 
that leucine was present in five of these peptide bonds, glutamic acid was present 
in three and lysine in two.  
A peptide bond was designated a major cleavage site based on at least 6 peptides 
having a common N- and/or C-terminus. The following peptide bonds were 
accordingly identified as major cleavage sites within αS1-casein; Pro(2)-Lys(3), 
His(4)-Pro(5), Leu(21)-Arg(22), Asn(38)-Glu(39), Asp(56)-Ile(57), Val(167)-Pro(168), 
Asp(175)-Ala(176), Pro(177)-Ser(178), Asp(181)-Ile(182), Asn(184)-Pro(185), 
Gly(187)-Ser(188), Asn(190)-Ser(191) and  Leu(198)-Trp(199).  Proline was present 
in five of these major cleavage sites, while asparagine, aspartic acid or serine were 
each present in three. Of the 326 αS1-casein derived peptides, only one had a 
reported biological activity, i.e., αS1-casein (f194-199); this hexapeptide has been 
shown to have antihypertensive (Maruyama and Susuki, 1982; Maruyama et al., 
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1987; Meisel and Schlimme, 1994; Pihlanto-Leppala et al., 1998) and 
immunomodulatory properties (Parker et al., 1984; Migilore-Samour and Jolles, 
1988).  
Similarly, the 125 peptides identified from αS2-casein were evenly spread 
throughout its entire sequence. Based on the peptides identified in the current 
study, 47 bonds within αS2-casein were not hydrolysed during heating. Lysine and 
threonine were present in thirteen of these peptide bonds, glutamine was present 
in nine and leucine in eight. No major cleavage sites were identified in αS2-casein. 
Relative to the number of peptide bonds hydrolysed during heating, αS2-casein 
appeared to be the most heat-resistant of the caseins. None of the peptides 
identified from αS2-casein were biologically active peptides from data reported in 
the literature (Silva and Malcata, 2005). 
As with αS1- and αS2-casein, the peptides identified from β-casein were evenly 
spread throughout its entire sequence. Only five peptide bonds were not 
hydrolysed during heating, i.e., Arg(25)-Ile(26), Pro(112)-Lys(113), Leu(125)-
Thr(126), Pro(179)-Tyr(180) and Val(201)-Arg(202). Thirteen major cleavage sites 
were identified in β-casein, i.e., Val(8)-Pro(9), Asn(27)-Lys(28), Asp(43)-Glu(44), 
Gln(54)-Thr(55), Val(59)-Tyr(60), Pro(63)-Gly(64), Asn(68)-Ser(69), Pro(76)-Leu(77), 
Gln(79)-Thr(80), Thr(80)-Pro(81), Val(95)-Ser(96), Ser(96)-Lys(97) and His(148)-
Gln(149). Proline was present in four of these major cleavage sites, while threonine, 
valine and serine were each present in three. The abundance of proline and serine 
at the major cleavage sites of β-casein is consistent with the major cleavage sites of 
αS1-casein. Compared to the total number of peptide bonds hydrolysed, β-casein-
derived peptides were the most numerous, compared to the other caseins, 
accounting for 35% of the total peptides identified. Of the 353 β-casein-derived 
peptides, two had reported biological activites, i.e., β-casein (f58-72), which has 
reported angiotensin I-converting enzyme (ACE) inhibitory properties (Smacchi and 
Gobbetti, 1998), and β-casein (f193-199), which has been shown to have 
immunomdoulatory (Minkiewicz et al., 2000) and antimicrobial properties (Sandre 
et al., 2001). 
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The pattern of hydrolysis of к-casein differed from that of αS1-, αS2- and β-casein, 
i.e., the majority of peptides originated from its C-terminal region. It is interesting 
to note that, during cheese-making, the first bond in к-casein which is cleaved by 
chymosin, and indeed other aspartic proteases, is Phe(105)-Met(106), which 
releases a hydrophilic peptide from its C-terminal region, termed the 
caseinomacropeptide, into the serum phase (Horne and Banks, 2004). As can be 
seen from Figure 5.10, the vast majority of к-casein-derived peptides produced on 
heating originated from this region. In total, 26 bonds within к-casein were not 
hydrolysed during heating, of which nine contained tyrosine, six contained proline 
and five contained lysine. Seven major cleavage sites were identified within к-
casein, i.e., Ile(119)-Pro(120), Thr(121)-Ile(122), Asp(148)-Ser(149), Pro(150)-
Glu(151), Gln(163)-Val(164), Thr(165)-Ser(166) and Ala(168)-Val(169). Proline, 
isoleucine, threonine, serine and valine were each present in two major cleavage 
sites. As with αS1- and β-casein, proline and serine were abundant in the major 
cleavage sites of к-casein. None of the peptides identified from к-casein were 
















Figure 5.8 αS1-casein-derived peptides released from sodium caseinate during 
heating at 130°C, pH 7.0, over 120 min. Peptides were identified using quadropole 
time-of- flight mass spectrometry (n=3). 
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Figure 5.9 αS2-casein-derived peptides released from sodium caseinate during 
heating at 130°C, pH 7.0, over 120 min. Peptides were identified using quadropole 
time-of- flight mass spectrometry (n=3). 
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Figure 5.10 β-casein-derived peptides released from sodium caseinate during 
heating at 130°C, pH 7.0, over 120 min. Peptides were identified using quadropole 
time-of- flight mass spectrometry (n=3). 
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Figure 5.11 к-casein-derived peptides released from sodium caseinate during 
heating at 130°C, pH 7.0, over 120 min. Peptides were identified using quadropole 
time-of- flight mass spectrometry (n=3). 
1 10 20 30 40 50
Q E Q N Q E Q P I R C E K D E R F F S D K I A K Y I P I Q Y V L S R Y P S Y G L N Y Y Q Q K P V A L
60 70 80 90 100
I N N Q F L P Y P Y Y A K P A A V R S P A Q I L Q W Q V L S N T V P A K S C Q A Q P T T M A R H P H
110 120 130 140 150
P H L S F M A I P P K K N Q D K T E I P T I N T I A S G E P T S T P T T E A V E S T V A T L E D S P
160 169
E V I E S P P E I N T V Q V T S T A V
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A profile of all the 2% TCA-soluble peptides produced during heat-induced 
hydrolysis of sodium caseinate that were detected by LC-MS are described in 
Figures 5.8 to 5.11. This analysis was qualitative and the vast majority of peptides 
described were present at trace levels. When the relative intensity of each peptide 
was taken into account, only 11 out of the 1023 peptides identified were present at 
a significant level. The production and breakdown of the eleven most abundant 
peptides produced during heating were plotted as a function of time (Figures 5.12, 
5.14 & 5.15). Of these eleven peptides, seven came from αS1-casein (Figure 5.12), of 
which six originated from the C-terminal region and one originated from the N-
terminal region. Based on the sequences of these seven peptides, a sequential 
order of hydrolysis is proposed (Figure 5.13).  
It is likely that the first αS1-casein-derived peptide, produced from the C-terminal 
region on heating, was αS1-casein (f176-199). Production of this peptide required 
cleavage of αS1-casein at Asp(175)-Ala(176). Of all the αS1-casein-derived peptides 
shown in Figure 5.12, this peptide had the largest RP-UPLC peak area at each time 
point throughout the 120 min heating period, suggesting that it was present in the 
greatest abundance. Subsequently, αS1-casein (f176-199) was cleaved at Pro(177)-
Ser(178), Phe(179)-Ser(180), Asp(181)-Ile(182), Asn(184)-Pro(185) and Asn(190)-
Ser(191)/Leu(198)-Trp(199) to produce αS1-casein (f178-199), (f180-199), (f182-
199), (f185-199) and (f191-198). Four of these peptides were also identified by 
Gaucheron et al. (1999, 2001), i.e., αS1-CN (f176-199), (f178-199), (f182-199) and 
(f185-199). It should be noted that αS1-CN (f176-199), (f182-199), (f185-199) and 
(f191-198) were all present in the 2% TCA-soluble fraction of the unheated sodium 
caseinate, suggesting that these peptides were produced during manufacture. 
Dialysis of the unheated sodium caseinate prior to heating resulted in the removal 
of αS1-CN (f182-199) and (f191-198). αS1-CN (f176-199) and (f185-199) remained in 
the unheated sodium caseinate following dialysis; however, the relative intensity of 
these peptides was substantially reduced. αS1-CN (f182-199) and (f191-198) 
reappeared during the two min come up heating time. αS1-CN (f178-199) was 
detected after two min of heating at 130°C, while αS1-CN (f180-199) was detected 
after four min. The first αS1-casein-derived peptide, produced from the N-terminal 
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region, on heating, was αS1-casein (9-22). Production of this peptide required 
cleavage of αS1-casein at His(8)-Gln(9)/Arg(22)-Phe(23). This peptide was not 
present in unheated sodium caseinate, but appeared during the two min come-up 
heating time. Of the nine peptide bonds hydrolysed during the production of the 
seven major αS1-casein-derived peptides, serine was present in three, while proline, 
asparagine, phenylalanine and aspartic acid were each present in two. The 
presence of these amino acids, with the exception of phenylalanine, is in agreement 
with the qualitative results discussed earlier. The presence of asparagine and 
aspartic acid at heat-labile bonds is in agreement with the studies of Schultz (1967), 
Hustinx et al. (1997) and Gaucheron et al. (1999), who suggested that bonds 
containing these residues are more labile than other peptide bonds during heat 
treatment. Given that over 60% of the most abundant peptides produced in sodium 
caseinate during heating originated from αS1-casein, it is fair to assume that αS1-
casein was the most heat-labile of the caseins.  
Proteins and peptides are susceptible to a variety of chemical modifications which 
can affect their structure and biological function. Heat, in particular, has a large 
effect on proteins. Two αS1-casein-derived peptides were identified as being 
modified, of which there were two types. The first corresponded to the 
deamidation of asparagine and glutamine of αS1-casein (f9-22) after heating for 6 
min. Deamidation is a spontaneous non-enzymatic reaction (Geiger and Clarke, 
1987) which is commonly associated with protein degradation (Vlasak et al., 2009). 
Deamidation of asparagine occurs more readily than that of glutamine because the 
amide group of asparagine is closer to adjacent amino residues which may act as 
catalysts (Wright, 1991). Storage of milk and milk products at elevated 
temperatures has been reported by several authors to promote chemical changes 
such as deamidation (Holland et al., 2011, 2012; Le et al., 2012). Van Boekel (1999) 
reported that the extent of heat-induced deamidation of caseinate corresponds to 
the level of amide present in asparagine. The second chemical modification, 
involving αS1-casein (f191-198), was a dehydration reaction which occurred after 
heating for 2 min. In this case, a water molecule was removed from either Thr(194) 





Figure 5.12 Formation of 2% TCA-soluble peptides derived from αS1-casein during 
heat treatment of sodium caseinate (2.5%, w/v, pH 7.0) at 130°C for 0-120 min. 

































Figure 5.13 Proposed sequence of heat-induced hydrolysis of αS1-casein. Cleavage 
sites are indicated by a red line. 
 
 
Of the eleven major peptides, one came from the C-terminal region of β-casein, i.e., 
β-casein (f196-209). Production of this peptide required cleavage of Glu(195)-
Pro(196). This peptide was not present in the unheated sodium caseinate, but 
appeared during the two min come-up heating time. Figure 5.14 shows the 
production of this peptide as a function of time over 120 min. As with asparagine 
and aspartic acid, bonds containing glutamic acid are more labile than other 
peptide bonds during heat treatments (Schultz, 1967; Hustinx et al., 1997; 
Gaucheron et al., 1999). This peptide has not previously been reported as a result 
of heat treatment in dairy products.  No modifications of β-casein (f196-209) were 
observed during the heating period. 
 
 



















Figure 5.14 Formation of a 2% TCA-soluble peptides derived from β-casein, during 
heat treatment of sodium caseinate (2.5%, w/v, pH 7.0) at 130°C for 0-120 min. 
Peptides were identified using quadropole time-of- flight mass spectrometry (n=3). 
 
 
Three of the 11 major peptides identified in sodium caseinate during heating at 
130°C over 120 min originated from к-casein. Based on the sequences of these 
peptides, a sequential order of hydrolysis is proposed (Figure 5.16). Two of these 
peptides were from the C-terminal region, i.e., к-casein (149-169) and (f161-169). 
Production of these peptides required cleavage of Asp(148)-Ser(149) and Asn(160)-
Thr(161), respectively. The presence of asparagine and aspartic acid at these 
cleavage sites is consistent with previous results. As already mentioned, these types 
of bonds are more labile than other peptide bonds during heat treatment. Neither 
of these peptides were present in the unheated sodium caseinate, but appeared 


























terminal region, i.e., к-casein (f1-10), and required cleavage of Arg(10)-Cys(11). 
Similarly, this peptide was not present in the unheated sodium caseinate, but 
appeared after four min of heating. These three peptides have previously been 
reported during sterilization of milk (Gaucheron et al., 1999) and heat-induced 
proteolysis of casein molecules (Gaucheron et al., 2001). 
In addition to the two chemical modifications which occurred in the 11 most 
abundant peptides produced during heat-induced hydrolysis of sodium caseinate, 
several other modifications were observed in the less abundant peptides discussed 
earlier. These include methylation, glycosylation, oxidation of methionine residues, 
hydroxylation, carboxylation of glutamic acid residues and formylation (results not 
shown). 
Figure 5.15 Formation of a 2% TCA-soluble peptides derived from к-casein, during 
heat treatment of sodium caseinate (2.5%, w/v, pH 7.0) at 130°C for 0-120 min. 



























Figure 5.16 Predicted sequence of heat-induced hydrolysis of к-casein. Cleavage 
sites are indicated by a red line. 
 
 
The solubility of peptides in 2% TCA depends on size and hydrophobicity (Yvon et 
al., 1989). It is likely that peptides of high molar masses were produced during heat-
induced hydrolysis of sodium caseinate, but were insoluble in 2% TCA. In an 
attempt to identify some of these high molar mass peptides, bands were excised 
from SDS-PAGE electrophoretograms (Figure 5.17) and mass spectrometry was 
performed. Identification of the five bands analysed are shown in Table 5.1. Of the 
polypeptides identified, αS1-casein products were present in four of five bands, 
while αS2-, β- and к-casein products were present in five, two and four bands, 
respectively. Individual bands contained multiple protein products due to the 
nature of 1-D electrophoresis, i.e., proteins/polypeptides were not separated based 
on their relative isoelectric points, but rather according to their molecular weights. 
As shown earlier, heat-induced hydrolysis of sodium caseinate resulted in extensive 
hydrolysis of αS1-, αS2-, β- and к-caseins. Therefore, it was not surprising that each 
band contained products from several proteins.  
It is interesting to note that αS2-casein products were present in all 5 bands 
analysed. This is surprising as none of the 11 major peptides discussed earlier 
originated from αS2-casein. The observed molecular masses of each polypeptide 
were lower than the theoretical value. This was to be expected as the polypeptides 
present in each band were hydrolysis products of their respective parent proteins. 








The protein coverage of each polypeptide was only a rough estimate of the actual 
sequence, as it is possible that not all of the peptides produced during tryptic 
digestion were detected by mass spectrometry.  
 
 
Figure 5.17 SDS-PAGE electrophoretograms of sodium caseinate heated at 130°C 
and pH 7.0 for up to 120 min. Lane 1, molecular weight standard; lane 3, undialysed 
sodium caseinate; lane 4, unheated dialysed sodium caseinate; lane 5, heated 
dialysed sodium caseinate; lanes 6 – 15, dialysed sodium caseinate heated for 2, 4, 
6, 8, 10, 15, 20, 40, 60 and 120 min, respectively. Excised bands that were analysed 
















Table 5.1 Identification of bands from the SDS-PAGE electrophoretogram (Figure 
16), by LC-MS  
 
Protein reference (Ref.) correspond to the UniProt accession number; % cov. refers to sequence 
coverage. Theoretical molecular mass of proteins are as according to the amino acid and without 
consideration of degradation or modifications. Observed molecular mass are as observed with the 
position of the corresponding spots on the 1-DE gels 
Band no. Identified Ref. Uniprot Mol. mass No. of peptides % Cov. Peptides found Protein
parent protein (kDa) theor/obs Cov.
1 αS2-casein PO2663 26.02/19.73 8 14.86 115-125; 118-125; 161-165; 162-165; 163-165; 115-197
174-181; 189-197; 191-197
к-casein PO2668 21.27/19.73 4 14.74 25-34; 27-34; 69-83; 69-86 25-86
αS1-casein P02662 24.53/19.73 4 13.08 23-34; 91-100; 194-198; 194-199 23-199
2 αS1-casein P02662 24.53/18.13 3 15.42 8-22; 23-34; 194-199 8-199
к-casein PO2668 21.27/18.13 2 14.74 25-34; 69-86 25-86
β-casein P02666 25.11/18.13 3 14.73 170-176; 177-183; 184-202 170-202
αS2-casein PO2663 26.02/18.13 2 12.61 115-125; 174-181; 189-197 115-197
3 αS1-casein P02662 24.53/8.44 8 56.07 8-22; 23-34; 91-100; 104-119; 106-119; 8-199
133-151; 152-193; 194-199
αS2-casein PO2663 26.02/8.44 6 18.47 115-125; 118-125; 138-150; 174-181; 189-197; 115-197
190-197
β-casein P02666 25.11/8.44 8 17.86 170-176; 171-176; 177-183; 181-183; 184-202; 170-209
203-207; 203-208; 203-209
к-casein PO2668 21.27/8.44 3 17.74 25-34; 69-83; 69-86 25-86
4 αS2-casein P02663 26.02/20.27 15 25.7 81-91; 114-120; 114-125; 115-125; 118-125; 81-197
121-125; 138-149; 161-165; 162-165; 163-165; 
174-181; 177-181; 189-197; 190-197; 191-197
αS1-casein P02662 24.53/20.27 2 10.3 23-34; 91-100 23-100
к-casein P02668 21.27/20.27 1 5.3 25-34 25-34
5 αS2-casein P02663 26.02/16.4 5 18 115-125; 138-149; 174-181; 189-197; 190-197 115-197
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Biologically active peptides are most commonly produced by enzymatic hydrolysis 
of whole proteins (Kilara and Panyam, 2003; Korhonen and Pihlanto, 2003) using 
gastrointestinal enzymes, such as pepsin and trypsin, and enzymes from bacterial 
and fungal sources (Fitzgerald et al., 2004). In addition, several indigenous 
proteases have been identified in the milk of various mammalian species (Kelly and 
Fox, 2006), originating from the animal’s blood, somatic cells, and the apical 
membrane and cytoplasm of secretory cells (Fox and Kelly, 2006). Cleavage sites 
leading to the eleven most abundant peptides produced during heat-induced 
hydrolysis of sodium caseinate were compared with the cleavage specificity of 
elastase, plasmin, cathepsin G, cathepsin B, cathepsin D,  chymosin and trypsin on 
αS1-, β- and к-casein (Upadhyay et al., 2004) (Table 5.2). Production of these eleven 
peptides required cleavage of thirteen peptide bonds, of which three could also be 
cleaved by one or more of the enzymes listed above i.e., Arg(22)-Phe(23) of αS1-
casein is cleaved by plasmin and trypsin, Phe(179)-Ser(180) of αS1-casein is cleaved 
by cathepsin G, elastase and chymosin, and Arg(10)-Cis(11) of к-casein is cleaved by 
trypsin. Production of peptides in this manner, i.e. heat-induced hydrolysis, may 
represent a novel alternative to traditional methods commonly used in the food 
industry.  
Table 5.2 Idenitfication and characterisation by LC-MS of the eleven most abundant 
peptides produced during heat-induced hydrolysis of sodium caseinate. Also shown 
is whether these peptide bonds are cleaved by chymosin, trypsin, or the indigenous 
milk enzymes cathepsin G, cathepsin D, elastase and plasmin (yes/no) 
 
Peptide produced on heating N-terminal cleavage site C-terminal cleavage site Cathepsin G Cathepsin B Elastase Plasmin Cathepsin D Chymosin Trypsin
αs1-CN 191-198 Asn190-Ser191 Leu198-Trp199 N;N N;N N;N N;N N;N N;N N;N
αs1-CN 9-22 His8-Gln9 Arg22-Phe23 N;N N;N N;N N;Y N;N N;N N;Y
αs1-CN 185-199 Asn184-Pro185 N N N N N N N
αs1-CN 182-199 Asp181-Ile182 N N N N N N N
αs1-CN 176-199 Asp175-Ala176 N N N N N N N
αs1-CN 178-199 Pro177-Ser178 N N N N N N N
αs1-CN 180-199 Phe179-Ser180 Y N Y N N Y N
β-CN 196-209 Glu195-Pro196 N N N N N N N
к-CN 1-10 Arg10-Cis11 N/A N/A N/A N/A N/A N/A Y
к-CN 149-169 Asp148-SerP149 N/A N/A N/A N/A N/A N/A N
к-CN 161-169 Asn160-Thr161 N/A N/A N/A N/A N/A N/A N
N;N (N-terminal  cleavage s i te;C-terminal  cleavage s i te)
N/A Information not avai lable
333 
 
5.3.6 Effect of heat-treated sodium caseinate on IL-10 secretion from J774.2 
macrophages 
Interleukin (IL)-10 is an anti-inflammatory cytokine which is produced by numerous 
immune cells including monocytes, macrophages and dendritic cells (Mc Ardle et 
al., 2013). IL-10 was first recognized for its ability to inhibit activation and effector 
function of T cells, monocytes and macrophages (Moore et al., 2001). The main 
function of IL-10 appears to be in limiting and terminating inflammatory responses 
(Villalta et al., 2011). In the current study, murine macrophage cells (J774.2) were 
isolated, cultured and pre-treated with 1 mg/mL of the pH 4.6-soluble fraction of 
heat-hydrolysed sodium caseinate and unhydrolysed sodium caseinate for 24 h 
before inflammation was induced with 10 ng/mL LPS for 3 h. LPS is a key 
inflammatory component of Gram-negative bacteria, which induces a distinctive 
pattern of cytokine release that regulates inflammation (Singh and Jiang, 2003). In 
the current study, LPS was used to initiate an inflammatory response which 
resulted in increased secretion of IL-10 from J774.2 cells.  
The effect of the pH 4.6-soluble fraction of heat-hydrolysed sodium caseinate and 
unhydrolysed sodium caseinate on IL-10 secretion by J774.2 macrophages is shown 
in Figure 5.18. The pH 4.6-soluble fraction of heat-hydrolysed sodium caseinate 
caused a substantial increase the secretion of IL-10 compared to the LPS-positive 
control. Unhydrolysed sodium caseinate was used as a negative control, as it 
contained predominantly intact protein with relatively little peptide material. 
Unhydrolysed sodium caseinate caused a reduction in the secretion of IL-10 







Figure 5.18 Effect of the pH 4.6-soluble fraction of heat-hydrolysed sodium 
caseinate (130°C, pH 7.0 for 120 min) and unhydrolysed sodium caseinate on LPS-
induced IL-10 secretion by J774.2 macrophages after 48 h pre-treatment. 
Exponentially growing cells were pre-treated with 1 mg/mL of unhydrolysed and 
heat-hydrolysed sodium caseinate for 24 h and stimulated with 10 ng/mL LPS for 3 
h. The supernatant was removed and the concentration of cytokine quantified by 
ELISA. Data shown represent the mean (± SD) of measurements from three 
independent experiments. Values with different superscript letters were 
significantly different (p < 0.05). 
   
 
J774.2 macrophages were isolated, cultured and pre-treated with various 
concentrations of the pH 4.6-soluble fraction of heat-hydrolysed sodium caseinate 
and unhydrolysed sodium caseinate ranging from 0.001 to 1 mg/mL for 24 h before 
inflammation was induced with 10 ng/mL LPS for 3 h. The dose-response effect of 
the pH 4.6-soluble fraction of heat-hydrolysed sodium caseinate and unhydrolysed 
sodium caseinate on LPS-induced IL-10 secretion by J774.2 macrophages is shown 
in Figure 5.19. The pH 4.6-soluble fraction of heat-hydrolysed sodium caseinate 














































control at a concentration of 1 mg/mL, at a level similar to that shown in Figure 
5.18; however, no effect was observed in the concentration range 0.001 – 0.1 
mg/mL. Unhydrolysed sodium caseinate, which again served as a negative control, 




Figure 5.19 Dose-response effect of the pH 4.6-soluble fraction of heat-hydrolysed 
sodium caseinate (130°C, pH 7.0 for 120 min) or unhydrolysed sodium caseinate on 
LPS-induced IL-10 secretion by J774.2 macrophages after 48 h pre-treatment. 
Exponentially growing cells were pre-treated with various concentrations (mg/mL) 
of unhydrolysed and heat-hydrolysed sodium caseinate for 24 h and stimulated 
with 10ng/mL LPS for 3 h. The supernatant was removed and the concentration of 
cytokine quantified by ELISA. Data shown represent the mean (± SD) of 
measurements from three independent experiments. Values with different 




























































5.3.7 Effect of heat-treated sodium caseinate on TNF secretion from J774.2 
macrophages 
Tumor necrosis factor (TNF) is among the most studied and central pro-
inflammatory cytokines (Gillett et al., 2010). TNF is a key regulator of the 
inflammatory response whose ligands are known to play a central role in a variety 
of inflammatory conditions, e.g., rheumatoid arthiritis and inflammatory bowel 
disease (Croft et al., 2012). TNF-α is produced predominantly by activated 
macrophages and T-lymphocytes and is known to have numerous biological 
properties relating to inflammation, proliferation, differentiation and cancer growth 
(Patil et al., 2011). In the current study, J774.2 macrophages were isolated, cultured 
and pre-treated with 1 mg/mL of the pH 4.6-soluble fraction of heat-hydrolysed 
sodium caseinate and unhydrolysed sodium caseinate for 24 h before inflammation 
was induced with 10 ng/mL LPS for 3 h. The effect of the pH 4.6-soluble fraction of 
heat-hydrolysed sodium caseinate and unhydrolysed sodium caseinate on LPS-
induced TNF-α secretion is shown in Figure 5.20. The pH 4.6-soluble fraction of 
heat-hydrolysed sodium caseinate was found to have no effect on TNF-α secretion 
compared to the LPS-positive control. Dexamethasone is a synthetic member of the 
glucocorticoid class of steroid drugs that has anti-inflammatory and 
immunosuppressant properties (Chae et al., 2000).  Dexamethasone has been 
shown to have an inhibitory effect on TNF-α expression (Zilberfarb et al., 2001), as 
was seen in the current study (Figure 5.20). Unhydrolysed sodium caseinate caused 







Figure 5.20 Effect of the pH 4.6-soluble fraction of heat-hydrolysed sodium 
caseinate (130°C, pH 7.0 for 120 min) and unhydrolysed sodium caseinate on LPS-
induced TNF-α secretion by J774.2 macrophages. Exponentially growing cells were 
pre-treated with 1 mg/mL of unhydrolysed and heat-hydrolysed sodium caseinate 
for 24 h and stimulated with 10 ng/mL LPS for 3 h. The supernatant was removed 
and the concentration of cytokine quantified by ELISA. Data shown represent the 
mean (± SEM, n=3) of measurements from three independent experiments. Values 
with different superscript letters were significantly different (p < 0.05). 
























































Heat-induced hydrolysis of sodium caseinate at 130°C and pH 7.0 resulted in 
extensive hydrolysis of the caseins over a period of 120 min. Of the caseins, αS1-
casein was most susceptible to heat-induced hydrolysis, while к-casein appeared to 
be the most resistant. In total, 1023 peptides were identified and characterised in 
the 2% TCA-soluble fraction of heat-hydrolysed sodium caseinate, of which 326 
originated from αS1-casein, 125 from αS2-casein, 353 from β-casein and 219 from к-
casein; however, these peptides were not quantified, and so, were not 
representative of total proteolysis. For αS1-, αS2- and β-caseins, peptides were 
evenly dispersed throughout the entire sequence of each protein while, for к-
casein, peptides predominantly originated from the C-terminal region. Hydrolysis 
appeared to be specific, i.e., certain bonds within the caseins were preferentially 
hydrolysed, leading to the production of eleven predominant peptides. Of these 
eleven peptides, seven originated from αS1-casein, one from β-casein and three 
from к-casein. Proline, serine, asparagine and aspartic acid were consistently 
present in peptide bonds which were hydrolysed during the production of these 
eleven abundant peptides. Of the peptide bonds within the caseins which were not 
hydrolysed during heating, leucine and lysine were consistently present, suggesting 
that these amino acids were resistant to heat-induced hydrolysis.  
Results from the current study suggest that heat may represent an alternative to 
enzymatic or microbial hydrolysis of the caseins. Further work is needed to 
investigate the effect of varying the time, temperature and pH on the production of 
peptides. Of the peptides identified, 3 have previously been reported to have 
biological activities relating to the treatment of high blood pressure, modulation of 
the immune system and inhibition of microbial growth, i.e., αS1-casein (f194-199), 
β-casein (f58-72) and (f193-199). In the current study, a pH 4.6-soluble fraction of 
heat-hydrolysed sodium caseinate was found to cause a significant increase in the 
secretion of the anti-inflammatory cytokine IL-10 and may represent a potential 
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Bioactive peptides are protein fragments which have a positive impact on body 
function and conditions and may ultimately influence health; however, most of these 
biological activities are not active within the parent protein. The aim of this study was 
to generate a milk-derived bioactive peptide by enzymatic hydrolysis of sodium 
caseinate which targets gastric satiety signals, in particular glucagon-like peptide-1 
(GLP-1). It was found that sodium caseinate (30 mg/mL), adjusted to pH 5.6, hydrolysed 
by chymosin (180 IMCU per gram of sodium caseinate) at 37°C for 10, 40 or 120 min, 
caused an increase in the secretion of GLP-1 from STC-1 cells compared with 
unhydrolysed sodium caseinate. The hydrolysate produced in 40 min was identified as 
the most potent activator of GLP-1 in vitro and was found to cause a significant 
reduction in feed intake in mice when injected intraperitoneally, compared with 
control mice. The hydrolysis protocol was optimised in several ways in order to make it 
more suitable for commercial production, i.e., solids level increased from 3 to 10%, 
enzyme:substrate ratio reduced 20-fold (which required an increase in the reaction 
time from 40 to 220 min), and pH increased from 5.6 to 6.5. The hydrolysate was also 
fractionated by isoelectric precipitation of casein and ultrafiltration of the soluble 
fraction in an attempt to identify the bioactive component. Bioactivity was in the order: 
3 kDa permeate of a pH 4.6-soluble extract > pH 4.6-soluble > crude hydrolysate > 
unhydrolysed sodium caseinate > 3 kDa retentate of a pH 4.6-soluble extract > pH 4.6-
insoluble; the 3 kDa permeate of a pH 4.6-soluble extract resulted in the greatest 
secretion of GLP-1. Urea-polyacrylamide gel electrophoresis (PAGE) was used to study 
protein breakdown and the main polypeptides produced were αS1-casein (f24-199 and 
f102-199) and β-casein (f1-189/192 and f1-163/165); however, these polypeptides had 
no effect on GLP-1 secretion. LC-MS was used to study peptide formation and the main 
peptides produced were β-casein (f193-209) and αS1-casein (f1-23 and f3-23); however, 
these peptides also did not cause an increase in GLP-1 secretion. While the bioactive 
component was thus not identified, combined in vitro and in vivo results from the 
current study suggest that this hydrolysate could be used in the formulation of a 





Obesity and its associated complications present significant public health problems, 
as obese people have a higher incidence of type two diabetes and cardiovascular 
disease (Huda et al., 2006). Current International Obesity Taskforce (IOTF) 
estimates suggest that at least 1.1 billion people are overweight, and 312 million of 
these are obese (body mass index [BMI] ≥ 30) (James et al., 2004). Peptide 
hormones released from the gut are important factors in controlling appetite and 
satiety; these include ghrelin, peptide YY (PYY), pancreatic polypeptide (PP), 
oxyntomodulin (Oxm), cholecystokinin (CCK), and glucagon-like peptide-1 (GLP-1). 
With the exception of ghrelin, these hormones act to increase satiety and decrease 
food intake (Druce et al., 2004). Gut-derived satiety hormones reduce food intake 
in several ways, such as by reduction of gut motility, delaying gastric emptying, 
activation of mechanoreceptors, and acting directly on neurons in hypothalamic 
and brainstem areas (Chaudri et al., 2006). 
Milk proteins play an important role in the diet from a nutritional point of view; the 
protein fraction of milk contains many valuable components and biologically active 
substances. Bioactive peptides can be defined as specific protein fragments that 
have a positive impact on body functions and conditions and may ultimately 
influence health (Kitts and Weiler, 2003). These bioactive peptides are inactive 
within the primary sequence of the native protein (Meisel, 1998); however, they 
can be liberated in several ways (Korhonen, 2009), i.e., gastrointestinal digestion of 
milk (Boutrou et al., 2013), fermentation of milk with proteolytic starter cultures 
(Takano, 2002; Fitzgerald and Murray, 2006) or hydrolysis by proteolytic enzymes 
(Fitzgerald and Meisel, 2003; Korhonen and Pihlanto, 2003a; Meisel and Fitzgerald, 
2003). The most commonly used method of producing bioactive peptides is through 
enzymatic hydrolysis of milk proteins. Pancreatic enzymes, in particular trypsin, are 
most commonly used to generate bioactive peptides; however, other enzymes and 
different combinations of proteinases – including alcalase, chymotrypsin, 
pancreatin and pepsin as well as enzymes from bacterial and fungal sources – have 
also been utilised (Clare and Swaisgood, 2000; Korhonen and Pihlanto, 2003b, 
2006). Dairy starter cultures, in particular lactic acid bacteria, the proteolytic system 
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of which is well characterised, are also commonly used to generate bioactive 
peptides (Phelan et al., 2009). 
A wide range of biological activities have been reported with milk-derived bioactive 
peptides, and can be divided into several categories based on their physiological 
effect on the body; antihypertensive (Hayes et al., 2006), antithrombotic (Zimecki 
and Kruzel, 2007), opioid (Clare and Swaisgood, 2000), immunomodulatory (Politis 
and Chronopoulou, 2008), antimicrobial (Severin and Wenshui, 2005) and 
cytomodulatory (Parodi, 2007). Recently, they have received much attention as 
potential functional foods aimed at diet-related chronic diseases, such as obesity 
(Aoyama et al., 2000), type two diabetes (Liu et al., 2006) and cardiovascular 
disease (Fitzgerald et al., 2004). Several authors have reported a positive 
correlation between dairy product consumption and maintenance of healthy body 
weight (Barr et al., 2000; Phillips et al., 2003; Ranganathan et al., 2005). This is 
achieved by suppression of short-term food intake, increased subjective satiety and 
stimulation of the mechanisms known to signal satiation and satiety (Aziz and 
Andersen, 2007).  
Chymosin (EC 3.4.23.4) is an aspartyl proteinase which is secreted in the stomach of 
young mammals. It is closely related to pepsin A (EC 3.4.23.1), which predominates 
in the stomach of adult mammals. Chymosin is produced intracellularly as 
preprochymosin. Preprochymosin is shortened by 16 amino acids during secretion 
and appears in the stomach as prochymosin, which, in turn, is activated to 
chymosin by cleavage of an additional 42 amino acids (Kumar et al., 2010). The 
molecular weight of chymosin is within the range of 23-49 kDa (Kumar et al., 2010); 
the exact value differs slightly between mammalian species. Chymosin has an acidic 
pH optimum (Fox, 1969) and its optimum temperature varies between 30 and 40°C 
(Berridge, 1952). The natural function of chymosin is to increase digestive efficiency 
by coagulating milk in the stomach of the neonate (McSweeney et al., 1993). It does 
so by hydrolysing the Phe(105)-Met(106) bond of к-casein; the removal of the C-
terminus of к-casein causes exposure of the hydrophobic core of casein micelles, 
leading to aggregation, gel formation and phase separation of the milk into curds 
and whey (Jensen et al., 2013). Within the food industry, chymosin is the principal 
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protease used in cheese-making. This is because it has a highly specific milk-clotting 
activity relative to its proteolytic activity (Hsieh and Pan, 2012). Traditionally, an 
enzyme extract of calf abomasal tissue was used to coagulate milk in cheese 
production. However, these extracts often did not meet the necessary 
requirements for quality and quantity. To meet industrial demand, genetic 
engineering is increasingly used, whereby chymosin is produced in its exact natural 
form from bacteria (E. coli), yeast (Kluveryomyces lactis), and moulds (Aspergillus 
niger) as microbial hosts (Kumar et al., 2010).  
The objectives of this study were: (1) to generate a milk protein hydrolysate using 
chymosin that targets gastric satiety signals, for the development of a functional 
food product; (2) to optimise and scale up the hydrolysis protocol for commercial 
production as a food ingredient; and (3) to fractionate and characterise the 















6.2 Materials and Methods 
6.2.1 Generation of a sodium caseinate hydrolysate 
Sodium caseinate (3% w/v) (Kerry Group, Tralee, Ireland) was made up in distilled 
water and the solution was allowed to hydrate overnight at 4°C. Following 
hydration, the solution was adjusted to pH 5.6 using 2N HCl and brought to 37°C in 
a waterbath (Techne TE-10A, Bibby Scientific, Stone, Staffordshire, UK). One mL 
chymosin solution (180 IMCU/mL) (Maxiren 180, DSM Food Specialities, Carbon 
Group, Ringaskiddy, Ireland) was added per gram of sodium caseinate. The solution 
was maintained at 37°C whilst being stirred using an overhead stirrer (Heidolph 
R2R-2021, Heidolph Instruments, Schwabach, Germany). Aliquots were taken at 10, 
40 and 120 min; at each time point, the enzyme was inactivated by heating in a 
waterbath at 80° for 10 min. Samples were then lyophilised and stored in a 
dessicator at -20°C. A negative control was prepared using the same protocol as 
above, except heat inactivated chymosin was used. Chymosin was inactivated by 
heating in a waterbath at 80°C for 10 min. 
 
6.2.2 Optimisation of hydrolysis conditions 
6.2.2.1 Total solids 
The total solids level of the sodium caseinate solution was increased from 3% to 
10% (w/v) in order to increase the yield of bioactive material. 
 
6.2.2.2 pH adjustment 
In some cases, 0.7% (w/v) glucono delta-lactone (GDL) was used instead of HCl to 
reduce the pH of the sodium caseinate solution (100 mg/mL) to pH 5.6 prior to 
hydrolysis. In solution, GDL is progressively hydrolysed to gluconic acid, which 
causes a reduction in pH. Prior to hydrolysis, pH was adjusted to values in the range 
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5.6 to 7, i.e., 5.6, 6, 6.5, ~6.7 (natural pH of sodium caseinate, no pH adjustment) 
and 7, with HCl/GDL/NaOH. 
  
6.2.2.3 Enzyme:substrate ratio 
For the purpose of this study, the enzyme:substrate ratio will refer to the ratio of 
chymosin solution:sodium caseinate. The original enzyme:substrate ratio used was 
1 mL chymosin (180 IMCU/mL) (Maxiren 180) per gram of sodium caseinate. This 
ratio was reduced 20-fold so that the enzyme:substrate ratio was 0.05 mL chymosin 
(9 IMCU) per gram of sodium caseinate. The enzyme:substrate ratio was reduced in 
order to reduce the cost of the enzyme preparation and also to minimise the 
addition of exogenous material originating from the enzyme preparation. 
   
6.2.3 Fractionation of sodium caseinate hydrolysate 
Unhydrolysed sodium caseinate and large polypeptides (pH 4.6-insoluble material) 
were removed by isoelectric precipitation according to the method of Kuchroo and 
Fox (1982), as described in Section 2.2.11. The pH 4.6-soluble material was further 
fractionated by ultrafiltration (20°C, regenerated cellulose membrane, 1 or 3 kDa 
nominal molecular weight limit; Merck Millipore Ltd, Cork, Ireland). All samples 
were then lyophilised and stored in a dessicator at -20°C. 
pH 4.6-soluble material (6.5% w/v) was redissolved in distilled water and allowed to 
hydrate overnight at 4°C. Following hydration, the solution was adjusted to pH 6.7 
using 1 N NaOH and brought to 50°C in a waterbath. The solution was further 
fractionated by ultrafiltration. Briefly, the pH 4.6-soluble material was filtered 
through a 0.2 µm membrane (Vivaflow 200, Sartorius Stedim, Dublin, Ireland) fitted 
with a variable speed peristaltic pump (Masterflex LS economy drive, Fisher 
Scientific, Dublin, Ireland). The 0.2 µm retentate was collected while the permeate 
was filtered through a 10 kDa membrane (Vivaflow 200, Sartorius Stedim, Dublin, 
Ireland). The 10 kDa retentate was collected while the permeate was filtered 
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through a 5 kDa membrane (Vivaflow 200, Sartorius Stedim, Dublin, Ireland). The 5 
kDa retentate was collected while the permeate was filtered through a 3 kDa 
membrane (Vivaflow 200, Sartorius Stedim, Dublin, Ireland). The 3 kDa retentate 
was collected while the permeate was filtered through a 1 kDa membrane (Tangenx 
Prostream, Novasep Process, France). Both the 1 kDa retentate and permeate were 
collected. A 5X diafiltration step was carried out using ultra pure water (Elga 
purelab option-Q; Veolia Water Solutions and Technologies, Marlow, United 
Kingdom).  All samples were lyophilised and stored in a dessicator at -20°C. 
 
6.2.4 One-dimensional  gel electrophoresis 
One dimensional urea-polyacrylamide gel electrophoresis (PAGE) was used to study 
proteolysis of the caseins. Electrophoresis in polyacrylamide gels (12.5% T, 4% C, pH 
8.9) was performed using a Protean II xi vertical slab-gel unit (Bio-Rad Laboratories 
Ltd., Watford, Herts., UK) according to the method of Andrews (1983), as described 
in Section 5.2.7.  
 
6.2.5 Two-dimensional gel electrophoresis (2-DE) 
Two-DE was performed on the sodium caseinate samples hydrolysed for 0, 10, 40 
and 120 min, as described in Section 3.2.7.  
 
6.2.6 Protein content 
Protein content was determined by the macro-Kjeldahl method (IDF, 1986), as 
described in Section 2.2.2. In some cases, the Bradford assay was used, as described 





6.2.7 Reverse phase-ultra performance liquid chromatography (RP-UPLC) 
Samples were adjusted to 2% TCA, as described in Section 5.2.4. RP-UPLC was 
performed on the 2% TCA-soluble fractions, as described in Section 3.2.8 with slight 
modifications. The sample was eluted for 0.37 min with 100% solvent A (0.1% 
trifluoroacetic acid acid [sequencing grade; Sigma-Aldrich Ireland Ltd, Arklow, Co 
Wicklow, Ireland] in deionised water [Milli Q System; Millipore Corp]), then with a 
linear gradient to 50% solvent B (0.1% trifluoroacetic acid in acetonitrile [HPLC far 
UV grade; Labscan Ltd, Dublin, Ireland]) over 6.23 min, maintained at 50% B for 
0.46 min, then with a linear gradient to 95% B over 0.68 min, before returning to 
the original starting conditions.  
 
6.2.8 Free amino acid analysis 
Samples were deproteinised by making up to a final concentration of 12% 
trichloroacetic acid (TCA), i.e., equal volumes of sample and 24% TCA solution were 
mixed, and allowed to stand for 10 min before being centrifuged at 14,400 g 
(Microcentaur, MSE, UK) for 10 min. Supernatants were removed and diluted with 
0.2 M sodium citrate buffer, pH 2.2, to give approximately 250 nmol of each amino 
acid residue. Samples were then diluted 1 in 2 with the internal standard, 
norleucine, to give a final concentration of 125 nmol/mL. Amino acids were 
quantified using a Jeol JLC-500/V amino acid analyser (Jeol (UK) Ltd., Welwyn 
Garden City, Herts, UK) fitted with a Jeol Na+ high performance cation-exchange 
column. 
 
6.2.9 Identification of peptides by Quadropole Time-of- flight Mass Spectrometry  
Peptides were identified using a Waters Acquity G2 Q-TOF LC-MS, as described in 




6.2.10 Synthesis of peptides 
Select peptides were synthesised using Microwave-assisted Solid Phase Peptide 
Synthesis (MW-SPPS) performed on a LibertyTM CEM microwave peptide 
synthesiser. αS1-Casein (f1-23) and (f3-23) were synthesised on an Fmoc-L-Phe 
Wang resin and β-casein (f190-209) and (f193-209) were synthesised on an Fmoc-L-
Val Wang resin (Matrix Innovation, Quebec, Canada). Synthetic peptides were 
purified using RP-HPLC on a Vydac (10 u, 300A) column (Vydac, California, USA) and 
peptides eluted using a 20-40% acetonitrile 0.1% TFA gradient over 40 min. The 
flow rate was 2.5 mL/min and eluent monitored at 214 nm.  Fractions containing 
the desired molecular mass were identified using MALDI TOF Mass Spectrometry 
(Shimadzu Biotech, Manchester UK) and were pooled and lyophilised on a Genevac 
HT 4X (Genevac Ltd. Ipswitch, UK) lyophiliser.  
 
6.2.11 Preparation of samples for cell exposure assays 
Lyophilised samples (0.5 g powder) were dissolved in 10 mL of sterile distilled water 
to give a 50 mg/mL stock solution, with stirring. The pH of the solution was adjusted 
to pH 7.4 using 1 M NaOH and the solution was then hydrated overnight at 4°C. 
Following hydration, the solution was centrifuged at 500 g for 5 min at room 
temperature and the supernatant was filter-sterilised using a 0.45 µm sterile filter 
(Sarstedt, Ireland). The stock solution was diluited in KREBS buffer (Sigma Aldrich, 
Ireland) containing 1% bovine serum albumin (BSA) (Sigma Aldrich, Ireland) to a 10 
mg/mL working solution for cellular bioassays. All test samples were tested at 10 
mg/mL, unless otherwise stated. 
 
6.2.12 Cell culture 
The STC-1 cell line (ATCC code: SD5482) was purchased from the American Tissue 
Culture Collection (LGC Standards, Teddington, UK). Cells were cultured in 
Dulbecco’s modified eagle medium (DMEM) containing 4.5 g/L glucose and L-
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glutamine (Sigma Aldrich, Dublin, Ireland). The medium was supplemented with 
10% foetal bovine serum, 100 U/mL penicillin and 100 mg/mL streptomycin. Cells 
were passaged upon reaching confluency, and all cells used in these studies were 
between passages 15-25. 
 
6.2.13 Measurement of cellular viability 
STC-1 cells were seeded into 96-well plates at a density of 2x104 cells/mL and 
incubated overnight at 37°C in the presence of 5% CO2. The medium was aspirated 
off and cells were washed with 50 µL KREBS/1% BSA per well. Cells were pre-
incubated for 1 h in 100 µL of Krebs-Hanseleit buffer (KREBS)/1% bovine serum 
albumin (BSA). Following the pre-incubation step, 100 µL KREBS/1% BSA (as a 
control) or 100 µL test sample (10 mg/mL) was added to the appropriate wells. 
Then, 20 µL of  [3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-
sulfophenyl)-2H-tetrazolium (MTS) (Medical Supply Company Ltd,  Fingal, Dublin, 
Ireland) was added to each well and the plate was incubated for 4 h at 37°C in the 
presence of 5% CO2. Absorbance was then measured at 490 nm using a Biotek 
Synergy HT microtitre plate-reader (Mason Technology, Dublin, Ireland). MTS is 
converted to formazon by dehydrogenase enzymes in metabolically active cells; 
therefore, the number of living cells in culture is directly proportional to the 
quantity of formazon product, as measured by absorbance at 490 nm. 
 
6.2.14 Cell exposures to measure GLP-1 peptide and harvest total RNA 
STC-1 cells were seeded into 6-well plates at a density of 1.5 x 106 cells/well and 
incubated at 37°C in the presence of 5% CO2 for 18 h prior to test sample addition. 
The medium was aspirated off and the cell monolayers in each well were washed 
with 1 mL of KREBS/1% BSA. Cells were pre-incubated for 1 h in 500 µL of KREBS/1% 
BSA, which was then aspirated off and replaced with 1 mL of test sample at the 
concentration specified, and plates were incubated for 4 h at 37°C, in the presence 
of 5% CO2. Test samples were analysed in duplicate on separate days. KREBS/1% 
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BSA added to cells alone acted as the basal control. Following the 4 h incubation 
period, 10 µL of 10 X Halt Protease and Phosphatase Inhibitor (Thermo Fisher 
scientific, Waltham, MA, USA) was added to each well to inactivate endogenous 
DPPIV activity. Cellular supernatants were collected by aspiration and stored at        
-80°C prior to GLP-1 analysis. Cell monolayers were washed with 1 mL per well of 
Hanks Balanced Salt Solution (HBSS) (Sigma Aldrich, Dublin, Ireland) and then lysed 
using Bioline Lysis Buffer (MyBio, Kilkenny, Ireland). Total RNA was extracted using 
the Bioline ISOLATE RNA Mini Kit (MyBio, Kilkenny, Ireland), according to the 
manufacturer’s instructions. 
Cellular supernatant levels of total GLP-1 were assayed using MSD® GLP-1 metabolic 
assay (Cat No: K150JVC-2, Meso Scale Discovery, Gaithersburg, MD, USA), according 
to the manufacturer’s instructions. GLP-1 concentrations (pM) in the samples were 
quantified by interpolating the intensity of emitted light from standard curves 
generated in the same assays. Each sample well was assayed in duplicate and plates 
were read using a Sector Imager 2400 (Meso Scale Discovery, Gaithersburg, MD, 
USA). 
 
6.2.15 Data analysis 
Analysis of variance (one-way ANOVA) was conducted using Minitab version 16 
(Minitab Inc., State College, PA, USA). When differences were significant (P ≤ 0.05), 









6.3 Results and Discussion 
 
6.3.1 Hydrolysis of individual caseins 
The current study focussed on the generation and proteomic characterisation of a 
hydrolysate of sodium caseinate produced by chymosin and its potential effect on 
satiety. Sodium caseinate was selected in order to avoid changes which occur when 
chymosin is added to milk, i.e., clotting. However, before hydrolysis of sodium 
caseinate was investigated, it was decided to examine hydrolysis of individual 
caseins by chymosin. The urea-PAGE electrophoretograms in Figure 6.1 shows αS1-
casein, adjusted to pH 5.6, hydrolysed by chymosin (180 IMCU per gram of αS1-
casein) at 37°C over a period of 60 min. In 0.1 M phosphate buffer, at pH 6.5, 
chymosin cleaves αS1-casein at Phe(23)-Phe(24), Phe(28)-Pro(29), Leu(40)-Ser(41), 
Leu(149)-Phe(150), Phe(153)-Tyr(154), Leu(156)-Asp(157), Tyr(159)-Pro(160), 
Trp(164)-Tyr(165) (McSweeney et al., 1993). Additionally, in 5% NaCl, at pH 5.2, 
chymosin also cleaves αS1-casein at Leu(11)-Pro(12), Phe(32)-Gly(33), Leu(101)-
Lys(102), Leu(142)-Ala(143) and Phe(179)-Ser(180). Figure 6.1 shows extensive 
hydrolysis of αS1-casein, as indicated by the decreased intensity of the αS1-casein 
band, which was virtually absent on the urea-PAGE electrophoretogram after a 
period of 60 min. The primary site of chymosin action on αS1-casein is Phe(23)-
Phe(24) (Carlos and Ribadeau-Dumas, 1985). Initially, αS1-casein (f24-199) was the 
predominant peptide produced; however, this peptide was further hydrolysed and 
became less abundant with time. αS1-Casein (f102-199) was also identified by urea-





Figure 6.1 Urea-polyacrylamide gel electrophoretograms of sodium caseinate (lane 
1) and bovine αS1-CN (10 mg/mL), adjusted to pH 5.6 and hydrolysed by chymosin 
(180 IMCU per gram of αS1-CN) at 37°C for 0, 10, 20, 30, 40, 50 and 60 min (lanes 2-
8). 
 
The urea-PAGE electrophoretograms in Figure 6.2 shows β-casein, adjusted to pH 
5.6 and hydrolysed by chymosin (180 IMCU per gram of β-casein) at 37°C over a 
period of 60 min. A similar trend was seen when compared with the hydrolysis of 
αS1-casein by chymosin (Figure 6.1), i.e., β-casein was extensively hydrolysed and 
virtually absent from the urea-PAGE electrophoretograms after a period of 60 min. 
In 0.05 M Na acetate buffer, pH 5.4, chymosin cleaves β-casein at Leu(192)-
Tyr(193), Ala(189)-Phe(190), Leu(165)-Ser(166), Gln(167)-Ser(168), Leu(163)-
Ser(164), Leu(139)-Leu(140) and Leu(127)-Thr(128) (Visser and Slangen, 1977). The 
predominant peptides produced in Figure 6.2 were β-casein (f1-189/192) and β-
casein (f1-163/165), both of which increased in concentration as a function of time, 
as shown by an increase in band intensity.  
 







Figure 6.2 Urea-polyacrylamide gel electrophoretograms of sodium caseinate (lane 
1) and bovine β-CN (10 mg/mL), adjusted to pH 5.6 and hydrolysed by chymosin 
(180 IMCU per gram of β-CN) at 37°C for 0, 10, 20, 30, 40, 50 and 60 min (lanes 2-
8). 
 
6.3.2 Hydrolysis of sodium caseinate 
The urea-PAGE electrophoretograms in Figure 6.3 shows sodium caseinate (30 
mg/mL), adjusted to pH 5.6 and hydrolysed by chymosin (180 IMCU per gram of 
sodium caseinate) at 37°C over a period of 120 min. The pattern of hydrolysis is 
comparable with that shown in Figures 6.1 and 6.2, i.e., both αS1- and β-casein were 
extensively hydrolysed; however, this was to a lesser extent than previously seen, 
as slightly more intact protein remained at the 60 min point in Figure 6.3. This was 
most likely due to a dilution in the ratio of chymosin:αS1/β-casein within sodium 
caseinate compared to the individual caseins. For this reason, the hydrolysis time 
was increased from 60 to 120 min in an attempt to ensure that the hydrolysis 
reaction reached a terminal point. As before, β-casein (f1-189/192) and αS1-casein 
(f24-199) were identified in the urea-PAGE electrophoretogram (Figure 6.3); 
however, the rate of production and degradation of αS1-casein (f24-199) does not 






match that shown in Figure 6.1, i.e., in Figure 6.1, αS1-casein (f24-199) was the 
predominant peptide at the 10 min point and subsequently degraded until 60 min, 
at which point it was virtually absent whereas, in Figure 6.3, the intensity of αS1-
casein (f24-199) increased with time, showing no signs of subsequent breakdown. 
This may have been due to differences in the ionic strength of the sodium caseinate 
and αS1-casein solutions, which has been shown to influence the hydrolysis of αS1-
casein by chymosin (Mulvhill and Fox, 1979). A negative control was prepared 
under the same conditions used to generate the hydrolysates with the exception 
that chymosin was heat-inactivated before use (80°C for 10 min); no hydrolysis was 
seen in the negative control sample, indicating that the enzyme was sufficiently 
denatured (results not shown). 
 
 
Figure 6.3 Urea-polyacrylamide gel electrophoretograms of sodium caseinate (30 
mg/mL), adjusted to pH 5.6 and hydrolysed by chymosin (180 IMCU per gram of 
sodium caseinate) at 37°C for 0, 10, 20, 40, 60 and 120 min (lanes 1-6). 
 
 







The two-dimensional gel electrophoretograms in Figure 6.4 show sodium caseinate 
(30 mg/mL), adjusted to pH 5.6 and hydrolysed by chymosin (180 IMCU per gram of 
sodium caseinate) at 37°C for (a) 0, (b) 10, (c) 40 and (d) 120 min. Varying degrees 
of hydrolysis were clearly evident, as shown by changes in the proportion of intact 
protein and peptide material across the 2D gels. Unhydrolysed sodium caseinate 
contained mostly intact protein, with small amounts of peptide material, which may 
have been produced during manufacture. Subsequent 2D gels clearly indicate 
extensive hydrolysis of αS1 and β-casein, and to a lesser extent к-casein, as shown 
by decreased band intensity and increased abundance of low molecular weight 
peptide material in the range 10-20 kDa.  
 
Figure 6.4 Two-dimensional gel electrophoretograms of sodium caseinate (30 
mg/mL), adjusted to pH 5.6, hydrolysed by chymosin (180 IMCU per gram of sodium 
caseinate) at 37°C for (a) 0, (b) 10, (c) 40 and (d) 120 min, separated under reducing 
conditions using a 7 cm pH 4-7 pI range for the first dimension and a 12% gradient 












The RP-UPLC chromatograms in Figure 6.5 show sodium caseinate (30 mg/mL), 
adjusted to pH 5.6, hydrolysed by chymosin (180 IMCU per gram of sodium 
caseinate) for (a) 0, (b) 10, (c) 40 and (d) 120 min. The RP-UPLC chromatogram of 
unhydrolysed sodium caseinate was dominated by two large co-eluting peaks, 
probably representing intact casein, while very little peptide material was found. 
Subsequent RP-UPLC chromatograms clearly indicated extensive hydrolysis, as 
shown by a decrease in peak area of intact casein (6.5 to 7.5 min) and increase in 
the abundance of peptides (4 to 6.5 min). As expected, sodium caseinate 
hydrolysed by chymosin for 120 min was the most extensively hydrolysed sample, 
as shown by the greatest abundance of peptide peaks, followed by the 40 min and 
10 min samples.  
6.3.2.1 Effect of sodium caseinate hydrolysates on GLP-1 secretion 
Glucagon-like peptide (GLP-1) is a gut-derived incretin hormone and has multiple 
physiological effects (Aaboe et al., 2008). In animal studies, GLP-1 stimulates β-cell 
proliferation and neogenesis (Zhou et al., 1999) and inhibits β-cell apoptosis (Farilla 
et al., 2003). In humans, GLP-1 enhances satiety and reduces food intake (Turton et 
al., 1996), stimulates insulin secretion and inhibits glucagon (Orskov et al., 1988) 
and gastrointestinal secretions and motility (Wettergren et al., 1993; Nauck et al., 
1997). Therefore, identification of a sodium caseinate hydrolysate which increases 
the secretion of GLP-1 would have great potential as a functional food ingredient 
for weight management. In the current study, the effect of exposure of STC-1 cells 
to sodium caseinate (30 mg/mL), adjusted to pH 5.6, hydrolysed by chymosin (180 
IMCU per gram sodium caseinate) at 37°C for 0, 10, 40 and 120 min, on GLP-1 
peptide levels was investigated (Figure 6.6). Samples were tested at 1, 5 and 10 
mg/mL. Sodium caseinate hydrolysates had no effect on STC-1 cell viability over 4 
hours compared to cells exposed to KREBS buffer only (results not shown). Levels of 
GLP-1 secreted from STC-1 cells following a 4 hour exposure to hydrolysed sodium 
caseinate samples were higher compared to levels in response to the unhydrolysed 
sodium caseinate control. With the exception of the 40 min time point, GLP-1 was 
not secreted in a dose-dependent manner. At concentrations of 5 and 10 mg/mL, 




Figure 6.5 Reversed-phase UPLC profiles of (a) unhydrolysed sodium caseinate and sodium caseinate (30 mg/mL), adjusted to pH 5.6 and 









































































Figure 6.6 The effect of exposure of STC-1 cells to sodium caseinate (30 mg/mL), 
adjusted to pH 5.6, hydrolysed by chymosin (180 IMCU per gram of sodium 
caseinate) at 37°C for 0, 10, 40 and 120 min, on GLP-1 peptide levels at 1, 5 and 10 
mg/mL (lyophilised powder), as measured by meso scale discovery (MSD). Values 
with different superscript letters were significantly different (p < 0.05). 
 
6.3.3 Optimisation of hydrolysis conditions 
The hydrolysis protocol described thus far was then modified to make it more 
suitable for large-scale commercial production. The total solids level of dissolved 
sodium caseinate was increased from 3 to 10%. While the enzyme:substrate ratio 
remained the same, the amount of enzyme added was increased accordingly. Also, 
in an attempt to minimise the ash content of the hydrolysate, in particular the low 
molecular weight fractions produced by ultrafiltration, the chemical used for pH 
adjustment was changed from hydrochloric acid to glucono-delta lactone (GDL). In 
solution, GDL is progressively hydrolysed to gluconic acid, which causes a reduction 
in pH. The amount of GDL required to decrease the pH of a 10% sodium caseinate 
solution to pH 5.6 was shown experimentally to be 0.7%.  
The urea-PAGE electrophoretograms in Figure 6.7 show sodium caseinate (100 
mg/mL), adjusted to pH 5.6 (0.7% GDL), hydrolysed by chymosin (180 IMCU per 
gram of sodium caseinate) over a period of 120 min. The aim here was to optimise 
hydrolysis conditions while maintaining the same degree of protein breakdown and 









































Figures 6.1, 6.2 and 6.3, i.e., αS1- and β-casein were progressively hydrolysed over 
120 min, at which point virtually no intact αS1- or β-casein remained. The 
predominant peptides produced were β-casein (f1-189/192 and 1-163/165) and 
αS1-casein (f102-199 and 24-199). Increased sample loading in the urea-PAGE 
electrophoretograms in Figure 6.7 compared with Figure 6.3 led to better 
resolution of electrophoretic bands in the lower half the electrophoretogram. 
Approximately 8 additional bands were observed; however, these bands were not 
identified. As before, a negative control was prepared under the same conditions 
used to generate the hydrolysates, with the exception that chymosin was heat-
inactivated before use; no hydrolysis was seen in the negative control sample, 
indicating again that the enzyme was sufficiently denatured (results not shown). 
 
 
Figure 6.7 Urea-polyacrylamide gel electrophoretograms of sodium caseinate (100 
mg/mL), adjusted to pH 5.6 (0.7% GDL) and hydrolysed by chymosin (180 IMCU per 
gram of sodium caseinate) at 37°C for 0, 10, 40 and 120 min (lanes 1-4). 
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6.3.3.1 Effect of optimised sodium caseinate hydrolysates on GLP-1 secretion 
Sodium caseinate hydrolysates produced under thus optimised conditions, i.e., 
sodium caseinate (100 mg/mL), adjusted to pH 5.6 (0.7% GDL) and hydrolysed by 
chymosin (180 IMCU per gram of sodium caseinate) at 37°C for 0, 10, 40 and 120 
min, were added to STC-1 cells at 1, 5 and 10 mg/mL to measure their effect on 
GLP-1 secretion (Figure 6.8). In addition to maintaining the same degree of protein 
breakdown and peptide formation during optimisation of hydrolysis conditions, it 
was vital to ensure the effect of these hydrolysates on GLP-1 secretion was 
reproducible. In general, results were similar to those shown in Figure 6.6, i.e., 
levels of GLP-1 secreted from STC-1 cells following a four-hour exposure to 
hydrolysed sodium caseinate samples were higher compared to levels in response 
to the unhydrolysed sodium caseinate sample, except at a concentration of 1 
mg/mL. The effect of the 10, 40 and 120 min time points on GLP-1 levels were dose-
dependent. As with the original hydrolysis conditions, the 40 min time point caused 
the greatest secretion of GLP-1.  
 
Figure 6.8 The effect of exposure of STC-1 cells to sodium caseinate (100 mg/mL), 
adjusted to pH 5.6 (0.7% GDL) and hydrolysed by chymosin (180 IMCU per gram of 
sodium caseinate) at 37°C for 0, 10, 40 and 120 min, on GLP-1 peptide levels at 1, 5 
and 10 mg/mL (lyophilised powder), as measured by MSD. Values with different 





































Based on GLP-1 secretion data, as shown in Figures 6.6 and 6.8, it was concluded 
that the hydrolysate produced in 40 min was the most potent activator of GLP-1 
secretion from STC-1 cells. Therefore, it was decided to proceed with this sample 
with the aim of identifying the bioactive component. The effect of the 40 min time 
point on GLP-1 secretion was shown to be dose-dependent, i.e., incubation of STC-1 
cells with increasing concentrations (0.1 to 20 mg/mL) of the sample correlated 
with an increase in GLP-1 secretion (Figure 6.9). The 40 min time point produced 
under both the original and optimised hydrolysis conditions were tested in parallel 
to compare the GLP-1 response of each sample. No differences in GLP-1 secretion 
were observed between samples, and so, the optimised hydrolysis conditions were 




Figure 6.9 Dose-response effect of sodium caseinate (100 mg/mL), adjusted to pH 
5.6 and hydrolysed by chymosin (180 IMCU per gram of sodium caseinate) at 37°C 
for 40 min at concentrations of  0.1, 0.5, 1, 2.5, 5, 7.5, 10 and 20 mg/mL on GLP-1 
peptide levels as measured by MSD. Values with different superscript letters were 




























6.3.4 Fractionation of crude hydrolysate 
In an attempt to isolate/enrich the bioactive component, the hydrolysate produced 
in 40 min was adjusted to pH 4.6 (pI of the caseins) to remove any intact casein and 
large polypeptides. The soluble fraction was further fractionated by ultrafiltration, 
as described in Section 6.2.3, to produce a 3 kDa retentate and permeate. These 
fractions are shown in the urea-PAGE electrophoretograms in Figure 6.10. The 
protein profile of the negative control was identical to that of the sodium caseinate 
standard, confirming that no hydrolysis had taken place. The unfractionated 40 min 
time point has already been discussed in detail. It was clear from Figure 6.10 that 
the predominant peptides in the hydrolysed sodium caseinate were insoluble at pH 
4.6. The pH 4.6-soluble fraction and subsequent 3 kDa retentate and permeate 
contained trace levels of β-casein (f1-189/192 and 1-163/165) and αS1-casein (f102-
199 and 24-199), in addition to some peptide material in the lower half of the 
electrophoretogram. 
 
The RP-UPLC chromatograms in Figure 6.11 show sodium caseinate (100 mg/mL), 
adjusted to pH 5.6 (0.7% GDL), hydrolysed by chymosin (180 IMCU per gram of 
sodium caseinate), at 37°C for 40 min, and fractions thereof. The RP-UPLC profile of 
the unfractionated 40 min time point produced under optimised conditions (Figure 
6.11a) differed slightly to that produced under the original hydrolysis conditions 
(Figure 6.5b), i.e., the optimised hydrolysate contained a greater proportion of 
intact casein relative to peptide material than the original sample; however, the 
peptide profile was similar. The pH 4.6-insoluble fraction contained a large amount 
of intact casein; however, quite a lot of peptide material also remained (Figure 
6.11b). This is in agreement with urea-PAGE analysis (Figure 6.10) where the 
majority of peptide material was present in the pH 4.6-insoluble fraction. The RP-
UPLC profile of the pH 4.6-soluble fraction showed depletion of intact casein and 
enrichment in peptide material. The RP-UPLC profile of the pH 4.6-soluble 3 kDa 
retentate (Figure 6.11d) was virtually identical to that of the pH 4.6-soluble fraction 
373 
 





Figure 6.10 Urea-polyacrylamide gel electrophoretograms of sodium caseinate (100 
mg/mL) (lane 1), adjusted to pH 5.6 (0.7% GDL), hydrolysed by chymosin (180 IMCU 
per gram of sodium caseinate) at 37°C for 0 and 40 min (lanes 2 and 3) and 
fractions thereof; pH 4.6-soluble fraction (lane 4), pH 4.6-insoluble fraction (lane 5), 
pH 4.6-soluble 3 kDa retentate (lane 6) and pH 4.6-soluble 3 kDa permeate (lane 7).  









Figure 6.11 Reversed-phase UPLC profile of sodium caseinate (100 mg/ml), adjusted to pH 5.6 (0.7% GDL) and hydrolysed by chymosin (180 
IMCU per gram of sodium caseinate) at 37°C for 40 min (a), and fractions thereof; (b) pH 4.6-insoluble, (c) pH 4.6-soluble, (d) pH 4.6-soluble 3   






































































































 6.3.4.1 Effect of a sodium caseinate hydrolysate, and fractions thereof, on GLP-1 
secretion 
Sodium caseinate (100 mg/mL), adjusted to pH 5.6 (0.7% GDL), hydrolysed by 
chymosin (180 IMCU per gram of sodium caseinate) for 40 min, and fractions 
thereof, were added to STC-1 cells to measure their effect on GLP-1 secretion 
(Figure 6.12). As previously shown (Figures 6.6 and 6.8), levels of GLP-1 secreted 
from STC-1 cells following a 4 hour exposure to hydrolysed sodium caseinate were 
higher compared to levels in response to the unhydrolysed sodium caseinate 
sample. After fractionation of the hydrolysate at pH 4.6, there was decreased 
secretion of GLP-1 in the response to the insoluble fraction and increased secretion 
of GLP-1 in response to the soluble fraction. This suggests that the bioactivity lies 
within the pH 4.6-soluble fraction and is not due to the abundant peptides 
identified in the pH 4.6-insoluble fraction by urea-PAGE (Figure 6.10), e.g., β-casein 
(f1-189/192 and 1-163/165) and αS1-casein (f102-199 and 24-199). Subsequent 
ultrafiltration of the pH 4.6-soluble fraction through a 3 kDa membrane resulted in 
decreased secretion of GLP-1 in response to the retentate and increased secretion 
of GLP-1 in response to the permeate. Based on these findings, it was proposed 





Figure 6.12 The effect of exposure of STC-1 cells to sodium caseinate (100 mg/mL) 
adjusted to pH 5.6 (0.7% GDL) and hydrolysed by chymosin (180 IMCU per gram of 
sodium caseinate) at 37°C for 40 min, and fractions thereof, on GLP-1 peptide levels 
as measured by MSD. Values with different superscript letters were significantly 
different (p < 0.05). 
 
6.3.5 Further optimisation of hydrolysis conditions 
6.3.5.1 pH adjustment 
The optimised hydrolysis protocol described earlier was further modified in an 
attempt to reduce/eliminate the need for pH adjustment. Sodium caseinate (100 
mg/mL) was adjusted to pH 5.6, 6 or 7, and hydrolysed by chymosin (180 IMCU per 
gram of sodium caseinate) for 40 min. Adjustment of pH was carried out using 
HCl/NaOH instead of GDL, as substantially less HCl was required to adjust the 
sodium caseinate solution to pH 6 and a very small quantity of NaOH was required 
to adjust the solution to pH 7 (sodium caseinate naturally has a pH of 
approximately 6.7). These hydrolysates are shown in the urea-PAGE 
electrophoretograms in Figure 6.13. It should be noted that hydrolysis was not 
maintained at the adjusted pH values, i.e., pH 5.6, 6 and 7. This was because of the 
relatively large quantity of enzyme preparation used, which was acidic, and so, on 
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kDa ret













sodium caseinate solutions adjusted to pH 5.6, 6 and 7, prior to hydrolysis, dropped 
to pH 5.3, 5.6 and 6.2, respectively, after addition of the enzyme. When sodium 
caseinate was adjusted to pH 5.6 before hydrolysis, the hydrolysis profile was 
similar to that shown in Figures 6.7 and 6.10. When adjusted to pH 6, the hydrolysis 
reaction was less extensive, as evident by more residual intact β-casein, decreased 
production of β-casein (f1-189/192 and 1-163/165) and decreased hydrolysis of αS1-
casein (f24-199), which subsequently led to decreased production of αS1-casein 
(f102-199). Reduced levels of hydrolysis were even more pronounced when sodium 
caseinate was adjusted to pH 7 before addition of the enzyme. Chymosin has an 
acidic pH optimum; Fox (1969) reported pH 5.8 as the optimum for proteolysis of 
whole casein by chymosin. Adjustment of the sodium caseinate solution to pH 6 
and pH 7, thus decreased the level of hydrolysis, as the pH was being moved away 
from its optimum. 
 
Figure 6.13 Urea-polyacrylamide gel electrophoretograms of unhydrolysed sodium 
caseinate (lane 1) and sodium caseinate (100 mg/mL), adjusted to pH 5.6 (lane 2), 
pH 6 (lane 3) or pH 7 (lane 4) and hydrolysed by chymosin (180 IMCU per gram of 











The RP-UPLC chromatograms in Figure 6.14 show sodium caseinate (100 mg/mL) 
adjusted to (a) pH 5.6, (b) 6 or (c) 7, hydrolysed by chymosin (180 IMCU per gram of 
sodium caseinate) at 37°C for 40 min. The results shown here are in agreement 
with those of Figure 6.13, i.e., moving away from the pH optimum of chymosin 
resulted in reduced hydrolysis of the caseins. As the pH was increased, more 
residual intact casein and less peptide material were observed. 
Figure 6.14 Reversed-phase UPLC profiles of sodium caseinate (100 mg/mL), 
adjusted to (a) pH 5.6, (b) pH 6 and (c) pH 7, hydrolysed by chymosin (180 IMCU per 


































































Sodium caseinate (100 mg/mL) adjusted to pH 5.6, 6 or 7, hydrolysed by chymosin 
(180 IMCU per gram of sodium caseinate) for 40 min, were added to STC-1 cells to 
measure their effect on GLP-1 secretion (Figure 6.15). There were no significant 
differences in GLP-1 secretion in response to varying the pH of the sodium 
caseinate solution before hydrolysis. Based on these results, it was decided to 
proceed with the hydrolysis conditions which required the least amount of pH 
adjustment before hydrolysis, i.e., pH 7. 
 
 
Figure 6.15 The effect of exposure of STC-1 cells to sodium caseinate (100 mg/mL) 
hydrolysed at 37°C by chymosin (180 IMCU per gram of sodium caseinate) at pH 
5.6, 6 and 7, as described in the text, for 40 min, on GLP-1 peptide levels as 
measured by MSD. Values with different superscript letters were significantly 
different (p < 0.05). 
 
The urea-PAGE electrophoretograms in Figure 6.16 show sodium caseinate (100 
mg/mL), adjusted to pH 7 and hydrolysed by chymosin (180 IMCU per gram of 
sodium caseinate) at 37°C over a period of 120 min. This experiment was carried 
out in order to investigate the breakdown of the caseins under the new hydrolysis 
conditions. Both αS1- and β-casein were progressively hydrolysed, but to varying 
degrees. Even after 120 min, a substantial amount of β-casein was still present, 
























163/165) and αS1-casein (f24-199 and 102-199) all increased with time. Hydrolysis 
of αS1- and β-casein was comparable to that shown in Figures 6.1, 6.2 and 6.3, but 
to a lesser extent, because, as already mentioned, at pH 7, chymosin was moving 
away from its pH optimum. The purity of the enzyme preparation was also 
investigated, as shown in Figure 6.16 (lane 14), i.e., the protein profile of Maxiren 
180 was dominated by the presence of a single electrophoretic band. 
 
 
Figure 6.16 Urea-polyacrylamide gel electrophoretograms of sodium caeseinate 
(100 mg/mL), adjusted to pH 7, hydrolysed by chymosin (180 IMCU per gram of 
sodium caseinate) at 37°C for 0, 10, 20, 30, 40, 50, 60, 70, 80, 90, 100, 110 and 120 
min (lanes 1-13 respectively) and the enzyme preparation (lane 14). 
 
6.3.5.2 In vivo mice study 
Based on the in vitro effects of the sodium caseinate hydrolysates described thus 
far, it was decided to proceed with an in vivo study measuring cumulative feed 
intake with 20 male mice of the common inbred strain, C57BL/6 (Figure 6.17). 
Sodium caseinate (100 mg/mL), adjusted to pH 7, and hydrolysed by chymosin (180 
IMCU per gram of sodium caseinate) at 37°C for 40 min, was injected 
intraperitoneally into ten mice at a dosage of 750 mg/kg. In parallel, 10 mice were 
injected intraperitoneally with Hank’s Balanced Salt Solution (HBSS) which acted as 
a vehicle control. The mice which were given the hydrolysed sodium caseinate 









demonstrated significantly lower feed intake when compared with control mice at 
all time points from 1 to 8 hours post-injection. No significant differences in 
cumulative feed intake (30 min post-injection) were observed between mice which 
were given the hydrolysed sodium caseinate and control. 
 
 
Figure 6.17 Effects of intra peritoneal (i.p.) administration of sodium caseinate (100 
mg/mL), adjusted to pH 7, hydrolysed by chymosin (180 IMCU per gram of sodium 
caseinate) at 37°C for 40 min, on cumulative feed intake in male C57/BL6 mice over 
8 hours. Each value represents mean ± SEM (n=20). Values with a superscript 
symbol (*) were significantly different (p < 0.05) from corresponding control 
groups. 
 
6.3.5.3 Enzyme:substrate ratio 
In an effort to optimise the hydrolysis conditions further, the significance of 
enzyme:substrate ratio was investigated. To this point, 180 IMCU per gram of 
sodium caseinate had been used. This ratio was by far in excess of that traditionally 
used in cheese making (approximately 180 IMCU per 100 g casein); however, very 
little hydrolysis, other than cleavage of the Phe(105)-Met(106) bond of к-casein, 










































20-fold so that 9 IMCU enzyme was now added per gram of sodium caseinate.  As 
previously discussed, the enzyme used was an acidic preparation which caused a 
drop in pH when added to the sodium caseinate solution. Reducing the quantity of 
enzyme used greatly reduced its effect on the pH of the sodium caseinate solution. 
It was found that chymosin had no effect on the hydrolysis of αS1- or β-casein at pH 
7 under these conditions, i.e., 20-fold enzyme reduction (results not shown), and 
so, hydrolysis was carried out at pH 6 and 6.5 with the 20-fold enzyme reduction, 
with the aim of maintaining the same degree of hydrolysis achieved with the 
original enzyme:substrate ratio. It was found that, at pH 6, when using 9 IMCU per 
gram of sodium caseinate, a reaction time of 100 min was required to achieve to 
same degree of hydrolysis as with the original conditions. Similarly, at pH 6.5, when 
using 9 IMCU per gram of sodium caseinate, a reaction time of 220 min was 
required to achieve the same degree of hydrolysis as with the original conditions. 
The RP-UPLC chromatograms in Figure 6.18 show the hydrolysis of sodium 
caseinate (100 mg/mL) hydrolysed at 37°C by chymosin (a) at pH 7 for 40 min (180 
IMCU per gram of sodium caseinate), (b) at pH 6 for 100 min (9 IMCU per gram of 












Figure 6.18 Reversed-phase UPLC profile of sodium caseinate (100 mg/mL), 
adjusted to (a) pH 7, (b) pH 6 and (c) pH 6.5, hydrolysed by chymosin (180 IMCU per 
gram of sodium caseinate at pH 7; 9 IMCU per gram of sodium caseinate at pH 6 






















































6.3.5.4 Effect of sodium caseinate hydrolysates, produced at different pH values, on 
GLP-1 secretion 
Sodium caseinate (100 mg/mL), adjusted to pH 6, pH 6.5 and pH 7, hydrolysed by 
chymosin (180 IMCU per gram of sodium caseinate at pH 7; 9 IMCU per gram of 
sodium caseinate at pH 6 and pH 6.5) at 37°C for 100, 220 and 40 min, respectively, 
were added to STC-1 cells to measure their effect on GLP-1 secretion (Figure 6.19). 
There were no significant differences in GLP-1 secretion in response to varying the 
enzyme:substrate ratio and pH. Based on these results, it was decided to proceed 
with the hydrolysis conditions whereby sodium caseinate was adjusted to pH 6.5 
before hydrolysis and hydrolysed using 9 IMCU per gram of sodium caseinate, as 
this was the most effective approach. 
 
 
Figure 6.19 The effect of exposure of STC-1 cells to sodium caseinate (100 mg/mL), 
adjusted to pH 7, pH 6 and pH 6.5, hydrolysed by chymosin (180 IMCU per gram of 
sodium caseinate at pH 7; 9 IMCU per gram of sodium caseinate at pH 6 and pH 6.5) 
at 37°C for 40, 100 and 220 min, respectively, on GLP-1 peptide levels as measured 























6.3.5.5 Fractionation of a sodium caseinate hydrolysate, produced under optimised 
conditions 
The RP-UPLC chromatograms of Figure 6.20 show the hydrolysis of sodium 
caseinate (100 mg/mL), adjusted to pH 6.5, hydrolysed by chymosin (9 IMCU per 
gram of sodium caseinate) at 37°C for 220 min, and fractions thereof. The profile of 
the unfractionated hydrolysate was similar to that shown in Figure 6.18c. The pH 
4.6-insoluble fraction was virtually identical to the unfractionated hydrolysate. The 
pH 4.6-soluble 1 kDa retentate is enriched in peptide material (3.6 to 6 min) and 
depleted with respect to intact casein, while the pH 4.6-soluble 1 kDa permeate is a 
very simple hydrolysate, containing only 3 major peaks. This suggests that the 
majority of peptide material in the pH 4.6-soluble fraction is greater than 1 kDa in 
size. 
 
6.3.5.6 Effect of a sodium caseinate hydrolysate, produced under optimised 
conditions, and fractions thereof, on GLP-1 secretion 
Sodium caseinate (100 mg/mL), adjusted to pH 6.5, hydrolysed by chymosin (9 
IMCU per gram of sodium caseinate) at 37°C for 220 min and fractions thereof; pH 
4.6-soluble, pH 4.6-insoluble, pH 4.6-soluble 1 kDa retentate and pH 4.6-soluble 1 
kDa permeate were exposed to STC-1 cells to measure their effect on GLP-1 
secretion (Figure 6.21). Adjustment of the hydrolysate to pH 4.6 resulted in 
increased secretion of GLP-1 in response to the soluble fraction, this was also seen 
in Figure 6.12. No difference in GLP-1 secretion was observed with the pH 4.6-
insoluble fraction compared to the unfractionated hydrolysate. The 1 kDa retentate 
and permeate had higher levels of GLP-1 secretion compared with the 
unfractionated hydrolysate, but lower levels than the pH 4.6-soluble fraction. When 
the protein concentration of each sample was taken into account, bioactivity was in 
the order: pH 4.6-soluble 1 kDa permeate > pH 4.6-soluble > pH 4.6-soluble 1 kDa 
retentate > unfractionated hydrolysate > pH 4.6-insoluble fraction. This order of 





Figure 6.20 Reversed-phase UPLC profile of sodium caseinate (100 mg/ml), adjusted to pH 6.5, hydrolysed by chymosin (9 IMCU per gram of 
sodium caseinate) at 37°C for 220 min (a) and fractions thereof; (b) pH 4.6-insoluble, (c) pH 4.6-soluble 1 kDa retentate and (d) pH 4.6-soluble 





















































































Figure 6.21 The effect of exposure of STC-1 cells to sodium caseinate (100 mg/mL), 
adjusted to pH 6.5, hydrolysed by chymosin (9 IMCU per gram of sodium caseinate) 
at 37°C for 220 min, and fractions thereof, on GLP-1 peptide levels as measured by 
MSD. Also shown is the protein content of each lyophilised sample, as determined 
by the Kjeldahl method. Values with different superscript letters were significantly 
different (p < 0.05). 
 
6.3.6 Free amino acid analysis of sodium caseinate hydrolysate 
GLP-1 is released from intestinal cells in response to several components of the 
diet, including carbohydrates, fats and proteins (Tolhurst et al., 2009). The effect of 
protein on GLP-1 secretion has been investigated by several authors (Elliot et al., 
1993; Herrmann et al., 1995); however, the underlying mechanism has yet to be 
elucidated. Amino acids are thought to play a role in GLP-1 secretion; Reimer (2006) 
reported a dose-dependant increase in GLP-1 secretion in response to a mixture of 
essential amino acids (EAA), while Reimann et al. (2004) observed that glutamine is 
a more potent GLP-1 secretagogue than glucose or other amino acids. To 
investigate the possibility of free amino acids causing a GLP-1 response in the 
current study, sodium caseinate (100 mg/mL), adjusted to pH 7, was hydrolysed by 
chymosin (180 IMCU per gram of sodium caseinate) at 37°C for 40 min. Aliquots 
were taken at 5 min intervals, the hydrolysis reaction stopped by heat inactivation 






































content (Table 6.1). Histidine and lysine were the only free amino acids present in 
the unhydrolysed sodium caseinate (T0).  
Aspartic acid and phenylalanine were present after 5 min at concentrations of 8.5 
and 35.7 µg/g, respectively, but were not present in any subsequent samples. The 
concentrations of glutamic acid, alanine and methionine after 5 min were 38.5, 29.4 
and 585.2 µg/g, respectively, and did not increase by more than 4% over 40 min. 
The concentrations of histidine and lysine increased from 10.5 and 31.0 µg/g to 
103.8 and 45.3 µg/g, respectively, over 40 min. As no free amino acids, with the 
exception of histidine and lysine, were present in the unhydrolysed sodium 
caseinate, it is likely that any free amino acids present in hydrolysed samples were 
introduced by the enzyme preparation, either naturally present or produced by the 
yeast strain used to produce chymosin recombinantly, i.e., Kluyveromyces lactis. 
This is a fair assumption as chymosin itself does not produce any free amino acids 
(Visser and Slangen, 1977; McSweeney et al., 1993; Upadhyay et al., 2004). It was 
thus concluded to be very unlikely that the increased GLP-1 secretion associated 
with the sodium caseinate hydrolysate was due to the presence of free amino acids, 
as they were present at extremely low concentrations.  
 
Table 6.1 Free amino acid (µg/g) analysis of sodium caseinate (100 mg/mL), 
adjusted to pH 7, and hydrolysed by chymosin (180 IMCU per gram of sodium 




Amino Acid T0 T5 T10 T15 T20 T25 T30 T35 T40
Cysteine 0.0 22.3 21.9 0.0 54.0 21.0 21.4 47.3 48.1
Aspartic Acid 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Glutamic Acid 0.0 38.5 41.7 40.5 40.0 41.4 43.0 38.1 35.3
Alanine 0.0 29.4 36.5 33.6 31.9 30.0 32.4 29.1 29.5
Methionine 0.0 585.2 622.3 623.0 637.3 611.3 623.3 644.5 606.1
Phenylalanine 0.0 35.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Histidine 10.5 63.4 77.6 76.1 83.3 79.0 105.2 107.1 103.8
Lysine 31.0 31.8 52.9 56.7 59.1 43.9 51.6 65.2 45.3
389 
 
6.3.7 Analysis of chymosin solution 
Figure 6.22 shows the RP-UPLC profile of the enzyme preparation. The 
chromatogram is dominated by one large peak which eluted at 4 min, which is most 
likely chymosin. Several minor peaks were present from 0.5 to 4.0 min; it is possible 
that these peaks were peptide material or free amino acids. 
 
 
Figure 6.22 RP-UPLC profile of Maxiren 180. 
 
6.3.8 Fractionation of pH 4.6-soluble peptide material 
In an attempt to identify the bioactive component responsible for increased GLP-1 
secretion in STC-1 cells, sodium caseinate (100 mg/mL), adjusted to pH 6.5, was 
hydrolysed by chymosin (9 IMCU per gram of sodium caseinate) at 37°C for 220 
min. The crude hydrolysate was adjusted to pH 4.6, as the soluble fraction was 
shown to have increased bioactivity compared with the crude hydrolysate and pH 
4.6-insoluble fraction (Figures 6.12 and 6.21). The pH 4.6-soluble fraction was 
further fractionated by filtering through a 0.2 µm membrane. This 0.2 µm permeate 
was then filtered through a series of ultrafiltration membranes which were set up in 
such a way that the permeate from each membrane became the feed solution for 
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Figure 6.23 shows the RP-UPLC profiles of the crude hydrolysate, pH 4.6-soluble 
fraction, and subsequent fractions. The pH 4.6-soluble fraction was dominated by 
two peptide peaks, at approximately 5 and 5.5 min, with several minor peaks visible 
from 2.0 to 6.0 min. These two abundant peaks were also present in the 0.2 µm 
retentate, but at much lower levels. The function of the 0.2 µm membrane was to 
remove any large aggregated peptide material. As can be seen from Figure 6.23 (c), 
only a very small proportion of the peptide material in the pH 4.6-soluble fraction 
existed in an aggregated form. The peptide which eluted at 5 min in the pH 4.6-
soluble fraction was present in the 10 kDa retentate, as was a peptide at 5.2 min; 
however, the peptide at 5.5 min was not present. The peptide profiles of the 5, 3 
and 1 kDa retentates and 1 kDa permeate were very similar, which suggests that UF 




Figure 6.23 Reversed-phase UPLC profiles of sodium caseinate (100 mg/ml), adjusted to pH 6.5, hydrolysed by chymosin (9 IMCU per gram of 
sodium caseinate) at 37°C for 220 min, and fractions thereof; (a) crude hydrolysate, (b) pH 4.6-soluble, (c) 0.2 µm retentate, (d) 10 kDa 

































































































































































6.3.8.1 Effect of a pH 4.6-soluble fraction of a sodium caseinate hydrolysate, and 
fractions thereof, on GLP-1 secretion 
 Sodium caseinate (100 mg/mL), adjusted to pH 6.5 and hydrolysed by chymosin (9 
IMCU per gram of sodium caseinate) at 37°C for 220 min, and fractions thereof, 
were added to STC-1 cells to measure their effect on GLP-1 secretion (Figure 6.24). 
Adjustment of the hydrolysate to pH 4.6 resulted in increased secretion of GLP-1 in 
response to the soluble fraction, as also seen in Figures 6.12 and 6.21; however, the 
effect was not as pronounced in this case. Filtration of the pH 4.6-soluble fraction 
through a 0.2 µm membrane resulted in a large increase in GLP-1 secretion in 
response to the retentate. Overall, bioactivity was in the order: 0.2 µm retentate > 
1 kDa retentate = 5 kDa retentate = 3 kDa retentate > pH 4.6-soluble fraction > 1 
kDa permeate > crude hydrolysate > 10 kDa retentate. These samples were tested 
for their effect on GLP-1 secretion on an equal solids basis. When the protein 
concentration was taken into account, assuming the bioactivity was protein-based, 
bioactivity was in the order 1 kDa permeate > 5 kDa retentate > 1 kDa retentate > 3 
kDa retentate > 0.2 µm retentate > pH 4.6-soluble fraction > 10 kDa retentate > 
crude hydrolysate. 
 
Figure 6.24 The effect of exposure of STC-1 cells to sodium caseinate (100 mg/mL), 
adjusted to pH 6.5, hydrolysed by chymosin (9 IMCU per gram of sodium caseinate) 
at 37°C for 220 min, and fractions thereof, on GLP-1 peptide levels as measured by 
MSD. Also shown is the protein content of each lyophilised sample, as determined 
by the Bradford method for protein determination. Values with different 

































6.3.9 Identification of peptides by LC-MS 
The LC-MS profiles in Figure 6.25 show sodium caseinate (100 mg/mL), adjusted to 
pH 6.5, hydrolysed by chymosin (9 IMCU per gram sodium caseinate) at 37°C for 
220 min, and fractions thereof. The ten most abundant peptides present in each of 
these samples, selected according to relative peak intensity, were identified by LC-
MS (Table 6.2). With the exception of the 10 kDa retentate (Figure 6.25d), the LC-
MS profiles of all samples were quite similar. β-Casein (f193-209) was the most 
abundant peptide present in all samples, except for the 10 kDa retentate. This 
peptide has previously been isolated and identified in yoghurt, fermented milk and 
cheese (Dionysius et al., 2000; Gagnaire et al., 2001; Hernandez-Ledesma et al., 
2004) and is a major cause of bitterness in Gouda (Visser et al., 1983) and Cheddar 
(Kelly et al., 1996) cheese. It is a hydrophobic peptide composed of 17 amino acids, 
with a molecular mass of 1881.2 Da (Singh et al., 2005), and has been shown by 
several authors to have immunomodulatory properties: mitogenic activity on 
primed lymph node cells and unprimed rat spleen cells (Coste et al., 1992), 
chemotactic activity on L14 lymphoblastoid cell line (Frontenau et al., 1998), and 
enhanced phagocytosis in rat macrophages (Sandre et al., 2001). Regazzo et al. 
(2010) provided evidence for the bioavailability of this peptide, showing that it is 
transported across the Caco-2 cell monolayer by resisting the action of brush-
border membrane-peptidases. β-Casein (f193-209) has also been shown to have 
antimicrobial activity against Escherichia coli DH5α (Birkemo et al., 2009); Lee et al. 
(1987) investigated the emulsifying properties of casein-derived peptides and found 
a synergistic effect in emulsion activity between β-casein (f193-209) and к-casein 
(f106-169) (glycomacropeptide).  
The primary site of chymosin action on αS1-casein is Phe(23)-Phe(24) (McSweeney 
et al., 1993). The second most abundant peptide identified in all samples, again 
with the exception of the 10 kDa retentate, was αS1-casein (f1-23). This is a 
hydrophilic peptide composed of 23 amino acids with a molecular mass of 2764.2 
Da. αS1-Casein (f1-23) is a positively charged antimicrobial peptide which has a 
broad spectrum of activity against Gram-positive bacteria (Hill et al., 1974) and the 
pathogenic strains Enterobacter sakazakii ATCC 12868 and Escherichia coli DPC5063 
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(Hayes et al., 2006). This peptide is both therapeutic and prophylactic and 
responses to its therapeutic effect can produce long-term immune responses 
(Lahov and Regelson, 1996). 
The third most abundant peptide identified in all samples, with the exception of the 
10 kDa retentate, was αS1-casein (f3-23). This is a hydrophilic peptide composed of 
21 amino acids with a molecular mass of 2510.9 Da. To the best of our knowledge, 
this peptide has not previously been reported as a product of chymosin action on 
αS1-casein. Nor is it produced by the indigenous milk proteinases, plasmin, elastase, 
cathepsin D or cathepsin G (Upadhyay et al., 2004). This peptide is, however, 
produced by the action of cathepsin B on αS1-casein (Considine et al., 2004). In the 
current study, it was most likely the result of cleavage of the Pro(2)-Lys(3) bond of 
αS1-casein (f1-23) by chymosin. 
In general, the ten most abundant peptides identified across all samples were 
derived from individual caseins in the order αS1- > β- > к- > αS2-casein. Peptides 
ranged from 3 amino acids with a molecular mass of 373.5 Da (β-casein f190-192) 
to 59 amino acids with a molecular mass of 6758.4 Da (β-CN f15-73). Peptides 
which were identified in multiple samples, besides β-casein (f193-209), αS1-casein 
(f1-23) and αS1-casein (f3-23), were αS1-casein (f1-20), αS1-casein (f1-22), αS1-casein 
(f17-23), αS1-casein (f19-23), αS1-casein (f21-23), αS1-casein (f25-32), αS1-casein 
(f176-199), β-casein (f74-89), β-casein (f166-189) and β-casein (f190-209). αS1-
Casein-derived peptides originated mainly from the N-terminal region of the 
protein, and in most cases were products of αS1-casein (f1-23). The only peptide 
identified derived from αS2-casein was αS2-casein (f164-168). The Phe(163)-Leu(164) 
bond of αS2-casein is a recognised cleavage site of chymosin (McSweeney et al., 
1994). 
During cheesemaking, к-casein is hydrolysed at its Phe(105)-Met(106) bond to 
produce para-к-casein, which remains attached to the micelle core, and 
glycomacropeptide (GMP), which diffuses into the aqueous phase (Crabbe, 2004). 
GMP is unique in its amino acid composition as it lacks aromatic amino acids and is 
rich in branched chain amino acids (Silva and Malcatta, 2005). GMP has several 
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reported biological activities: ability to bind cholera toxins (Kawasaki et al., 1992) 
and E. coli enterotoxins (Isoda et al., 1994), inhibition of bacterial and viral adhesion 
(Dosaka et al., 1992), suppression of gastric secretions (Yvon et al., 1994), 
promotion of bifidobacterial growth (Proulx et al., 1992) and modulation of 
immune system responses (Monnai and Otani, 1997). The Phe(105)-Met(106) bond 
of к-casein is the primary cleavage site of chymosin in the milk protein system (Reid 
et al., 1997) and is many times more susceptible than any other bond in milk 
proteins (Upadhyay et al., 2004). Interestingly, GMP was not identified in the 
current study by LC-MS; however, several peptides within its sequence were found, 
i.e., к-casein (f106-131, f106-129, f161-169). Of these peptides, к-casein (f161-169) 
has previously been identified as a secondary hydrolysis product of the action of 




Figure 6.25  LC-MS profiles of sodium caseinate (100 mg/ml), adjusted to pH 6.5 and hydrolysed by chymosin (9 IMCU per gram of sodium 
caseinate) at 37°C for 220 min and fractions thereof; (a) crude hydrolysate, (b) pH 4.6-soluble fraction, (c) pH 4.6-soluble 0.2 µm retentate, (d) 
pH 4.6-soluble 10 kDa retentate, (e) pH 4.6-soluble 5 kDa retentate, (f) pH 4.6-soluble 3 kDa retentate, (g) pH 4.6-soluble 1 kDa retentate, and 
(h) pH 4.6-soluble 1 kDa permeate. 
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Table 6.2  Identification of  the  ten  most  abundant  peptides  present  in  sodium caseinate  (100 mg/mL),  adjusted  to  pH  6.5,  hydrolysed   by  chymosin (9 IMCU  per gram of sodium
caseinate) at 37°C for 220 min and fractions thereof measured by Q-TOF LC-MS; pH 4.6-soluble fraction, pH 4.6-soluble 0.2 µm retentate, pH 4.6-soluble 10 kDa retentate, pH 4.6-soluble
5 kDa retentate, pH 4.6-soluble 3 kDa retentate, pH 4.6-soluble 1 kDa retentate, and pH 4.6-soluble 1 kDa permeate
Sample Peptide Sequence Retention Time Relative Intensity
Crude hydrolysate β-CN f(193-209) YQEPVLGPVRGPFPIIV 4.83 1818581
αS1-CN f(1-23) RPKHPIKHQGLPQEVLNENLLRF 3.02 1187726
αS1-CN f(3-23) KHPIKHQGLPQEVLNENLLRF 3.28 145204
αS1-CN f(1-11) RPKHPIKHQGL 3.02 80936
αS1-CN f(17-23) NENLLRF 3.01 64446
αS1-CN f(31-42) VFGKEKVNELSK 3.28 36391
αS1-CN f(19-23) NLLRF 3.01 24403
αS1-CN f(21-23) LRF 3.01 23630
αS1-CN f(5-13) PIKHQGLPQ 3.01 22906
β-CN f(64-89) GPIPNSLPQNIPPLTQTPVVVPPFLQ 3.60 21914
pH 4.6-soluble fraction β-CN f(193-209) YQEPVLGPVRGPFPIIV 4.79 4476712
αS1-CN f(1-23) RPKHPIKHQGLPQEVLNENLLRF 2.96 2448382
αS1-CN f(3-23) KHPIKHQGLPQEVLNENLLRF 3.21 522308
β-CN f(74-89) IPPLTQTPVVVPPFLQ 2.96 333647
αS1-CN f(25-32) VAPFPEVF 2.95 111752
β-CN f(15-73) SLSSSEESITRINKKIEKFQSEEQQQTEDELQDKIHPFAQTQSLVYPFPGPIPNSLPQN 4.58 100581
β-CN f(190-192) FLL 3.44 98828
αS1-CN f(1-20) RPKHPIKHQGLPQEVLNENL 2.58 96670
αs2-CN f(164-184) LKKISQRYQKFALPQYLKTVY 2.89 84559
αS1-CN f(14-24) EVLNENLLRFF 3.21 79417
pH 4.6-sol 0.2 µm retentate β-CN f(193-209) YQEPVLGPVRGPFPIIV 4.79 689653
αS1-CN f(1-23) RPKHPIKHQGLPQEVLNENLLRF 3.00 475033
αS1-CN f(3-23) KHPIKHQGLPQEVLNENLLRF 3.23 47688
αS1-CN f(1-22) RPKHPIKHQGLPQEVLNENLLR 2.70 46716
αS1-CN f(25-32) VAPFPEVF 3.00 30205
αS1-CN f(1-18) RPKHPIKHQGLPQEVLNE 3.00 18732
αS1-CN f(21-23) LRF 2.99 16444
β-CN f(104-161) PKHKEMPFPKYPVEPFTESQSLTLTDVENLHLPLPLLQSWMHQPHQPLPPTVMFPPQS 5.14 15381
αS1-CN f(19-23) NLLRF 3.00 14937
αS1-CN f(1-14) RPKHPIKHQGLPQE 3.36 14528
pH 4.6-sol 10 kDa retentate αS1-CN f(1-23) RPKHPIKHQGLPQEVLNENLLRF 2.91 1389943
β-CN f(69-85) SLPQNIPPLTQTPVVVP 2.97 261351
β-CN f(193-209) YQEPVLGPVRGPFPIIV 4.86 144784
αS1-CN f(3-23) KHPIKHQGLPQEVLNENLLRF 3.13 142366
αS1-CN f(1-22) RPKHPIKHQGLPQEVLNENLLR 2.62 91819
к-CN f(106-129) MAIPPKKNQDKTEIPTINTIASGE 5.13 89757
αS1-CN f(1-13) RPKHPIKHQGLPQ 2.91 88294
β-CN f(75-103) PPLTQTPVVVPPFLQPEVMGVSKVKEAMA 2.87 79093
к-CN f(161-169) TVQVTSTAV 2.91 73201





Sample Peptide Sequence Retention Time Relative Intensity
pH 4.6-sol 5 kDa retentate β-CN f(193-209) YQEPVLGPVRGPFPIIV 4.55 4801312
αS1-CN f(1-23) RPKHPIKHQGLPQEVLNENLLRF 2.87 849292
αS1-CN f(3-23) KHPIKHQGLPQEVLNENLLRF 3.04 464084
αS1-CN f(81-100) IQKEDVPSERYLGYLEQLLR 3.65 163756
αS1-CN f(176-199) APSFSDIPNPIGSENSEKTTMPLW 4.37 146975
β-CN f(74-89) IPPLTQTPVVVPPFLQ 2.86 134994
αS1-CN f(1-20) RPKHPIKHQGLPQEVLNENL 2.48 102315
β-CN f(190-209) FLLYQEPVLGPVRGPFPIIV 5.79 83489
αS1-CN f(3-14) KHPIKHQGLPQE 3.12 79367
к-CN f(106-131) MAIPPKKNQDKTEIPTINTIASGEPT 2.68 70691
pH 4.6-sol 3 kDa retentate β-CN f(193-209) YQEPVLGPVRGPFPIIV 4.44 8796597
αS1-CN f(1-23) RPKHPIKHQGLPQEVLNENLLRF 2.81 1120830
αS1-CN f(3-23) KHPIKHQGLPQEVLNENLLRF 2.99 682015
αS1-CN f(176-199) APSFSDIPNPIGSENSEKTTMPLW 4.33 229825
αS1-CN f(1-20) RPKHPIKHQGLPQEVLNENL 2.44 195561
αS1-CN f(143-174) AYFYPELFRQFYQLDAYPSGAWYYVPLGTQYT 5.11 178529
β-CN f(73-88) NIPPLTQTPVVVPPFL 2.80 176486
β-CN f(166-189) SQSKVLPVPQKAVPYPQRDMPIQA 2.67 157004
β-CN f(190-209) FLLYQEPVLGPVRGPFPIIV 5.81 148505
к-CN f(77-94) QVLSNTVPAKSCQAQPTT 3.71 123410
pH 4.6-sol 1 kDa retentate β-CN f(193-209) YQEPVLGPVRGPFPIIV 4.35 10605850
αS1-CN f(1-23) RPKHPIKHQGLPQEVLNENLLRF 2.77 1304473
αS1-CN f(3-23) KHPIKHQGLPQEVLNENLLRF 2.98 765448
αS1-CN f(81-100) IQKEDVPSERYLGYLEQLLR 3.64 217304
αS1-CN f(1-20) RPKHPIKHQGLPQEVLNENL 2.43 196019
к-CN f(102-113) HLSFMAIPPKKN 2.86 171744
β-CN f(166-192) SQSKVLPVPQKAVPYPQRDMPIQAFLL 3.88 163985
β-CN f(166-189) SQSKVLPVPQKAVPYPQRDMPIQA 2.65 159020
αS1-CN f(185-199) PIGSENSEKTTMPLW 3.22 127558
β-CN f(190-209) FLLYQEPVLGPVRGPFPIIV 5.81 118345
pH 4.6-sol 1 kDa permeate β-CN f(193-209) YQEPVLGPVRGPFPIIV 4.78 5459459
αS1-CN f(1-23) RPKHPIKHQGLPQEVLNENLLRF 2.94 2330794
αS1-CN f(3-23) KHPIKHQGLPQEVLNENLLRF 3.19 518411
β-CN f(193-208) YQEPVLGPVRGPFPII 4.65 93850
αS1-CN f(17-23) NENLLRF 2.94 85820
αS1-CN f(1-20) RPKHPIKHQGLPQEVLNENL 2.59 81329
к-CN f(62-77) AKPAAVRSPAQILQWQ 4.78 63904
αS1-CN f(24-34) FVAPFPEVFGK 4.07 58253
αS1-CN f(21-23) LRF 2.93 47130




6.3.10 Synthetic peptides 
Based on the LC-MS data shown in Table 6.2, four of the most abundant peptides 
identified in the sodium caseinate hydrolysate were artificially synthesised. Figures 
6.26 and 6.27 show the RP-UPLC profiles of these peptides, i.e., β-casein (f193-209 
and f190-209) and αS1-casein (f1-23 and f3-23). These peptides were exposed to 
STC-1 cells at 0.01, 0.1 and 0.5 mg/mL to measure their effect on GLP-1 secretion 
(Figure 6.28). Sodium caseinate (100 mg/mL), adjusted to pH 6.5, hydrolysed by 
chymosin (9 IMCU per gram sodium caseinate) at 37°C for 220 min was used as a 
positive control for GLP-1 secretion. None of the synthetic peptides were found to 
cause an increase in the secretion of GLP-1 from STC-1 cells. 
 
 
Figure 6.26 RP-UPLC chromatograms of αS1-casein (f3-23), β-casein (f193-209) and 
sodium caseinate (100 mg/mL), adjusted to pH 6.5 and hydrolysed by chymosin (9 
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Figure 6.27 RP-UPLC chromatograms of αS1-casein (f1-23), β-casein (f190-209) and 
sodium caseinate (100 mg/mL), adjusted to pH 6.5, hydrolysed by chymosin (9 
IMCU per gram of sodium caseinate) at 37°C for 220 min. 
 
 
Figure 6.28 The effect of exposure of STC-1 cells to sodium caseinate (100 mg/mL), 
adjusted to pH 6.5 and hydrolysed by chymosin (9 IMCU per gram of sodium 
caseinate) at 37°C for 220 min, αS1-CN (f3-23 and f3-23) and β-CN (f193-209), on 
GLP-1 peptide levels as measured by MSD. Values with different superscript letters 
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The current study focussed on the generation of a sodium caseinate and chymosin 
hydrolysate which targets the gut-derived satiety hormone glucagon-like peptide-1 
(GLP-1). Initially, sodium caseinate (30 mg/mL), adjusted to pH 5.6, was hydrolysed 
by chymosin (180 IMCU per gram of sodium caseinate) at 37°C for 10, 40 or 120 
min. When exposed to STC-1 cells, hydrolysed sodium caseinate samples caused a 
significant increase in the secretion of GLP-1 compared to the unhydrolysed 
control. Sodium caseinate, hydrolysed by chymosin for 40 min, was found to be the 
most potent promoter of GLP-1 secretion in vitro, suggesting that the bioactive 
component was produced during the initial stages of the hydrolysis reaction. The 
unfractionated hydrolysate was used in a mice feeding study and was found to 
significantly lower feed intake when compared with control mice.  
The hydrolysis protocol was optimised in several ways in order to make it more 
suitable for large scale commercial production. Total solids level of the sodium 
caseinate solution was increased from 3 to 10%, the pH of which sodium caseinate 
was adjusted to before hydrolysis was varied in the range 5.6 to 7.0, and the 
enzyme:substrate ratio was reduced 20-fold. The optimised hydrolysis protocol was 
considered to be industrially feasible and economically viable. 
Fractionation of the crude hydrolysate was carried out by isoelectric precipitation 
of the caseins and ultrafiltration of the soluble fraction in an attempt to identify the 
bioactive component/s. The pH 4.6-insoluble fraction, which was composed 
predominantly of intact casein and large polypeptides, had no effect on GLP-1 
secretion. Bioactivity was associated with the pH 4.6-soluble fraction and was most 
concentrated in the < 1 kDa size range, suggesting that the bioactive component/s 
was a peptide of approximately 7 amino acids in length (assuming the mean 
molecular mass of an amino acid to be 136.75 Da). The three most abundant 2% 
TCA-soluble peptides produced during hydrolysis of sodium caseinate by chymosin 
were identified by LC-MS, synthesised, and tested for their effect on GLP-1 
secretion, however, no effects were observed. Hence, the bioactive component/s 




Even though the bioactive component/s was not identified, this sodium caseinate 
hydrolysate has proven in vitro and in vivo effects on GLP-1 secretion and could 
potentially be used in a functional food product which targets gastric satiety signals. 
Identification of cellular targets and mechanisms involved in GLP-1 release using 
this in vitro model could provide important insights for the design of future human 
trials aimed at designing novel nutritional strategies for the treatment of obesity 
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7.1 General discussion 
 
The major role of milk proteins is to supply young mammals with amino acids and 
organic nitrogen. In recent years, extensive research has been carried out on the 
health benefits of milk proteins and peptides. Biologically active peptides are 
defined as specific protein fragments which have a positive impact on the 
physiological functions of the body. These peptides are inactive within the parent 
protein, but can be released by gastrointestinal digestion of milk, fermentation of 
milk with proteolytic starter cultures or hydrolysis by proteolytic enzymes. Milk-
derived biologically active peptides have a wide range of reported health benefits 
which include opioid, antihypertensive, antithrombotic, mineral binding, 
immunomodulating and antimicrobial properties. The aim of this thesis was to 
investigate not only the traditional methods used for the generation of bioactive 
peptides, but also novel processes such as heat treatment, and  the role of 
indigenous milk proteases, e.g., in mastitic milk, in the production of such peptides. 
In addition, colostrum was characterised as a source of bioactive proteins and 
peptides.  
Bovine colostrum is the initial milk secreted by cows and is an excellent source of 
nutrients, antibodies and growth factors for the suckling calf. Colostrum was 
therefore identified as a rich source of bioactive material which was most likely 
present in mature milk but at significantly reduced levels. There are few reports in 
the literature on the composition and physico-chemical properties of colostrum 
throughout the early-lactation period, and so a comprehensive study of these 
factors was undertaken (Chapter 2). Distinct differences were observed, not only 
compared with mature milk, but also between individual cows and consecutive 
milkings. The most notable differences were observed during the transition from 




secretions were not comparable to mature milk. The pH of colostrum was very low 
initially and increased with time post partum, while the protein concentration was 
highest initially, due mainly to elevated levels of whey proteins, and decreased with 
time post partum. The concentration of α-lactalbumin, β-lactoglobulin, 
immunoglobulins, serum albumin and lactoferrin were all higher in colostrum than 
in mature milk. The concentration of casein was also higher in colostrum than in 
mature milk, but not to the same extent as some of the whey proteins. It was found 
that a significant proportion of casein micelles in colostrum, especially in earlier 
milkings, were non-sedimentable at 100,000 g x 1 h. The reason for this is unclear, 
but it was speculated that the high viscosity of certain colostrum samples resulted 
in poor sedimentability of casein micelles. The average diameter of casein micelles 
in first milkings were larger than in subsequent milkings. The concentrations of Na, 
Mg, P, K and Ca were higher in colostrum than in mature milk while the 
concentration of lactose was lower. The concentration of lactose in colostrum was 
inversely related to the concentration of oligosaccharides. The colour of colostrum 
was highly variable; early milkings had a reddish-yellow colour due to the presence 
of carotenoid pigments and red blood cells. Colostrum had poor heat stability and 
early milkings were the most heat-labile. Colostrum was found to have good rennet 
coagulation properties but poor acid gelation properties. In several colostrum 
samples, casein did not precipitate at pH 4.6. These samples seem to have 
experienced a shift in pI, possibly due to high levels of glycosylated к-casein. 
In recent years, colostrum has attracted considerable interest as a functional food 
ingredient due to its superior nutritional and protective value compared to mature 
milk. Colostrum has reported benefits for the treatment of a wide range of 
conditions, e.g., various gastrointestinal disorders, respiratory tract infection, 
rheumatoid arthiritis and healing injured tissues of the body. In Chapter 3, various 
fractions of colostrum were characterised and tested for their effect on the 
secretion of pro- and anti-inflammatory cytokines from a macrophage cell line and 
bone marrow dendritic cells, as well as insulin secretion from a pancreatic beta cell 




the pro-infammatory cytokines, tumor necrosis factor (TNF)-α, interleukin (IL)-6, IL-
1β and IL-12, and a significant increase in the secretion of the anti-inflammatory 
cytokine, IL-10. Based on these findings, buttermilk from colostrum may represent a 
functional food product/ingredient which targets low-grade systemic inflammation 
and consequently the development and progression of several multifactorial 
disorders including artherosclerosis, metabolic syndrome, type 2 diabetes, and 
cardiovascular diseases. It is speculated that the reduction in the secretion of pro-
inflammatory cytokines and increase in the secretion of anti-inflammatory 
cytokines observed in Chapter 3 may have been due to milk fat globule membrane 
(MFGM) associated proteins which were present in higher concentrations in 
buttermilk from colostrum compared with buttermilk from mature milk, i.e., 
xanthine oxidoreductase, periodic acid Schiff 6/7, butyrophilin and adipophilin. The 
inflammatory potential of buttermilk from colostrum may also be due to its 
carbohydrate and/or lipid components, several of which are also up-regulated in 
buttermilk from colostrum compared with buttermilk from mature milk. The serum 
phase of colostrum caused a significant increase in insulin secretion when 
administered to a pancreatic β-cell line. These results suggest that the serum phase 
of colostrum may be of benefit in the treatment of type 2 diabetes, where the 
glucose-sensing capacity of pancreatic β-cells is reduced. The insulinotrophic 
potential of the serum phase of colostrum observed in Chapter 3 may have been 
due to essential amino acids and/or free fatty acids.  
Mastitis is an inflammation of the mammary gland which is characterised by an 
increase in the somatic cell count (SCC) and level of proteolysis in milk. In Chapter 
4, proteomic changes in the milk of 8 cows in response to infusion with the 
endotoxin lipopolysaccharide (LPS) at quarter level in a model mastitic system were 
examined. A significant increase in the SCC of milk from LPS-challenged cows was 
observed, which was reflected by marked differences in the corresponding protein 
and peptide profiles. Generally, milk samples from LPS-challenged quarters showed 
an increase in the level of hydrolysis of the caseins and an increased concentration 




manner would require an intramammary injection of LPS to mimic bacterial 
invasion without an actual live bacterial infection and may represent a novel 
alternative to traditional methods; however, ethical issues regarding animal welfare 
need to be investigated. The pH 4.6-soluble fraction of this milk was found to cause 
a significant induction in the secretion of IL-10 from a murine macrophage cell line. 
IL-10 is an anti-inflammatory cytokine, the primary function of which appears to be 
the limitation and termination of inflammatory responses and the regulation of 
differentiation and proliferation of several immune cells. As mentioned in Chapter 
3, development of a functional food product/ingredient which targets IL-10 may 
have potential in treating low-grade systemic inflammation and several associated 
disorders. 
One aspect which most of the methods currently being used for the generation of 
bioactive peptides have in common is that they all use protease activity. In Chapter 
5, heat-induced hydrolysis of sodium caseinate was investigated as an alternative to 
enzymatic hydrolysis of the caseins from the viewpoints of protein breakdown and 
peptide formation. Results showed that at 130°C and pH 7, extensive hydrolysis of 
αS1-, αS2-, β- and к-caseins occurred over a 120 min period, after which time very 
little intact protein remained. In total, 1023 peptides were identified and 
characterised in the 2% trichloroacetic acid (TCA)-soluble fraction of heat-
hydrolysed sodium caseinate, of which 326 originated from αS1-casein, 125 from 
αS2-casein, 353 from β-casein and 219 from к-casein. With the exception of к-
casein, peptides were uniformly dispersed throughout the entire sequence of the 
each protein. The vast majority of the 1023 peptides identified were present at 
trace levels, but eleven peptides were produced in abundance. Of these, 7 
originated from αS1-casein, 1 from β-casein and 3 from к-casein. Three of the 
peptides identified in Chapter 5 have previously been reported to have biological 
activities relating to treatment of high blood pressure, modulation of the immune 
system and inhibition of microbial growth. A peptide fraction produced during heat-
induced hydrolysis of sodium caseinate was found to cause a significant increase in 




cell line. As discussed in Chapters 3 and 4, peptides which regulate IL-10 in vivo may 
be used for the treatment of various inflammatory disorders. Results from Chapter 
5 provide a good body of evidence to suggest that heat-induced hydrolysis 
represents an alternative to enzymatic or microbial hydrolysis of milk proteins for 
the generation of bioactive peptides. 
Chymosin is the most commonly used enzyme in the food industry. Proteolysis in 
cheese is extremely complex as it is catalysed by proteinases and peptidases from 
five sources, i.e., the coagulant, the milk, starter lactic acid bacteria, non-starter 
lactic acid bacteria and secondary starter. In Chapter 6, sodium caseinate was 
hydrolysed by chymosin in an attempt to reduce the complexity of proteolysis 
which occurs in cheese and the effects of sodium caseinate hydrolysed by chymosin 
on the gut-derived satiety hormone glucagon-like peptide-1 (GLP-1) were 
investigated. Initially, three sodium caseinate hydrolysates were produced with 
varying degrees of hydrolysis, i.e., low, medium and high, of which the sample with 
the medium degree of hydrolysis caused the greatest secretion of GLP-1 from STC-1 
cells. In addition, this sample significantly reduced feed intake in mice when 
injected intraperitoneally when compared with control mice. Several optimisation 
steps were investigated to make the hydrolysis protocol more suitable for large 
scale commercial production, i.e., increasing total solids level, varying the pH at 
which hydrolysis was carried out, and reduction of the enzyme:substrate ratio. 
Fractionation of the crude hydrolysate by isoelectric precipitation of casein and 
ultrafiltration of the soluble fraction showed that the bioactive component(s) was 
enriched in the < 1 kDa fraction. The three most abundant peptides produced 
during hydrolysis of sodium caseinate by chymosin were identified and 
characterised by LC-MS and subsequently synthesised and tested for their effect on 
GLP-1 secretion; however, no effect was observed. Even though the bioactive 
component/s was not identified, this sodium caseinate hydrolysate had good in 
vitro and in vivo effects on GLP-1 secretion and feed intake, and hence, would make 
a suitable candidate for a functional food product/ingredient for the treatment of 




Overall, the studies described in this thesis expand on current knowledge and 
provide good evidence for the use of novel methods for the isolation, generation 
and characterisation of bioactive proteins and/or peptides. 
 
7.2 General conclusion 
 
Functional foods are those which possess characteristics that help in maintaining or 
achieving good health, in addition to providing basic nutrition. In recent years, the 
demand for functional food products has risen considerably due to a number of 
factors, i.e., increased awareness by the public of the links between diet and 
disease, increased interest in healthier lifestyles, and rising healthcare costs. Milk, 
and its various components, are a rich source of bioactive compounds with the 
potential to promote human health and wellbeing.  
In particular, the results in this thesis indicate that colostrum represents a potential 
functional food product/ingredient which is rich in naturally occurring bioactive 
components, e.g., immunoglobulins, MFGM proteins, lactoferrin, cytokines, growth 
factors, oligosaccharides and lipid components. Special care is needed when 
processing colostrum, as its composition and physico-chemical properties differ 
markedly from that of mature milk, e.g., low pH, high concentration of serum 
components, non-sedimentability of a large proportion of casein micelles at 
100,000 g for 1 h and non-precipitability of casein micelles at pH 4.6.  
Numerous studies have reported the health benefits of milk-derived bioactive 
peptides which, in most cases, are not active within the native protein molecule. 
Enzymatic hydrolysis is the most commonly used method in the generation of 
bioactive peptides. The results described in this thesis provide information on a 
number of alternative methods in the generation of such peptides, i.e., heat-
induced hydrolysis, and amplification of the activity of indigenous milk proteases in 




the treatment of various inflammatory and immune-related disorders. In addition, a 
hydrolysate of sodium caseinate was shown to increase the secretion of the gut-
derived satiety hormone, GLP-1, which may represent a functional food 
product/ingredient which targets obesity and its associated complications. Further 
work is needed to evaluate the commercial feasibility of these methods as well as 
the mechanisms involved in both their production and biological activities. 
 
7.3 Suggested future work 
 
Chapter 2 
 The high viscosity of certain colostrum samples was considered the cause of 
non-sedimentability at 100,000 g x 1 h of a high proportion of casein 
micelles. This hypothesis could be tested by investigating the effect of 
viscosity of mature milk on sedimentability at 100,000 g x 1 h of casein 
micelles. This would involve increasing the viscosity of mature milk using a 
thickening agent, e.g., starch. 
 The reason for the non-precipitability of casein micelles at pH 4.6 in certain 
colostrum samples was unclear, although high levels of glycosylated к-casein 
were thought to be responsible. This hypothesis could be tested by 
investigating the effect of varying the level of glycosylation of к-casein in 
mature milk on isoelectric precipitability of casein micelles.  
 
Chapter 3 
 Buttermilk and the serum phase of colostrum displayed in vitro anti-
inflammatory and insulinotrophic properties. Further work is needed to 
determine if these in vitro bioactive effects can be replicated in vivo. This is 





 The protein and peptide profile of LPS-induced mastitic milk were analysed 
by polyacrylamide gel electrophoresis and reversed phase-ultra 
performance liquid chromatography. A more detailed proteomic 
characterisation by mass spectrometry would enhance understanding of 
changes which occur in mastitic milk. 
 A pH 4.6-soluble fraction of LPS-induced mastitic milk showed good anti-
inflammatory properties. The next step in identifying the bioactive 




 Heat-induced hydrolysis of sodium caseinate was investigated at 130°C    
and pH 7 over 120 min. It would be interesting to investigate the effect of 
altering the time, temperature and pH on heat-induced hydrolysis of sodium 
caseinate and possibly other milk proteins.  
 A peptide fraction of heat-hydrolysed sodium caseinate showed good anti-
inflammatory properties, most likely due to one of eleven major peptides. 
Isolation/synthesis and testing of these peptides would confirm this. 
 
Chapter 6 
 Following on from this study, an animal trial was performed looking at the 
effects of a sodium caseinate and chymosin hydrolysate on feed intake in 
pigs (data not shown). No significant differences were observed compared 
with pigs fed an unhydrolysed control. Based on these results, the bioactive 
component(s) do not appear to survive gastric transit. Therefore, 
encapsulation of the hydrolysate may be required in the future. 
 
